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Abstracts 
English 
Plasma-medicine is the field of research describing the medical applications of plasmas, 
mainly at atmospheric pressure. Cold plasmas are a state of matter characterized by the 
presence of free electrons with a kinetic energy of several electron volts even though the 
ions and neutrals may be at room temperature. This transient state, apart from thermal 
equilibrium, produces highly reactive chemical species. 
The objective of this multidisciplinary work was to evaluate the anti-tumor potential of 
cold plasmas. Two types of devices have been designed and manufactured by 3D-
printing: Dielectric Barrier Discharge and plasma-jets. In-vitro and in-vivo studies were 
conducted with TC1 and CT26 cell lines. The production of reactive species produced in 
a liquid exposed to plasma has been studied in order to understand the in-vitro results 
and to compare the plasma devices with those of other teams. Various plasma devices 
have been made to study the effect of the energy deposited during the in-vivo treatment 
of skin and subcutaneous tumors. A device cooled with liquid nitrogen has been 
developed to limit skin damage induced by heating. 
Finally, a numerical simulation modeling the heat transfers of tumors and tissues under 
plasmas exposure enables to quantify the hyperthermia and the associated lesions by 
validating the model on experimental results. A critical review of in-vivo plasma-medicine 
studies published in the literature is proposed to evaluate the role of hyperthermia in the 
therapeutic effects reported. 
Français 
« La médecine- plasma» est le domaine de recherche décrivant les applications 
médicales des plasmas, principalement à pression atmosphérique. Les plasmas froids 
sont un état de la matière caractérisé par la présence d'électrons libres ayant une 
énergie cinétique de plusieurs eV alors même que les ions et les neutres peuvent être à 
température ambiante. Cet état transitoire, hors équilibre thermique, produit des espèces 
chimiques très réactives. 
L’objectif de ce travail multidisciplinaire a été d’évaluer le potentiel anti-tumoral des 
plasmas-froids. Deux types de dispositifs ont été conçus et fabriqués par impression 3D: 
des Décharges à Barrière Diélectrique et des jets plasmas. Des études in-vitro et in-vivo 
ont été menées avec les  lignées cellulaires TC1 et CT26. La production d’espèces 
réactives produites dans un liquide exposé à un plasma a été étudiée afin de 
comprendre les résultats in-vitro et de comparer les dispositifs plasma entre eux. 
Différents dispositifs à plasmas ont été réalisés afin d’étudier in-vivo, l’effet de l’énergie 
déposée lors du traitement sur la peau et les tumeurs. Afin de limiter l’échauffement 
cutané et les lésions induites un dispositif refroidi à l’azote liquide a été développé.  
Enfin, une simulation numérique modélisant les transferts thermiques des tumeurs et 
tissus sous exposition plasmas a permis  de quantifier l’hyperthermie et les lésions 
associées en validant le modèle sur des résulats expérimentaux. Une revue critique 
d’études in-vivo de « médecine plasma » publiées dans la littérature est proposée afin 
d’évaluer le rôle de l’hyperthermie dans les effets thérapeutiques observés. 
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Introduction 
Scientific context 
Plasma-medicine is the field of research, which describes applications of plasma to 
medicine. Cold plasmas at atmospheric pressure are a transient state of matter 
characterized by the presence of free electrons with a kinetic energy of several electron 
volts, whereas ions and neutrals can be near ambient temperature. The idea of applying 
plasmas to the treatment of living targets started from the observation that cold plasmas 
can sterilize a certain number of surfaces. The use of cold plasmas is considered as a 
means of decontamination and even sterilization, of medical equipment sensitive to heat 
(like plastic materials). The sterilization of endoscopes seems to be an important outlet. 
Several startups already offer cold plasma sterilization capabilities, and the study of the 
sterilizing properties of plasmas is one of the most active research fields in plasma 
medicine. 
The sterilization of temperature-sensitive object requires to pay close attention to the 
heating up produced. Finally, the treatment of living organisms has the same kind of 
constraint, since the biological target should stay below 42 °C, the temperature beyond 
which cell damage becomes irreversible. Moreover, since many wounds are difficult to 
treat because of local infections, the used of cold plasmas to promote wound healing has 
emerged as a natural outlet. This field of research quickly attracted the attention of 
biologists and dermatologists. Therapeutic effects were observed in animals and humans 
on a wide variety of wounds. One of the major issues of medicine for which plasmas 
could bring benefits is the treatment of diabetic wounds. 
The application of cold plasmas to cancer treatments is not an obvious idea in itself. It 
was justified by the fact that anti-tumor effects were rapidly observed in-vitro, on several 
cell lines. In addition, it is known that plasmas produce reactive species from oxygen and 
nitrogen (RONS) involved in the mechanisms of cell signaling. The radical species 
produced by plasma also have an analogy with those produced in radiotherapy (on the 
other hand with radiotherapy, the radical species are also produced directly within the 
cell nucleus and cause direct damage to DNA). 
Plasma-based cancer treatments have led to numerous in-vitro studies. Unfortunately, 
in-vivo studies are much rarer. The mode of action of cold plasmas is not known with 
certainty. The primary working hypothesis gives a leading role to the chemical species 
produced by plasma-treatment. The direct action of these radicals and reactive species, 
or, at least, the cascades of biological reactions induced by these species, would have 
an anti-tumor effect. It is also very often considered that the electric field can play a role 
via the electroporation of a part of the tumor. Depending upon the plasma device, a 
significant electric field (few tens of kiloVolts per centimeter) may be generated in the 
upper layers of the tissues. 
The study of the chemistry of plasma-treated liquid is useful since the reactive species 
are supposed to play a key role in the therapeutic effects. At least, it enables to 
understand in-vitro results and perform a comparison with other groups. The study of the 
production of Reactive oxygen and nitrogen Species (RONS)  is a problem in its own 
right. However, it appears that the reliability of measurement methods presented in many 
biochemistry papers is controversial according to the critical review of Wardman et al. [1] 
and Tarpey et Fridovich [2]. The biases are due to imperfect knowledge of the underlying 
chemistry. It is therefore advisable to be particularly careful using any chemical 
diagnostic. Especially since the chemical environment of plasma-treated liquids is often 
very different from that for which the chemical diagnostic was designed. We will show for 
example that in this context, the results of Griess’reagents can be completely biased. To 
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find the reason amongst the numerous  published papers, it is advisable to focus on the 
papers made by chemists studying the diagnostic itself, to read the evidence and 
mechanisms, to track the biases listed by critical reviews and above all, beware of over-
interpreting. Fortunately, the results obtained in other fields are of great help: 
radiochemistry, sonochemistry, radical chemistry, photochemistry can help to build a 
critical point of view. 
I wish to point out the limited scope of in-vitro studies in predicting the in-vivo potential of 
such treatments. The fact that plasmas produce all the complex stimuli listed below at 
the same time is a major source of complexity. 
 Reactive oxygen and nitrogen species, radical species 
 High voltage short Pulse 
 UV and visible emission 
 Heat 
 mechanical vibrations 
In-vitro experiments, although very useful to understand mechanisms, are obviously not 
sufficient to develop new therapeutics. In-vivo studies are necessary to obtain a higher 
degree of evidence. The observation of apoptosis in-vitro triggered by precise pathways 
does not guarantee that the same phenomenon takes place in-vivo with the same 
pathways and because of the same part of the stimuli. 
Finally, all that is written below tends toward a single objective: conducting in-vivo 
experiments able to evaluate the anti-tumor efficiency of cold plasma treatments. Only 
this type of experiment can increase the level of evidence of plasma-cancer therapy 
towards human’s applications.  
Structure of the thesis 
In the first chapter, a brief state of the art is presented. Particular attention is given to the 
devices that have been used in vivo for dermatological or antitumor purposes. The 
devices that have been the subject of the characterization of the chemistry they induce in 
the liquid phase are listed.  
The second chapter describes the materials and methods commonly used in the three 
following chapters. For the sake of clarity, the protocols specific to each experiment are 
described in the experimental chapters. This chapter includes a description of the 
fabrication and geometric characteristics of the different plasma device used: “single-
channel jet,” “multi-channel jet” and “multi-channel jet”. Dielectric Barrier Discharges and 
plasma-jets were designed and manufactured by 3D printing. This chapter also contains 
a discussion of power measurement problems: in the measurement method using 
Lissajous curves, the capacitance placed in series with the plasma-device cannot be 
chosen arbitrarily. It was necessary to develop electrical diagnostics to measure the 
power in real time above the biological targets (in-vitro and in-vivo). Finally, this chapter 
discusses the interference and bias related to chemical diagnostic. Particular attention is 
paid to the use of Griess reagent for the determination of nitrite, and the amplex red 
method for the quantification of H2O2. Calibration curves and methods are also 
described. Regarding the quantification of hydroxyl radical, this chapter explains why it is 
not possible to calibrate this method with Fenton reactions. Further discussion of the 
measurement method is presented in the chapter dedicated to the experimental results 
of liquid-phase chemical diagnostics. 
The third chapter describes the chemical characterization of the liquid phase treated by 
plasma. The production of chemical species is systematically characterized for the 
single-channel jet. The production of H2O2, nitrites, and nitrates in the liquid phase is 
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measured when the experimental parameters are modified. The use of terephthalic acid 
(TPA) as a means of quantifying the hydroxyl radical is the subject of a discussion. This 
chapter also contains a discussion of the consumption of H2O2 by cells and tissues. How 
deep can H2O2 diffuse if the existence of cutaneous anti-oxidant defenses is taken into 
account? 
The fourth chapter describes the in-vitro experiments performed during the thesis. In-
vitro studies were performed with two different devices (single-jet and DBD) on two cell 
lines: TC1 and NRS1. The experiments were performed with several incubation times 
after treatment. The effect of chemical reagents at concentrations similar to those 
produced by plasma has been studied separately. 
The fifth chapter is devoted to in-vivo experiments. The results and treatment conditions 
of the five experimental campaigns are exposed. The treated groups included a group 
treated with single jet, DBD and injections of plasma-treated medium. During the third 
experiment, the frequency of the power supply and the plasma jet nozzle were changed. 
The electrical power consumed by the device was significantly higher than that of the two 
previous experiments. The skin reached a temperature ~45 ° C, and skin damage was 
observed with processing times of a few minutes. This damage was attributed to the 
hyperthermia experienced by the tissues. During the last two experiments, the plasma 
device was cooled with liquid nitrogen before treatment. This pre-cooling of the device 
enables to treat the skin with the same power consumption (~ 4 W) without 
hyperthermia. This has been proven by surface temperature measurements made with 
an infrared camera. Others groups were also exposed to an inhibitor of the catalase   (3-
amino-1, 2, 4-triazole) just before being treated with plasmas, in the hope that the anti-
tumor action would be increased. 
The sixth chapter is dedicated to hyperthermia. The first aim is to understand the result 
of the experimental campaign that caused damage to the skin. A numerical simulation of 
the propagation of heat and the occurrence of damage has been made. The code for 
one of the simulated situations is available in Appendix I. Key findings from the literature 
related to hyperthermia and hyperthermia related to cancer treatment are discussed. The 
precise meaning of "the biological effect of hyperthermia" is specified. It turns out that 
significant biological effects occur below 42 ° C. The means to quantify the damage 
induced by hyperthermia are explained. Curiously, it turns out that the signaling 
pathways of mild-hyperthermia are very close to those seen in plasma medicine in-vivo 
experiments. Some published experiments show substantial heating of the skin and 
tumors. The Numerical simulations of the skin and subcutaneous tumors enable to 
quantify the damage of hyperthermia, to select thermometric methods that can detect it, 
and predict in what extent plasma-induced hyperthermia may be involved in anti-tumor 
effects. 
Summary of the scientific issues addressed 
The formulation of a scientific problem and its resolution requires an in-depth 
contextualization to detail the meaning of each term of the scientific question. 
Nevertheless, for an introduction, it is interesting to propose a list of the questions 
addressed. The content of the whole document is the context and the discussion of 
these questions. 
Chapter Questions addressed 
2 What is the electrical power of the plasma device? How to measure it? 
2 What is the limit of chemical diagnostics in the context of plasma-liquid 
interaction? How to calibrate? 
3 
chemistry 
What is the production of reactive species of plasma devices? 
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3 
chemistry 
How the parameters of the experiments (peak to peak Voltage, flow, 
distance …) modify the production of species? Is there a link with the 
electrical power consumed by the devices? 
3 
chemistry 
Is it possible to quantify the production of the hydroxyl radical with the 
diagnostic based on terephthalic acid? 
3 
chemistry 
how fast H2O2 crosses cell membranes? 
3 
chemistry 
What do we know about the diffusion of H2O2 through the skin? What 
models can be proposed for the transport and consumption of H2O2 
through living tissue? 
4 
in-vitro 
What treatment time affects cell viability? After how much incubation time 
does this difference in viability manifest itself? 
4 
in-vitro 
Does the chemical species alone have an equivalent effect to that of the 
liquid treated by plasma? 
4 
in-vitro 
Do two lines react in the same way? 
5 
in-vivo 
Which plasmas-devices do elicit an anti-tumor response? 
5 
in-vivo 
What is the temperature on the surface of the tumor? What treatment 
time causes damage? 
5 
in-vivo 
What happens when the effect of hyperthermia is totally excluded by a 
cooling of the plasma source? 
6 
hyperthermia 
What is hyperthermia? What are the thresholds of hyperthermia? 
6 
hyperthermia 
How to simulate the propagation of heat and model biological tissues. 
6 
hyperthermia 
How to measure tissue temperature in the context of plasma medicine? 
Which biases lead to underestimating the temperature? 
6 
hyperthermia 
Do the published in-vivo studies exclude the possibility that tissues have 
been subjected to hyperthermia depending on the measurement method 
used? 
In the event of an adverse answer. In what extent the results could be 
attributed to hyperthermia? 
 
About interdisciplinarity 
This study was made possible by the collaboration of teams from two others laboratories. 
The team of Lori Bridal (LIB) and the team of François Lemoine and Geraldine Lescaille 
(CIMI) were involved. The in-vivo studies on CT26 and TC1 lines were performed in the 
animal-house associated with each laboratory. 
It was not only a matter of accessing experimental equipment and installations or the 
solving of prosaic logistics problems. Above all, it was the building of a critical view on 
the scientific problems and experimental choices to answer them. Such topics force to 
decompartmentalize scientific disciplines. Even the basic and practical problem are at 
the crossroads of disciplines like: 
 create a tolerable plasma source for the mouse 
 To characterize the production of chemical species, it is necessary not only to 
measure the electric power consumed by the plasma but also to develop a 
method for determining the chemical species. Generally, it is hazardous to use a 
commercially available diagnostic kit without conducting a thorough reflection on 
the chemical reactions involved in the operation of the diagnostic. Biases can be 
surprisingly numerous and subtle, as in the case of amplex-red reagent. 
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 It is necessary to design a transportable device to reduce at best all the sources 
of uncertainties related to the plasma while respecting the constraints of sterility 
during in-vitro experiments. 
 To model the thermal effect of plasma on mouse skin, it is necessary to know the 
equations of heat propagation but also the vascular structure of the skin. 
An interdisciplinary research topic is not inherently difficult. It is merely a matter of 
applying the scientific method with the same rigor on other scientific objects. It is evident 
that this rigor can only be built by the time, a lot of discussions and criticism (received 
and formulated). 
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Chapter I State of the art  
This chapter is divided into six parts. 
First, the general context is described. This is followed by a brief presentation of the type 
of plasma sources used. Then, the literature regarding the chemistry elicited in the liquid 
phase by the interaction plasma-liquid is presented. The biological effects of so-called 
reactive oxygen and nitrogen species (RONS) are discussed after that. 
Some remarkable results obtained in recent years with in-vitro studies are presented in 
I.5 and finally the studies showing evidence of an in-vivo plasma anti-tumor effect. 
Other parts of this document contain bibliographic studies, and it seemed more 
appropriate to place them directly in the relevant chapters.  
 Chapter III contains a description of the antioxidant defenses of the skin (section 
III.6.1, page 93, “Anti-oxidant defense of the skin, relevant orders of magnitude”). 
 The biological effects of hyperthermia are described in Chapter VI (section VI.1, 
page 172, “What is hyperthermia? How to model and simulate it?”). 
Several sections are dedicated to critical approaches of the literature: 
 Regarding the transport of reactive species through living tissues (section III.6.4, 
page 101) 
 Regarding the role of hyperthermia in plasma-medicine and how tissue 
temperature was measured (section VI.3, page 253) 
 
I.1 General context 
The use of cold plasmas produced by electric discharges for biomedical applications 
(Plasma-medicine) has considerably evolved over with major advances in the field of 
plasma-assisted haemostasis [3], biomaterials, dental surgery [4], sterilization, wound 
and ulcers healing [5], tumor treatment [6], skin treatment and dermatology [7]. Plasma-
Medicine is an interdisciplinary field, which grows fast and brings together plasma 
physicists and chemists with medical doctors and biologists working on clinical aspects 
and fundamental biological issues. 
Plasma usage in dermatology covers areas such as sterilization of tissues, treatment of 
skin diseases, cosmetic applications, blood coagulation and wound healing. It has been 
known for a long time that plasma has biocide effects; however, the exact mechanism of 
plasma disinfection is not yet fully understood. Plasma factors that believed to be 
relevant for sterilization are charged particles (electrons and ions), UV (A,B and C) 
radiation, strong electric fields and the reactive species of oxygen and nitrogen (O,N, O2-, 
O3, OH°, H2O2, NO, OH etc.) and excited states of molecules and atoms (O2(a¹Δg), 
N2(A3Σu)). The synergy between several plasma parameters could be responsible for the 
disinfecting effect of plasma [8]. Thus, UV radiation and electric field can directly damage 
cellular macromolecules and affect membrane, while DNA proteins and lipids are 
irreparably harmed by oxidative stress. Successful plasma treatment of chronic skin 
diseases like dermatitis [9], Hailey–Hailey disease [10] and eczema [5] shows that 
plasma efficiently eliminates bacterial colonization, e.g., Staphylococcus aureus, by 
inducing reactive oxygen and nitrogen species on the treatment surface (O3, NO, etc.). 
Cold atmospheric plasmas (CAP) for cancer treatment 
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If numerous studies use cold plasma to treat tumor cells [11], the nature of the 
interaction between CAP and cancer tissue remains poorly understood. In nude mice 
bearing subcutaneous bladder cancer tumors, regression was observed for tumors 
treated with CAP whereas the untreated neighboring tumors were unaffected [12]. 
Several genes associated with apoptotic and oxidative stresses were observed to be 
deregulated. Vandamme et al. evaluated the effect of CAP on tumor volume in glioma-
bearing mice with bioluminescence imaging (BLI) and cellular biomarkers [6]. Compared 
to untreated mice, the CAP treatment induced a ~40% inhibition of tumor growth by the 
end of the study. It has been suggested that DNA damage and reactive species 
generated by the plasma may be the main cause of tumor cell apoptosis [13], [14]. ROS 
generated by CAP can, under certain conditions, modify endothelial cell proliferation 
[15];or lead to apoptosis [13]-[16]–[20]. This is consistent with the mechanisms used by 
radiotherapy to induce lethal DNA damage based on the formation of ROS in targeted 
cells that include superoxide, hydrogen peroxide and free hydroxyl. It should be noted, 
however, that radiotherapy produces the reactive species directly within the cell. 
Such tumors have been treated with direct treatment. As an alternative, an indirect 
contact approach has been recently developed. It consists of plasma-activating a liquid 
medium (PAM), hereafter put in contact with the tumor [21].The utilization of PAM is 
relevant for the treatment of subcutaneous or barely accessible tumors to prevent any 
surgical operation before treatment. The value of PAMs has been demonstrated through 
antitumor effects on Glioblastoma, ovarian cancers and gastric cancers [21], [22]. 
However, it must be ensured that PAM injection is consistent with a therapeutic 
approach. For example, injecting PAM only 24h after the injection of tumor cells does not 
constitute a good biological model of the therapeutic effect that plasma would elicit. 
Treatment should be done when the tumor has already reached several mm in diameter. 
A majority of these studies have been performed in-vitro with murine cancer cell lines 
(lung, melanoma, head and neck, brain and bladder). 
Oral squamous cell carcinomas (OSCCs) 
Head and neck squamous cell carcinomas (HNSCC), including cancers from oral 
(pharynx, larynx, paranasal sinuses) and nasal cavities, are the sixth most common 
malignancy worldwide [23].They represent a major public health problem since, despite 
conventional treatment (i.e., surgery, with or without radiotherapy and chemotherapy), 
the prognosis remains very low with 35-55% relapse within two years and less than 20% 
overall survival at ten years [24]. Furthermore, due to their localization, these cancers 
affect some of the most vital functions of the body leading to a very poor quality of life. 
Long considered as a uniform group, HNSCCs are actually heterogeneous, depending 
first on their anatomic site and association with known risk factors (i.e., alcohol and 
tobacco, papillomavirus infection, HPV). Among HNSCCs, oral cancers (OSCCs) 
represent the ones located in the oral cavity and the oropharynx. Whereas 
oropharyngeal cancers (tonsils and base of the tongue) are known to be mostly 
associated with HPV infection, oral cavity squamous cell carcinomas (buccal mucosa, 
gums, front two-thirds of the tongue, the floor of the mouth below the tongue, hard 
palate) are mostly not [25], [26].Second, there is marked heterogeneity in therapeutic 
responses to one or more of the conventional treatments. Currently, despite this known 
heterogeneity, patients are treated with a similar global strategy. Standard treatment 
strategies for HNSCCs include surgery, radiation and/or chemotherapy, mainly platinum-
based drugs (Cisplatin) and 5-Fluorouracil (5-FU). The choice of these treatments and 
their combinations is based on site of disease and degree of invasion and metastases. 
However, approximately 60% of HNSCCs patients have locally advanced disease at 
presentation, and about 15 to 20% of them are not eligible for surgery because of tumor 
size and/or poor general state of health. Different innovative therapies have been 
developed and/or are currently under evaluation in HNSSCs. Those include the use of 
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monoclonal antibodies such as anti-
VEGF, anti-EGFR, checkpoint 
inhibitors, therapeutic vaccines, or 
targeted therapies [27]. Because most 
of them appear not efficient enough or 
are under further studies, there is an 
urgent need to develop innovative 
strategies such as CAP. Thanks to 
their localization, OSCCs are 
accessible to CAP exposure [28]. 
Furthermore, these cancers relapse in 
a locoregional manner with little or no 
metastasis. 
I.2 Plasma sources for bio-medicine 
Plasma sources generated at atmospheric pressure in air or air containing mixture 
produce ROS, RNS, UV, ions, electric field. The chemical composition of plasma 
sources in air containing mixture has been extensively studied experimentally [29] and 
numerically [30]. Numerical modeling predicts down-regulation of NO, O and O2- when 
switching from dry air to the air with 30 % humidity while concentrations N2O, NO3, N2O5, 
and O3 would increase and new species like OH-, HO2, H2O2 and HNO3 would be 
formed. The electric field seen by the treated object will be the sum of the applied electric 
field and strong local electric field which results from with the streamer propagation.  
Following the commonly used terminology [31] currently available atmospheric plasma 
sources for biomedical applications can be divided into two groups [18], [32] depending 
on how plasma is delivered to the object to be treated.  
Dielectric Barrier Discharges (DBD) are filamentary at 
atmospheric conditions with rather uniform plasma 
filament distribution over treated surface due to the 
surface charging and electrical repulsion of the 
filaments. UV emission of such plasmas is associated 
with excitation state of molecular nitrogen and OH° 
radical in the range of 300-400 nm and NOγ 
emission between 200 and 300 nm [33]–[35].  
Plasma Jets: in Plasma-Jet configuration, the plasma is confined in 
dielectric tube or capillary. Depending on excitation source electrode 
configuration may be DBD-like for pulsed and low-frequency jets [36] 
and corona-like for devices which operate at radio frequency [37]. 
Plasma jets are operated in noble gas flow (Helium, Argon, Neon, 
etc.) or in a mixture of noble gas with air or oxygen admixture. The 
ability to modify gas mixture is an advantage of plasma jets since it 
enables the tailoring of ROS and RNS produced in plasma zone or in 
the plume due to mixing with ambient air [38].  
Fig 1 (a) Direct contact approach. The plasma is applied 
directly on the carcinoma located in the oral cavity (b) 
Indirect contact approach. A physiological medium is 
first plasma-activated (PAM) and then injected on the 
carcinoma located in the oropharynx. 
Fig 2 DBD treatment 
Fig 3 plasma-jet 
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I.3 Chemistry of plasma-liquid interaction 
Why is it interesting to study the plasma-liquid interaction and in particular the chemical 
composition of the liquid phase? First, such measurement could give clues on the intake 
of a chemical species at the boundary of the treated tissue. However, It appears that the 
conductivity of the target modifies the chemistry of the gas phase [39]. Consequently, it 
is likely that the intake above the biological tissue is different from that above liquid. 
So, it is important to avoid to overextend the scope of the results obtained with liquids to 
in-vivo experiments. On the other hand, it is fully relevant to use the results of plasma-
liquid experiments for the interpretation of in-vitro1 experiments or PAM treatments. The 
chemistry of the interaction plasma-liquid has others applications than plasm-medicine: 
water-decontamination [40], sterilization and decontamination of medical devices [41], 
plasma-chemicals process, plasma-agriculture [42]. The chemical mechanisms of the 
plasma-liquid interaction at the origin of these species are not necessarily all known and 
remain an open question despite the progress of the last ten years [43]. 
It is relevant to make a distinction between short-lived species and long-lived species 
(more than a few minutes). The long-lived species can be measured several hours after 
treatment. Hydrogen peroxide (H2O2), nitrites (NO2-) and nitrates (NO3-) are part of the 
long-lived species. Among short-lived species, there are singlet oxygen, peroxynitrites 
(HOONO), ozone (O3), hypochlorite anion (ClO-) and radicals such as superoxide anion 
O2-, NO° and hydroxyl radicals HO° [43]. When experiments of the therapeutic and 
biological effects of PAM are carried out, the short-lived species generated by the 
plasma which no longer exists, cannot be at the origin of the biological effects. Moreover, 
Adachi et al. [44] and Judée et al. [45] shows that PAM retains a therapeutic effect for 
several days. In addition, the long-lived species contained in the PAM produce short-
lived species. H2O2 can react with nitrites and give peroxynitrites: half-life of peroxynitrite 
is few tens of ms in biologic conditions  [46], [47]. Then, among other reactions, 
peroxynitrite give HO° radical and nitrate [48]. The lifetime of this radical is of the order of 
ns in biological media [49]. Another example: when H2O2 solution is exposed to UV rays, 
it decomposes by photolysis and gives HO°. Otherwise, the therapeutic effects of PAMs 
are also due to the short-lived species produced by PAM species that react together or 
with biological molecules. So, if the distinction between short and long live species is not 
relevant regarding therapeutics effects, it is relevant for an experimental point of view: 
the probes of short-lived species need to be in the treated liquid during the treatment, 
and this fact could be another source of bias and complexity 
The roadmap of Adamovitch et al. summarizes the physics and the chemistry of plasma-
liquid interaction [50]. It provides precious information on how to model the liquid plasma 
interaction. Adamovitch et al. and Bruggeman et al. propose an overview of the 
chemistry that takes place in the gas phase, at the interface, and in the liquid phase (see 
Fig 4) [50] [51]. 
 
 
                                               
1 In this case, the liquid is the culture medium in which the cells are immersed. Caution should be 
exercised with regard to the reactions that occur with the culture medium. 
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Fig 4 Overview of plasma-liquid chemistry, from [50], [52]. © IOP Publishing Ltd 
I.4 Biological effect of reactive oxygen and nitrogen 
species (RONS) alone 
Regarding, the field of sterilization and decontamination, the problem is rather 
straightforward. Hydrogen peroxide and other reactive nitrogen and oxygen species have 
an anti-microbial effect known from tenth. The open questions, in this case, are to know, 
if other properties of plasma could play a significant role or not. For instance, is the effect 
of electroporation negligible or not? What is the precise contribution of UV radiation to 
the decontamination of the surface? There is a lot of work to do regarding the precise 
understanding and optimisation of plasma treatment applied to decontamination and 
sterilization. When a sufficient amount of this reactive species is produced, the cells die 
because of the toxicity of this species. The question is to know what the cellular 
mechanisms are implied in the dead of this cells 
Regarding, “plasma-cancer,” the question is more complex. Studies who show an anti-
tumor effect propose an explanation based on a RONS-mediated anti-tumor effect, 
which means that the input of chemical species could induce a biological response 
leading to cell death via necrosis or complex response like apoptosis [53]–[55]. 
Toxicity of H2O2 
Hydrogen peroxide is not classified as a mutagen or carcinogen according to the 
European Union Risk Assessment report [56]. According to the report of INRS [57, p. 
123], There are no signs of reproductive toxicity, carcinogenicity or mutagenicity. INRS 
(“Institut national de recherche et de sécurité”) is the French research and Safety 
Institute for the prevention of accidents at work and occupational diseases which edit 
material safety data sheet. 
It appears that genotoxicity is widely observed in-vitro [56], [57]. Watt et al. explain that 
three mechanisms are involved in the toxicity of hydrogen peroxide: lipid peroxidation, 
corrosive damage, and oxygen gas formation [58]. In the event of accidental injection or 
ingestion, significant neurological damages may occur. Dermal exposition causes skin 
damage, inflammation and blistering among which erythema, focal epidermal necrosis, 
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purpura (red spots due to bleeding under the skin) and subcutaneous emphysema, a 
condition in which gas is present under the skin.  
Hydrogen peroxide is not only a poison, but this also a major intracellular messenger 
involved in several signaling pathways [59]. Stones et Yang indicate extracellular and 
intracellular concentration ranges that may cause cell proliferation or morbidity (see Fig 
5, [60]. 
 
Fig 5 Legend and figure from the paper of Yang et al. Vertebral response to H2O2 [60] © Mary Ann 
Liebert, Inc. 
Hydrogen peroxide is sometimes considered as means to deliver oxygen to skin. For 
instance to assist in the treatment of ulcers [61]. 
Toxicity of nitrate and nitrites 
The toxicity of nitrates is well documented. Standards have been established to limit 
human and animal exposure. Deleterious effects are mainly due to the transformation of 
nitrate into nitrite [62]. According to [63], nitrite is ten times more toxic than nitrate. The 
lethal oral doses for human beings are established in 80–800 mg nitrate/kg body weight 
and 33–250 mg nitrite/kg body weight. 
I.5 In-vitro evidence of cytotoxic responses 
In-vitro experiments are used as a model for the disease and the treatment. An in-vitro 
experiment provides a lower level of evidence than in-vivo experiments in the 
development of therapies. On the other hand, the degree of control of these experiments 
is higher. Consequently, it is easier to understand the mechanisms which explain how a 
therapy works with in-vitro model. Currently, most of the work done in plasma-medicine 
is in-vitro experiments [64]. We will focus on the work related to oral cavity cancer. 
Selectivity against cancerous cells 
The most exciting results are that CAP can have selective effects against cancer cells. 
This means that in an in-vitro experiment, there are treatment times for which it is 
possible to kill cancer cells without killing healthy cells. However, the result depends also 
on what is chosen as “normal cell”. In a recent review, Yan et al. counted the number of 
papers showing evidence of selectivity of plasma treatments against cancer cells [65]. It 
appears that a very high selectivity has been observed for 25 different lines. In contrast, 
an absence of selectivity has been reported in only two lines. However, it is likely that 
negative results on the selectivity of plasma treatments have not been published. 
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The selectivity of plasma treatment is generally attributed to the idea that cancer cells 
could have weakened anti-oxidant defenses; the RONS provided by plasma treatment 
would then overcome their defense and induce an apoptotic response. Normal cells 
would have their anti-oxidant defense intact, which would protect them in higher 
concentrations than cancer cells can withstand. However, this concept of “redox 
equilibrium” is very controversial for the biologists; it is likely that this concept poorly 
represents the behavior of the cell in all its complexity. The complexity of the biological 
response to CAP was clearly shown by Keidar et al. since dozens of genes are modified 
toward an over-or-under expression after plasma treatment [12]. 
Regarding anti-cancer selectivity and head and neck cancer lines; Guerrero-Preston et 
al. have shown that cold plasma selectively decreased the viability of SCC25 and JHU-
028 cancerous cells [66]. The viability was measured by MTT assay seven days after 
plasma-treatment. The normal cells, OKF6 and NOKsi, were poorly affected by 30 and 
45 s treatments, whereas the cancerous lines O22 and O28 were dead after a 10s-
treatment. It may be noted, however, that normal and cancerous cells have not been 
cultured precisely in the same medium. It would be interesting to verify that the anti-
oxidant capacity of the culture medium is the same in both cases. 
Plasma treatment elicit DNA damages 
Han et al. observed that plasma treatment promote DNA double-strand breaks [67]. The 
treatment of SCC-25 oral cancer was performed with a plasma jet of N2 powered at a 
frequency of 28 kHz, and peak to peak Voltage ~ 22.4 kV, Φ( ଶܰ) = 1500 ݏݏܿ݉. DNA 
damages were observed in the nuclei just after plasma treatment. 30 s of plasma 
treatment cause damage in 60% of the cells exposed to plasma. 
Chang et al. performed experiments on four cell carcinoma lines (MSK QLL1, SCC1483, 
SCC15, and SCC25) [20]. All of these cell lines are models of oral cancer of human 
origin. The wells were treated with an (He+O2) plasma jet powered at 2 or 4 kV. The 
precise frequency is not specified (in the range 20-30 kHz). Neither gas composition nor 
gas flow is specified (even in the paper done by physicist [68]). The treatment time is 1 s. 
The authors show the production of DNA damage Double-strand breaks and especially 
that the p53 signaling channel is activated. 
Role of reactive oxygen species 
Girard et al. exposed several lines (MRC5Vi, HCT116 ) to cold plasma-jet [69]. The  
DBD-plasma-jet was powered by high voltage pulse generator (amplitude 8 kV, rise time 
280 ns, full with at half maximum of 540 ns). They found a dose-dependent increase in 
cell mortality. Chemistry experiments were performed to measure the amount of H2O2 
and nitrites present in culture wells. For one minute of treatment, the concentrations of 
H2O2, ܱܰଶି and ܱܰଷି reached are respectively ~400 µM, ~400 µM and, ~100 µM. 
Subsequently, in a very clever way, they performed a comparison between the effects of 
chemical mixture which have the same composition than plasma-activated medium. 
They observed that NO2- and H2O2 act synergistically to induce cell death, and conclude 
that these two species alone are sufficient to explain plasma-induced cell death. 
Bekeschus et al. have compared the treatment done with a Dielectric Barrier Discharge, 
and kINPen11 [70] on CT26 cell line. They show that H2O2 play a dominant role in the 
decrease of viability observed after 21 h of incubation. Comparisons were made with 
bolus addition of H2O2. The effect of kINPen is well explained by the amount of 
H2O2produced by the device. In contrast, DBD produced an unknown species that 
increases the toxicity of the treatment compared to the bolus addition of H2O2. 
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I.6 Cold Plasma and oncology 
Clinical case 
Metelmann et al. report the follow-up of 12 patients afflicted with advanced squamous 
cell carcinoma of the head and neck [28]. This protocol has been authorized to 
decontaminate infected cancerous ulceration. This study was not designed to study the 
anti-cancer potentialities of cold plasma but improve the understanding of how such 
treatment could take place. The patients were treated with kINPen MED powered at 1 
MHz with a sinusoid waveform (2->3 kV peak) modulated with 2.5 kHz at 8 mm of the 
tissue and flow between 3 and 6 slm of Argon. 
Cold plasma treatments were delivered in 3 single treatments within 1 week, followed by 
an intermittence of 1 week without CAP exposure. Note that plasma exposure conditions 
have been maximized: every square centimeter of the ulceration was exposed for 1 min. 
In some patients, the exposure time has exceeded 30 minutes 
Metelmann et al. have shown that plasma treatment brings benefits related to i) the 
reduction of pain ii) reduction of fetid odor which reflects the fact that the antibacterial 
action of kINPen has been effective iii) gain of weight and reduction of medications.  
It also appears that the effect of cold plasma was not immediately observable. Visible 
change appears after two weeks of treatments (i.e., 3 weeks after the first exposure). 
The totality of the treated area did not respond uniformly. Some patients presented areas 
of partial remission. These results are quite encouraging. Note also that plasma is used 
in pulsed mode which totally excludes the occurrence of hyperthermia but also 
decreases the production rate of chemical species. Perhaps it would be possible to 
increase the chemical action of such devices by making them operate at higher power in 
continuous mode while reducing the temperature of the carrier gas upstream of the 
plasma source (in order to avoid hyperthermia2). 
Regarding this clinical assay, Schuster et al.[71] also report that the number of apoptotic 
cells was higher in the group treated by plasma. 
Which mechanisms? 
The crucial role played by the development or reactivation of an antitumor immune 
response in the eradication of the tumor and in the therapeutic clinical response is now 
well established. If both innate and adaptative immunity is essential for eradication of 
tumor cells, the latter is, however, crucial in order to favor a better protection against 
relapses, that are frequent in HNSCCs, as well as to envision combination with 
chemotherapy for patients non-eligible to surgery. T cells as effectors (cytotoxic CD8), 
helpers (Th) or regulators (TREG), may play diverse roles in the evolution of the tumor, 
being pro-tumor or the opposite. Intensive studies over the past years of tumor-infiltrating 
lymphocytes (TIL) highlight the clinical relevance for the infiltration of high numbers of T 
cells at the tumor site in many solid cancers, CD8 memory T cells being a key 
denominator for overall survival whereas TREG infiltration being associated with a poor 
clinical outcome [72]. 
Several studies have been focused on the key processes which could elicit efficient 
immune responses against tumor cells. First, there are growing evidence that some 
                                               
2 what we tried to achieve in the section V.3, page 147. See also the discussion concerning 
hyperthermia in Chapter VI. 
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chemotherapeutic and radiotherapeutic regimens trigger cancer cell death while 
stimulating an active immune response against the tumor [73], [74]. As shown in Fig 6. 
 
Fig 6 Adapted from Zitvogel et al. [74]. Mechanisms of the impact of conventional anticancer 
therapies on immune responses. Anticancer therapeutics can inhibit suppressive mechanisms of 
tumor-induced immune tolerance (blue circle), boost T and/or B cell responses (pink circle), or stress 
tumor cells in such a way that  tumor cells become immunogenic and sensitive to lysis (yellow 
circle). The main drugs driving these effects are also shown. 
The immunogenic cell death relies on the emission of signals from dying cancer cells 
and their perception by the host immune system in a first step. Secondly, an appropriate 
localization and migration of immune cells is required. In particular, T-cells is a 
prerequisite for antitumor immunity. However, immune cells accumulate more efficiently 
in the surrounding stroma than in the tumor islets and can be influenced by modulation in 
vascularization. So, the structure of the tumor stroma-vascular filling and network 
distribution, local microstructure, cellularity, as well as fibrosis and necrotic core - play 
key roles in the positioning and migration of immune cells [75]. 
Pre-clinical model: B16-F10 melanoma C57/BL6 line 
First of all, it should be noted that among plasma-treated tumors experiments, one has 
been repeated by several independent groups with different plasma sources. This line, 
the melanoma B16-F10 was treated by Keidar et al. [12], Daeschlein et al. [76], Chernets 
at al. and Mashayekh et al. [77]. The four groups reported a positive effect of plasma 
treatment which induces a slowdown in the rate of tumor growth. In contrast, the 
magnitude of the slowdown is different depending on the device used. 
Keidar et al. treated B16-F10 melanoma and SCaBER tumor model [12]. 
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Fig 7 Adapted from Keidar et al. [12]. © 2011 Cancer Research UK 
However one can note the presence of damages on the skin right after the end of the 
plasma treatment (Fig 8). This type of observation has been correlated with treatment 
inducing hyperthermia by Dobrynin et al. [78] 
 
 
Fig 8 Adapted from Keidar et al. [12]. This picture shows the damage on mice bearing SCaBER 
tumor. © 2011 Cancer Research UK 
Daeschlein et al. compared the antitumor effect of two plasma sources against B16-
melanoma [76]. DBD and Kinpen09 were used alone or in combination with other 
therapies. The anticancer effect of plasma treatment alone is smaller than observed in 
the work of Keidar et al. [12]. Indeed, regarding the survival, the groups treated with DBD 
or plasma-jet shownd no significant improvement of their survival rate. Regarding, the 
kinetics of tumor growth, Daeschlein et al. shownd that the tumor growth acceleration3 
(TGA) is significantly smaller in DBD (D) and plasma-jets (J) groups than control (K) (see 
Fig 9). Besides the paper signals that the plasma does not elicit skin injury4. 
                                               
3 TGA is the coefficient  ܽଶ, in the fitting of tumor volume by a second-degree polynome in time 
ܸ(݀ܽݕ) = ܽ଴ + ܽଵ × ݀ܽݕ + ܽଶ × ݀ܽݕ
ଶ.  
4 private communication of Dr Daeschlein: we measured maximal around 40°C during and directly 
after Jet therapy and never > 35°C after DBD using a laser equipped tool 
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Fig 9 Adapted from  [76]. K is the control group. D the group treated by DBD and J the group treated 
by kINPen09. 
 
Chernets at al. got a stronger effect than observed by Daeschlein et al. on the same line 
of melanoma [79]. Indeed, in addition to tumor slowing, an increase in survival rate was 
observed (Fig 10). 
 
Fig 10 Adapted from Chernets et al.  [79] 
However, measurements show that the temperature at the center of the tumor is 27 ° C 
higher than average tissues temperature. It turns out also that damage is visible just after 
treatment (Fig 11). 
 
Fig 11 Adapted from Chernets et al.  [79] 
Mashayekh et al. show that the therapeutic effect of plasma is equivalent to that of 
chemotherapy (Fig 12) [77]. Mashayekh also indicates that the mice were treated 
conscious and that the skin showed no sign of damage after treatment (private 
communication of Mashayekh). 
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Fig 12 Adapted from Mashayekh et al.   [77] 
Slowdown in tumor growth and increase in lifespan were also observed in the works of 
Partecke et al. [80], tumour-chorio-allantoic model of tumor, Walk et al. [81] regarding 
treatment of the neuroblastoma line neuro2a, Mirpour et al. [82] regarding 4T1 breast 
tumor model, Kang et al, [83] regarding FaDu line, Vandamme et al. [84] [85], 2010, 
regarding the human glioblastome U87 implanted in nude mice, Robert et al. [86] 
regarding the treatment of MIA Paca2-luc and HCT116-Luc endoscopic system, Brullé et 
al. 2012, [87] regarding MIA PaCa-2.  
The injection of plasma-treated medium in the vicinity of the tumors is another modality 
of therapy envisaged. Utsumi et al. bring evidence of the benefits of such approach with 
a model of ovarian cancer [21]. 
 
 
Consequently, 
 We began by designing and electrically characterizing our plasma sources 
(Chapter II) 
 Then we wanted to characterize the chemistry they induced in a liquid phase 
and/or living cells 
 Then we conducted in-vitro experiments to observe the anti-tumor effect of the 
treatment 
 Finally, in-vivo experiments led us to discuss the role of temperature and to 
simulate it 
The bibliography of specific topic is treated in 
 Chapter III contains a description of the antioxidant defenses of the skin (section 
III.6.1, page 93, “Anti-oxidant defense of the skin, relevant orders of magnitude”). 
 The biological effects of hyperthermia are described in Chapter VI (section VI.1, 
page 172, “What is hyperthermia? How to model and simulate it?”). 
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Chapter II Materials and methods 
This chapter briefly presents the manufactured plasma devices, the method of 
measurement of the electric power consumed, the methods of chemical assays and the 
biological material. 
Few points deserve particular attention: 
 The manufacturing process of the plasma-device takes an original form. 
 A discussion of chemical biases regarding the exploration of the chemistry of the 
liquid exposed to plasma. The chemical diagnostics should not be used as black 
boxes: this chapter illustrates the severity of some biases in the context of 
plasma-liquid experiment. The bias related to Griess reagent is particularly 
emphasized. 
 Similarly, in the section dealing with electronics, it will be explain that the choice 
of components necessary to achieve a correct power measurement is not as 
obvious as it looks at first glance. The effect of the measuring system: 
oscilloscope and measuring probe is modeled and plays a major role. 
 The complex chemistry of the reaction of terephthalic acid with the hydroxyl 
radical begins to be addressed in this chapter. We specify important notions 
about the Fenton reaction. 
II.1 Engineering of plasma sources 
II.1.1 Fast prototyping with 3D-printing in the laboratory  
At the beginning of this work, the plasma-devices available in the laboratory were not 
suitable for medical applications. Regarding plasma-jet, the capillaries were too thin, and 
easily broken and not suited for reliable and routine use. Glass-DBDs consisting of a 
tungsten tip coated in glass were tested. The result was rather disappointing. Two of 
these electrodes were broken during in-vivo experiments after few hours of use. 
Moreover, it was not really possible to choose precisely the thickness of glass 
surrounding the tungsten tip (~1.5-2 mm). 
The need of a versatile, high speed and economical manufacturing process led to 
choose 3D-printing. In the case of plasma jets, 3D-printing enables fast modifications of 
the geometry of the nozzle in a trial-error process. It was possible to create more 
complex nozzle geometries than those commonly used. Ultimately, it would be possible 
to optimize the production rate of one class of chemical species (e.g., nitrogen species) 
compare to another to improve the therapeutic efficacy in a rational way. 
Advantages 
 On average, there were less than four days between the design of the part and 
the functional plasma source. This speed enables to use trial and error approach. 
 3D-printing enables to manufacture a large number of parts and obtain a better 
reproducibility. One of the sources was manufactured in 6 copies. Each 
experimenter could reproduce the experiments and the plasma-device which is 
used. The 3D design of one of the devices is given in Appendix M. This code is 
open with OpenSCAD, free open-source software. 
 The spatial resolution of the part reaches 50 μm along Z axis and 70 μm along 
XY axis. 
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Drawbacks 
 Plastics are generally good insulators. But the way the plastic is printed can 
degrade the quality of the electrical insulation. Some precautions should be taken 
during printing: a reduced z-layer thickness, a high printing temperature and a 
relatively slow printing speed are required to ensure adhesion of the new layers 
and the partial melting of the underlying layer. Gas sealing is another reason to 
choose this kind of printing parameter. 
 Constraints on the geometry of the object that can be printed. 
II.1.2 Settings of 3D-printer 
3D-printing is part of additive manufacturing techniques. The material is added layer by 
layer from bottom to top. Each part was printed with a Creatr-HS purchased from 
Leapfrog3D (Fig 13, left). The printing technique belongs to the family of Fused 
Deposition Modelling (FDM) technology. A plastic filament contained in a coil is fed into 
an extrusion nozzle head by motors. The extruder is heated to a temperature appropriate 
to the material (about 220 °C for PLA or PETG). The printing speed, the temperature of 
the extruders, the size of the plastic layers (see Fig 13, right), and the kinetics of cooling 
are the main parameters. 
 
Fig 13 Left: 3D-printer in operation. Right: size of extruded filament. Layer height and extrusion width 
are directly related to the spatial resolution of 3D-printing. 
The distance between the print head and the print surface is critical for printing quality 
(Fig 14). This distance depends on the height of the layers and is usually around 100 
μm. Plasma source printing requires different settings from those used to print a 
decorative object. For example, the walls of the objects must be thick enough to ensure 
sealing and electrical insulation. 
Extrusion nozzle 
Printing head 
Print bed 
Plastic filament 
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Fig 14 Adjusting head distance is critical for printing quality. Too high: the print does not stick well 
to the surface and can detach at any time. Too low: the pressure on the filament may cause it to twist 
and jam in the print head. Moreover, if the plastic remains in the nozzle for too long, the extruder may 
clog. 
II.1.3 Manufacturing of Dielectric Barrier Discharge (DBD) 
A DBD device is made of one or more layers of dielectrics placed between the high 
voltage electrode and the ground. This layer limits the current flow and enables the re-
starting of the discharge from one-half period to another. Epoxy resin was used to 
constitute the dielectric layer. Epoxy resin was purchased from DIL France (Resolcoat 
1060ES7, Résoltech). This resin has high mechanical and chemical resistance. 
Dielectric strength and dielectric constant at 100 Hz are respectively 25.5 kV/mm and 
4.8. The polymerization takes place in about one day when the constituents are mixed. 
Immediately after mixing, the viscous liquid is centrifuged (around 3000 rpm) to prevent 
bubbles5 from being trapped in the dielectric layer. A copper rivet was used as the 
conductive part. The outside of the part is printed in Polylactic Acid (PLA) or 
Polyethylene terephthalate glycol-modified (PETG). The model of this part is in the left 
part of Fig 15. The dimensions are shown on the right of the figure. 
 
Fig 15 Left: a sectional view along the X axis of the plastic part of DBD: the two channels that make 
possible to insert the resin and to evacuate the air bubbles during the polymerization are visible.  
Right: a sectional view of the DBD along the Z-axis. In orange: copper rivet, d= 5 mm, in blue: epoxy 
resin. In black: PETG, thickness of 1.3 mm.  
Once the plastic part is printed, the copper rivet is placed inside (Fig 16). The plastic part 
is designed in such a way that the end of the rivet extends to a lower depth than the 
plastic part. The distance e represents the thickness of dielectric; it is in the set {1.3, 1.4, 
1.5 mm}. These values prevent dielectric breakage up to 30 kV peak to peak. A margin 
                                               
 5  This would significantly reduce the quality of the electrical insulation. 
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of safety is taken since the device is used above living organisms (mice). The bottom of 
the part is closed by duct tape during the polymerization. The DBD is connected to HV 
power supply by a shielded HV Cable (reference 2124 from hivolt.de). 
 
Fig 16 Sketch describing the manufacture of DBDs. Printing time of PETG part is about three h. The 
polymerization time is approximately two days. e is the thickness of dielectric layer. 
II.1.4 Manufacturing of single-channel-jet 
The simplest DBD-plasma-jet is a gas tube surrounded by an electrode powered by AC-
voltage. A rare6 gas flows into the tube. When the difference in electric potential between 
the high voltage electrode and the biological target is high enough, the discharge is 
ignited. 3D-printing enables to produce such device called “single-channel jet” or “single-
jet” in the dissertation. The electrode was printed in a conductive plastic. Plastics are 
excellent insulators which become conductive when they contain graphite or graphene 
fibbers. Two conductive plastics were used: PLA-Graphite (resistivity ߩ = 44 ݉ߗ. ݉ from 
Proto-Pasta) and PLA-Graphene (ߩ = 6 ݉ߗ. ݉, BLACKMAGIC3D). The electrical 
resistance of the part printed with PLA-Graphene is of the order of a few ohms from one 
side to another. A polymer of Poly-Lactic Acid (PLA-white, Esun) was used to make the 
insulating part (Fig 17). Note that the insulating ring between the high voltage electrode 
and the gas tube is made of PLA. 
                                               
6 generally argon, helium or neon. 
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Fig 17 Left: view of the single jet. Blue arrow: connection to the high voltage electrode. The gas 
outlet towards biological targets is at the top of the figure. The distance between High Voltage 
electrode and gas outlet is 60 mm. The gas intake is below (not visible). At the bottom of the figure, 
the structure made of several circles and radius ensures that the print remains attached to the 
printing bed. Right: sectional view of the single jet. In this representation, the structure of the gas 
tube is visible by transparency. The gas inlet (below) has a conical shape which enables to fix the 
arrival of rare gas. The position of the high voltage electrode is visible. The conductive part is 
separated from the gas by a thickness e (PLA). Printing time: 12 h. 
The conductive part is separated from the gas tube of diameter d by a thickness e of 
PLA (Fig 18). All around the PLA-graphene electrode, 15 mm of PLA ensure the 
electrical insulation. The distance between high voltage electrode and gas outlet is 60 
mm. 8 plasma jets with six couples of parameters (d, e) were manufactured. d is in the 
set {2, 3 , 4 mm}; e in  {1, 1.5 mm}. 
  
Fig 18 Left, sectional view of the single-jet along z-axis at the position of the conductive part. Internal 
diameter of gas tube: d. Thickness of the PLA dielectric wall e. Right: view of the conductive part in 
PLA-Graphene, height = 2 mm. 
 
II.1.5 Manufacturing of multi-channel plasma-jet 
The single-channel plasma-jet has one disadvantage. Like the other plasma-jet, the area 
of plasma-skin interaction is very small (~1 mm). It is necessary to move the plasma-
device above the animal to treat the tumor or the wound. This can be an issue in terms 
60 mm 
2 mm 
High Voltage 
electrode 
gas inlet 
HV 
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of homogeneity and reliability if the movement7 of the device is not automated. A large 
nozzle with several channels was printed to address this problem. It was possible to treat 
large tumors (~ 8mm) without moving the mouse or the nozzle. The body of the plasma-
device was printed in PETG (Fig 19). Dielectric layer is made of blue resin 1060ES7 
(thickness = 1.4 mm). High voltage electrode is embedded in the resin. 
 
Fig 19 Left, view of a multi-channel plasma jet. The gas circulates in five rectangular channels 
(૚. ૞ × ૜ ࢓࢓). The high voltage electrode is placed 1.4 mm above these channels. The polymerized 
resin 1060ES7 made the dielectric layer and gas sealing. At the position of the nozzle each, channel 
is divided in two. The ten channels are distributed over a length of about 1 cm. Right, view of the 
nozzle facing a black paper stuck on the electrical ground. 
II.1.6 Manufacturing of refrigerated multi-channel plasma jet 
Excessive heating of the skin was observed in some in-vivo experiments. Several 
solutions can be envisaged8. It was chosen to refrigerate the whole device with liquid 
nitrogen whose boiling point is at −196 °ܥ at atmospheric pressure. A nitrogen tank was 
added to the printed part and filled with liquid nitrogen for about 10 min (Fig 20). Just 
before treatment, the liquid nitrogen was removed. Since the heat exchanges between 
plastic and helium is very efficient, the plasma jet was considerably cooled. Chapter V 
shows that the amount of thermal damage was considerably reduced with this device. At 
the bottom of the tank, heat exchange surface is a rectangular area  16 ݉݉ × 44 ݉݉. 
The entire device is cooled during 10 min. Fig 20 shows that the tank has already 
warmed up after 1 min of treatment. 
 
Fig 20 Left, view of the refrigerated multi-channel plasma jet. Right, infrared image of refrigerated 
multi-channel plasma jet after 1 min. The plastic in contact with the gas has a temperature slightly 
below 0 ° C (yellow color). 
                                               
7 It would be interesting to keep the plasma device at a constant distance from the skin. Since the 
tumors are curved, it would be interesting to tilt the plasma device. 
8 move the plasma source fast enough. Perform short and repeated treatments. 
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The contact of liquid nitrogen with the solid material at room temperature cause 
mechanical stress. However, the thickness of tanks walls (~3 mm) is sufficient to prevent 
them from breaking. The multi-channel plasma jet supports repeated cooling-heating 
cycles without damages, gas leaks or loss of electrical insulation. Frost is formed on the 
outside (Fig 21). This could be an issue9. It is even possible to follow how the multi-
channel jet warms up during the treatment. 
 
Fig 21 Left: multi-channel plasma jet after 1min. Right after 6 min, the warming of the device is 
clearly visible since the frost disapear in the heated area. 
The manufacturing process consists of four steps. 
 Printing of PETG parts (around 20 h) 
 One layer of Mylar (~ 50 µm) is taped to the surface to prevent the resin from 
blocking the channels. 
 A plastic bar with appropriate dimensions is covered with aluminium and fix 1.4 
mm above the Mylar layer (Fig 22).  
 The resin is added to constitute the insulator. After one day of polymerization, 
the device can be used. The thickness of the dielectric layer is equal to 1.4 mm. 
  
 
Fig 22 Refrigerated multijet, just before the addition of blue resin 1060ES7. Mylar is the yellow sheet. 
The rectangular bar which is covered with aluminium tape can be seen in the center. The space 
between the bottom of the bar covered by aluminium and the top of the channels covered by Mylar 
sheet is 1.4 mm. 
                                               
9 The buildup of melting ice near parts at high voltage can be dangerous. It is necessary to dry the 
device regularly. If water enters in gas channel, the discharge may not be able to ignite. 
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II.1.7 Mechanical supports 
In addition to plasma-device, many parts have been designed and manufactured. Fig 23 
shows five printed parts which have mechanical functions. They enable to choose the 
vertical and horizontal position of the plasma-jet relatively to the well. This is particularly 
important for the reproducibility, and the reliability of the experiments since the chemistry 
of plasma-liquid interaction strongly depends on the position (see Chapter III). I have 
tried to take into account the constraints10 imposed by the work in the sterile 
environment. For example, DBD supports do not block the flow of laminar hoods. 
 
Fig 23 In addition to the single jet visible in the foreground and the DBD visible in the background, 
many supporting parts (five in this picture!) were drawn and printed. 
II.2 Electrical characterization 
Voltage measurement was acquired with an Oscilloscope (WaveRunner 6 Zi, band-pass 
=2.5 GHz, Lecroy). Passive probes PP08 and PPE20kV provide respectively a /10 and 
/1000 attenuation.  
II.2.1 Power supply 
Three homemade generators were used for this work. They were made by Sebastien 
Thomassier during his internship in electronics engineering. The generator with a 
sinusoidal waveform is composed of three stages. The signal of a function generator is 
amplified by an audio amplifier which gives low voltage and high current signal. The 
output of the amplifier is connected to a transformer to obtain a high voltage and low 
current signal. 
 Sinusoidale generator, f = 500 Hz, maximum peak to peak voltage = 30 kV.  
                                               
10 in addition to the constraints of safety and ergonomics 
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 Sinusoidal generator, f = 10 kHz, maximum peak to peak voltage = 14 kV in 
continuous operation. The voltage can be increased to 18 kV for a few minutes. 
Excessive heating triggers the shutdown of the components. 
 A 500 Hz power supply whose voltage waveform is a kind of square with 
resonance peak (Fig 24). Maximum peak to peak voltage is 30 kV. Beyond, the 
electrical insulation of the transformer is insufficient. 
 
Fig 24 Waveform of the 500 Hz power supply. 
II.2.2 Power measurement 
A capacitor Cm is connected in series with the target of the DBD or plasma jet. The 
quantity of stored charges is known by measuring the Voltage Um at the terminals of this 
capacitor, with the relation  ܳ =  ܥ݉ × ܷ݉. The current flowing through the measuring 
capacitor is known according to the expression  ܫ =  ܥ݉ ௗ௎௠
ௗ௧
. 
DBD and DBD-plasma-jet can be modeled by a dipole D whose characteristics change 
over time depending on whether the plasma is on or off. The amount of energy E 
consumed from time ݐ = 0 to  ݐ = ߬ is defined by  ∫ (ܸ݈ܽ݅݉ − ܷ݉)ܫ݀ݐ
ఛ
଴ . 
The amount of charges ܫ݀ݐ flowing during dt starts at the potential ܸ݈ܽ݅݉ (with a potential 
energy ܸ݈ܽ݅݉ܫ݀ݐ). Theses charges cross the dipole D and reach electrical potentiel ܷ௠. 
At this point, potential energy is ܷ݉ܫ݀ݐ. The difference is the energy that the charges 
lose by crossing D (Fig 25). 
 
Fig 25  The capacitor Cm with a known capacitance is placed in series between plasma source and 
ground. It enables the measurement of the mean power consumption. 
Cm can be chosen so that Um is negligible with respect to Valim. In that purpose, the 
impedance of Cm must be negligible with respect to those of D. Regarding DBD; we can 
estimate an upper bound of D-capacitance. D is modeled by a capacitor representing the 
capacitance of the dielectric layer in series with the capacitance of the gas layer between 
the surface of the DBD and the counter electrode.  
Um 
Valim 
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By neglecting edge effect11, the capacitance of the dielectric layer is: 
ܥ݀݅݁ =
ߝ଴ߝ௥ܵ
݁
 
Where e is the thickness of the dielectric layer; S the area of conductive plate and ߝ଴ߝ௥ 
the absolute permittivity of the dielectric material. 
Numerical application in the case of a cylinder of radius 2.5 mm, thickness 1.4 mm 
made of resin 1060ES7: 
ܥ݀݅݁ =
଼.଼ହ ଵ଴షభమ× ସ.଼ × గ(ଶ.ହ ଵ଴షయ)మ
ଵ.ସଵ଴షయ
= 0.60 ݌ܨ, 
With the same approximation: an air slab defined as a cylinder of a radius 2.5 mm and 
thickness 1.5 mm has a capacitance of 0.17 pF. Since the capacitances are combined in 
series, the equivalent capacitance is of few pF. 
Lissajous curves enable to measure these values experimentally. The presence of 
plasma decreases the capacity of air slab. The measurements obtain from Lissajous 
curves, and the RLC-meter confirms this ordering. 
To conclude, this order of magnitude (few pF) is an upper bound of the equivalent 
capacitance D whatever the state of the discharge and the plasma-devices, since the 
geometrical parameters of the dielectrics are substantially the same. 
Since the impedance of a capacitor is  ܼ = ଵ
௝஼ఠ
, 
The approximation ܷ݉ ≪ ܸ݈ܽ݅݉ is valid12 if  ܥ݉ ≫ ܥ݀. A measuring capacitor of a few nF 
should be suitable for carrying out the measurement. This value correspond to those 
presented in the reference13 [89] which is a review of methodologies regarding DBD 
power measurement. 
With the approximation ܷ݉ ≪ ܸ݈ܽ݅݉, The amount of energy E consumed from 0 to ߬ is 
 
ܧ = ∫ ܸ݈ܽ݅݉ ܫ ݀ݐ
ఛ
଴ = න ܸ݈ܽ݅݉ ܥ݉ 
ௗ௎௠
ௗ௧
 ݀ݐ
ఛ
଴
, 
which gives for a period ߬ of electrical signal: 
 
ܧ = න ܸ݈ܽ݅݉ ݀ܳ(ݐ) = ∫ ܸ݈ܽ݅݉ ݀ܳ
ொ௠௔௫
ொ௠௜௡
ఛ
଴
. 
thus, when Lissajous curve is plotted, i.e., the curve with following parametric equation,  
(ݐ → (ݔ = ܷ݉(ݐ), ݕ = ܸ݈ܽ݅݉(ݐ)), 
E is also the internal area delimited by the parametric curve multiplied by Cm. 
                                               
11 Of course, in this case (e = 1.5 mm, for a disk of 2.5 mm radius), it is not correct to 
neglect the edge effects. It slightly increases the capacitance since the lines of fields are 
curved at the edges of the disk, polarizing a greater volume of dielectric. The reference 
[88] enables to take the edges effects into account. In previous configuration edge 
effects add a capacitance of 0.48 pF to Cdie. 
12 With the assumption that the impedance of the resistive part of D is negligible with 
respect to the capacitive part. This is confirmed by the fact that the transient electrical 
resistance attributed to plasma is ~1-1000 kΩ  
13  “Since the capacitance of typical actuators used in published studies is very low (5 pF to 200 pF), 
typical monitor capacitors are selected with a value between 10 nF and 330 nF. The capacitance is usually 
selected to provide a voltage that is adequately low for measurement by instruments.” [89] 
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II.2.3 Equivalent circuit of measurement system 
It will appear that the disturbances induced by the measuring system impose a more 
restrictive condition on Cm than  Cm ≫ Cd. Before the discussion of this point; it is 
necessary to model the measurement system. The voltage Um is measured with a 
passive probe connected to the oscilloscope (PP08, /10 attenuations). The probe 
enables to obtain an attenuation of the voltage in such a way that it becomes 
measurable by the oscilloscope. The electrical circuit modeling the measuring system is 
described in Fig 26. 
At low frequency, the circuit {probe + cable + oscilloscope} is equivalent to two resistors 
connected in series. Since input resistance is 1 MΩ, Rprobe should be 9MΩ to obtain a 
/10 attenuation. 
At high frequency, the characteristic time ߬ of the two circuits {probe} and {oscilloscope + 
cable} must be equal in such a way that the signal is not deformed. 
τ = R୮୰୭ୠୣC୮୰୭ୠୣ = R୭ୱୡC୭ୱୡ 
 
Fig 26 Modeling of the measuring system consisting of the probe and the oscilloscope. Cosc= 115 
pF. Capacitance of the cable = 100pF, input capacitance of oscilloscope = 15 pF . Rosc= 1 MΩ. 
Rprobe = 9 MΩ. The adjustable capacitor Cprobe enables to obtain a reliable attenuation at high 
frequencies. The capacity can be adjusted with a screw. 
Since  ܥ݋ݏܿ = 115 ݌ܨ, this relation imposes ܥ݌ݎ݋ܾ݁ = 12.8 ݌ܨ for a well-adjusted probe. 
The influence of the probe and the oscilloscope can be modeled as a capacitance Ceq 
and a resistance Req connected in parallel with Cm. An elementary calculation give 
Req=10 MΩ and Ceq= 11.5 pF (Fig 27). 
 
Fig 27 Equivalent circuit of the measuring system and Dielectric Barrier Discharge. 
II.2.4 How to choose the capacity? 
Let us consider what happens if D is a pure capacitor  ܥ݀ = 1 ݌ܨ. D contains no 
dissipative elements; the energy consumption is strictly zero over one period. 
Um 
Valim 
Um 
Valim 
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The Current flowing through D is 
݅݀ = (ܥ݉ + ܥ݁ݍ)
ܷ݀݉
݀ݐ
+
ܷ݉
ܴ݁ݍ
 
thus during one period, E is the sum of four integrals: 
ܧ = න (ܸ݈ܽ݅݉ − ܷ݉)݅݀ ݀ݐ
ఛ
଴
= න ܸ݈ܽ݅݉ (ܥ݉ + ܥ݁ݍ)
ܷ݀݉
݀ݐ
݀ݐ + න ܸ݈ܽ݅݉
ܷ݉
ܴ݁ݍ
݀ݐ − න (ܥ݉ + ܥ݁ݍ)ܷ݉
ܷ݀݉
݀ݐ
݀ݐ
ఛ
଴
ఛ
଴
ఛ
଴
− න
ܷ݉ଶ
ܴ݁ݍ
݀ݐ
ఛ
଴
 
The third integral is zero over one period. 
Consider that Valim is a sinusoidal signal of amplitude 15 kV at 500 Hz. In a first step, it 
is assumed that  ܥ݉ = 1 ݊ܨ. Note that Cm respects the condition  Cm ≫ Cd. The error 
which is made by neglecting the effect of the measuring circuit is calculated with an 
electrical simulation (Ltspice software). 
Order of magnitude:  
The absolute value of impedance is: 
ܼ݉ = ቚ
ଵ
௝஼ఠ
ቚ =
ଵ
ଶగ×ହ଴଴×ଵ଴షవ
= 3.2 × 10ହ ߗ,   ܼௗ = ቚ
ଵ
௝஼ఠ
ቚ =
ଵ
ଶగ×ହ଴଴×ଵ଴షభమ
= 3.2 × 10଼ ߗ 
ܼ(ܥ݁ݍ) = ቚ
ଵ
௝஼௘௤ఠ
ቚ =
ଵ
ଶగ×ହ଴଴×ଵଵ.ହ×ଵ଴షభమ
= 2.8 × 10଻ Ω,  ܼ(ܴ݁ݍ) = ܴ݁ݍ = 10଻Ω, 
 
Neglecting the effect of the measuring system is equivalent to take  ܴ݁ݍ = ∞, ܽ݊݀ ܥ݁ݍ =
ܱ. Consequently, at the first order of approximation  ܷ݉ = ܸ݈ܽ݅݉ ܼ݉
ܼ݉+ܼ݀
≅ ܸ݈ܽ݅݉
1000
 
ܧ = ܸ݈ܽ݅݉ଶ [න  (ܥ݉ + ܥ݁ݍ)
݀ ቀ
ܷ݉
ܸ݈ܽ݅݉ቁ
݀ݐ
݀ݐ + න
ܷ݉
ܴ݁ݍ ܸ݈ܽ݅݉
݀ݐ − 0
ఛ
଴
ఛ
଴
− න
ܷ݉ଶ
ܸ݈ܽ݅݉ଶܴ݁ݍ
݀ݐ 
ఛ
଴
] 
 
The second and fourth integrals are negligible compared to the first. Moreover, the fourth 
integral is of order 2 in  ܷ݉/ ௔ܸ௟௜௠, thus negligible with respect to the second integral. 
Consequently, an error of the order of ∫ ܸ݈ܽ݅݉
௎௠
ோ௘௤
݀ݐ
ఛ
଴  is commited by neglegtinc the 
effect of probe and oscilloscope. 
ܧݎݎ݋ݎ ≅ ∫ ܸ݈ܽ݅݉
௎௠
ோ௘௤
݀ݐ
ఛ
଴ =
ଵହ ଴଴଴మ
ଶ
ଵ
ଵ଴଴଴
ଵ
ଵ଴ళ
× ߬ = 22.5 μܬ  with ߬ = 2 ݉ݏ 
The measured power is less than the actual power from 22.5 × 10ି଺ × 500 = 11.3 ܹ݉. 
This error is far from negligible compared to the consumption of DBDs which is of the 
order of 100 mW with the same power supply. 
Simulation of electrical circuit: 
The software (LTspice® IV) is used to simulate the electrical circuit (Fig 28). D, Cm and 
ܥ݁ݍ are pure capacitance of 1 pF, 1nF and 11.5 pF respectively. The codes on the left 
are used to define the measurements made on the simulation. 
“real energy” is the integral of the power received by the dipole D during one period of 
power supply (between 8 and 10 ms). The simulation gives “real energy”= -2.5 10-13 J, 
this is the order of magnitude of the numerical error committed during the simulation. 
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 “measured energy” is the value of the energy consumed by the dipole D, that would be 
measured if the effect of the measuring system was not taken into account. The 
simulation gives “measured energy”= - 21.9 µJ. This value is greater than the numerical 
error and conforms to the order of magnitude obtained in the previous paragraph. When 
the power consumed by the DBD is of the order of 100 mW and elicit an underestimation 
of the power by approximately 10%. 
 
Fig 28  Left: line which enables to calculate power consumption if the effect of the probing system is 
taken into account or not. Right: simulated electrical circuit. 
This error can be corrected with a modification of the calculations. Another solution is to 
increase the value of the measuring capacitor. For example, with  ܥ݉ = 100 ݊ܨ, the 
“measured energy” is equal to -0.22 µJ which gives an error of -0.11 mW (which 
is  ≪ 100 ܹ݉). 
Finally, the choice of capacitance Cm is a compromise between the error due to probing 
system and the need to have a signal of sufficient amplitude for the oscilloscope. 100 nF 
is a good compromise because the amplitude at the terminal of Cm is 150 mV in the 
absence of plasma. 
Among the components available in the laboratory, some capacitor previously used 
show a strong sensitivity to thermal variation (1 nF for few °C). Subsequently, less 
temperature-sensitive capacities were selected (0.1 nF for 10 K over 100 nF). The 
capacitance was measured with a capacitance meter (accuracy of 0.1 nF); the value was 
used to perform power calculations. 
Power consumption is calculated in real time. The oscilloscopes used the software 
option “Xdev” which enables to perform the calculations. The code is written in Appendix 
K. After each acquisition; this code plots the integral function of instantaneous power. A 
temporal gate located at the end of acquisition window enables to record the energy 
consumption during one acquisition. The signal is acquired during the entire plasma 
treatment. The result is given as a mean value ±uncertainty. 
The acquisition time is 2ms (= one period of the 500 Hz generator). The acquisition rate 
is 25 MS/s. The voltage is represented with 8 bits of memory (i.e., 256 levels of voltage, 
since the signal is numeric). The size of the signal should cover the entire display to 
obtain the best accuracy. 
II.3 Chemical diagnostics 
II.3.1 Fluorometry 
A fluorometer is an instrument for exciting the molecules contained in a liquid at a given 
wavelength and to measure the fluorescence spectrum. The light source is a xenon 
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lamp. A monochromator enables to select the excitation wavelength λex. The bandwidth 
Δλex can be chosen by changing the opening of the input and output slits of the 
monochromator (Fig 29, left). Fluoromax-4 a fluorimeter from Horiba is used to carry out 
all the experiments. The excitation beam passes through a 4 ml cuvet in PMMA (Optical 
path of 1 cm with four optical faces). The emitted light is observed at right angle. Another 
monochromator enables to filter the emission spectrum. Emission wavelength and 
bandwidth are chosen: λem, Δλem. The light from the monochromator strikes a 
photomultiplier (Fig 29, right). 
The photons extract electrons from a thin metallic plate called photocathode, and then 
these electrons are accelerated by a potential difference. These electrons gain energy. 
One electron extracts secondary-electrons by striking successive dynodes. The optical 
signal has therefore been converted into an electrical signal and amplified. The relation 
between optical intensity and the electrical signal delivered by the photomultiplier is 
nonlinear when it exceeds 10 million counts per second (CPS). A photodiode captures a 
portion of the light exiting the excitation monochromator. The signal of this photodiode (a 
current in μA) is proportional to the luminous intensity. The signal of the photodiode thus 
makes it possible to compensate the evolution of the intensity of the xenon lamp (and its 
spectrum also) over time (heating, aging of the lamp). A signal is detectable when it 
exceeds the average noise level by 3 times the standard deviation of the noise around its 
mean value. 
 
 
Fig 29 Left: diagram of a monochromator, the wavelength to be observed is selected by rotating the 
diffraction grating (1200 line / mm). The bandwidth Δλ can be chosen by changing the opening of the 
input and output slits of the monochromator. Right: diagram of fluorimeter and photomultiplier. 
II.3.2 Quantification of Hydrogen peroxide produced by 
plasma 
The production of H2O2 was measured with two independent methods. The first use the 
conversion of titanium(IV) oxysulfate (TiOSO4) to a compound having a very high 
absorbance. The range of measurement is [25 µM; 5000 µM]. In the second, the 
production is quantified using Amplex red reagent. Amplex red react with H2O2 and an 
enzyme called horseradish peroxidase (HRP) to form the resorufin, a fluorescent 
compound. 
II.3.2.1 Titanium(IV) oxysulfate method 
Reagent. Titanium (IV) oxysulfate, TiOSO4 is an intermediate product in the synthesis of 
the titanium dioxide TiO2, a widespread industrial product. For example, TiO2 is used as 
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a pigment, a food additive (sometimes in nanometric form!), a catalyst for photolysis 
reaction. Titanium (IV) oxysulfate (TiOSO4) solution was obtained from Sigma-Aldrich 
(ref: 34244). In commercial solution, the concentration of TiOSO4 is close to 2 w% which 
corresponds to [TiOSO4] ~0.13 M. The reagent is stored in an acid medium. The manual 
indicates that the concentration14 of sulfuric acid is between 5 and 10 w%. TiOSO4 
solution is also called titanyl sulfate because Ti=02+, the titanyl ion, should exist in this 
solution. However, his existence was unproven in 1999 and remain controversial in 2008 
according to [90] and [91]. 
With this concentration of H2SO4, and according to the literature Ti(OH)3HSO4(aq) is the 
main species in the commercial solution of TiOSO4 [90]. As the kinetics of hydrolysis is 
very slow [90], these species remain after a dilution by ten15. Consequently, this is this 
chemical which is in the balance of the chemical equation (and not Ti4+). 
Reaction with H2O2. TiOSO4 reacts stoichiometrically with H2O2 and give peroxo-
titanium complex. The commercial solution is dilute by ten during the experiments; 
therefore the pH is close to 0.82 with the assumption that the strong acid is wholly 
dissociated.  In these conditions, according to [92], peroxo-titanium complex is 
Ti(O2)OH+. So, the complex formed is not H2TIO4 which would be a yellow solid formed 
after several days of reaction [92]. Consequently, the balance equation is: 
Ti(OH)ଷHSOସ(ୟ୯) + HଶOଶ(ୟ୯) = Ti(Oଶ)OH
ା
(ୟ୯) + HSOସ
ି
(ୟ୯) + 2HଶO(୪). 
For a preliminary experiment, a solution of H2O2 at 1.5 mM was prepared by diluting 3% 
hydrogen peroxide solution (Sigma-Aldrich, ref 88597) in demineralized water. 900 µL of 
this solution was mixed with 100 µL of the commercial TiOSO4 solution. The solution is 
yellow; its absorbance spectrum is plotted in Fig 30. 
In the same way, the blank is obtained by mixing 900 µL of water and 100 µL of TiOSO4 
solution. The peroxo-titanium complex has a maximum absorbance at 408 nm; this is 
consistent with [92] and [93]. 
 
Fig 30 Absorbance curve after an addition of 100 µL of the commercial solution of TiOSO4 to a 
solution of hydrogen peroxide in water (Volume of the sample: 900 µL,  [H2O2] = 1.5 mM). The 
maximum of absorbance is obtained for  ࣅ࢓ࢇ࢞ = ૝૙ૡ ࢔࢓. Optical path = 1 cm.  
                                               
14 7.5 %w corresponds to 0.76 M for sulfuric acid 
15 Several days would enable to add another OH group and form the thermodynamically stable 
product at this concentration of sulfuric acid 
Chapter II—Materials and methods  
42 
Protocol. For the quantification of H2O2, the protocol consists in mixing 900 μL of 
unknown sample (PAM), with 100 μL of the commercial solution of TiOSO4. The 
absorbance is then measured at 408 nm using a UV-line-9100 spectrophotometer in 
PMMA cuvet with 1 cm of optical path. The reaction is instantaneous. If dilutions are 
required to fall within the operating range, they are made in water. 
The buffered solutions used by biologists such as PBS (from Thermo Fisher-14200067) 
and RPMI (Thermo Fischer-31870017) cannot be used with this diagnostic. In this case, 
a precipitate is formed which give a turbid solution and disturb the measurements of 
absorbance (Fig 31). The precipitate is likely made of the salt NaCl and KCl. In [69] a 
different PBS containing 0.9 mM CaCl 2 and 0.49 mM MgCl 2 was used and no 
precipitation was observed. 
 
Fig 31 Left vial: 900 µL of PBS1X+100 µL of TiOSO4 (2 w%) solution. Right: same solution after 
addition of 1µL H2O2 3 w%. The white precipitate distorts the absorbance measurements. Attempts to 
eliminate by centrifugation and filtration have failed. 
Calibration curve. Hydrogen peroxide solutions were prepared by diluting 3 w% 
commercial solution in water. The concentration is in the range [100 µM ; 10 mM]. The 
previous protocol was used, solutions were made in duplicate. Above 5 mM, the 
absorbance is higher than 3 and spectrophotometer measurement does not work 
anymore (not enough intensity). Absorbance was plotted as a function of H2O2 
concentration in the sample (Fig 32). In the range [100 µM; 5 mM], the absorbance is 
proportionally linked to [H2O2]. The slope is 6.79e-4 µM-1 and R2= 0.99885.  
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Fig 32 Calibration curve of TiOSO4 diagnostic. Absorbance at λ= 408 nm as a function of [H2O2] in the 
900 µL sample. Cuvets contain 900 µL of the sample and 100 µL of the TiOSO4 commercial solution.   
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Interferences and stability. An interference with formaldehyde CH2O was reported in 
[94]. No interferences were reported for seven other species including acetone and 
methanol. Nitrites and nitrates interferences were tested. No significant interferences of 
nitrite and nitrate at 2 mM were found. This is due to the very high rate of reaction which 
forms a peroxo-titanium complex. The reaction between nitrite and H2O2, which occurs in 
acidic medium (like here), is rather slow [43]. That’s why there is no interference when 
nitrite is added. Peroxo-titanium complex is also stable for several hours according to our 
own experiments. 
II.3.2.2 Amplex red method for H2O2 quantification 
Reagent. Amplex red (10-Acetyl-3,7-dihydroxyphenoxazine, Fig 33) was purchased from 
Sigma-Aldrich (92001 Ampliflu ™ Red kit). There is 1 mg of reagent in each of the 10 
vials. A stock solution of Amplex red is prepared, by adding 388.7 µL of DMSO in a vial, 
leading to a 10 mM Amplex red solution. Stock solutions are protected from light and 
stored at 2-8 °C during one month. Amplex red may be used for in-vitro experiments. 
 
Fig 33 Structure of 10-Acetyl-3,7-dihydroxyphenoxazine (Amplex-red) 
Horseradish peroxidase (HRP) is isolated from horseradish roots (Amoracia rusticana). 
HRP is a single chain polypeptide containing four disulfide bridges. At least seven 
isozymes of HRP exist. HRP Type VI-A was from Sigma-Aldrich (6782-10MG), this is a 
lyophilized powder.The amount of enzyme is close to 300 units/mg solid. One unit forms 
1.0 mg purpurogallin from pyrogallol in 20 sec at pH 6.0 at 20 °C. 1 mg of HRP is diluted 
in 2 ml of deionized water. This solution was diluted by 10 in water. Twenty solutions of 1 
mL were prepared and stored in the fridge at - 20°C. Each aliquot contains 15 unit of 
HRP. 
Sodium azide (NaN3), cyanide, L-cystine, dichromate, ethylene thiourea, hydroxylamine, 
sulfide, vanadate, p-aminobenzoic acid, as well as Cd2+, Co2+, Cu2+, Fe3+, Mn2+, Ni2+, and 
Pb2+ ions are found to inhibit the enzyme activity. So, Azide, which is often used to 
scavenge nitrite, cannot be used with this diagnostic. 
II.3.2.2.1 Reaction with H2O2. Interferences and stability 
HRP form a complex with H2O2.  This molecule, HRP-H2O2, reacts stoichiometrically with 
Amplex Red and release resorufin, a fluorescent compound (Fig 34). This method has a 
higher sensitivity to H2O2 than the diagnostic which uses TiOSO4. Indeed, the range of 
detection of TiOSO4 is [100 µM; 5mM] whereas the following protocol gives [5 µM, 80 
µM]. 
Amplex red can be used in PBS whereas TiOSO4 causes precipitation. However, the 
selectivity of Amplex red is lower than those of TiOSO4. For instance, the five following 
dietary antioxidants induce an artifactual16 increase of fluorescence: Gallic acid, Ascorbic 
acid, (-)-Epicatechin, Quercetin and Vanillic acid [95].  
                                               
16 The interaction between HRP and antioxidants could explain some paradoxical observation: in 
some case adding an antioxidant increase the oxidation of AR to resorufin [95]. We have the 
impression to detect more oxidants by adding antioxidants... 
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Oxidation of Amplex red can be induced by exposure to light [96]. Ambient light or light 
use for measurement can induce this photooxidation. The residual resorufin in Amplex-
red stock solution is excited by the light and react with Amplex red which gives a new 
molecule of resorufin. Both NADH (b-nicotinamide adenine dinucleotide) and reduced 
glutathione (GSH) react with HRP to generate H2O2 that can subsequently oxidize 
Amplex-red [97]. This diagnostic must, therefore, be used with caution to quantify the 
production of H2O2 during in-vitro experiments [1]. 
 
Fig 34 Structure of resorufin. Excitation wavelength: maximum at 571 nm. Emission wavelength: 
maximum at 585 nm.   
II.3.2.2.2 Protocol and calibration curve 
Before the experiment, 1 ml solution of HRP 15 U/ml is diluted by ten in water or PBS 
leading to 10 ml at 1.5 U/ml (solution HRP-A). 50 µl of the 10 mM stock solution of 
Amplex red is diluted in 10 mL of water or PBS, leading to 10 mL at 50 µM (solution AR-
A). 
The following reagents are introduced in a fluorimetric cuvet with this order: 50 µl of 
HRP-A, 3 ml of water or PBS, 100 µL of AR-A, 50 µL of a sample containing H2O2 in the 
range [5 µM, 80 µM] and 1 ml of water or PBS (for homogenization). After 20 of min 
incubation in the dark: the fluorescence signal is detected with excitation wavelengths at 
571 nm and emission wavelength 585 nm. The final solution is characterized by the 
following concentrations: [ܣ݉݌݈݁ݔ ݎ݁݀]  =  1.25 μܯ and [ܪܴܲ] =  6.2 × 10ିଶ ܷ/݈݉. 
The solvent is the same to prepare the dilutions of the reagents and PAM samples. Fig 
35 shows the fluorescence signal in Count Per Second (CPS) as a function of [H2O2] in 
the sample. The fluorescence is acquired with the following set of parameters: excitation 
wavelength λex = 571 (bandpass Δλex= 1 nm) and an emission wavelength λem = 585 
(bandpass Δλem= 1 nm). The saturation of the signal is simply due to an excess of H2O2, 
and not to the saturation of the photomultiplier. 
0 100 200 300 400 500 600
0 k
50 k
100 k
150 k
200 k
250 k
Fl
uo
re
sc
en
ce
 (C
P
S
)
[H2O2] µM
 Fluorescence signal (CPS)
 
Fig 35  Fluorescence signal in CPS of Amplex-red reagent after reaction with HRP-H2O2 complex. λex 
= 571, Δλ= 1 nm,  λem = 585, Δλ= 1 nm. Time of acquisition: 3s (integration time = 0.1 s per measure). 
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Fig 36 shows the fluorescence signal in the range of concentration [5 µM; 200 µM]. 
Beyond 100 μM, the fluorescence no longer depends linearly on the amount of H2O2 
added. The fluorescence is acquired with the set of parameter (λex = 571, Δλex= 1 nm, 
λem = 585, Δλem= 2 nm). 
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Fig 36   Fluorescence signal in CPS of Amplex-red reagent after reaction with HRP-H2O2 complex. λex 
= 571, Δλ= 1 nm,  λem = 585, Δλ= 2 nm. Time of acquisition: 3s (integration time = 0.1 s per measure), 
10 accumulations. 
In the last version of the protocol, the excitation and emission slits have respectively 1 
nm and 5 nm bandpass. The concentrations and the volumes used to prepare the 
dilutions are the same than those of the previous paragraph. Each acquisition lasts six17 
seconds. Care must be taken to avoid the saturation18 of the photomultiplier. On Fig 37, 
a calibration curve is acquired in triplicate. Error bar represents the standard deviation. 
The error bar is smaller than the size of the dots for six points. The signal represented 
(S1/R1) is the ratio of the signal of the photomultiplier in CPS by the signal of the 
reference photodiode in µA. The calibration curve must be done for each experiment at 
the same time as the samples. 
Y = 45003*X + 1.282e+006
 
Fig 37 Example of calibration curve obtained with standard solutions of H2O2, S1/R1 in CPS/µA as a 
function of [H2O2]. According to the standard protocol: λex = 571/1 nm, λem = 585/5 nm, acquisition 
time = 6 s (60 points, integration time of 0.1 s per point). The calibration protocol was repeated for 
each experiment (same incubation time, similar handling conditions and light exposure...). 
                                               
17 The 60 measurement points are acquired in 6 s, integration time of 0.1 s for each point. 
18 which occurs when the signal is greater than 107 CPS 
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II.3.3 Measure nitrite and nitrate concentrations 
There are several commercial kits for measuring the concentration of nitrite in a liquid, in 
an extracellular sample or intracellularly. Most kits producing a fluorescent compound 
are based on the transformation of 2,3-diaminonaphthalene (DAN) in 2,3-naphthotriazole 
(NAT), a highly fluorescent product in acidic condition. The kits based on an absorbance 
usually use Griess reagent or one of its variants. In all cases, the reaction has a step in 
acidic medium. Griess reagent is a blend of sulfanilic acid and 2-Naphthylamine. At low 
pH, nitrous acid HNO2 reacts with sulfanilic acid to form a diazonium (Fig 38). 2-
Naphthylamine reacts with this diazonium (diazo-coupling) to form a compound 
absorbing in the visible. 
 
 
Fig 38 Chemical reactions of Griess assay. The sulfanilic acid reacts with nitrite in acidic conditions. 
Scavenger 
Two scavengers are usually used against nitrite: sulfamic acid and Sodium Azide. It is 
better to avoid putting these species in solution when the plasma is on because they can 
interfere with short-lived RONS. For example, according to [98], the reaction between 
Azide19 and ozone can be used to synthesize peroxynitrite. 
II.3.3.1 Dealing with Griess Reagents interference 
The reagent used is a blend of Griess reagent and concentrated acetic acid (Sigma-
Aldrich, 03553-100mL). A nitrite solution at 10 µM was prepared by diluting the 
commercial solution at 0.1 M in demineralized water. The absorbance spectrum of the 
compound is measured by UVLINE 9100 spectrophotometer (Cloup®, Fig 39). The 
sample was made by mixing 975 µl of 10 µM nitrite with 25 µl of the Griess reagent 
commercial solution. The blank is obtained by mixing 975 µl of water with 25 µl of Griess 
reagent. The absorbance peak is at 522 nm.  
                                               
19 This product is particularly dangerous because of its high toxicity, and its ability to generate 
explosive compounds. 
Sulfanilic acid diazonium 2-Naphthylamine 
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Fig 39 absorbance spectrum of a nitrite solution (10 µM). 
The reaction kinetics was studied to develop the diagnostic. Standard solutions of nitrites 
were prepared. 975 µl of these solutions were mixed with 25 µl of Griess reagent. The 
absorbance was measured 10 min or 30 min after the mixing at a wavelength of 522 nm. 
Blank solution was prepared by mixing 975 µl of water and 25 µl of Griess reagent. Each 
sample is measured twice in 4 mL cuvet with four optical faces. Each cuvet is rotated by 
90° between the two measurements denoted “A” and “B” in Fig 40. 
It appears that the solution did not reach a steady state after 10 min of incubation since 
the absorbance at 30 min is significantly higher than those at 10 min. 
 
Fig 40 Absorbance at 522 nm measured 10 or 30 min after mixing as a function of the amount of 
nitrite in the cuvet. 25 µL of Griess reagent + 975 µL of nitrite solutions. 
 
Moreover, it appears that the difference of the absorbance measured at two different 
times (10 and 30 min) and in the same cuvet is proportional to the concentration of 
nitrite. Indeed ߂ܾܽݏ =  ܣܾݏ(30 ݉݅݊) –  ܣܾݏ(10 ݉݅݊) plotted in Fig 41 is a line, the kinetics 
of the reaction should be of order 1 relatively to nitrite concentration. 
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Fig 41 ࢤࢇ࢈࢙ =  ࡭࢈࢙(૜૙ ࢓࢏࢔) –  ࡭࢈࢙(૚૙ ܕܑܖ) as a function of nitrite concentration. The line mean 
that the kinetics is of order 1 with respect to [NO2-]. 
The absorbance of the cuvet containing 30 nmol of nitrites was followed over time (Fig 
42). It is clear that the steady state is not reached, even after 80 min of reaction. 
Consequently, the protocol must be modified since it is easier to obtain a reliable and 
sensitive measurement when the stationary state of the dosing reaction is reached. 
 
Fig 42 Kinetics of Griess reaction 50 to 80 min after the mixing. Absorbance at 522 nm as a function 
of time. The cuvet contains 30 nmol of nitrite. Total volume = 1 mL, volume of Griess reagent = 25 µL. 
A slow reaction is not an issue when the probed product is stable. In the context of 
plasma-liquid interaction, the nitrites react with H2O2 in acidic medium to form 
peroxynitrite that quickly gives nitrate and hydroxyl radicals. Consequently, it is 
preferable to have a faster reaction to minimize this bias. The speed of reaction is 
increased by multiplying the amount of Griess reagent by four so that the reaction 
reaches the steady state after only 15 min (Fig 43). 
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Fig 43 Absorbance at 522 nm as a function of time. 30 nmol of nitrite in the cuvet, total volume = 1 
mL, volume of Griess reagent = 100 µL. The concentration of Griess reagent is greater than in the 
previous experiment consequently the reaction reaches a steady state in less than 15 minutes. 
The operating range of the diagnostic was determined: 100 µL of Griess reagent was 
mixed with 900 µl of standards samples. The absorbance was measured at 522 nm after 
20 min of incubation (Fig 44). It appears that the range of nitrite concentration which 
gives a linear response is between 0 and 60 µM (red dots). An uncertainty20 of 0.010 can 
be attributed to each measure. Since the sample of concentration [ܱܰଶି]  =  1 μܯ has an 
absorbance of 0.035 which represents three times the level of uncertainties, we can 
define the operating range of the diagnostic with the interval [1; 60 µM]. 
 
 
Fig 44 Absorbance after reaction with nitrite in deionized water. Absorbance of nitrites samples (522 
nm) as a function of the nitrite concentration contained in the 900 µL sample. 100 µL of Griess 
reagent was added 20 min before absorbance measurement. The red dots are in the range of linearity 
of the diagnostics, not the blue ones. 
PAM contains H2O2. The addition of 100 µL of Griess reagent containing concentrated 
acetic acid decreases the pH (pH~2). At low pH, the peroxynitrite formation reaction is 
significantly accelerated21 [99]. Consequently, it is necessary to study if the presence of 
H2O2 interferes with the diagnostic or not. Solutions containing nitrites and hydrogen 
peroxide were prepared. The concentration of H2O2 is 2 mM. This is ten times the typical 
concentration obtains after treatment of 4 min (Chapter III). Nitrite concentration is 
                                               
20 this value is obtained by repeating the measurement in several cuvets containing the same 
solution. The standard deviation of the distribution was ~10ିଶ.   
21 since the speed of the reaction which form peroxinitrite is proportional to [H+]. 
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chosen in the interval [1 µm; 80 µM]. The previous protocol of measurement was used. 
Three groups were prepared and measured (Fig 45). 
The red dots correspond to pure nitrite samples. The black dots correspond to the 
samples which contain H2O2 and nitrite. The protocol of measurement started just after 
the mixing of the two species: Griess reagent was added at the same time than H2O2. 
The blue dots correspond to the samples which contain H2O2 and nitrite. In this case, 
the protocol was started22 60 minutes after the mixing. 
Since the blue dots are below black and red dots, it appears that the presence of H2O2 
disturbs the protocol. This supports the assumption that H2O2 destroyed nitrite to 
produce peroxynitrite before the production of the diazonium. The fact that the blue dots 
are slightly below23 the black ones show that nitrites are destroyed, even at higher24 pH. 
[NO2-] µM
in the sample of 900 µL
0 20 40 60 80 100
0.0
0.5
1.0
1.5
2.0
NO2
- in water
NO2- + 2 mM H2O2 + 60 min of incubation
NO2- + 2 mM H2O2 + 0 min of incubation
 
Fig 45 Absorbance of the samples at 522 nm as a function of nitrite concentration. Red : nitrite 
without H2O2, Black : [H2O2]= 2 mM, Blue : [H2O2]= 2 mM + 60 min of incubation before the addition of 
Griess reagent. 
The interference with H2O2 is avoided by adding Catalase enzyme in the liquid before the 
addition of Griess reagent (10 µl of a solution prepared by the dissolution of 10 mg in 1 
mL). Another solution is to use diluted solutions of nitrites in buffer (PBS 1X or 10X) that 
will prevent the pH from falling too much. 
Fig 46 the red dots represent the absorbance of the pure nitrite solutions in PBS. The 
blue dots correspond to the solutions containing nitrites and H2O2 (2 mM). The protocol 
was initiated after 60 min incubation of the mixing of H2O2 with NO2-. 
The fact that the two sets of points are on the same line show that the interference due 
to the presence of H2O2 has been avoided. PBS enables to obtain a pH~4 (rather than 1-
2) after the addition of Griess reagent. The pH is low enough to produce the diazonium 
at a significant rate in such a way that the production of peroxynitrite is negligible 
compared to diazonium production. The slope of the calibration curve enables to know 
the concentration of nitrite. It was also checked that nitrates do not form a colored 
compound with Griess reagent. Finally, this protocol is specific for NO2- with respect to 
NO3- and H2O2 in the range [1, 60 µM]. Similarly, it has been shown that the addition of 
                                               
22 which means that 100µL of Griess reagent are added to 900 µL of sample. 
23 except two points attributable to an experimental error 
24 but at a much lower rate of what is observed in acidic conditions 
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Catalase mentioned above does not disturb25 the measurement. The protocol obtained is 
specific for nitrites. 
Calibration curve of nitrite in PBS 1X
with or without H2O2
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Fig 46 Absorbance at 522 nm as a function of nitrite concentration. Red dots: solutions of nitrite in 
PBS 1X. Blue dots: [H2O2]= 2 mM + 60 min of incubation. Since the pH does not decrease too much, 
the reaction producing the peroxynitrites (and destroying the nitrites) is kinetically disadvantageous 
compared to the reaction which forms the diazonium. 
II.3.3.2 Quantification of nitrate 
In the previous section, we explained how and especially why it was necessary to adapt 
the nitrite measurement protocols. The problem arises in the same form regarding the 
determination of nitrates, since the majority of the kits transform the nitrates into nitrites 
before dosing them. 
Standard solutions are prepared from sodium nitrate powder (Sigma-Aldrich, ref S5506-
250G-D). The solubility is about 1kg/l in water. Culture media such RPMI-1640 contains 
nitrates. Consequently, the quantification of the production due to plasma-liquid 
interaction may be inaccurate in such media. 
Nitrate reductase method (kit Sigma-Aldrich) 
Material. Nitrite/Nitrate Assay kit was obtained from Sigma-Aldrich (23479). This kit was 
used in accordance with manual instructions with the exception of two points. First, 
catalase (C1345, Sigma-Aldrich) was added to the sample to destroy H2O2 and avoid the 
formation of peroxynitrite from H2O2 and nitrite. Second, 300 µL of PBS 1X were added 
just before the measurement of absorbance to obtain a sufficient volume to fill the cuvets 
of the spectrophotometer (UV-line 9100, Cloup®). 
Protocol. First PAMs are prepared for several sets of parameters (time, height above 
the liquid, voltage, He flow). Then, 10 µL of a solution of bovine liver catalase (10 mg/ml) 
is added to destroy H2O2. Quantification of nitrites is done independently using the 
protocol described in the previous section using the Griess reagents for microscopy. 80 
µL of PAM diluted in the buffer for reaching the range of measurement are mixed with 
Nitrate Reductase and co-factor. In the process, ܱܰଷି is converted to ܱܰଶି by the 
enzyme Nitrate Reductase. After 2h of incubation at ambient temperature Griess 
                                               
25 Unless the concentration of Catalase is too high, but the value mentioned in the text enables to 
destroy the H2O2 produced by the plasma in a few minutes without disturbing the absorbance 
measurement. The calibration curves were redone. 
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reagents are added. The absorbance at 540 nm is given by the UV-line9100 
spectrophotometer. The result is the sum of nitrite and nitrate concentration. The 
calibration solutions are included in the kit. 
Electrochemistry 
pH measurements were made with a glass electrode (Consort, ref: SP10B). Some 
concentration of nitrate was measured with an ion selective electrode (CONSORT, ref: 
ISE31B). The range of measurement is [6 µM; 1M]. Following species cause 
interferences: I-, ClO4-, CN-, BF, NO2-. This electrode has a polymer membrane, which 
consists of ion-exchange materials in an inert matrix: PVC or polythene. The potential at 
the membrane surface is related to [NO3-]. We noticed that the interference of nitrite 
could be corrected if [NO2-] is known. The major drawback is that the time required to 
measure one point is particularly long (several minutes + time of cleaning of the probe 
between each point). This diagnostic confirmed the measurements obtained with the kit 
of Sigma-Aldrich. 
II.3.4 Quantification of hydroxyl radical produced by plasma 
II.3.4.1 Terephthalic acid (TPA) method 
Terephthalic acid (TPA) (ref 185361) and 2-hydroxyterephtalic acid (ref 752525) were 
purchased from Sigma-Aldrich. A fluorometer (fluoromax-4 from Horiba) was used for 
fluorescence measurement. Fig 47 shows the balance of the reactions which occurs 
between terephthalic acid, a non-fluorescent compound, and hydroxyl radical. The main 
product is 2-hydroxyterephtalic acid (TPA-OH) which is a fluorescent compound with an 
excitation wavelength of 317 nm and an emission wavelength at 433 nm.  
 
 
 
Fig 47 Left: balance equation of the hydroxylation of terephthalic acid (TPA) to 2-hydroxyterephtalic 
acid (TPA-OH). Right: cuvet filled with a solution of TPA in KOH treated by plasma. [OH-]=20 mM and 
[TPA] =4.1 mM. LED emits at 315 nm with a bandpass of 10 nm. Before plasma treatment, no 
fluorescence is visible. After treatment, the fluorescence is clearly visible. The measurements are 
made in PMMA cuvets 
Standard solutions are prepared with 2-hydroxyterephtalic acid (TPA-OH). KOH 
solutions are added to the samples so that the pH is the same in samples and standard 
solutions. Excitation and emission spectra were acquired to optimize the sensitivity by 
selecting the excitation and emission wavelengths. Excitation spectrum is plotted in Fig 
48. The central wavelength of excitation is changed while emission wavelength is fixed at 
Terephthalic acid (TPA) 2-hydroxyterephtalic acid  
(TPA-OH) 
λmax= 315 nm, 
bandwith = 10 nm 
Non-fluorescent Fluorescent 
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434 nm. This curve answer to the question: what wavelength is the most effective to 
excite the targeted molecule? 
Since the spectrum of the xenon lamp exciting the medium is not flat, the fluorescence 
signal (in CPS) at one wavelength is divided by the reference signal (in µA). The 
reference signal is acquired with a photodiode measuring a fraction of the light at the 
output of the excitation monochromator. For small wavelengths (λ<240 nm) the intensity 
emitted by the xenon lamp is so small that the signal reaches the level of the noise. This 
can explain why the fluorescence signal (in CPS/ µA) is noisy at low wavelength (Fig 48). 
The mean value of the signal is high at small wavelength. This is probably explained by 
the fact that the electrical delivered by the photomultiplier has a small offset (due to dark 
current). Consequently, the signal at small wavelength comes from the noise and has no 
chemical sense. It also appears that the most efficient wavelength for exciting TPA-OH is 
318 nm. 
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Fig 48 Excitation spectrum of TPA-OH. The central wavelength of excitation is changed while 
emission wavelength is fixed at 434 nm. The signal at small wavelength is probably due to noise and 
has no sense. For wavelength higher than 250 nm, the signal is significant. Thus, the most efficient 
wavelength for exciting TPA-OH is 318 nm. 
The emission spectrum is plotted in Fig 49. The central wavelength of emission is 
changed while excitation wavelength is fixed at 310 nm. This curve is an answer to the 
question: what wavelength is the most effective to obtain the best sensitivity and 
selectivity of the fluorescent molecule?  
Since a fixed wavelength is used, it is possible to represent only the response of 
photomultiplier as a function of excitation wavelength, without dividing it by reference 
signal. Moreover, it appears that the signal delivered above 10 million CPS is no longer 
linear. So, it is careful to plot some values in CPS to avoid the saturation. The maximum 
emission is found at 435 nm; this is consistent with reported value. The 
excitation/emission couple chosen is therefore 317/435 nm with bandpass Δλ= 5 nm for 
excitation and emission. Up to one day, the fluorescence of the solutions did not evolve 
significantly when the solutions are stored at 4 °C in the dark. 
due to 
noise. 
ߣ௠௔௫ =  318 ݊݉ 
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Fig 49 Emission spectrum of TPA-OH. The maximum emission wavelength 435 nm. 
II.3.4.2 Which calibration? 
The Fenton reaction is the reaction that occurs between Fe2+ and hydrogen peroxide and 
releases hydroxyl radicals HO° (Fig 50). This reaction26 is often used to explain why 
some RONS, which are not very reactive (like H2O2) can induce severe damage to living 
organisms. In fact, the situation is not so simple since the metal atoms at the origin of the 
homolytic rupture of the O-O bonds in ܪଶܱଶ are often linked or even chelated by many 
biological molecules. It turns out that it is not obvious to guess if these interactions speed 
up or slow down the Fenton reactions [100]. Here, the question is to known if it is 
relevant to use this reaction in calibration purpose27.  
 
Fig 50 The Fenton reaction. The oxidation of Fe2+ in Fe3+ enables fast production of HO° from H2O2. 
At first sight, this reaction to look like a very convenient method and some experiments 
were done to test this idea. The solutions whose compositions are indicated below have 
been prepared in spectroscopic cuvets:  
 500 µL of TPA solution at a concentration of 4.1 mM,  
 a volume V of ܨ݁ଶା solution diluted in demineralized water with [Fe2+] = 200 µM 
and V in the range [5; 500 µL].  
 The same volume V of a hydrogen peroxide solution diluted in demineralized 
water with [H2O2 ]= 200 µM. 
 1500 − 2ܸ μܮ of demineralized, so that the final volume is 2 mL. 
 
                                               
26 and the Fenton-like reactions which take place with another metal atom, for example Cu. 
27 The question arises from a discussion with one of our Japanese colleagues who claims that his 
measurement was “obviously” valid since the Fenton reaction was used to calibrate the 
diagnostic. 
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The experiments were done in triplicate. Fluorescence measurements were made after 
10 min of incubation. Fluorometer parameters are λex=317 nm, λem=435 nm, Δλ= 5 nm 
for excitation, emission and bandpass. Fig 51 shows the fluorescence signal as a 
function of the amount of H2O2 introduced.  
It appears that the reproducibility of the triplicate is excellent. The value of the 
fluorescence is in the range of linearity of the photomultiplier with the exception of the 
last point28. The six other points are in the range of linearity. The slope is 30 kCPS/µA 
per nmol of ܪଶܱଶ introduced in 2000 µL which represents a slope of 60 kCPS/µA/µM in 
terms of concentration. With such characteristic (linearity, sensitivity), Fenton's reaction 
seems very attractive and therefore some group use Fenton reaction for calibrations 
purpose. However... 
Y = 30432*X + 81453
 
Fig 51 fluorescence signal in CPS/µA as a function of the amount of H2O2 or Fe2+ introduced in 
solution. The slope of the linear fit is 30432 CPS/µA/nmol. In order to compare this value with the 
other calibration method, it is interesting to have the slope as a function of the concentration of H2O2 
introduced in 2 mL. it would be [TPA-OH] if all the reactions (Fenton and hydroxylation) had a yield of 
100%. Slope is: 60864 CPS/µA/µM 
However, this approach failed because Fenton reaction does not produce only free HO° 
radical [101], [102]. HO° stay in the vicinity of Fe ions. The relevant reagent is a complex 
of Fe whose one of the water molecule is replaced by HO°. These complexes also have 
strong oxidizing properties, but, unfortunately, their reactivity is quite different from those 
of free HO° and explained the rate of Fenton reaction [103]. 
Saran et al. show that these complex considerably changes29 the reactivity during the 
hydroxylation of terephthalic acid [102]. It appears that the reaction which produces TPA-
OH from TPA is a multi-step reaction. One of these steps implies the oxidation of the 
aromatic ring by dissolved oxygen. The yield of formation of TPA-OH change when 
oxygen is replaced by one of these complexes. Moreover, the rate of reaction becomes 
sensitive to pH (Fig 52), and manual mixing of the component can induce concentrations 
inhomogeneity which modify the yield [104]. 
Consequently, even if the yield30 of the reaction “TPA + free radical HO°” is known; since 
radiolysis experiments produced free HO° like the plasma-liquid interaction. The 
calibration with Fenton reaction is false because they are unable to reproduce the yield 
of reaction between TPA with free HO°. 
 
                                               
28 signal of photomultiplier is close to 12 millions of CPS, that give 1.8 million (CPS/µA) 
29 Compare to the reactivity observed with the free HO° produced by ߛ − ݎܽ݀݅݋݈ݕݏ݅ݏ 
30 35% in the presence of oxygen according to radiolysis experiments [105] 
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Fig 52 Figure and legend adapted from the work of Saran et al. [102]. It appears that the 
hydroxylation of terephthalic acid by crypto-OH° (e.g., the radical constituted by the bonding of OH° 
to the metal atom having catalyzed the breaking of the O-O bond) strongly depends on pH whereas 
hydroxylation by free OH° is almost independent of pH. The curve for free OH° (triangles) was 
obtained by gamma-irradiation of TPA-containing 50mM phosphate buffer; that for crypto-OH° 
(circles) by injecting boli of 8 µM FeSO4 into phosphate buffer containing 460 µM TPA; pH was 
adjusted by mixing Na2HPO4 and NaH2PO4. 
The solution is to calibrate the fluorescence measurements with TPA-OH solutions. By 
doing this, the fluorescence signal obtained can be associated with the amount of TPA-
OH present in solution. 
Standards samples were prepared from TPA-OH (ref 752525), a yellow solid.  
19.6 mg of TPA-OH (182.13 g/mol) was dissolved in 250 mL of deionized water. We 
obtain a 0.43 mM solution. Standard solutions were prepared by dilution of this solution 
in a KOH solution (20 mM) in water. Fluorometer parameter are λex=317nm, 
λem=435nm, with Δλ= 5 nm for excitation and emission. S1/R1 signal of standard 
samples (i.e., the ratio of photomultiplier signal and reference photodiode signal, section 
II.3.1) is plotted on Fig 53. There is a linear relationship between the concentration of 
TPA-OH and fluorescence up to 3 µM. The slope31 is 601 000 CPS/µA/µM. At higher 
concentration than 3 µM, the fluorescence increases nonlinearly and then decreases32. It 
is found that the slope of this curve is ten times the slope of the curve obtained with the 
Fenton reaction, which means that the succession of Fenton and hydroxylation reactions 
has a yield of the order of 10%.  
 
This is the experimental confirmation that the use of the Fenton reaction should be 
avoided for calibration purpose. At this point, the reader should notice that we do not 
have a calibrated diagnostic of the hydroxyl radical. The yield of the reaction which 
produces TPA-OH from TPA and HO° is still to be discussed. At first glance, the solution 
seems simple too: the efficiency of the reaction was measured during the radiolysis 
experiment, and for our working conditions (saturated solution in air) the yields should be 
around 35% [106]. 
However, it turns out that the question of the yield is more complex than expected. We 
will see that plasma-liquid interaction experiments do not produce HO° in the same 
                                               
31 the experiments presented in section III.5.3 are made with another brand of optical cuvet, in this 
case: the slope of the calibration curve is: 426885 ± 7522 CPS/µA /µM of TPA-OH 
32 This decrease is probably due to self-absorption: the wavelength of emission of TPA-OH 
molecule is immediately reabsorbed by the fluorophore itself. 
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range of concentrations than water radiolysis. Since the rate of recombination of HO° 
depends greatly on this concentration, we will see that a sufficient concentration in TPA 
should be chosen to avoid that the reaction producing TPA-OH loses the competition 
against the recombination reaction of two hydroxyl radicals. We will see that what 
appeared at the beginning as an additional complexity, enables obtain information on the 
liquid phase over the lifetime of HO° (few ns). This discussion is exposed in section III.5 
(page 82). 
601426 ± 23660
 
Fig 53 fluorescence signal S1/R1 of standard samples as a function of [TPA-OH]. There is a linear 
relationship between TPA-OH concentration and fluorescence signal up to 3 µM. For higher 
concentration fluorescence increases nonlinearly and then decreases. This decrease is probably due 
to the self-absorption of TPA-OH molecule. 
II.4 In vitro experiments 
These experiments took place at hospital Pitié-Salpêtrière in the team of François 
Lemoine from CIMI laboratory (CIMI-Paris - UPMC UMRS CR7, INSERM U1135, CNRS 
ERL 8255). 
II.4.1 Cell Number 
In vitro experiments were performed with two cell lines: TC1 and NR-S1. TC-1 cell line 
(CRL-2785; American Type Culture Collection [ATCC]) is an immortalized, C57Bl/6-
derived, mouse epithelial cell line that expresses HPV-oncoproteins E6 and E7. NR-S1 
cells were derived from a spontaneous oral carcinoma in C3H mice. These cells do not 
express HPV-16 oncoproteins [107]. More information can be found about the lines in 
the references [108]–[110]. 
The cells were plated in 12 or 24 wells plastic plates (Costar®) at a density of 30 000 
cells/well (24-well plates) and 60 000 cells/well (12-wells plate). Cells were grown for 24 
hours at 37°C, 5% CO2. Cultures were performed in complete culture medium that 
corresponds to Roswell Park Memorial Institute RPMI-1640 medium containing 10% 
Fetal Bovine Serum (FBS) and supplemented with 100 U/ml penicillin, and 100 µg/ml 
streptomycin (Invitrogen). Before treatment, the cells received fresh medium. 
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The “direct” treatment consists of exposing the well containing the cells to the plasma-jet 
or the DBD. The “indirect” or “PAM” treatment consists of replacing the culture medium 
by a medium previously treated by plasma. The “chemical treatment” designate the fact 
to expose the cells to combinations of nitrites and hydrogen peroxide prepared from 
standard solution. 
After treatment, cells were grown for 24, 48 or 72h at 37°C, 5% CO2 and 95% O2. After 
this incubation, the medium was removed, and the cells were treated with trypsin at 
37°C. Trypsin action was stopped by adding FBS before the samples were centrifuged, 
washed and counted. The trypan blue exclusion technique was carried out (10% trypan 
blue). The numbers of stained and unstained cells were counted by using Malassez cell. 
Dead cells take up the stain, whereas living cells do not. 
II.4.2 Plasma-jet, DBD or chemicals treatment 
Plasma-jet 
The plasma-jet device used for all the in-vitro experiments is the single-channel jet 
described in Chapter II.1.4 (see Fig 17 and Fig 18). We use the square power supply at 
500 Hz AC. Peak to peak Voltage is 19.5 kV or 30 kV. Height above the liquid is 1.7 or 
9.7 mm (linear translation stage at ± 10 µm). He flow rate is 200 or 400 sscm. The 
chemical yield H2O2 is around 2 nmol/J. Power consumption was measured in real time, 
which enables to obtain precisely the targeted energy (and so H2O2 concentration, see 
Chapter III, section H2O2). Treatment times between 30 and 300 s are chosen to reach 
the targeted energy with an uncertainty of the order of 2 J. 
 
Fig 54 experimental setup for in-vitro and chemistry experiments 
Experiments with the DBD 
The Dielectric Barrier Discharge (DBD) used in the in-vitro experiments is described in 
section II.1.3. Few modifications are made to the experimental set-up. Due to the size33 
of the DBD, it is necessary to work with 12-wells plates (instead of 24). Consequently, 
                                               
33 In fact the plasma source is compatible with the wells of 24-well plates. However, in these 
conditions a part of the discharges occur between the edge of the DBD and the plastic walls of 
the well. Since not all discharges reach the surface of the liquid, it is likely that the concentration 
of chemical species produced in the liquid phase would have been very different for the same 
power consumed. In addition, this situation poses problems of experimental reproducibility. Hence 
the choice of larger wells. 
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the number of cells per well has been doubled (60 000 cells 1 days before treatment). 
The volume of medium is also doubled in such a way that the cells have the same 
amount of nutrients as the cells located in the 24-well plates. 
Additions of chemicals 
The chemicals were prepared from the commercial solution of nitrite at 0.1 M (Sigma 
Aldrich, ref 72586) and 3w% h hydrogen peroxide solution (Sigma Aldrich, ref 88597). 
II.5 In vivo experiments 
II.5.1 Collaboration with CIMI laboratory 
These experiments were done at hospital Pitié-Salpêtrière in the team of F Lemoine from 
CIMI laboratory (Sorbonne Universités, UPMC/Paris 06, UMR-S INSERM U1135, CNRS 
ERL 8255, Center d’Immunologie et Maladies Infectieuses (CIMI-Paris), Paris, 
France). 
Mice 
Seven- to 8-week-old female C57BL/6 mice were purchased from Janvier (Le Genest 
Saint Isle, France) and kept under specific pathogen-free conditions at the UMS28 
animal facility (UFR 969, Pitié-Salpêtrière). Experiments were performed according to 
the European Economic Community guidelines and approved by the local ethics 
committee. Mice were anesthetized with 2 % (v/v) isoflurane in medical air at 1 l/min. 
Tumor model 
C57BL/6 mice were injected with 5.104 TC-1 cells. Cells were subcutaneously (SC) 
implanted into the flank of animals or in the cheek of the animal. Mice were monitored 
every two days for tumor progression and individual weight. Tumor growth was 
determined using a caliper and according to the formula: (௟௘௡௚௧௛×௪௜ௗ௧௛
మ)
ଶ
, which is an 
approximation of the volume of an ellipsoide. Mice were sacrificed when tumors reached 
volumes of 2000 mm3 (respectively 800 mm3 if the tumor is in the cheek) or when body 
weight loss is more than 10%  
For the sake of simplicity, the precise protocol of each experiment is described in 
Chapter V before the exposure of results. Some experiments were done with an inhibitor 
of catalase. Catalase is a very efficient enzyme whose function is to remove H2O2. Since 
one of the key species which could be implied in the therapeutic effects of plasma is 
H2O2. It was expected that an addition of a biocompatible inhibitor of catalase could 
drastically enhance the effect of plasma. The inhibitor chosen was 3-amino-1, 2, 4-
triazole (Sigma Aldrich, ref A8056, Fig 55) [111]. A lipid-rich cream (Dexeril®), was used 
to enhance the penetration of the chemical. The solid was dissolved in water and mixed 
with the Dexeril® before application to the skin of the mice. 
 
Fig 55 inhibitor of catalase: 3-amino-1, 2, 4-triazole (Sigma Aldrich, ref A8056) 
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II.5.2 Collaboration with LIB laboratory 
These experiments were made the CEF (Centre d’Explorations Fonctionnelles, 
Cordeliers’ Research Center, facility agreement no. A75-06-12) in the team of Lori Bridal 
from LIB laboratory (the Laboratoire d’Imagerie Biomedicale, CNRS, IN- SERM, UPMC 
Univ Paris 06, Sorbonne Universités, Paris F-75006, France). The mice were housed at 
the CEF. All experiments were conducted in accordance with the institutional guidelines 
and the recommendations for the care and use of laboratory animals established by the 
French Ministry of Agriculture. Mice were anesthetized with 2 % (v/v) isoflurane in the 
medical air at 1 l/min. The temperature of the animal was maintained at 37 °C. Mice were 
sacrificed when tumors reached volumes of 2000 mm 3, or when body weight loss was 
more than 10%. 
Ultrasound diagnostic. 
The system of imagery is described in the thesis of Alexandre Dizeux ([112]) from the 
team of Lori Bridal at LIB. Stiffness and mode-B and quantitative ultrasound 
measurements were carried out with a clinical ultrasound System (Aixplorer, SuperSonic 
Imagine). Contrast imaging was performed with A Sequoia 512 clinical ultrasound 
system (AcusonSiemens Healthcare, MoutainView, CA, USA). 
B-mode Imaging 
Transducers made of piezo-electrical material have the ability to modify their volume 
when an electric field is applied. Respectively, in response to mechanical stress, 
piezoelectric components produce a difference of potential. These transducers are used 
to produce ultrasound in biological tissue and measured the backscattered signals. The 
backscattered signals are produced when the wave reaches a structure which has a 
different impedance (mechanical impedance). The frequency is of the order of few MHz. 
The choice of one frequency is a compromise between the resolution (better at high 
frequency) and the attenuation of the signal (higher at high frequency). 
Shear Wave elastography 
This kind of elastography enables to obtain a map of the young Modulus M in the vicinity 
of the tumor. The ultrasound transducer focalizes the wave at one point; a shear wave 
propagates from the focal point with a speed which depends on the M. These shear 
waves propagate in the plane normal to the direction defined by TF the segment 
between the transducer and the focal point. The observation of the propagation of this 
shear-wave (by the backscattered signal to the transducer) provides a horizontal section 
of the young Modulus in the vicinity of the tumor. 
Quantitative ultrasound 
Quantitative ultrasound uses the frequency-dependent information contained in the 
backscattered signals. They provide information about tissue microstructure at smaller 
spatial scales than B-mode imaging ([112]). 
Contrast-enhanced ultrasound (CEUS) 
In this kind of experiments, a contrast agent, made of microbubbles containing SF6 gas 
(Sonovue®), is injected in the tail vein of the mouse. The transducer produces ultrasound 
with an intensity which enables to elicit a non-linear response of the bubbles. The 
bubbles are excited at the frequency f and vibrate at the frequency 2f. The response is 
observed at the frequency 2f. Similarly to mode-B the time between the emission at 
frequency f and the reception of the signal at frequency 2f enables to find the position of 
the micro-bubbles. Since micro-bubbles circulate in the blood, the signal will give 
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information about the vascularization of the tumor. The protocol consists of defining a 
region of interest covering the tumor (red zone surrounded in Fig 56). Then the intensity 
of the signal reflected by this area is plotted as a function of time (right part of Fig 56). 
This curve enables to obtain functional parameters which characterize the 
vascularization of the tumor. The definition of this six parameters is explained in the 
legend of Fig 56 from the thesis of Alexandre Dizeux [112]. 
 
Fig 56 Legend and figure from the thesis of Alexandre Dizeux [112].  The contrast passage  is 
 quantified  in  a  range of interest  by  fitting  echo-power  data  to  a  lognormal model.  Functional 
parameters are extracted from the fit curve.  Peak-enhancement  (PE)  corresponds  to  the maximum 
 echo-power  value  of  the  curve;  time  to  peak (TTP)  is  the  time  to  reach  PE;  wash-in  and 
 washout  rate  (WIR and  WOR)  are  related  to  the  maximum  slope  at  the  initial  and  late  phase 
 of  contrast  uptake,  respectively. The mean  transit  time  (MTT)  is  the  mean  value  of  the 
 lognormal  distribution  of  transit  times  in  the  imaging  plane, and the  (AUC)  parameter  is  the 
 area  under  the  curve. 
  
Chapter II—Materials and methods  
62 
  
Chapter III—Liquid phase chemistry after and during plasma-liquid interaction  
 
63 
 
Chapter III Liquid phase chemistry after and 
during plasma-liquid interaction 
In the field of “plasma-medicine”, one of the central assumptions is that the reactive 
species produced by the plasma contributes significantly or even predominantly to the 
therapeutic effects. For example, it is generally accepted that the oxidative chemical 
species produced by the plasma can trigger inter and intracellular signals leading to cell 
death or activation of the immune system against cancer [64]. Unfortunately, the vast 
majority of the arguments supporting this hypothesis are related to in-vitro experiments. 
This hypothesis is often questioned. Unfortunately, it is often a question of wondering 
which of the chemical species produced by the plasma could contribute to the biological 
responses. The question of the “chemical dose”, the quantification of the chemical effect 
is rarely tackled frontally. This precise question is the subject of few in-vitro studies; 
some results are presented in Chapter IV Regarding the action of hydrogen peroxide and 
nitrites on TC1 line. 
The question: how to measure the chemistry of life in-vivo still remains a major scientific 
issue of the biology. The question of the “chemical dose” can be reformulated in a less 
ambitious form: 
Even with imperfect knowledge of the reactive species created by the plasma, is it 
credible that the reactive species produced by the plasma have a biological effect, 
in-vivo? Alternatively, is the amount so small, so quickly destroyed by the anti-
oxidant network that they have no chance to produce any effect? 
In this Chapter, we will focus on measurements of H2O2, NO2-, NO3- and HO° in liquid 
using different plasma jets described in the previous chapter. We will discuss the 
relevance of the molecular probes diagnostics (following Chapter II), and put forward a 
tentative discussion about the diffusion of such RONS in living tissues.  
This chapter proposes some paths of reflection. First, we need to know the chemistry 
produced by our plasma sources and if possible the link between the power consumption 
of the device and the production of chemical species in liquid phase. Consequently, we 
represent the chemistry induced in the liquid phase by two quantities: 
 The production rate in pmol/s. This is the amount of chemical species (in nmol) 
produced per second of operation of the plasma device. 
 The Yield in nmol/J. This is the amount of chemical species (in nmol) produced 
by the number of joules that we measure consumed by the plasma. Other fields 
like sonochemistry and radiolysis used such notion. 
This presupposes that we have characterized our chemical diagnostic (specificity, yield, 
kinetics...). This question is far from being obvious, even for the most straightforward 
diagnostic. The correct use of Amplex-red and Griess reagents34 is explained in Chapter 
II. 
The first four paragraphs contain the results of parametric study implying the 
quantification of H2O2, ܱܰଶି and ܱܰଷି. Two single-jet and the multi-channel jet. In each 
                                               
34 It is recalled that Amplex-red is very sensitive to light, exposure to ambient light and even more 
so to that produced by the plasma can completely distort the diagnostic. The fact that the nitrite 
detection test operates in an acidic medium can lead to a significant underestimation of the 
nitrites since if H2O2 react with nitrite to form peroxinitrite. 
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experiment one of the parameter change, all other being constant (Table 1 and Fig 57). 
The results are exposed in terms of production rate and yield respectively in pmol/s and 
nmol/J. The results are not immediately interpreted and discussed. 
Table 1 List of the parameter modified during parametric studies 
Plasma-jet (single or multi-channel) DBD 
peak to peak voltage peak to peak voltage 
the distance between the output of the    
nozzle and the surface of the liquid 
the distance between the surface of 
the liquid and the surface of the 
dielectric 
time of treatment time of treatment 
gas flow, controlled by a mass-flow controller 
(Brooks®) 
- 
radial position: relatively to the center of the 
well  
- 
         
Fig 57 Picture and schema of the single jet operating above a 24-well culture dish. 
The fifth section describes experiments related to the quantification of hydroxyl radical, 
principally with the use of terephthalic acid (TPA). A significant part of the discussion is 
devoted to the setting up and validation of the diagnostic. The choice of an appropriate 
concentration of TPA depends on the rate of production of OH° radical. The results and 
the interpretations of experiments using the scavengers of hydroxyl radical like methanol 
are also presented and discussed in Appendix B. 
The sixth section is a discussion of the results of parametric studies, in the light of 
published literature. 
The seventh section contains a discussion of the interaction of H2O2 with cells, its 
diffusion and its destruction by the anti-oxidant defenses of the skin. 
The use of the fluorescent probe (NBD-Cl) has been studied and is presented in 
Appendix L. According to the literature, this probe enables the quantification of 
superoxide radical ܱଶି without interference of H2O2. However, it seems there is an 
interference with H2O2, in the context of plasma-medicine ([H2O2] ~ 1 mM). 
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III.1 Single-channel jet, H2O2 production 
This section35 regards the H2O2 chemistry of the single-channel in the liquid phase. The 
device is defined by the following dimensions:  
di = 3 mm, e = 1.5 mm, H = 60 mm (see Chapter II) 
Where di is the inner diameter of the tube; e is dielectric thickness; H is the distance 
between the High-voltage-electrode and nozzle output. The voltage waveform “500 Hz 
generator n°3” is described in Chapter II (II.2.1, Power supply). 
The production of H2O2 is studied in 24-well-plates (Costar flat-bottomed). The nozzle 
has been positioned in the center of the well. The dosing protocol36 is described in 
Chapter II, section II.3.2.2. This protocol is based on Amplex-red method.  All the 
measurements presented here were acquired at the same time than those of calibration 
curve (same incubation time, similar handling conditions and light exposure...). The 
calibration curve has been acquired in triplicate. Dilutions have been made to reach the 
range of detection. 
III.1.1 Adjustable parameter: treatment time 
The treatment time varies in the range: 1-6 min. The set of constant parameters is 
(voltage = 29.2 kV,  Φு௘ = 500 ݏݏܿ݉, height = 5 mm). The amount of H2O2 increases 
quite linearly as function of time (Fig 58). The slope of the line defines the rate of 
production of H2O2: ~1.2 nmol/s with this set of parameters. Even while trying to fix the 
other parameters, we find that the electrical power consumed is not constant above each 
well. This lack of stability is probably due to the sensitivity of the electrical power with 
respect to the others parameters. 
Y = 1.215*X + 14.86
 
Fig 58 Left: amount of H2O2 (nmol) as a function of time. Right: power consumption. Treatment time = 
1-6 min, frequency of power supply = 500 Hz, peak to peak voltage = 29.2 kV,  ઴ࡴࢋ = ૞૙૙ ࢙࢙ࢉ࢓, height 
= 5 mm, power supply = “500 Hz generator n°3” (II.2.1, Power supply). Error bars represent the 
standard error of the mean. Each well of the 24-well plate (flat bottom) contains 500 µL of PBS 10X. 
The amount of H2O2 is plotted as a function of the energy in Fig 59. It appears that with 
this choice of abscissa, the linear fit is better. This shows the interest of using and 
                                               
35 and in the sections III.2, III.4 and III.5 for the nitrite, nitrate and hydroxyle radical respectively. 
36 The acquisition parameters are as described in the “last version” of the protocol described in 
Chapter II (i.e. λex = 571/1 nm, λem = 585/5 nm, acquisition time = 6 s (60 points, integration time 
of 0.1 s per point.) 
Chapter III—Liquid phase chemistry after and during plasma-liquid interaction  
66 
measuring power during each experiment. Even if the power varies for some reason, the 
link between power consumption and chemical production remains strong. The slope of 
the line defines the yield (~1.9 nmol/J with this set of parameters). 
Y = 1.862*X - 4.482
 
Fig 59 Amount of H2O2 as a function of energy consumption. Treatment time = 1-6 min, frequency of 
power supply = 500 Hz, peak to peak voltage = 29 kV,  ઴ࡴࢋ = ૞૙૙ ࢙࢙ࢉ࢓, height = 5 mm, power supply 
= “500 Hz generator n°3” (II.2.1, Power supply). Each well of the 24-well plate (flat bottom) contains 
500 µL of PBS 10X. 
III.1.2 Adjustable parameter: helium flow rate 
Similarly, experiments are carried out with variable helium flow Φு௘ = 200 − 800 ݏݏܿ݉ 
(Fig 60). The set of constant parameters is (voltage = 29 kV, height = 5 mm, treatment 
time = 2 min). In the chosen range of flow, the power consumed is constant (with respect 
to the uncertainty of repeated experiments...). However, we note that the rate of 
production and the yield decrease when the flow increases. The yields obtained are 
between 1 and 3 nmol / J. Production rates between 900 and 1500 pmol/s. 
 
Fig 60 Left: power as a function of helium flow. Right: Yield (nmol/J) and rate of production of H2O2 
(pmol/s). Treatment time = 2 min, frequency of power supply = 500 Hz, peak to peak voltage = 29 
kV,  ઴ࡴࢋ = ૛૙૙ − ૡ૙૙ ࢙࢙ࢉ࢓, height = 5 mm, power supply = “500 Hz generator n°3” (II.2.1, Power 
supply).  Each well of the 24-well plate (flat bottom) contains 500 µL of PBS 10X. 
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III.1.3 Adjustable parameter: height above liquid 
The variable parameter is the height which is the distance between the nozzle and the 
surface of the liquid (Fig 61). The set of constant parameters is (voltage = 29 kV, 
Φு௘ = 500 ݏݏܿ݉, treatment time = 2 min). The power decreases substantially above 8 
mm. With regard to the yield and the rate of production they continually increase up to 8 
mm. The yield is between 0.7 and 4 nmol/J. 
 
Fig 61 Left: power as a function of height. Right: Yield (nmol/J) and rate of production of H2O2 
(pmol/s). Treatment time = 2 min, frequency of power supply = 500 Hz, peak to peak voltage = 29 
kV,  ઴ࡴࢋ = ૞૙૙ ࢙࢙ࢉ࢓, height = 1.5-11 mm, power supply = “500 Hz generator n°3” (II.2.1, Power 
supply).  Each well of the 24-well plate (flat bottom) contains 500 µL of PBS 10X. 
III.1.4 Adjustable parameter: peak to peak voltage 
In this experiment, the voltage of the power supply is in the range 17.5-29.5 kV. The set 
of constant parameters is (height=5.7 mm, Φு௘ = 500 ݏݏܿ݉, treatment time = 2 min). 
Unlike the previous cases, the power consumed changes considerably (between ~150 
mW and 1 W). The rate of production increases with power and voltage, while the yield 
tends to decrease. The yield and the rate evolve in the range 1.3-2.6 nmol/J and 300-
1300 pmol/s respectively. 
 
Fig 62 Left: power as a function of voltage. Right: Yield (nmol/J) and rate of production of H2O2 
(pmol/s). Treatment time = 2 min, frequency of power supply = 500 Hz, peak to peak voltage = 17.5-29 
kV,  ઴ࡴࢋ = ૞૙૙ ࢙࢙ࢉ࢓, height = 5.7 mm, power supply = “500 Hz generator n°3” (II.2.1, Power supply). 
Each well of the 24-well plate (flat bottom) contains 500 µL of PBS 10X. 
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III.2 Single-channel jet, NO2- production 
This section regards the nitrite chemistry of the single-channel jet. The experimental 
setup is the same in the previous section. The nozzle has been positioned in the center 
of the well (except in section III.2.4).The dosing protocol37 is based on Griess reagent 
method (described in Chapter II, section II.3.3). Dilutions have been made to reach the 
range of detection. Initially, the wells contain 1400 µl of PBS 10X. The average volume is 
1200 ± 100 µL after treatment. 
III.2.1 Adjustable parameter: treatment time 
The treatment time  varies in the range: 1-10 min. The set of constant parameters is 
(voltage = 27.6 kV,  Φு௘ = 500 ݏݏܿ݉, height = 5.7 mm). The amount of nitrite as a 
function of time is shown in Fig 63. These treatments were repeated in triplicate (except 
t= 10 min, duplicate ). Nitrite production increases over time, which is consistent. 
However, the data points are far from being on a line. 
 
Fig 63 Left: the amount of nitrite (nmol) as a function of time. Right: power consumption. Except for 
the last point (duplicate), all measurements are triplicated. Treatment time = 1-10 min, frequency of 
power supply = 500 Hz, peak to peak voltage = 27.6 kV,  ઴ࡴࢋ = ૞૙૙ ࢙࢙ࢉ࢓, height = 5.7 mm. Error bars 
= standard deviation of the mean. 
As the amount of H2O2, the amount of nitrite depends linearly on the energy (Fig 64). 
The energy is a better parameter of control than the time of exposure, for this plasma 
device powered at 500 Hz. 
                                               
37 In brief, the absorbance of a 1 mL solution containing 100 μL of Griess reagent (Sigma-Aldrich, 
03553-100mL) and 900 μL of sample is measured at a 522 nm after 20 min of incubation. 
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Y = 0.7886*X - 0.0
 
Fig 64 Amount of nitrite in nmol as a function of energy consumption. All other things being equal, 
the treatment time is at the origin of the changes in the value of energy. Treatment time = 1-10 min, 
frequency of power supply = 500 Hz, peak to peak voltage = 27.6 kV,  ઴ࡴࢋ = ૞૙૙ ࢙࢙ࢉ࢓, height = 5.7 
mm. 
The yield and the production rate are plotted in Fig 65. The production rate is ~800 
pmol/s, the yield ~0.9 nmol/J for ݐ ≤ 6 ݉݅݊. Curiously, the yield decrease: 0.7 nmol/J at 
10 min. This point cannot be explained by the fact that the voltage decreases38 during 
this time since a decreasing voltage increase the yield (see Fig 69). For the same 
reason, the fact that there is more evaporation in 10 min than in 6 min (thus an 
increasing height) does not explain that point (Fig 67). The reaction between NO and 
H2O2 could explain this observation. 
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Fig 65 Yield (nmol/J) and production rate (pmol/s) of nitrite  as a function of treatment time. 
Treatment time = 1-10 min, frequency of power supply = 500 Hz, peak to peak voltage = 27.6 
kV,  ઴ࡴࢋ = ૞૙૙ ࢙࢙ࢉ࢓, height = 5.7 mm. triplicate, except last point duplicate. Error bars represent the 
standard error of the mean. 
III.2.2 Adjustable parameter: helium flow rate 
The variable parameter is the flow (Φு௘ = 100 − 1000 ݏݏܿ݉). The set of constant 
parameters is (voltage = 27.4 kV, height = 5.5 mm, treatment time = 3 min). The power 
                                               
38 During 10 min the average value of the applied voltage is 27kV. During the first six minutes 
~27.6 kV. This is due to the heating of the components (especially the resistors) of this 
homemade generator. 
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increase with the flow and reaches a plateau for Φு௘ ≥ 400 ݏݏܿ݉ (Fig 66). This behavior 
is different from that observed during the determination of H2O2. This is probably due to 
the fact that the voltage is higher (29 kV) in previous experiment. The height was also 
slightly lower (5 mm). 
Yield and production rate increase and reach a maximum at 300 sscm, then decrease at 
higher flow rates. The yield and the rate of production are in the range 0.07-1.2 nmol/J, 
50-810 pmol/s. Note that the range of relative variation of the production rate is greater 
for the nitrite than for H2O2. A flow rate of 300 sccm optimizes the production since the 
yield, and the rate are equal to 1.2 nmol/J and 810 pmol/s.  
Fig 66 Left: power consumption (mW) as a function of helium flow rate (sscm). Right: yield (nmol/J) 
and production rate (pmol/s) as a function of helium flow rate (sscm). Treatment time = 3 min, height 
=5.5 mm, voltage = 27.4 kV, power supply = “500 Hz generator n°3” (II.2.1, Power supply). Each well 
of the 24-well plate (flat bottom) contains 1.4 ml of PBS 10X. Duplicate experiment. 
III.2.3 Adjustable parameter: height above liquid 
The variable parameter is the height (height = 1.5-12.5 mm). The set of constant 
parameters is (voltage = 27.4 kV, Φு௘ = 500 ݏݏܿ݉, treatment time = 3 min, except height 
= 1.5 or 2.5 mm where treatment time = 5 min). The evolution of the power is similar to 
those of the previous experiment as a function oh height (constant before 11 mm, decay 
beyond, Fig 67). Similarly, the yield and the rate of production are similar39. 
                                               
39 except that the decrease in production rate is not observed in the H2O2 experiment probably 
since height ≤ 12 ݉݉. 
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Fig 67 Left: power consumption (mW) as a function of height above the liquid. Right: yield (nmol/J) 
and production rate of nitrite (pmol/s) as a function of height. Treatment time = 3 min except for the 
height = 1.5 or 2. 5 mm where treatment time is 5 min to obtain a measurable concentration, ઴ࡴࢋ =
૞૙૙ ࢙࢙ࢉ࢓, height =1.5-12.5 mm, voltage = 27.3 kV, power supply = “500 Hz generator n°3” (II.2.1, 
Power supply). Each well of the 24-well plate (flat bottom) contains 1.4 ml of PBS 10X. Duplicate 
experiment. 
III.2.4 Adjustable parameter: radial position 
In this section, the variable parameter is the radial position of the nozzle. Since the outer 
radius of the single-jet40 is 4 mm and since the wells have a diameter of 16 mm; the 
position of the center of the nozzle can vary from the position 4 mm to the position 12 
mm. The set of constant parameters is (voltage = 27.4 kV, Φு௘ = 500 ݏݏܿ݉, height = 8.7 
mm, treatment time = 3 min).  
At this height and when the nozzle is close to the edge, a fraction of the discharges 
touches the edge of the well and not the surface of the liquid. The power is constant (Fig 
68), whereas the yield and the production rate decreases close to the wall. 
Subsequently, it is necessary to center the plasma source to achieve reliable 
experiment. Nevertheless, there is a tolerance of ~±2 mm regarding the radial position. 
In addition, this effect decreases with decreasing height (not shown here). 
 
Fig 68 Left: power in mW as a function of radial position. Right: yield (nmol/J) and production rate 
(nmol/s) as a function of radial position in mm. Treatment time = 3 min, ઴ࡴࢋ = ૞૙૙ ࢙࢙ࢉ࢓, height = 8.7 
                                               
40 outer radius = 4 mm, inner radius of gas tube = 1.5 mm. 
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mm, voltage = 27.3 kV, power supply = “500 Hz generator n°3” (II.2.1, Power supply). Each well of the 
24-well plate (flat bottom) contains 1.4 ml of PBS 10X. Duplicate experiment. 
III.2.5 Adjustable parameter: peak to peak voltage 
In this experiment, the voltage of the power supply is in the range 19-29.5 kV. The set of 
constant parameters is (height=5.7 mm, Φு௘ = 500 ݏݏܿ݉, treatment time = 3 min). The 
power changes considerably (between 200 mW and 750 mW). The rate of production 
increases with voltage, while the yield tends to decrease (Fig 69). The yield and the rate 
evolve in the range 0.6-1 nmol/J and 200-400 pmol/s respectively. 
 
Fig 69 Left: power consumption as a function of voltage. Right: yield (nmol/J) and production rate 
(nmol/s)  as a function of voltage. Treatment time = 3 min, ઴ࡴࢋ = ૞૙૙ ࢙࢙ࢉ࢓, height = 5.7 mm, voltage 
= 19-29.5 kV, power supply = “500 Hz generator n°3” (II.2.1, Power supply). Each well of the 24-well 
plate (flat bottom) contains 1.4 ml of PBS 10X. 
III.3 Multi-channel jet: H2O2 and NO2- 
In this experiment, the amount of ܱܰଶି and ܪଶܱଶ have been 
measured in each well treated by the multi-channel jet. As 
the nozzle is larger, it is necessary to use culture plates with 
larger wells (6-well plate, Costar®, flat-bottom). This nozzle 
requires41 higher gas flow rates (~1000-2800 sscm) than that 
used for the single-channel jet (~100-1000 sscm). The 
measurement of H2O2 is based on Amplex-red diagnostic, that of nitrites on Griess 
reagent method (the two methods were used in the two previous sections and are 
described in Chapter II). Dilutions have been made to reach the range of detection. 
Initially, the wells contains 5000 µl of PBS 1X.  
                                               
41 below, the discharge becomes particularly unstable, which considerably increases the 
dispersion. 
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III.3.1 Adjustable parameter: treatment time 
The time varies in the range: 1-6 min. The set of constant parameters is (voltage = 23 
kV,  Φு௘ = 2600 ݏݏܿ݉, height
42 = 5.5 mm). The power is constant over time (~1500 mW); 
moreover with the chosen parameters the dispersion of the measurements is quite low 
(Fig 70). It is also found, similarly to the single-channel jet that the amount of nitrite and 
H2O2 increases linearly as a function of the treatment time. We can observe that the 
amount of H2O2 is greater than the amount of nitrite. 
 
Fig 70 Left: power as a function of treatment time (black dots), energy consumed during the 
treatment of each well (yellow). Right: amount of H2O2 and nitrite produced in each well. Treatment 
time = 1-6 min, ઴ࡴࢋ = ૛૟૙૙ ࢙࢙ࢉ࢓, height = 5 mm, voltage = 23 kV, power supply = “500 Hz generator 
n°3” (II.2.1, Power supply). Each well of the 6-well plate (flat bottom) contains 5 ml of PBS 1X. 
Triplicate experiment, error bar = standard deviation of the mean. 
The yields and the production rate are described in Fig 71. They belong to the same 
range than the single-channel jet. 
 
Fig 71 Yield  (nmol/J) and production rate (pmol/s) as a function of treatment time. Left: H2O2, Right: 
nitrite. Treatment time = 1-6 min, ઴ࡴࢋ = ૛૟૙૙ ࢙࢙ࢉ࢓, height = 5 mm, voltage = 23 kV, power supply = 
                                               
42 Due to the curve of the nozzle the height is defined as the distance between the lowest point of 
the nozzle and the surface of the liquid. As with the single-jet, this position is identified by lowering 
the nozzle until it touches the surface of the liquid (the measurement is repeated and the flow of 
gas is cut to make the height calibration). 
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“500 Hz generator n°3” (II.2.1, Power supply). Each well of the 6-well plate (flat bottom) contains 5 ml 
of PBS 1X. Triplicate experiment, error bar = standard deviation of the mean. 
III.3.2 Adjustable parameter: helium flow rate 
The variable parameter is the flow (Φு௘ = 1200 − 2800 ݏݏܿ݉). The set of constant 
parameters is: (voltage = 23 kV, height = 5 mm, treatment time = 3 min). The power is 
fairly constant = 1270 ± 15 mW (SEM), (Fig 72). In contrast, the amount of NO2- and 
H2O2 evolve in opposite directions for Φୌୣ ≤ 2000 sscm. With this device, the production 
of H2O2 evolves in the opposite direction of that observed with the single-channel jet. 
Moreover, even if the nitrite evolves in the same direction than the single-channel 
plasma jet, the decrease does not reach the magnitude43 observed with the single-
channel jet (in 24-well plates). 
 
Fig 72 Left: power as a function of helium flow. Right: amount of H2O2 and nitrite (nmol) produced in 
each well. Treatment time = 3 min, ઴ࡴࢋ = ૚૛૙૙ − ૛ૡ૙૙ ࢙࢙ࢉ࢓, height = 5 mm, voltage = 23 kV, power 
supply = “500 Hz generator n°3” (II.2.1, Power supply). Each well of the 6-well plate (flat bottom) 
contains 5 ml of PBS 1X. Triplicate experiment, error bar = standard deviation of the mean. 
The yields and the production rate are described in Fig 73. They belong to the same 
range than those observed during single-channel experiments. 
                                               
43 There is probably much air in the vicinity of the plasma produced by the multi-channel jet in 
large wells than in the poorly-ventilated well treated with the single jet. 
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Fig 73 Yield  nmol/J) and production rate (pmol/s) as a function of He flow. Left: H2O2, Right: nitrite. 
Treatment time = 3 min, ઴ࡴࢋ = ૚૛૙૙ − ૛ૡ૙૙ ࢙࢙ࢉ࢓, height = 5mm, voltage = 23 kV, power supply = 
“500 Hz generator n°3” (II.2.1, Power supply). Each well of the 6-well plate (flat bottom) contains 5 ml 
of PBS 1X. Triplicate experiment, error bar = standard deviation of the mean. 
III.3.3 Adjustable parameter: height above liquid 
The variable parameter is the height = 2-12 mm (Fig 74). The set of constant parameters 
is (voltage = 23 kV, Φு௘ = 2600 ݏݏܿ݉, treatment time = 3 min). The power decreases 
continuously above 4 mm. The yield and the rate of production of H2O2 increase and 
reach a plateau above 4 mm. Yield and production rate of nitrite increase continuously 
for increasing height (Fig 75). This is similar to the beginning of the curve observed with 
the single-channel plasma jet. 
 
Fig 74 Left: power as a function of height. Right: amount of H2O2 and nitrite produced in each well. 
Treatment time = 3 min, ઴ࡴࢋ = ૛૟૙૙ ࢙࢙ࢉ࢓, height = 2-12 mm, voltage = 23 kV, power supply = “500 
Hz generator n°3” (II.2.1, Power supply). Each well of the 6-well plate (flat bottom) contains 5 ml of 
PBS 1X. Triplicate experiment, error bar = standard deviation of the mean. 
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Fig 75 Yield  (nmol/J) and production rate (pmol/s) as a function of height. Left: H2O2, Right: nitrite. 
Treatment time = 3 min, ઴ࡴࢋ = ૛૟૙૙ ࢙࢙ࢉ࢓, height = 2-12 mm, voltage = 23 kV, power supply = “500 
Hz generator n°3” (II.2.1, Power supply). Each well of the 6-well plate (flat bottom) contains 5 ml of 
PBS 1X. Triplicate experiment, error bar = standard deviation of the mean. 
III.3.4 Adjustable parameter: peak to peak voltage 
In this experiment, the voltage of the power supply is in the range 14-28.2 kV. The set of 
constant parameters is (height=5 mm, Φு௘ = 2600 ݏݏܿ݉, treatment time = 3 min). The 
power is between 98 mW and 3770 mW and the amount of H2O2 and nitrites increases 
with the voltage (Fig 76). 
 
Fig 76 Left: power as a function of voltage. Right: amount of H2O2 and nitrite produced in each well. 
Treatment time = 3 min, ઴ࡴࢋ = ૛૟૙૙ ࢙࢙ࢉ࢓, height = 5 mm, voltage = 14-28.2 kV, power supply = “500 
Hz generator n°3” (II.2.1, Power supply). Each well of the 6-well plate (flat bottom) contains 5 ml of 
PBS 1X. Triplicate experiment, error bar = standard deviation of the mean. 
Regarding H2O2, the rate of production increases continuously, whereas the yield 
reaches a maximum around 16 kV and then decrease (Fig 77). This is consistent with 
the observations made with the single-channel plasma jet. 
Regarding  ܱܰଶି, the rate of production increases continuously whereas the yield 
increase and reach a plateau above 24 kV. This behavior is different from those of the 
single-channel jet whose yield decrease continuously. 
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Fig 77 Yield  (nmol/J) and production rate (pmol/s) as a function of peak to peak voltage. Left: H2O2, 
Right: nitrite. Treatment time = 3 min, ઴ࡴࢋ = ૛૟૙૙ ࢙࢙ࢉ࢓, height = 5 mm, voltage = 14-28.2 kV, power 
supply = “500 Hz generator n°3” (II.2.1, Power supply). Each well of the 6-well plate (flat bottom) 
contains 5 ml of PBS 1X. Triplicate experiment, error bar = standard deviation of the mean. 
III.4 Single-channel jet: NO2- and NO3- 
In this experiment, the amount of nitrite and nitrate has been measured in each well 
treated with the single-channel jet. This experiment implies to do two measurements for 
each sample: the first measurement gives the concentration of nitrite; the second gives 
the sum of nitrite and nitrate concentration. The experimental setup is described in the 
sections III.1 and III.2. The nozzle is positioned in the center of the well. It appears that 
the evolutions of nitrite and nitrates productions are relatively similar and that nitrate is 
produced in larger quantities than nitrite (~three times). Note that in some cases, both 
species have been represented with different scales so that the nitrite variation is visible. 
The measurement method is based on the modified nitrate reductase method (kit Sigma-
Aldrich). The protocol44 is described in Chapter II. Dilutions have been made to reach the 
range of detection. Initially, the wells contain 1250 µl of deionized water. I warmly thank 
Constance Duchesne and Bo Liu for helping at the beginning of their thesis. Alone, it 
would not have been possible to make as many measurements while performing the 
series of dilution, calculations, and mixture required by nitrate determination. 
III.4.1 Adjustable parameter: treatment time 
The time varies in the range: 1-6 min. The set of constant parameters is (voltage = 28.5 
kV,  Φு௘ = 500 ݏݏܿ݉, height = 5.5 mm). The power is constant (~620 mW), Fig 78.  
The amount of nitrite and nitrate increases linearly as a function of the treatment time. 
The slopes are ~810 pmol/s and 230 pmol/s respectively for nitrate and nitrite. Note that 
the amount of nitrate is approximately 3.6 times greater than the amount of nitrite. The 
graph which represents the yield and the production rates confirm these results (Fig 79) 
                                               
44 Compared to the supplier's instructions, the main change is to add catalase before nitrite and 
nitrate determination. The catalase is added just after the plasma treatment to minimize the 
reaction with H2O2 at neutral pH. 
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Fig 78 Left: power as a function of He flow. Right: amount of nitrite and nitrate produced in each well. 
Treatment time = 1-6 min, ઴ࡴࢋ = ૞૙૙ ࢙࢙ࢉ࢓, height = 5.5 mm, voltage = 28.5 kV, power supply = “500 
Hz generator n°3” (II.2.1, Power supply). Each well of the 24-well plate (flat bottom) contains 1.25 ml 
of deionised water.  The addition of Catalase takes place just after the plasma treatment. Triplicate 
experiment, error bar = standard deviation of the mean 
 
Fig 79 Yield  (nmol/J) and production rate (pmol/s) as a function of treatment time. Left: nitrite, Right: 
nitrate. Treatment time = 1-6 min, ઴ࡴࢋ = ૞૙૙ ࢙࢙ࢉ࢓, height = 5.5 mm, voltage = 28.5 kV, power supply 
= “500 Hz generator n°3” (II.2.1, Power supply). Each well of the 24-well plate (flat bottom) contains 
1.25 ml of deionised water.  The addition of Catalase takes place just after the plasma treatment. 
Triplicate experiment, error bar = standard deviation of the mean. 
III.4.2 Adjustable parameter: helium flow rate 
The variable parameter is the flow (Φு௘ = 100 − 800 ݏݏܿ݉). The set of constant 
parameters is: (voltage = 28.5 kV, height = 5.5 mm, treatment time = 3 min). The power 
is fairly constant = 485 ± 48 mW (SEM), (Fig 80). The evolution of yield and rate of 
production are similar for nitrites, nitrates and similar to previous measurements (Fig 81). 
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Fig 80 Left: power as a function of He flow. Right: amount of nitrite and nitrate produced in each well. 
Treatment time = 3 min, ઴ࡴࢋ = ૚૙૙ − ૡ૙૙ ࢙࢙ࢉ࢓, height = 5.5 mm, voltage = 28.5 kV, power supply = 
“500 Hz generator n°3” (II.2.1, Power supply). Each well of the 24-well plate (flat bottom) contains 
1.25 ml of deionised water.  The addition of Catalase takes place just after the plasma treatment. 
Triplicate experiment, error bar = standard deviation of the mean 
 
Fig 81 Yield  (nmol/J) and production rate (pmol/s) as a function of He flow. Left: nitrite, Right: 
nitrate. Treatment time = 3 min, ઴ࡴࢋ = ૚૙૙ − ૡ૙૙ ࢙࢙ࢉ࢓, height = 5.5 mm, voltage = 28.5 kV, power 
supply = “500 Hz generator n°3” (II.2.1, Power supply). Each well of the 24-well plate (flat bottom) 
contains 1.25 ml of deionised water.  The addition of Catalase takes place just after the plasma 
treatment. Triplicate experiment, error bar = standard deviation of the mean. 
III.4.3 Adjustable parameter: height above liquid 
The variable parameter is the height = 3-13 mm (Fig 82). The set of constant parameters 
is (voltage = 28.5 kV, Φு௘ = 500 ݏݏܿ݉, treatment time = 3 min). The power is constant 
until 11 mm and decreases above. The power, the yield and the rate of production 
evolve similarly to the previous experiment involving the single-channel plasma jet (Fig 
83). For example, the production rate reaches its maximum at the same height ~11 mm. 
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Fig 82 Left: power as a function of height. Right: amount of nitrite and nitrate produced in each well. 
Treatment time = 3 min, ઴ࡴࢋ = ૞૙૙ ࢙࢙ࢉ࢓, height = 3-13 mm, voltage = 28.5 kV, power supply = “500 
Hz generator n°3” (II.2.1, Power supply). Each well of the 24-well plate (flat bottom) contains 1.25 ml 
of deionised water.  The addition of Catalase takes place just after the plasma treatment. Triplicate 
experiment, error bar = standard deviation of the mean. 
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Fig 83 Yield  (nmol/J) and production rate (pmol/s) as a function of height. Left: nitrite, Right: nitrate. 
Treatment time = 3 min, ઴ࡴࢋ = ૞૙૙ ࢙࢙ࢉ࢓, height = 3-13 mm, voltage = 28.5 kV, power supply = “500 
Hz generator n°3” (II.2.1, Power supply). Each well of the 24-well plate (flat bottom) contains 1.25 ml 
of deionised water.  The addition of Catalase takes place just after the plasma treatment. Triplicate 
experiment, error bar = standard deviation of the mean. 
III.4.4 Adjustable parameter: peak to peak voltage 
In this experiment, the voltage of the power supply is in the range 19-28.5 kV. The set of 
constant parameters is (height=5.5 mm, Φு௘ = 500 ݏݏܿ݉, treatment time = 3 min). The 
power is between 200 mW and 600 mW. The amount of nitrates and nitrites increases 
with the voltage (Fig 84 and Fig 85). Once again the evolution of nitrates and nitrites 
depends on the voltage in a similar way. The results obtained with the nitrites confirm 
those obtained during the previous experiment (section III.2). 
Chapter III—Liquid phase chemistry after and during plasma-liquid interaction  
 
81 
 
 
Fig 84 Left: power as a function of voltage. Right: amount of nitrite and nitrate produced in each well. 
Treatment time = 3 min, ઴ࡴࢋ = ૞૙૙ ࢙࢙ࢉ࢓, height = 5.5 mm, voltage = 19-28.5 kV, power supply = “500 
Hz generator n°3” (II.2.1, Power supply). Each well of the 24-well plate (flat bottom) contains 1.25 ml 
of deionised water.  The addition of catalase takes place just after the plasma treatment. Triplicate 
experiment, error bar = standard deviation of the mean. 
 
Fig 85 Yield  (nmol/J) and production rate (pmol/s) as a function of peak to peak voltage. Left: nitrite, 
Right: nitrate. Treatment time = 3 min, ઴ࡴࢋ = ૞૙૙ ࢙࢙ࢉ࢓, height = 5.5 mm, voltage = 19-28.5 kV, power 
supply = “500 Hz generator n°3” (II.2.1, Power supply). Each well of the 24-well plate (flat bottom) 
contains 1.25 ml of deionised water.  The addition of Catalase takes place just after the plasma 
treatment. Triplicate experiment, error bar = standard deviation of the mean. 
III.4.5 Ratio nitrate/nitrite 
To confirm the link between nitrate and nitrite production, the ration of nitrate/nitrite was 
computed for the four previous experiments (Fig 86). The ratio is equal to 3.9±1. This 
means that on average 3.9 molecules of nitrates are produced for one nitrite molecule. It 
would be interesting to discuss about the mechanism that could provide such ratio. 
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Fig 86 Ratio of the amount of nitrate over nitrite. Concatenation of the four previous experiments. 
III.5 Quantification of hydroxyl radical 
Before parametric experiments, we need to discuss how works the chemical diagnostic. 
The whole beginning of this discussion was done in Chapter II (section II.3.4, page 52). 
The use of terephthalic acid (TPA) as a scavenger of HO ° is not evident because its 
yield is not 1, and this is not a one-step reaction. 
III.5.1 Yield of terephthalate as a dosimeter 
Let's start with an experimental result. We perform the same plasma treatment with 
several concentrations of TPA. After correction with the signal of white samples, and use 
of TPA-OH calibration-curves (see Chapter II). The following concentrations of TPA-OH 
were obtained (Fig 87). It turns out that power was approximately the same for each well. 
There is an increase in the formation of TPA-OH which is necessarily linked to a 
chemical process, not to a modification of the discharge above the well. The 
concentration reaches a kind of plateau for TPA~20-30 mM. How to interpret this? 
[T
P
A
-O
H
] (
µM
)
 
Fig 87 TPA-OH concentration obtained as a function of TPA concentration for the set of parameters: 
single jet, 2 min, height = 5 mm, Vpp=27.7 kV, He flow = 500 sscm. (V=500 µL). Power ~500 mW. 
Power supply n°3. 
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First, radiolysis or sonochemistry studies have shown that the yield of the reaction 
ܶܲܣ + ܱܪ−>  ܶܲܣ − ܱܪ (which is the sum of several step) 
is limited. In an aerated solution (air saturated), it appears that the yield is 35% ([105], 
[106], [113]–[115]) 
I will not detail the chemical mechanisms involved, but this 35% yield is (mainly) not due 
to the first step of the reaction (position of the hydroxylation). It is unlikely that the yield of 
the others steps changes with increasing TPA concentration. Therefore it will always be 
necessary to take it into account. Here we observe a change in yield that depends on the 
concentration of TPA. It means that there is a competition for the scavenging of HO° 
during the first step of TPA+HO° reaction. 
It will, therefore, be necessary to take into account the fact that in the plasma 
experiments the yield could be limited by the competition during the first reaction stage, 
but also the yield of 35% above. Since they have not the same origin, more information 
is available about this topic in the references ([105], [114], [116]–[120]). 
Lifetime and length of diffusion of HO° in pure water 
In this paragraph, the lifetime of a homogeneous solution of HO° in pure water is 
calculated. It is also assumed that only HO° recombination plays. Data on reaction 
kinetics were obtained from the paper of Buxton et al. [121]. The recombination reaction 
is: 
ܪܱ° + ܪܱ° → ܪଶܱଶ  kଶ = 5.5 × 10ଽ  L. sିଵ. molିଵ   in pure water [121] 
Consequently, HO° disappears according to: 
݀[ܪܱ°]
݀ݐ
= −2 × ݇ଶ[ܪܱ°]ଶ 
So, with ݊଴ the inital concentration in HO° and ݊(ݐ) the concentration in HO°: 
න
܌[۶۽°]
[۶۽°]૛
ܖ
ܖ૙
= න −૛ × ܓ૛ × ܌ܜ
ܜ
૙
 
Consequently, 
૚
࢔૙
−
૚
࢔(࢚)
= −૛࢑૛࢚ 
Thus, 
࢔(࢚) =
࢔૙
૚ + ૛࢑૛࢔૙࢚
 
This equation enables to obtain a time which characterizes the lifetime of HO°: this is 
merely the expression: 
࣎ =
૚
૛࢑૛࢔૙
 
Note that ࣎ depends on the initial concentration. if ࢔૙ = ૚૙ି૝ࡹ, then ࣎ = ૙. ૢ μ࢙. The 
recombination of HO ° was represented as a function of time in Fig 88 during 15 µs. 
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Fig 88 [HO°] as a function of time in a homogeneous solution of water for several ࢔૙ 
It can be seen that at each initial concentration corresponds a characteristic time needed 
to observe a significant decrease. It is also interesting to have an idea of how deep 
H0°can spread during such time. The paper of Buxton et al. provides the diffusion 
coefficient of HO° in pure water: 
ܦ(ܱܪ°) = 2.3 × 10ିଽ݉ଶ. ݏିଵ      [121] 
According to this value, the characteristic length of diffusion is:  ܮ(߬) = √ܦ߬ 
࣎ Characteristic length of diffusion during ࣎ 
100 ns 
~lifetime of plasma above water 
ܮ(߬ = 100 ݊ݏ) = √ܦ߬ ≅ 15 ݊݉ 
10 µs ܮ(߬ = 10 μݏ) = √ܦ߬ ≅ 150 ݊݉ 
100 µs ܮ(߬ = 100 μݏ) = √ܦ߬ ≅ 480 ݊݉ 
 
2 ms  
= One period of the power supply. 
ܮ(߬ = 2 ݉ݏ) = √ܦ߬ ≅ 2.1 μ݉ 
 
 
It is therefore quite certain that HO ° will not be able to diffuse more than a few tens of 
nm from the air-liquid interface. But what happens when TPA is added to the solution? 
Does the TPA have the same concentration at the interface gas-liquid? 
Xiao et al. describe the scavenging of HO° by three organic compounds: terephthalic 
acid (TPA), ibuprofen and ciprofloxacin [117]. The aim of these experiments is to find if 
TPA scavenges HO° in bulk solution or HO° at the gas-liquid interface. The sonolysis of 
the solution (at 20 or 620 kHz) is at the origin of HO° in bulk solution or at the bubble-
water interface. It turns out that Ciprofloxacin and ibuprofen are respectively hydrophilic 
and hydrophobic. It is the hydrophobic or hydrophilic nature of a compound that will 
determine whether it accumulates on the surface or not. This character can be quantified 
by the octanol-water partition coefficient (Kow), i.e. the ratio of the concentrations the 
compound in octanol over the concentration in water. A low Kow number (less than 10) 
corresponds to a hydrophilic compound and high Kow (more than 104) to a hydrophobic 
compound. 
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According to the paper of Xiao et al, Log(Kow(TPA)) is -1.52 when pH=8.5 and according 
to PubChem database, Log(Kow(TPA))=2 [122]. As the TPA solutions were prepared with 
KOH at 20 mM so ݌ܪ~12. Under these conditions TPA is rather hydrophilic and 
therefore will not tend to concentrate at the air-liquid interface. It would be interesting to 
use the same approach than Tauber et al. which estimate the interfacial concentration 
from gas-fugacity [123], [124]. In the following, we consider that the interfacial and bulk 
concentrations are the same. 
Lifetime and length of diffusion of HO° in TPA 
According to the paper of Mark et al., the first step of the reaction leading to TPA (with a 
yield < 1) is the hydroxylation of TPA by HO° [115] 
ܶܲܣ + ܪܱ° → "ܫ݊ݐ݁ݎ݉݁݀݅ܽݐ݁ ݌ݎ݋݀ݑܿݐ"  (R1)  kଵ = 3.3 × 10ଽ L. sିଵ . molିଵ 
If it is assumed that TPA is in large excess compared to HO° and that the others 
reactions are negligible, the decay of OH° due to TPA is: 
݀[ܪܱ°]
݀ݐ
= −݇ଵ[ܶܲܣ][ܪܱ°] 
Thus, HO ° decreases exponentially with a characteristic time ߬ = ଵ
௞భ[்௉஺]
,  
݊(ݐ) = ݊଴exp (−ݐൗ߬ ) 
Generally, the experiments were done with  [ܶܲܣ]  = 4.11 ݉ܯ. Consequently  ߬ ≅ 74 ݊ݏ. 
At first glance, the dosing reaction is much more effective to scavenge HO°. Generally 
such [TPA] is sufficient to dominate the recombination reaction completely. But if it's true 
why the production of TPA-OH does depends on [TPA]? 
III.5.2 Competition between HO° recombination and the 
hydroxylation of TPA 
Actually, the situif it is assumedation is more complex because HO° is produced in a very 
short time and at high concentration. It is therefore necessary to study the competition of 
the two reactions and see if this can explain the fact that the concentration of TPA has 
an influence on the quantity of TPA-OH produced.  
ܶܲܣ + ܪܱ° → "ܫ݊ݐ݁ݎ݉݁݀݅ܽݐ݁ ݌ݎ݋݀ݑܿݐ"     (R1)  kଵ = 3.3 × 10ଽ L. sିଵ . molିଵ 
ܪܱ° + ܪܱ° → ܪଶܱଶ       (R2)      kଶ = 5.5 × 10ଽ L. sିଵ . molିଵ 
݀["ܫ݊ݐ݁ݎ݉݁݀݅ܽݐ݁ ݌ݎ݋݀ݑܿݐ"]
݀ݐ
= ݇ଵ[ܶܲܣ][ܪܱ°] 
݀[ܪଶܱଶ]
݀ݐ
= ݇ଶ[ܪܱ°]ଶ 
The effect of plasma-liquid interaction is model by a source term S, such as 
݀[ܪܱ°]
݀ݐ
= ܵ 
We will study the situation in the steady state 
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݀[ܪܱ°]
݀ݐ
≅ 0 
Thus 
ௗ[ுை°]
ௗ௧
= 0 = ܵ − ݇ଵ[ܶܲܣ][ܪܱ°] − 2݇ଶ[ܪܱ°]ଶ, 
We obtain a polynomial of the second degree in [HO°]: 
[ܪܱ°]ଶ +
݇ଵ[ܶܲܣ]
2݇ଶ
[ܪܱ°] −
ܵ
2݇ଶ
= 0 
The discriminant is: 
Δ = ൬
݇ଵ[ܶܲܣ]
2݇ଶ
൰
ଶ
− 4 × ൬−
ܵ
2݇ଶ
൰ = ൬
݇ଵ[ܶܲܣ]
2݇ଶ
൰
ଶ
+
2ܵ
݇ଶ
 
Consequently, [ܪܱ°] = ଵ
ଶ
[ቀ−
௞భ[்௉஺]
ଶ௞మ
ቁ + √Δ], thus 
݀[ܫ݊ݐ݁ݎ݉݁݀݅ܽݐ݁ ݌ݎ݋݀ݑܿݐ]
݀ݐ
= ݇ଵ[ܶܲܣ]
1
2
[ቆ−
݇ଵ[ܶܲܣ]
2݇ଶ
ቇ + √Δ] 
The concentration of TPA-OH, obtained after a time t is given by the integration of this 
equation. However, it is necessary, to take into account the fact that the yield is of the 
order of 35% (oxygenated solution). Moreover, we can assume that the volume where 
HO° exists is not the total volume of the solution (~500 µL). We defined an effective 
volume  ௘ܸ௙௙, this is the volume of solution accessible by HO° during the discharge. 
Consequently, we need to define an effective time of reaction, which is different from the 
treatment time (2 min in this case). Because we need to assume that [HO°] is 
established only during plasma-surface-interaction (and plasma has a short lifetime ~200 
ns at the surface of the liquid). In this condition [TPA-OH] is: 
[ܶܲܣ − ܱܪ] = ܻ ௘ܶ௙௙
଴ܸ
௘ܸ௙௙
݇ଵ
ଶ[ܶܲܣ]ଶ
4݇ଶ
(ඥ1 + ܥଶ[ܶܲܣ]ିଶ − 1) 
Where, ܥଶ =
଼ௌ௞మ
௞భ
మ  and Y=35% is the yield of formation of TPA-OH from “Intermediate 
product”, and  ௞భ
మ
ସ௞మ
= 4.95 × 10଼ ܮ. ݏିଵ. ݉݋݈ିଵ. 
This equation enables to fit of our experimental results (Fig 89). The result is quite 
satisfactory and gives a value to S. 
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Fig 89 TPA-OH concentration obtained as a function of TPA concentration for the same parameters 
of treatments: single jet, 2 min, height = 5 mm, Vpp=27.7 kV, He flow = 500 sscm. 
ܵ =
1
2
ܥଶ
݇ଵ
ଶ
4݇ଶ
=
4.95 × 10଼
2
5.893 × 10ିହ = 1.5 × 10ସ ݉݋݈. ܮିଵ . ݏିଵ 
Thus, the “steady” concentration of HO° can be evaluated with 
[ܪܱ°] =
1
2
቎ቆ−
݇ଵ[ܶܲܣ]
2݇ଶ
ቇ + ඨ൬
݇ଵ[ܶܲܣ]
2݇ଶ
൰
ଶ
+
2ܵ
݇ଶ
቏ =
݇ଵ[ܶܲܣ]
4݇ଶ
ቈට1 + ܥ2ൣܶܲܣ൧
−2
 
− 1቉
= 6.9 × 10ିସ ܯ  
Is it coherent? 
The fitted value (ܸ݂݁ ி݂ூ் = 1.12 × 10ିସ  ݉ܮ) represents the effecive volume of reaction 
divided by Teff the proportion of time where plasma is “on” compared to total time. It is 
also assumed that the production time of HO° is 100 ns (of the order of magnitude of the 
life of the ionized column). We assume that our generator has a frequency of 500 Hz and 
that there is 1 discharge per half-period. Thus, 
݂݂ܶ݁ = 2 × 500 × 10ି଻ = 10ିସ 
In these conditions, the “true” volume is 
ܸ݂݂݁ = ܸ݂݁ ி݂ூ் × ݂݂ܶ݁ = 1.12 × 10ି଼  ݉ܮ 
As we know the diffusion thickness of HO ° during the treatment time: let us try to find 
the associated surface, which should correspond more or less to the surface of the liquid 
in contact with the plasma. 
ܮ(߬ = 100 ݊ݏ) = √ܦ߬ ≅ 15 ݊݉ 
ܣݎ݁ܽ =
1.12 × 10ି଼ × 10ି଺
15 × 10ିଽ
≅ 7.5 × 10ି଻݉ଶ = 0.75 ݉݉ଶ 
This is consistent with what we can see in the photos. The average production rate 
predicted by the fitting is: 
݌ݎ݋݀ݑܿݐ݅݋݊ ݎܽݐ݁ = ܵ × ܸ݂݂݁ × ݂݂ܶ݁ = 16 ݌݉݋݈. ݏିଵ 
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This is (about one) order of magnitude below the values that we will obtain in the 
experiments (see next sections). So there is a problem. The chemical reactions do not 
stop the production of TPA-OH instantaneously after the end of the discharge. The 
concentration of OH° will decay because of the reaction with TPA at the "long" times, i.e., 
several  ߬ = 74 ݊ݏ. Perhaps it is necessary to consider an “effective time of reaction” 
longer than100 ns per discharge. For example, doubling this time in our model, will 
cause a doubling of the production rate. 
Finally, it is certain that at this frequency, with this generator, there are several 
discharges per half-period (and rather less than 10 than hundreds, see Appendix A). 
This would lead us to predict a production rate consistent with the experimental results. 
Of course, the whole of the preceding approach is questionable on several points, and a 
numerical simulation could be of great help. 
How does HO° react in this range of concentration? 
Now, it is assumed that [ܪܱ°] = 6.9 × 10ିସ  ܯ  and the reaction rates of HO ° with 
several chemical is obtained: 
1-Recombination reaction: 
݀[ܪܱ°]
݀ݐ
= −2݇ଶ[ܪܱ°]ଶ = −5240 ݉݋݈. ܮିଵ. ݏିଵ 
2- Scavenging reaction (with [TPA]=4.11 mM) 
݀[ܪܱ°]
݀ݐ
= −݇ଵ[ܶܲܣ][ܪܱ°] = −9360 ݉݋݈. ܮିଵ. ݏିଵ 
3-ܪܱ° + ܪଶܱଶ → ܪܱଶ° + ܪଶܱ with ݇ଷ = 2.7 × 10଻, [121] and [ܪଶܱଶ] ≅ 1 ݉ܯ 
݀[ܪܱ°]
݀ݐ
= −݇ଷ[ܪܱ°][ܪଶܱଶ] ≅ −18.6 ݉݋݈. ܮିଵ. ݏିଵ 
Consequently, this reaction is likely negligible, whatever [H2O2] 
4- ܪܱ° + ܱܰଶି → ܱܰଶ° + ܱܪି with ݇ସ = 9.1 × 10ଽ  [43, p. 252] and [ܱܰଶି] ≅ 1 ݉ܯ 
݀[ܪܱ°]
݀ݐ
= −݇ସ[ܱܰଶ
ି][ܪܱ°] ≅ −6300 ݉݋݈. ܮିଵ. ݏିଵ 
Consequently, if ܱܰଶି = 1 ݉ܯ, this reaction is not negligible compared to the reaction 
between TPA and HO°. In this case, the concentration of TPA should be increased to 
effectively scavenge HO°. 
However, in most of the experimental cases encountered so far, the concentration of 
nitrites remained ~ 100 µM, and so this reaction was negligible. 
To conclude, measurements of relative yield as a function of TPA concentration enables 
to propose an order of magnitude of the mean concentration of hydroxyl radical in the 
effective volume where TPA and Hydroxyl radicals react. The orders of quantities 
proposed are consistent. It appears that the quantity of TPA-OH produced when TPA = 
4.11 mM (concentration used in the following sections) represents only 65% of the 
maximum that could be obtained by increasing [TPA]. This value was obtained with the 
fit seen in Fig 89. 
Chapter III—Liquid phase chemistry after and during plasma-liquid interaction  
 
89 
 
III.5.3 Single-channel jet, Hydroxyl radical HO° 
The following four sections contain the results of a parametric study performed on the 
single-channel jet. The experimental setup is exactly the same in the three previous 
experiments characterizing the production of nitrite, nitrate, and H2O2. The fluorescence 
of the sample was measured45 as described in Chapter II (section II.3.4.2). The 
calibration curve enables to determine the concentration of TPA-OH present after 
plasma treatment. 
Each well of the 24-well plate (flat bottom) contains 1400 µL of a solution with the 
following composition46: 
[TPA] = 4.11 mM   +  [KOH]= 20 mM + deionised water, 
After treatment, the final volume was around 1200 µL. The amount of hydroxyl radical is 
obtained from the amount of TPA-OH by making two assumptions regarding the yield of 
the reaction producing TPA-OH: 
i) Since  [ܶܲܣ] = 4.11 ݉ܯ, it is assumed that the first step of the hydroxylation 
of TPA by HO° reaches only 65% of its maximum value because of the 
competition with the recombination reaction (ܪܱ° + ܪܱ° → ܪଶܱଶ). 
ii) Since the liquid phase is initially saturated with air, and assuming that the 
amount of dissolved oxygen does not decrease significantly47 in only 3 
minutes, it can be considered that the mechanisms which produce TPA-OH, 
after the first step of reaction (i.e., the addition of HO°) have a yield of 35% 
[105], [115]. 
It is therefore considered that only 65% × 35%~22.8% of the molecules of HO° 
produces one molecule of TPA-OH. This correction has been applied to the results of the 
four following sections. 
III.5.3.1 Adjustable parameter: treatment time 
The treatment time varies in the range: 1-6 min. The set of constant parameters is 
voltage = 27.5 kV,  Φு௘ = 500 ݏݏܿ݉, height = 5.6 mm. The amount of HO° detected 
increases linearly as a function of the treatment time (Fig 90). The slope represents a 
production rate ~240 pmol/s. The power is  580 ± 70 (ܵܦ) ܹ݉. 
                                               
45  λex=317nm, λem=435nm, with bandpass Δλ= 5 nm for excitation and emission. 
46 The choice [KOH]=20 mM, is necessary for the solubilization of terephthalic acid. The use of di-
sodium terephtalate which is easier to solubilize enables to do experiments at neutral pH. 
Preliminary experiments show that the results are identical at neutral pH. 
47 This hypothesis is debatable, but let us remembers that the volume is around 1200 µL. and that 
the helium flux is moderate and does not bubble in the liquid, which limits gas exchange. 
Moreover, according to [105], “the terephthalate system does not show a significant O2 dependence of 
the hydroxylation reaction. Thus, even as the oxygen content of the water drops during sonication, the 
amount of OH radical production can still be measured with confidence.” 
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Y = 0.2401*X - 0.0
 
Fig 90 Left power consumption (mW) as a function of time. Right amount of HO° (nmol) measured as 
a function of time. Treatment time = 1-6 min, frequency of power supply = 500 Hz, peak to peak 
voltage = 27.5 kV,  ઴ࡴࢋ = ૞૙૙ ࢙࢙ࢉ࢓, height = 5.6 mm, power supply = “500 Hz generator n°3” (II.2.1, 
Power supply).  Each well of the 24-well plate (flat bottom) contains 1400 µL of the TPA +KOH 
solution. Duplicate. 
 
On average, the yield is ~0.4 nmol/J (Fig 91). Note that the amount of H2O2 that would 
be produced by the recombination of all HO° in pure water is much lower than the 
amount of H2O2 observed. Indeed, HO° would produce only48 ~0.2 nmol/J, whereas the 
yield of H2O2 is ~ 1.7 nmol/J with the same parameters (see Fig 62, p 68). Consequently, 
HO° is probably not the only species which contributes to the production of H2O2 in liquid 
phase. We can imagine that H2O2 is formed in gas phase, or from the superoxide radical 
in liquid phase in these precise experimental conditions. 
Y = 0.4241*X - 0.0
 
Fig 91 Left: amount of HO° radical as a function of energy consumption. Treatment time is between 1 
and 6 min. Right: Yield and production rate of HO° as a function of time. Treatment time = 1-6 min, 
frequency of power supply = 500 Hz, peak to peak voltage = 27.5 kV,  ઴ࡴࢋ = ૞૙૙ ࢙࢙ࢉ࢓, height = 5.6 
mm, power supply = “500 Hz generator n°3” (II.2.1, Power supply).  Each well of the 24-well plate (flat 
bottom) contains 1400 µL of the TPA +KOH solution. Duplicate.  
III.5.3.2 Adjustable parameter: helium flow rate 
The variable parameter is the flow (Φு௘ = 100 − 700 ݏݏܿ݉). The set of constant 
parameters is: (voltage = 25.6 kV, height = 5.7 mm, treatment time = 3 min). Power 
                                               
48 It takes two HO ° to make one H2O2 
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consumption is quite constant ܲ = 400 ± 50 ܹ݉ (ܵܦ) (Fig 92). The yield is in the range 
0.3-0.6 nmol/J and increase with helium flow rate Φு௘ ≤ 500 ݏݏܿ݉. The production rate 
is between 100 and 250 pmol/s and increase. The trends are opposite to that of H2O2 
(decrease of yield and production rate, see Fig 60, page 66). This is another argument 
against the statement: “HO ° in the liquid phase is the main species at the origin of 
H2O2”. 
 
Fig 92 Left: power (mW) as a function of Helium flow rate. Right: yield (nmol/J)and production rate 
(pmol/s) of HO° as a function of flow rate. Treatment time = 3 min, frequency of power supply = 500 
Hz, peak to peak voltage = 25.6 kV,  ઴ࡴࢋ = ૚૙૙ − ૠ૙૙ ࢙࢙ࢉ࢓, height = 5.7 mm, power supply = “500 Hz 
generator n°3” (II.2.1, Power supply).  Each well of the 24-well plate (flat bottom) contains 1400 µL of 
the TPA +KOH solution. Duplicate. 
III.5.3.3 Adjustable Parameter: height above liquid 
The variable parameter is the height = 1.5-10.5 mm (Fig 93). The set of constant 
parameters is: (voltage = 28.1 kV, Φு௘ = 500 ݏݏܿ݉, treatment time = 3 min). The power 
is constant ~575 ± 60 mW. Beyond 6 mm in height, the yield and production rate were 
halved compared to the value they have below 3 mm. Once again, the trend is the 
opposite of that found for H2O2 production (see Fig 61, page 67). 
 
Fig 93 Left: power (mW) as a function of height. Right: yield (nmol/J) and production rate (pmol/s) of 
HO° as a function of height. Treatment time = 3 min, frequency of power supply = 500 Hz, peak to 
peak voltage = 28.1 kV,  ઴ࡴࢋ = ૞૙૙ ࢙࢙ࢉ࢓, height = 1.5-10.5 mm, power supply = “500 Hz generator 
n°3” (II.2.1, Power supply).  Each well of the 24-well plate (flat bottom) contains 1400 µL of the TPA 
+KOH solution. Duplicate. 
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III.5.3.4 Adjustable parameter: peak to peak voltage 
In this experiment, the voltage of the power supply is in the range 16.5-29 kV. The set of 
constant parameters is (height=5.7 mm, Φு௘ = 500 ݏݏܿ݉, treatment time = 3 min). The 
power changes considerably (between 200 mW and 750 mW). The rate of production 
increases with voltage, while the yield tends to decrease (Fig 69). The yield and the rate 
evolve in the range 0.2-1.1 nmol/J and 150-250 pmol/s respectively. 
 
Fig 94 Left: power as a function of voltage. Right: yield (nmol/J) and rate of production of HO° 
(pmol/s). Treatment time = 3 min, frequency of power supply = 500 Hz, peak to peak voltage = 16.5-29 
kV,  ઴ࡴࢋ = ૞૙૙ ࢙࢙ࢉ࢓, height = 5.7 mm, power supply = “500 Hz generator n°3” (II.2.1, Power supply).  
Each well of the 24-well plate (flat bottom) contains 1400 µL of the TPA +KOH solution. Duplicate. 
III.6 In a living organism, what is the depth of 
penetration of H2O2? 
In the field of plasma-medicine, it is widely accepted that RONS and particularly H2O2 
can probably diffuse through living tissue over several mm [64]. H2O2 is described as a 
relatively stable species, especially compared to the hydroxyl radical [100]. According to 
this assumption, it is logical to assume that this species could be at the origin of anti-
tumor effects.  Indeed, in-vitro studies prove that H2O2 can induce cell death per necrosis 
or apoptosis beyond a concentration of a few hundred μM. At higher concentration, 
>~10%, H2O2 is even considered as a corrosive product [56]. 
Unfortunately, a crucial point is often neglected: the anti-oxidant defenses. Cells have 
the ability to remove ROS very efficiently. In particular, the skin and its outermost layer 
provided several mechanisms to deal with oxidizing aggressions. This set of molecules, 
enzymes, and metabolic pathways is called the antioxidant network. 
We begin with a brief description of the antioxidant defenses of the skin. Emphasis is 
placed on quantitative data, such the amount of catalase or other anti-oxidant systems 
present in the different layers of the skin. 
Then, the notion of cell membrane permeability (H2O2) is described. This value enables 
to determinate the flux of H2O2 crossing the plasma membrane as a function of the 
extracellular concentration in H2O2. This model enables to find the lifetime of H2O2 in the 
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presence of cells49. The result is consistent with the results our team (C. Duchesne) and 
with the literature. 
An in-vivo diffusion model which integrates the effect of the anti-oxidant is then 
described. The simulations by finite element method could extend the results of this 
section. 
Finally, a critical approach of the papers which address this question is proposed. The 
use of gelatine layer as a “good” tissue-model to understand RONS is disputed. 
III.6.1 Anti-oxidant defense of the skin, relevant orders of 
magnitude 
How H2O2 enters into the cells? 
The transportation of H2O2, from the extracellular medium to the intracellular medium is 
an area of active research. It appears that the natural diffusivity across the phospholipid 
membrane cannot explain the intake of H2O2 which is greater than expected [125]. The 
cells can exchange molecules with the extracellular environment by means of various 
channels, i.e., complex assemblies of proteins crossing the membrane and whose 
activation depends on internal or external cellular signals. The aquaporins are part of the 
channels responsible for exchanging water50 between the external and internal 
environment. Because the molecular structure of water and H2O2 are relatively close  
[127]; H2O2 cross the membrane preferentially through aquaporins. 
Even if the underlying phenomenon is complex51, the transport of H2O2 is described by a 
quantity called permeability that represents the ability of H2O2 to pass through a 
membrane: 
The permeability PH2O2 is the ratio of the incoming flow (in ݉݋݈. ݉ିଶ. ݏିଵ) by the 
extracellular concentration of H2O2 (in ݉݋݈. ݉ିଷ). 
P =
஍
[ୌమ୓మ]
  m. sିଵ. 
Permeability: orders of magnitude 
Henzler et al. report that the H2O2-permeability of the cells of the plant Chara Corallina is  
~3.6 × 10ି଺ ݉. ݏିଵ [127]. For this plant, the main barrier of water and/or H2O2 transport is 
mainly due to the plasma membrane. 
Antunes et al. depict the kinetics of H2O2 consumption by the Catalase and Glutathione 
peroxidase (GPX) enzyme [128]. They expose Jurkat T-cells to an external source of 
H2O2. The permeability of these cells is 2 × 10ି଺ ݉. ݏିଵ. This paper also indicates that 
the permeability of the human erythrocytes is tree-fold greater: ~6 × 10ି଺ ݉. ݏିଵ. Most 
mammalian cells have permeability of the order of  ~10ି଺ ݉. ݏିଵ. Erythrocytes are part of 
the higher value in terms of permeability. 
                                               
49 it has been checked that the culture medium itself does not destroy H2O2. Beware of media 
containing sodium pyruvate which is a scavenger of H2O2. 
50 and others non-charged charged and partially polar molecules [125], [126] 
51 the active pumping of molecules controlled by a cell responding to the modifications of its 
environment! 
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Antunes et al. also indicate that approximately 1 s is needed to build the gradient of 
[H2O2] at the plasma membrane. Since the cells contain organelles which are separately 
enclosed, there is also H2O2 transport across these membranes. In particular, the 
peroxisomes contain catalase which is enclosed in this specific part of the cell. The 
Glutathione peroxidase (GPX) enzyme is present in the entire cytosol. On the other 
hand, they have lower activity than catalase and contribute mainly to the destruction of 
H2O2 at low concentration. In the approximation of low concentrations, Antunes et al. 
show that GPX contributes for 90% to the destruction of H2O2. The 10% remaining are 
due to the activity of catalase (less accessible because of his location in peroxisomes). 
In these conditions, Fig 95 shows the concentration of H2O2 expected in the cytosol and 
peroxisomes. 
 
Fig 95 Figure and legend adapted from the paper of Antunes et al. [128].Profile of H2O2 concentration 
in Jurkat T-cells upon incubation with an external source of H2O2. [H2O2] log scale axis has arbitrary 
units. 
Too high, the concentration of H2O2 can inhibit the GPX [129]. It is likely that the 
inactivation of the GPX occurs in a few minutes, if [H2O2] is ~100 mM, which means that 
the extracellular concentration should be ~700 mM according to Fig 95. Such 
concentration may be accessible for the higher layers of the skin exposed to plasma. 
Regarding the kinetics, the reaction rate of the Michaelis-Menten constant (Km) of 
catalase52 is higher than the Km of GPX [130]. Consequently, at high concentration 
(~ 10 ݉ܯ) of H2O2, the activity of catalase continue to increase while that of GPX no. 
The situation is different for erythrocytes since catalase is present in the cytosol. They 
contain higher level of catalase than the others cells according to Agar et al. [131]. In 
these cells the catalase predominantly contributes to the elimination of H2O2 [132]; 
among the others anti-oxidant defenses [133]. So, since the H2O2-permeability is 
approximately three times higher in erythrocyte than in other cells, the blood is extremely 
efficient for destroying H2O2. Therefore it is very unlikely that H2O2 can spread without 
being destroyed over a substantial distance in the blood53 or in irrigated tissues such as 
the dermis or tumor.  
The permeability of yeasts to H2O2 is modified according to whether they are in 
exponential division phases, or whether they maintain a stable population. In the case of 
exponential growth, the membrane is 5 times less permeable. Sousa-Lopes et al. point 
out that this remarkable behavior allows these yeasts to protect themselves from 
oxidative stress when they are the most vulnerable [134]. Finally, the reader can consult 
the excellent review of Bienert et al. to get more information about H2O2 transport [125]. 
                                               
52 Km is the concentration of substrate (H2O2)at which the reaction rate is at half-maximum 
53 The surgeons are very well aware of the danger of treating a bloody wound with too much 
oxygenated water: gaseous embolisms or emphysema caused by an oxygen concentration so 
excessive that it is no longer soluble in tissues can be deadly. 
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Anti-oxidants defense of the skin 
The skin is frequently and directly exposed to prooxidative environment including UV 
radiation, air pollutants, and drugs. Skin contains antioxidants systems which counteract 
the harmful effects of ROS. Thiele et al. detail the prevalence of each anti-oxidants 
present in the skin and how they act [135]. The following species play a significant role in 
the defense of the skin: vitamin C, Glutathione GSH54, Urate55, Vitamine E56, the couple 
Ubiquinols/Ubiquinones, Carotenoids and Vitamin A, The enzymatic Glutathione 
system57, superoxide dismutase and catalase. Further discussions outside of the scope 
of this thesis can be found in [100], [111], [136]–[144] 
Some factors may contribute to the destruction of the antioxidant defenses of the skin. 
Valacchi et al. show that UV, cigarette smoke, and ozone can potentiate their effects and 
lead to a depletion in Vitamine-E, α-tocopherol [145]–[147]. 
Sometimes it is interesting that chemical species cross the skin. A drug must cross the 
epidermis before reaching the dermis and blood circulation. The hydrophilic or 
hydrophobic character of the applied molecule, the presence of emollient, and the 
thickness of the stratum corneum are key factors in the penetration of organic compound 
[148]–[153]. 
Orders of magnitude related to the prevalence of catalase 
The concentration of catalase is generally represented in terms of unit of enzymatic 
activity. One unit of catalase is the quantity of catalase that will decompose 1.0 µmole of 
H2O2 per minute at pH 7.0 at 25 °C, while the H2O2 concentration falls from 10.3 mM to 
9.2 mM. 
Shindo et al. measured that the catalase activity is: 30.4 ± 4.3 U/mg protein in murine 
epidermis and 33.3 U/mg protein in murine dermis [140]. According to [135] and [140], 
the catalase activities is higher in human epidermis (62 ± 6 U/mg protein), but lower in 
the dermis (14.5 ± 2.9 U/mg protein) compared to the mouse. This is potentially an issue 
for the translation58 of an effective murine treatment to humans treatments. 
In-vivo and ex-vivo experiments, origin of the skin whitening exposed to H2O2 
It is well known59 that the application of H2O2 on the surface of the skin causes a 
whitening phenomenon. Zonios et al. explain that this transient phenomenon is attributed 
to vasoconstriction [154]. Zonios et al. have applied different concentrations of H2O2 (0.5 
-6 %w, i.e., ~ 1.6 M) at the top of the skin and measured the reflectance of the skin. This 
method enables to detect an oxidized form of hemoglobin or melanin. They emit serious 
doubt about the fact that H2O2 can spread to the dermis without being totally destroyed 
by the anti-oxidant defenses of the skin. The results they obtain can be explained by the 
release of O2 resulting from the reaction between H2O2 and catalase. They explain that 
                                               
54 An essential cofactor of GPX enzyme 
55 deprotaned form of uric acid 
56 “The major antioxidant role of vitamin E is generally considered to be the arrest of chain 
propagation by scavenging lipid peroxyl radicals” [135] 
57 This system reduces H2O2 and lipid hydroperoxides at the expense of two molecules of GSH, 
58 If anti-tumor effect are maily caused by prooxidative action of plasma-treatment. 
59 a commercial solution at 3% enables to observe this effect when we keep a few droplets in the 
palm of the hand for a few minutes. 
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O2 alone may cause vasoconstriction60.  Zonios et al., also suggest that contact of H2O2 
with blood61 will result in accelerated scavenging of H2O2.  
Nocchi et al. studied the ability of catalase contained in the stratum corneum to destroy 
H2O2 [157]. For this, 500 µm of human skin62 was brought into contact with a solution of 
H2O2 (0.5 or 1 mM in PBS) on its outer face; and a Clark type electrode measuring the 
oxygen on its inner face (see Fig 96). They also mention that acidic pH (݌ܪ ≤ 2) 
probably decrease catalase efficency in-vivo. They removed the stratum corneum layer 
by layer by tap-stripping and observed the signal of Clark electrode (proportional to [O2]). 
This experiment confirms the strong activity of catalase in the epidermis, but does not 
enables to conclude with regard to the diffusion of H2O2 itself and its total destruction or 
not by epidermis and dermis. 
 
Fig 96 Legend and figure from the paper of Nocchi et al. [157]. Photo of oxygen electrode covered 
with skin membrane. 
III.6.2 Modeling of an in-vitro experiment 
In order to quantify the contribution of ܪଶܱଶ to the whound healing induced by cold-
plasma treatment, our colleague C.Duchesne exposed humans fibroblastes and 
keratynocytes to ܪଶܱଶ. [H2O2] was measured over time. Each wells contained, ܰ =
200 000 cells in 2 mL. It appears that the time to decrease the concentration of 
extracellular H2O2 from 100% to 37% is ~2 h. 
The purpose of this section is to model the removing of H2O2 due to cell permeability and 
compare the results with those of the in-vitro experiments. First, it is assumed that all the 
molecules of H2O2 crossing the membrane are destroyed. We consider that membrane 
                                               
60 In contrast the role of H2O2 alone is less clear, since H2O2 alone can be both vasoconstrictor 
and vasodilator [155] 
61 Zonios et al. [154] “However, we have seen no evidence of their production here, which means 
that either H2O2 decomposed before it was given the chance to react with haemoglobin or that the 
produced oxidized haemoglobin forms were quickly reduced owing to the action of reducing 
agents available in vivo such as ascorbate. In general, skin appears to have a very strong 
antioxidant capacity and H2O2 may be decomposed following numerous other pathways besides 
the straightforward one that involves its reaction with catalase. Some evidence supporting this 
argument is offered by oxygen bubbles observed histologically in the skin after reaction with the 
35% solution of H2O2 ([156]).” 
62 this thickness includes the epidermis and part of the dermis 
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permeability works as described above. The differential equation which predicts the 
temporal evolution of ܪଶܱଶ takes the form: 
δn
δt
= −n × Pୗ × A୲୭୲ ×
1
V
  
Where n is H2O2 concentration (mol. mିଷ), Pୗ is the permeability (m. sିଵ), A୲୭୲ is the total 
area of all the cells and V is the volume of the well in which the experiment takes place. 
The solution of this equation is: 
n = n଴exp (− t τൗ ) 
where n଴ is the initial concentration and 
τ =
V
Pୗ × A୲୭୲
 
is the time which characterizes the decay of HଶOଶ. 
For the calculation, we assume that Pୗ = 2 × 10ି଺ m. sିଵ. This is the H2O2-permeability of 
the mammalian cells according to Antunes et al. [128]. In the first approach, we assumed 
that the cells are spherical with radius r = 10 μm. Thus, the total area is A୲୭୲ = N × 4πrଶ, 
where N is the number of cells in the well. Since N = 200 000, 
A୲୭୲ = 200 000 × 4π(10ିହ)ଶ = 2.51 × 10ିସ mଶ 
and then 
τ =
2 × 10ି଺
2 × 10ି଺  × 2.51 × 10ିସ
≅ 4000 s = 1h +  6 mi݊  
This time is consistent with the experiments (~ 2h). This order of magnitude is also 
consistent with the experimental results obtained by others groups ([125], [127], [128], 
[134]), especially regarding the fibroblast [158]. Similarly, these teams propose the same 
kind of interpretation, based on permeability calculations. 
In this model, we have considered perfectly spherical cells whose entire surface is freely 
accessible. In fact, the free area of the cells is probably smaller than modeled since the 
cells adhere at the bottom of the well. Moreover, the cells are almost confluent. This 
decrease of the free surface could explain why the model predicts a faster decay than 
observed. Wagner et al. show experimental results that are consistent with this 
hypothesis [159]. Indeed, they observed that detached cells destroy H2O2 faster than 
attached ones. 
III.6.3 In vivo: diffusion model 
The purpose of this section is to question the hypothesis “H2O2 can spread over several 
mm in living tissue”. Is this realistic? Or not? 
Similarly, it is assumed that the totality of H2O2 entering the cells is suppressed by the 
intra-cellular anti-oxidant63. For the sake of simplicity, it is also assumed that there are no 
anti-oxidants in the extracellular environment and that the cells occupy all space. It 
described an epithelium-like structure. 
                                               
63 whatever the antioxidant mechanism at work (GSH or catalase, non-enzymatic system...) 
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Let’s start with an orders-of-magnitude calculation. 
First, we must find the number of cells present in the skin per unit volume. If it is 
assumed that the cells are spherical with a radius ݎ = 10 μ݉. The number of cells per 
unit volume is:  
݊௖ =
1
4
3 ߨݎ
ଷ
= 2.39 × 10ଵସ ݉ିଷ 
This order of magnitude is quite good since the density of fibroblasts in the human 
dermis is 3 × 10ଵଶ and 10ଵସ  ݉ିଷ, respectively for reticular and papillary dermis 
according to [160]. 
For the calculation, we choose the value: ݊௖ = 10ଵଷ ݉ିଷ,  with this assumption the 
volume of one cell is 10ିଵଷ ݉ଷ. The surface of this single cell64 is ~10ି଼ ݉ଶ. 
Consequently, the total area of the cells per unit of volume is: 
ܵ஼ = ݊஼ × 10ି଼ = 10ହ ݉ଶ/݉ଷ 
As seen in the in-vitro model, it is assumed that the permeability is Pୗ = 2 × 10ି଺ m. sିଵ 
[128]. The volumic consumption of H2O2 takes the form: 
−ܵ஼ ௌܲ݊ 
The equation representing the diffusion of H2O2 is: 
ப୬
ப୲
= DΔn − SେPୗn  
where D is the diffusion coefficient. For this order-of-magnitude calculation, it is assumed 
that the material is homogeneous and isotropic65. As in the work of Marquez-Lago et al. 
who simulate the skin with a mortar-diffusion model66, we assume67 that ܦ =
10ି଻ ܿ݉ଶ. ݏିଵ = 10ିଵଵ  ݉ଶ. ݏିଵ [161].  
With this model, the ROS introduced at the top of the skin are carried by passive 
diffusion and consumed by the anti-oxidant defenses when they cross the membrane of 
a cell. The RONS produced by the cold plasma is modeled with a constant surfacic term: 
Φ = ܥܵܶ  ݉݋݈. ݏିଵ. ݉ିଶ. For this order-of-magnitude calculation, we consider the 1-
dimensional problem. In this framework, the problem is summarized by: 
 
⎩
⎪
⎨
⎪
⎧ ∂n
∂t
= D
d2n
 
dx2
− SCPSn
+ boundary condition:     − ܦ
݀݊
݀ݔ
(ݔ = 0, ݐ ≥ 0) = Φ
+  initial condition:                                     n = 0
 
 
                                               
64 spherical cells approximation 
65 Strictly speaking, this is false for the skin. 
66 It would be possible to develop one simulation based on the work of Marquez-Lago et al. [161]. 
67 we suppose that the diffusion coefficient is the same for water and H2O2, which is likely true in 
terms of order of magnitude. 
઴ ࢓࢕࢒. ࢓ି૛. ࢙ି૚ 
Chapter III—Liquid phase chemistry after and during plasma-liquid interaction  
 
99 
 
 
We want to know the characteristic time and length of attenuation lengths of time. After 
the transient regime we have: 
0 = D
dଶn 
dxଶ
− SେPୗn 
Consequently, the characteristic length is ܮ஼஺ோ such that: 
D
Lେ୅ୖ
ଶ = SେPୗ 
thus,    Lେ୅ୖ = ට
ୈ
ୗి୔౏
= ට
ଵ଴షభభ
ଵ଴ఱ×ଶ×ଵ଴షల
≅ 7 μ݉  
and the concentration take the form: ݊(ݔ) =
஍௅಴ಲೃ
஽
exp (−
௫
௅಴ಲೃ
). 
In this model, the surface concentration is directly related to the incident flux. This 
incident flow can be evaluated with our chemistry experiments. It can be considered that 
the single-channel plasma jet produces approximately 1 nmol of H2O2 per second over 
an area of 1 mm ². Thus Φ = 10ିଷ mol. mିଶ. sିଵ and 
n(x = 0) ≅ 700 mol. mିଷ = 0.7 mol. Lିଵ 
This order of magnitude is not absurd, besides the commercial H2O2 solutions are 
concentrated at 3% w ≅ 0.9 mol. Lିଵ. 
According to this model, on what depth H2O2 will damage the cells? 
According to Stone and Yang (see [60] and our own in-vitro experiments, see Chapter 
IV), it is unlikely that an extracellular concentration of H2O2 below 10 µM cause cell 
death, or slow cell growth. This concentration is reached for x = Lୈ୉୅୘ୌ such that: 
n(x = Lୈ୉୅୘ୌ) = 10 μM = 10ି଼ mol. mିଷ 
thus, 
 ݊(ݔ = ܮ஽ா஺்ு ) = ݊(ݔ = 0)݁ݔ݌ (−
௅ವಶಲ೅ಹ
௅಴ಲೃ
)  and  ௅ವಶಲ೅ಹ
௅಴ಲೃ
= −ܮ݊ ቀ
 ௡(௫ୀ௅ವಶಲ೅ಹ)
௡(௫ୀ଴)
ቁ ≅ 25 
Consequently, ܮ஽ா஺்ு ≅ 25 ܮ௖௔௥ ≅ 175 μ݉, 
According to this model, it is therefore unlikely that the damage caused by H2O2 could 
damage the skin to a depth of more than 175 μm. This depth68 is in the human dermis 
and exceeds the depth of the mouse dermis by a few tens of μm.  
Now, I am going to criticize this model, some aspects of this model lead to an 
underestimation of the depth of penetration, while others lead to an overestimation: 
This model could underestimate the depth of penetration because: 
i) It is assumed that H2O2 is removed as soon as the molecules have crossed 
the membrane for any external concentration of H2O2. This is obviously false. 
                                               
68  [162] see Chapter VI, section VI.1.1 for the comparison of human and mouse skin. 
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For the upper layer of cells, the antioxidant defenses of the cell are 
overloaded by the molar concentration of H2O2. It is likely that the intracellular 
concentration is high. This causes DNA damage and kills the cell. The 
amount of H2O2 that these cells will take to the external environment will be 
lower than modeled. However, the catalase works well even at high 
concentration of H2O2 (several mol.L-1, [163], [164]). In case of destruction of 
the cell membrane, it is not easy to guess whether catalase, released from 
the cell, will see its anti-oxidant activity increased or not ... 
ii) H2O2 transport is modeled as a purely diffusive phenomenon. According to 
this model, ܮ(߬ = 10 min) = √ܦ × ߬ = 77 μ݉. A weak but continuous electric 
field, due to the establishment of a constant potential difference on the 
surface of the skin, could contribute to an accelerated migration of chemical 
species. In the same way, could the mechanical vibrations caused by the 
treatment modify the transport of the chemicals?  
iii) The reaction of cells to such oxidative stress is not really predictable. New 
metabolic pathways can be triggered by this stress. In some cases, the cells 
develop a tolerance to oxidative stress [165], [166]. However, the open 
questions regard the time scale of these phenomena. Are they relevant 
compare to the time scale of plasma treatment?  
iv) It is false to model the material as homogeneous at the scale of the cell. 
Since the value ܮ௖௔௥ has a size similar to those of a cell, its validity may be 
debatable. However, having a such value of ܮ஼஺ோ is not shocking by itself, 
since it is considered that the H2O2 consumption results from an averaging of 
the amount of H2O2 absorbed by the surfaces of several cells. ܮ௖௔௥ has a 
statistical meaning. Finally, while it is certain that n(x) is wrong at cell scale, it 
does not mean that the description is incorrect for the sizes representing 
thicknesses of several cells. 
This model could overestimate the depth of penetration because: 
i) This is a 1D model. Since, the diffusion can occur in all directions, [H2O2] 
decreases faster as a function of depth than in this model. 
ii) The dermis is a very well irrigated tissue. Blood flow could help eliminate 
H2O2 in a much more effective way. Indeed, the erythrocytes are the most 
common blood cell. The H2O2-permeability is higher69 in erythrocyte than in 
other cells [128]. They contain higher level of catalase than the others cells 
according to Agar et al. [131]. In these cells the catalase predominantly 
contributes to the elimination of H2O2 [132]; among the others anti-oxidant 
defenses [133]. Wagner et al. specify the numerical values for the human 
erythrocyte [159]. 
iii) If electroporation takes places, it could enhance the H2O2-intake of the cells 
located in the upper layer of the skin and the molecules consumed by these 
cells could not diffuse below. 
iv) The model does not take into account the effect of other anti-oxidant systems 
present in the extracellular matrix [138]–[140]. 
To go further, it is necessary to use the numerical simulations. It would be interesting to 
address the question of the geometry of the diffusion and to take into account the 
kinetics of enzymatic reactions. The inhomogeneous nature of the skin could be 
addressed by a mortar-diffusion model. 
                                               
69 approximatively three times higher than the main mammalian cells, ௌܲ௕௟௢௢ௗ = 6 × 10
ି଺݉. ݏିଵ 
[128] 
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III.6.4 Critical approach 
As said in the introduction, it seems widely accepted by the community that the RONS 
produced by the plasma can diffuse freely over distances of several mm [64]. However, 
this belief is based on a very limited number of experimental works. The numerical 
simulations of plasma-antitumor effect are still an embryonic topic [167]. The work of 
Murphy et al. does not even consider the presence of anti-oxidant defenses [168]. 
The main criticisms addressed relate to three crucial points. 
1) The diffusion of all chemical species must be considered. The chemical probes 
used can diffuse into the skin/gel ... but also the colored or fluorescent product 
formed during the reaction of the probe with the RONS. Since the diffusivity of 
colored products and RONS have the same order of magnitude, it is not possible 
to neglect the diffusion of one species compared to the other. 
2) In some case, the chemical diagnostic may have been biased because its use as 
an in-vivo or ex-vivo probe is inappropriate. Moreover, it appears that the kinetics 
of the chemical reaction used to detect the RONS is slow. For example, H2O2 
does not react instantly with the Amplex Red reagent70 or Griess Reagent. The 
chemical problem posed by these manipulations is more complex than assumed. 
In fact, the detection reaction takes place in a system that reacts and diffuses at 
the same time... For example, if someone increases the concentration of the 
probe, a smaller diffusion length could be observed since the RONS would have 
been consumed at higher speed in the upper layer of the skin/gel. 
3) The use of gelatine layer is very questionable. These models totally neglect the 
existence of the antioxidant defenses of the skin. Moreover, the main result of the 
experiments involving the gels implies that the diffusion of the RONS is 
accelerated by plasma treatment compared to the case where a droplet of the 
RONS to be detected is placed at the surface of the gel. However, if the 
concentration in the droplet does not represent the concentrations elicited by 
plasma treatment, the non-detection of RONS crossing the membrane does not 
prove that the plasma has accelerated the diffusion. Both experiences are only 
incomparable. 
 
Let's start with the work of by Dobrynin et al. [169]. 
Dobrynin et al. have injected 200 µl under the skin of the sacrificed rat, performed a 
plasma treatment and then cut the piece of skin and observed the position of the colored 
reagent71. The result is visible in Fig 97. 
                                               
70 in manual instructions, and according to our own protocol, the incubation time is ~15-20 min for 
diagnostics under normal conditions of use 
71  [169] “To measure the H2O2 in and the pH of tissue, the dyes were injected using a syringe into a 1-cm-
thick 4×4-cm sample of skinless chicken breast tissue at various points to the depth of up to 1 cm. Ex vivo 
measurements were done in a rat tissue: a hairless Sprague-Dawley male rat was killed right before the 
procedure; 200 μL of dye solution (Amplex UltraRed) was injected subcutaneously using a sterile syringe, 
and the animal’s skin was treated with floating electrode DBD plasma at various time points after a 5-
minute incubation period (Fig 97). Right after the treatment, samples of skin tissue were extracted and 
analyzed as follows. Treated samples were cut in a vertical direction into slices with a thickness of 1 mm; 
fluo-rescence was measured” 
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Fig 97 Adapted from the paper of Dobrynin et al. [169]. Cross-section of the skin sample just before 
measurement. 
They concluded72 that H2O2 can diffuse over several mm. This conclusion is highly 
questionable because of the previous argument (n°1 and 2). The diffusion coefficients of 
amplex-Ultrared and his fluorescent product are not known because the structure of the 
molecule has not been provided by the manufacturer. We can, however, suppose that 
the value close to that of Amplex-red and resorufin, since Amplex-Ultrared is a derivative 
of the Amplex-red with a slightly higher molar mass. 
Regarding the diffusivity of the two species:  
 the diffusion coefficient of resorufin in water is ܦ௥௘௦ = 4 × 10ିଵ଴ ݉ଶ. ݏିଵ [170]. 
 the diffusion coefficient of H2O2 in a phosphate buffer at 25 °C is ~14 ×
10ିଵ଴ ݉ଶ. ݏିଵ [171] 
Since the characteristic length of diffusion is ∝ √ܦ, H2O2 will spread over a distance 1.8 
times greater than that of the resorufin. Consequently, it is not possible to neglect the 
diffusion of the resorufin througth gel/skin. It is therefore possible that the resorufin is 
formed only in the upper layers of the skin. In fact the Amplex-Ultrared (like Amplex-red) 
is not transformed into its product with a chemical reaction in a single step. The reaction 
starts with a reaction between the enzyme HRP and H2O2. Therefore, the diffusion of 
HRP-H2O2 should also be considered 
Secondly, this probe is not suitable for in-vivo or ex-vivo measurements. Its use for 
measuring H2O2 in extracellular fluids is even explicitly discouraged by Tarpey et al. 
[172].  Moreover, an experiment of Snyrychová  et al. on leaves show that Amplex-
Ultrared is more sensitive to photooxidation73 than Amplex-red74 [173]. 
Finally, all the sources of bias already mentioned in chapter two, enjoin to avoid this kind 
of reagent for tissues, and for direct exposure measurement ([96], [97], [174], [175]). 
                                               
72  [169] “In summary, we show that plasma effects may be transferred several millimeters deep inside a 
tissue, as measured in ex vivo chicken tissue and rat skin models. We detected penetration behavior of 2 
simple active components, namely H2O2 and pH, but other species may be detected and measured using 
other fluorescent dyes or techniques. In addition, we have shown that a simple agar gel model may express 
physicochemical properties similar to those of real tissue, resulting in comparable penetration effects of 
active species.” 
73 an order of magnitude calculation (not reproduced here) shows that the amount of UV emitted 
by the plasma could be sufficient to cause the color change in the absence of H2O2. 
74 Which is rather sensitive.  I observe personally that the results are totally biased by ambient 
light. 
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layer of gel, a good tissue-model? 
Gaur et al. propose to use gelatine layer as a skin model [176]. A layer of gelatine or 
PVA is placed above the liquid. The authors detect RONS in liquid phase and claims, 
insofar, that this system mimics the chemical transports induced by plasma through the 
skin. The scheme of the experiment used is visible below. First of all, it is necessary to 
point out that just mimicking the elasticity of the skin does not allow to obtain a "good" 
model of the skin, in any way. With this gelatine model, the effect of the antioxidant 
defenses of the skin is totally neglected75. The skin contains a complex system of 
enzyme and small molecules located in the vicinity or at the surface of the cells (whose 
most famous representatives are vitamins and catalase). It is precisely this chemistry 
that makes skin an anti-oxidant barrier. 
 
Fig 98 Figure adapted from Gaur et al. [176] 
Moreover, the supplementary data76 of this paper are very clear; the chemical probe was 
in contact with gelatine during the entire experiment. In that situation, it is obvious that 
“RONS reporters” diffuse and is present at the top of the gelatine when treatment begins. 
Consequently, these reporters are able to react. The product formed, diffuse quite freely 
in gelatin too77 and can go into the bulk solution. This point of chemistry was not 
considered by the authors. Yet, it changes considerably the interpretation of the 
experiment. For instance, no need to evocate the photolysis to understand why HO° is 
detected below this layer of gelatine... These biases also concern the work of Szili et al. 
[177] and [178]. 
The results of this kind of experiment should be interpreted by considering the diffusion 
of the ROS, the chemical probe, and the fluorescent product. It is also necessary to the 
study at which point the gelatine promote the diffusion of one chemical species compare 
to another. It is an interesting physicochemical problem but very far from biological 
reality. It doesn’t prove that the RONS produced in the plasma can diffuse through the 
skin across several mm. 
In the paper  [177] of the same team, Szili et al. claim the two following things:  
Statement 1 [177] “Gelatin was chosen because it consists of collagen, which is a major protein in skin, 
bone, and connective tissue [179]; gelatin also provides a barrier to H2O2 (when spotted as solution on top 
of the gelatin surface) and potentially to other RONS.” 
                                               
75 Gelatin will react with the most reactive species like HO °, but probably not with H2O2 
76 “The RONS reporters were used at a volume of 400 µl per well of a 96-well plate. This volume ensured 
the solution always remained in contact with the gelatin or PVA targets that were placed over the wells.” 
77 since rons repporters are « small molecules » i.e not proteines. 
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Statement 2[177] “Experiments with the tissue models have revealed the key RONS delivered into tissue 
(speciation) and likely relative (but not absolute) concentrations (doses) and depths of delivery. From these 
findings it is clear that plasma treatment can induce physical and chemical modifications deep within tissue 
to millimeter depths. Since our earlier studies, other groups have started utilizing gelatin and agarose 
tissue models with different plasma sources and also observed relatively deep penetration of RONS to 
millimeter depths [180], [181]” 
The statement 1 is debatable since the concentration of H2O2 spotted at the surface of 
the gelatine is smaller than that expected during a plasma treatment (1 mM vs 1 M) 
[178]. 
The statement 2 is debatable since the existence of anti-oxidants is forgotten. Is it 
reasonable to say that such experiments are models of what is happening in the skin, 
whereas the main phenomenon (the scavenging of ROS by anti-oxidant defenses) is 
neglected? 
In a recent experiment, the same team reproduces the “droplet experiment” with pig skin  
[182] (see Fig 99). Once again, there is bias since H2O2 concentration does not 
necessarily represents surface concentration under plasma-treatment (1 mM, against 1 
M according to our calculations). Moreover, this sample of skin is another source of bias 
since: “obtained  as  a  waste product from a pig that was sacrificed for food” [182].  
Indeed, for food preparation, pigs skin undergo a significant heat treatment (~ 60 ° C) to 
facilitate the separation78 of the skin from the rest of the body [183]. This heat treatment 
is able to denature the enzymes and the structure of the skin; such sample is a bad 
model of living skin. 
 
Fig 99 from the accepted manuscript [182] 
Similarly, the conclusions of Duan et al. [184]: 
 
 [184] -“Besides, it is exciting to found that the RONS produced by the plasma can penetrate through up to 
1.25mm thick of the biological tissue.” 
 
are false according to the argument n°1 (i.e., all chemical species diffuses through the 
skin not only the RONS…) [184]. Note also that the use of TPA is particularly biased in 
this study, since the TPA is used at low concentration (~200 µM) and that absolutely no 
observation is made regarding the yield of the reaction TPA + OH, whose yield is 
assumed to be 1 ... which is far from being true ... 
                                               
78 The  plant  specifications for  the  scalding operation  are  that  the carcasses are  immersed for 
6.5  min  in water maintained  at  60°C,  which  contains  a  commercial  scalding  tank  additive  
that  both  acts  as  a  wetting  agent  and  raises  the  water  pH  to  12 
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Regarding the chemistry of the probe used in the paper of Szili et al. (2018) [182]. It 
appears that RONS activity was observed with Luminol: 
[182]-“ ROS react with Luminol to form a luminescent product underneath the skin. The Luminol-ROS 
reaction product lifetime is approximately 30 seconds. No luminescence was detected in the control group 
of rodents with the tumours treated with the control He gas flow (figures 3A and C). This result indicates 
that the He gas flow on its own does not deliver ROS into the tumours. After He plasma jet treatment, a 
strong luminescent signal was detected (figures 3B and C).  This signal was statistically higher compared 
to the He gas flow control (n = 5, p <0.05), indicating that ROS were evidently delivered through the 
tumours by the He plasma jet. “ 
Now let's see what says, those who have a critical eye on the use of such a chemical 
probe (i.e., Wardmann [1]): 
 
Fig 100 From Wardman [1]. 
Now back to the paper by Szili et al.: 
[182]-“This result was relatively surprising because it shows the He plasma jet delivered ROS across an 
intact epidermal layer that normally provides an effective barrier to, for example, harmful agents and 
moisture ingress.” 
Knowing the huge interference associated with the use of Luminol, it seems difficult to 
draw strong conclusions from the experiment of Szili et al. For example if the plasma 
causes an increase in tissue oxygenation (due to hyperthermia or a breakdown of H2O2 
by the catalase contained in the skin), this could also contribute to the increase of the 
fluorescence signal observed in the entire body. Moreover, there is no evidence that 
hyperthermia didn’t play (see Chapter VI) 
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III.6.5 Perspectives about the measurement of H2O2 
measurement? 
Van de Bittner et al. have developed a new family of in-vivo probes called Peroxy Caged 
Luciferin-1 [185].  This bioluminescent probe appears to be chemoselective and enables 
the quantification of H2O2 in real time and in the whole mouse. As pointed out, the 
development of new H2O2-in-vivo diagnostics is a very active field of research [186], 
[187]. Indeed, the probes like Amplex-red or Amplex-Ultrared present serious limitation 
which considerably limits the possibility of obtaining credible results in-vivo. The probe of 
Van de Bittner et al. is better in terms of chemical selectivity. On the other hand, it 
requires the use of genetically modified mice to express the precursor of the fluorescent 
product [188]. A probe based on a similar principle has been developed by Wu et al. 
[189]. 
Another class of molecules, the hydrocyanine, enables the in-vivo detection of H2O2. The 
probe is converted by H2O2 into a detectable fluorescent molecule [190], [191]. There are 
also electrochemical probes for H2O2, and NO that can be used in-vivo, some are already 
commercialized [192]. It would be interesting if one of these "new generation" probes 
could be used with plasma treatments. 
III.7 Conclusion 
This chapter was dedicated to the chemistry of plasma-liquid interaction.  Long-lived 
species, i.e., H2O2, NO2-, NO3-, were measured with minor modifications of the protocols 
(see Chapter II section II.3, page 39).The production of HO° was measured through the 
production of the fluorescent specieTPA-OH. The diagnostic used during the systematic 
experiment presented in this chapter are summarized in Table 2. 
Table 2 Summary of the diagnostic used during systematic experiments 
Section/device Diagnostics Variable 
III.1/single channel jet Amplex-red/H2O2 Time/height/gas 
flow/Voltage 
III.2/single channel jet Griess/NO2- - 
III.3/multi-channel jet Amplex red + Griess - 
III.4/single-channel jet Griess + modified Nitrate-kit - 
III.5/single-channel jet TPA - 
 
It was found that the yield of the reaction between terephthalic acid (TPA) and hydroxyl 
radical depends on TPA concentration. In fact, the reaction producing the fluorescent 
compound is likely in competition with the recombination reaction of the radicals HO°. 
This is due to the high concentration of HO° in the first nm below the air-liquid interface. 
This model enables to estimate HO° concentrations during the plasma discharge: 
[ܪܱ°] ≅ 6.9 × 10ିସܯ. It provides also the production rate of HO° by volume that the 
plasma-liquid interaction should bring to maintain this concentration of HO°: ܵ = 1.5 ×
10ସ ݉݋݈. ܮିଵ. ݏିଵ. This simple model explain why the concentration of TPA-OH obtained, 
depends on [TPA] for the same plasma treatment. The orders of magnitude regarding 
the “effective Volume Veff” (i.e. the volume of liquid under the plasma where OH° exists 
at high concentration) seems consistent. 
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The plasma-devices have been characterized in terms of production rate in pmol/s and 
yield in nmol/J (Table 3). 
Table 3 Range of chemical yield (nmol/J) and production rate (pmol/s) measured during systematic 
experiments. “0” means that the concentration was below the range of detection of the diagnostic. 
The power supply has a frequency of 500 Hz for the totality of systematic experiments. 
Section/device Species Range of chemical 
yield (nmol/J) 
Range of 
production rate 
(pmol/s) 
III.1/single channel 
jet 
H2O2 0.7-4 300-1500 
III.2/single channel 
jet 
NO2- 0.03-1.5 50-1500 
III.3/multi-channel jet H2O2/ NO2- 0.5-1.9 /0.2-1.3 0-2500 /0-2000 
 
III.4/single-channel 
jet 
NO3- , 0.2-9 20-4000 
III.5/single-channel 
jet 
HO° 0.2-1.1 100-400 
 
These experiments show also that it is possible to optimize the amount of nitrite and 
nitrate produced in liquid phase by the single-channel jet by choosing   Φ(ܪ݁) =
300 ݏݏܿ݉, when peak to peak voltage is 27.4 kV and height is 5.5 mm. In such condition, 
the production rate of nitrite is  ~750 ݌݉݋݈. ݏିଵ and the yield is  ~1.2 ݊݉݋݈. ܬିଵ. By 
comparing the production rate of nitrites and nitrates for all the devices, it appears that 
the ratio of the two seems relatively constant: about 4 molecules of nitrate are measured 
for one molecule of nitrite.  
Regarding the single-channel plasma jet powered with 500 Hz power supply, the 
production rate of H2O2, NO2-, NO3- and HO° were measured in the range: 300-1500, 50-
1500, 20-4000 and 100-400 pmol.s-1 respectively; the yields were in the range 0.7-4, 
0.03-1.5, 0.2-9, 0.2-1.1 nmol.J-1 respectively. The multichannel-plasma jet is more 
powerful up to 3500 mW (vs. 800 mW for single-channel jet), which contributes to the 
increase in production rates. On the other hand, the yield is very similar to that of single-
jet. 
The aim of the parametric studies was not only to understand the plasma-liquid 
interactions but also to choose the set of parameters which optimize the production of 
chemical species (assuming that the production follow the same law above a living tissu, 
which is probably false). The underlying idea was to maximize the biological effect by 
increasing the amount of species produced.  
A critical reading of the experiments studying the diffusion of chemical species in gels or 
mouse skin was proposed. The hypothesis that the oxidizing species produced by the 
plasma diffuse deeply (beyond the dermis) was also questioned. The results suggest 
that the antioxidant defenses of the skin can considerably limit the ability of H2O2 to 
diffuse deeply into the living tissues (175 μ݉ <). Incidentally, it was explained how the 
studies [176] and [169] that defend the opposite hypothesis could have been biased. 
Further studies should be carried out on the subject, especially regarding the other 
RONS. 
Perspective 
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The comparison between experiments and simulations/model is absolutely fundamental. 
It can only be improved by choosing experimental setup in close collaboration with the 
team interested in the simulation of plasma-liquid interaction. The chemistry of the first 
nanometers below the interface liquid-gas is crucial. The presence of an interface 
considerably complicates the chemical and physical aspects. However, sonochemistry 
faces the same challenges: a mixture of UV-absorption, radical chemistry, in the vicinity 
of the air-liquid interface. 
To complicate things, we face an epistemological problem: as mentioned previously, the 
scientific literature related to the RONS may contain biased work due to the misuse of 
chemical probes. The authors of the critical reviews (Wardman et al. [1] and Tarpey et 
Fridovich [2]) sadly describe this situation as “the triumph of hope over reality”. 
According to these authors, several thousand of papers are involved.  We can only wish 
that plasma-medicine literature evolves in a healthier direction than that related to 
RONS. 
It would be interesting to collaborate with the researchers of the emerging field called 
“Quantitative Redox Biology” [159], [193]. The ambition of this field is to “gain the next 
level of understanding of redox processes” by developing mathematical models. 
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Chapter IV Results of in-vitro experiments 
This chapter describes the results of in-vitro experiments carried out on two cell lines. In 
the first place, the purpose of these experiments was to assay the cytotoxicity of plasma 
treatments on cancer lines before the in-vivo studies. The aim was to show that plasma 
treatment could have an anti-tumor effect. Indeed, it is unlikely that a significant effect 
occurs in-vivo without a cytotoxic response in-vitro. Two cancerous lines were used: TC1 
and NRS1. 
The two plasma sources and the two cell lines (TC1 and NRS1) are described in Chapter 
II. The left panel of Fig 101 presents a photo and a schematic diagram of the single-
channel plasma-jet. The right panel of the figure shows the Dielectric Barrier Discharge 
(DBD) facing a conductive surface connected to the ground. These two devices have 
been fed by the power supply n°3 described in Chapter II (section II.2.1). The waveform 
of voltage was a square waveform summed with a resonance peak at the time of 
switching. The power supply has a frequency of 500 Hz. The method for measuring 
power was described in Chapter II. 
These two sources were also used during some of the in-vivo experiments presented in 
the next chapter. Some features of the experiments are described in Chapter II. These 
experiments were carried out in the team of François Lemoine at CIMI laboratory (Pitié-
salpêtrière hospital). It has been checked that plasma treatments (DBD or single-channel 
plasma jet) do not cause any heating of the liquid. For this purpose, a thermocouple was 
immersed in the liquid during the treatment. DBD treatment does not cause any 
measurable increase in temperature; the plasma-jet decreases the temperature of the 
liquid (up to 17-18 °C). The biological diagnostics of the samples consist of trypan blue 
cell counts. 
 
Fig 101 Left, photo of treatment made with the single-channel plasma-jet above a 24-wells 
plate. Center, a diagram of the single-channel-jet, electrical circuit, that was used for power  
measurements. Right: photo of the dielectric barrier discharge facing a conductive surface 
connected to the ground. Diameter of blue resin = 15 mm. Diameter of copper cylinder = 5 
mm embedded in the resin. 
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IV.1 Viability of TC-1 cells after 24, 48 or 72H of 
incubation 
This experiment shows a comparison of the viability of cells treated by plasma-jet 
(single-channel), PAM or H2O2 treatment. The cells were counted with the Trypan blue 
method described in Chapter II. The number of cells in each well and the schedule of this 
experiment are shown in Fig 102. Each well contained 500 μL of liquid. The medium is 
composed of RPMI-1640 supplemented with L-glutamine (0.3 g/L), fetal calf serum (1 %) 
(SVF). In this experiment, the medium does not contain antibiotics. 
Regarding the exposure to plasma, the energy consumption was measured between 0.1 
and 200 J. Chemistry experiments have shown that this exposes the cells to H2O2 
concentrations between 0.4 and 800 μM. The Plasma activated Medium (PAM) was 
prepared by treating 500 μL of medium with the plasma jet. The effect of PAM on cells 
viability was compared with direct treatment after 24 h and 48 h incubation, but no 
significant difference appeared79. 
The effect of the direct treatment was compared with those of H2O2 after 72 h of 
incubation. During these experiments, the power of the source is measured in real time, 
and the duration of exposure is increased to reach the target value of energy. We work 
with constant applied energy (and not constant treatment time). This choice is justified by 
the fact that in this experimental situation, energy is a parameter directly proportional to 
the quantity of H2O2 produced, even if the power of the source varies slightly from one 
treatment to another. 
 
Fig 102 Diagram and schedule of the dose-response experiment to the single jet, PAM and addition 
of H2O2. The majority of treatments are made in duplicates. Each plate contains 24 wells with a 
diameter of 15.6 mm. There was 500 µL of liquid in each well. 
For the experiments which involve an incubation time of 24 and 48 hours, the flow of 
helium is 400 sscm, the distance between the nozzle and the surface of the liquid is 
about 3 mm. Peak to peak voltage is around 18.5 kV for the following energies: {2.5, 5, 
10, 15, 20, 25, 30, 40, 50 J}. It takes about 5 min to reach the energy of 50 J. For higher 
                                               
79  Not shown in this manuscript 
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target energies, the peak-to-peak voltage is increased to decrease the total treatment 
time. The following targets of energy {50, 70, 80,100, 200 J}, are reached with a peak-to-
peak voltage of 30 kV. It takes about 5 min to obtain 200 J. Most treatments are done in 
duplicate. 
Fig 103 shows the cell count obtained after 24h, 48 and 72 h of incubation (trypan blue 
diagnostic). This is a comparison between the effect of direct treatments (plasma-jet, red 
dots) and PAM treatments (orange dots). 
During direct treatments, the wells containing the cells and the medium are treated with 
the single-channel plasma jet. The plasma plume touches the surface of the liquid. PAMs 
are prepared from the complete medium (without cells). Just after the preparation of 
PAM, the medium in which the cells are immersed is replaced by the PAM (less than 1 
min after its preparation). Since the treatments exhibit significant variability, it would be 
necessary to use more replicates. The results were grouped by the range of energy. No 
significant differences appear between treated and untreated wells since the error bars 
of the treatments done at the energy  ܧ = 200 ܬ are just below those of the untreated 
group. Moreover, there is no significant difference between direct and indirect 
treatments. 
Therefore, it can be concluded that no deleterious effect on viability occurs after 24 or 48 
hours of incubation in this range of energy. 
Regarding the experiment done with 72h of incubation. The treatment conditions were 
slightly modified. Half of the plates were treated with a flow rate of 400 sscm, with a 
height of 9.7 mm between the surface of the liquid and the nozzle. The other plates were 
treated at 200 sscm and a height of 1.7 mm. Similarly, the targeted energies (100 and 
200 J) were carried out with a peak-to-peak voltage of 30 kV while the other energies (2, 
4, 5, 6, 8, 10, 20, 50 J) were reached with a peak-to-peak voltage of 19-20 kV. At 30 kV, 
200 J corresponds to a 4 min treatment at 30 kV whereas 6 min of treatment is needed 
to obtain 50 J at 19-20 kV. 
No significant difference appears80 in terms of cell viability between the wells treated with 
the parameters (height = 9.7 mm, Φ = 400 ݏݏܿ݉) or the parameters (height = 1.7 mm, 
Φ = 200 ݏݏܿ݉). 
The cell division rate is unusually high as evidenced by the control group (over 2 million 
cells). The results of the untreated group are dispersed. However, the effect on cell 
viability is significant after 72h of incubation. The error bars represent the standard 
deviation of the data. Since the analysis of the results did not show any significant 
differences for the same energy in the two conditions of treatments (200 sscm/1.7 mm 
vs. 400 sscm/9.7 mm), the results of the two plates have been pooled. 
                                               
80 this result is not shown here for the sake of brievety 
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Fig 103 Cell count of living cell after 24 h, 48h and 72 H of incubation. The error bars represent the 
standard deviation of the data. The red dots represent the results of direct plasma treatments. The 
number in brackets refers to the range of energy pooled in the bar. For example, “Jet (26-50)” means 
that the cell counts of treatments with energy between 26 and 50 J are pooled. 
The results are summarised in the following statements: 
 The effect on viability is significant after 72h of incubation. The difference 
between treated and untreated wells is not significant at 24 or 48h, in the range of 
energy 0 -> 200 J. 
 Direct and indirect treatments (PAM) are not significantly different regarding cell 
viability after 24H or 48H of incubation (not shown) 
IV.2 Comparison between plasma-jet, DBD 
treatments and artificial PAM treatments 
By “artificial PAM”, I mean a mixture of H2O2 and NO2- prepared from pure species (not 
prepared by plasma). 
IV.2.1 Plasma jet versus H2O2 
Fig 104 shows the results of trypan blue diagnostic after 72h of incubation. The blue dots 
(black bars) represent the results of plasma jet treatments. The green dots represent the 
cell counts after exposure to H2O2 diluted in the medium. 
The treatment at ܧ = 10 ܬ is placed under the same brakets since the wells are exposed 
to a concentration of 40 μM of H2O2, which corresponds to the concentration of H2O2 
produced by the plasma for this energy. The second brace corresponds to 50 J/200 µM. 
To conclude, after 72h of incubation, H2O2 added from the bottle has a similar effect than 
those of direct treatments. For the same energy, viability is the same for this two 
conditions of treatment (height=1.7 mm, flux = 200 sscm) and (height = 9.7 mm, flux = 
400 sscm) (not shown) 
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Fig 104 Cell count of living cell after 72 h of incubation. The numbers in the brackets describe the 
range of energy consumption measured during the experiment. 
IV.2.2 Role of NO2- 
In the previous section, we have found that the mortality is observable after 72 hours of 
incubation (in this range of energy/concentration). Consequently, in the present section, 
all cell counts are carried out after 72 h of incubation. It was found that exposure to direct 
or indirect treatment has a similar effect on the viability. Lastly, the viability of cells 
exposed to an artificial PAM composed of hydrogen peroxide diluted in the culture 
medium is very similar to that of cells exposed to direct treatments. 
The experiment depicted in this section is a comparison between the mortality induced 
by direct treatment with i) the DBD  ii) the single-jet and iii) artificial PAM. A quick 
overview of the experiment is given in Table 4. Stepping back, this kind of experiments 
address the fundamental question: which chemical species (or combination of chemical 
species) produced by the plasma could explain the mortality of the cells? 
Plasma-liquids interactions produce essentially three long-lifetimes species: H2O2, 
nitrites, and nitrates. Among these species, H2O2 and nitrites have the highest toxicity81. 
Consequently, in the following experiment, TC-1 cells have been exposed to increasing 
concentrations of H2O2, nitrites, and combinations of these two. It is a matter of 
understanding whether the addition of nitrites, increases the toxicity already induced by 
H2O2. The concentration ranges chosen correspond to those measured in Chapter III. 
The case of [ܱܰଶି] =1 mM higher than that obtained with plasma treatments, is also 
examined. 
In this experiment (plate 1, 2 and 3 in Table 4) the concentrations of hydrogen peroxide 
and nitrites take the following concentrations: 
                                               
81 nitrates are less toxic, see Chapter I. 
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 [HଶOଶ] ∈ {0, 100, 200 μM}  [NOଶି] ∈ {0, 10, 50, 100, 150, 200, 600, 1000 μM} 
Table 4 Content of each plate used for the comparison of plasma-jet, DBD, and treatments with 
artificial PAMs 
ID of culture plate/ 
Number of wells per plate 
Description 
Plate 1, 24 wells [ܪଶܱଶ]  =  0 μܯ, 
[NO2-] is in the range  [0, 1000 µM] 
Plate 2, 24 wells [ܪଶܱଶ]  =  100 μܯ 
[NO2-] is in the range  [0, 1000 µM] 
Plate 3, 24 wells [H2O2]= 200 µM 
[NO2-] is in the range [50, 150 µM] 
Plate 4 and 5, 24 wells Dose-response experiment. 
Plasma jet. 
The duration of exposure was 
increased to reach the target value 
of energy consumption. 
Plate 6, 7, 8,  12 wells Dose-response experiment. 
DBD 
The duration of exposure was 
increased to reach the target value 
of energy consumption. 
Plate 9 = 24 wells plate 
Plate 10 = 12 wells plate 
Untreated 
 
The experiments are carried out in 24-well culture plates. Each well contains 500 µL of 
the medium (RMPI+ 10% FCS + L-Glutamine + antibiotics). A diagram of the experiment 
is shown in Fig 105. 24 h after the seeding of the wells with 30 000 TC-1; H2O2 and 
nitrites are added to the wells (at constant volume). The viability is measured 72 hours 
after the addition. At this time, the cells in control wells are not confluent. Otherwise, the 
results could be biased. Three wells are used for each combination of concentrations 
(triplicate experiments). 
 
Fig 105 Diagram and schedule of the dose-response experiment to artificial PAM. Three wells are 
used for each concentration (triplicate experiments). Each plate contains 24 wells with a diameter of 
15.6 mm 
The results of cell counts are shown in shows a greater number of dead cells for the 
higher concentrations of H2O2. Note that the cells counted are those that are colored by 
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trypan blue, dead cells whose cytoplasm has mixed with the extracellular medium are 
not counted. It also appears that the concentration of nitrite has no influences on cell 
viability, even in combination with H2O2. 
 
Fig 106 Left, cell count as a function of [NO2-] after 72 H of incubation. Right: percentage of dead 
cells. Trypan blue diagnostic. 
Bear in mind that the scope of such a statement is limited, the previous study regards 
 One line (TC-1). Other cells, more resistant to oxidative stress probably behave 
differently. 
 In the range of concentration [ܱܰଶି] < 1 ݉ܯ, [HଶOଶ] ∈ {0, 100, 200 μM}  In the framework of in-vitro experiments. Nothing proves that the in-vivo behavior 
is the same. 
Let us now examine the results of single-jet treatments (schematic in Fig 107). The 
culture conditions are the same. The experiments are carried out in 24-well culture 
plates. Each well contains 500 µL of the medium (RMPI-1640+ 10% FCS + L-Glutamine 
+ antibiotics). The treatment takes place 24 h after the seeding of the wells with 30 000 
TC-1. The duration of exposure is increased to reach one value of energy. The 
experiment is repeated for each value of the energy at least in three different wells 
(triplicate). 
 
Fig 107 Diagram and schedule of plasma jet experiment. Three wells are used for each value of 
energy. Each plate contains 24 wells with a diameter of 15.6 mm. 
The red dots of Fig 108 represent a group of wells treated with the same parameters. 
Peak to peak voltage is 26 kV, the flow of helium is 640 sscm, and the distance between 
the nozzle of the jet and the surface of the liquid is equal to 1 cm. For these points, the 
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value of energy respects the setpoint at ± 1 J. All the points are triplicates, except ܧ =
50 ܬ, which is a duplicate. This group of points is homogeneous in terms of processing 
conditions and compliance with the set value. The error bars represent the standard 
deviation of the data. 
The black dots contains the previous data and the two points for which the energetic 
setpoint was missed82 as well as the 8 points acquired with different parameters: 
௣ܸ௣ = 30 ܸ݇,  ℎ = 12 ݉݉, Φ = 640 ݏݏܿ݉. The error bars represent the standard deviation 
of the data. 
It seems that the small differences in the parameters do not fundamentally alter the 
trends observed with the red dots. This is consistent with the result of the previous 
experiment since the data are represented as a function of the energy and since Chapter 
III have shown that the yield of H2O2 (in nmol/J) vary little in this range of parameters. 
The viability of the cells decreases rapidly as a function of the energy applied, in 
accordance with the experiments of the previous section. There is about one-fifth of the 
cells in wells treated with 20 J compared to untreated. 
Note that there is only a slight increase in the percentage of dead cells among the cells 
counted. This can be explained by the fact that the diagnostic does not count the cells 
that are dead and whose cytoplasm has mixed with the extracellular environment. 
Moreover, with this experiment, it is not possible to know whether plasma killed cells, or 
slowed their growth. 
 
Fig 108 Results of trypan blue diagnostic. Left: number of living cells after 72 H of incubation. Right: 
percentage of dead cells. Red:  Vpp = 26 kV,  Φ = 640 sscm,  height = 1 cm. Errors bars = standard 
deviations. Triplicate experiments except for one duplicate for E=50 J. Black: Red dots + data 
acquired with the parameters Vpp = 30 kV,  Φ = 640 sscm,  height = 1.2 cm + data acquired with the 
set of parameter red and for which the energy does not respect the setpoint. 
 
Let us now discuss the results of DBD experiments (Fig 109). The culture conditions are 
different because the size of the DBD is close to the diameter of the wells of the 24-
                                               
82 In practice, some treatments were missed. In this case, the experiment was repeated 
in another well. For example, when the energy consumed over a single well was 45 J 
whereas the setpoint was 40 J. 
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wells-plates. Larger culture wells should be chosen to avoid the discharges between the 
edge of the DBD and the wall of the wells. These discharges could bias the link between 
power measurements and the production of chemicals. The wells of the 12-wells-plates 
have an area twice as large. Thus, the number of cells per well must be the twice as big 
so that the cells grow under similar conditions. It is also necessary to double the volume 
of liquid so that the cells have the same amount of nutrient. Moreover, by doubling the 
volume of liquid, the same distance is maintained between the surface of the liquid and 
the bottom of the well. The cells are at the same distance from the plasma-liquid 
interface as in the case of the 24-well plates. 
The experiments are carried out in 12-well culture plates. Each well contains 1 000 µL of 
the medium (RMPI-1640+ 10% SVF + L-Glutamine + antibiotics). The treatment takes 
place 24 h after the seeding of the wells with 60 000 TC-1 cells. The duration of 
exposure is increased to reach the value of energy in the set {10, 20, 30, 40, 50, 60}. 
The experiment is repeated in 3 different wells (triplicate) for each energy.  
.  
 
Fig 109 Diagram and schedule of DBD-dose-response experiment. Three wells are used for each 
concentration (triplicate experiments). Each plate contains 12 wells with a diameter of 22.1 mm. Each 
plate contains 24 wells with a diameter of 15.6 mm 
The results of trypan blue diagnostic are shown in Fig 110. Again, the number of cells 
decreases with higher energy. The dispersion is quite large, unlike the wells treated by 
the plasma jet. 
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Fig 110 Results of trypan blue diagnostic. Left: number of living cells after 72 H of incubation.  Right: 
percentage of dead cells. The cells counted are those whose membrane is still intact. Errors bars = 
standard deviation. Triplicate experiments except for the measurement at E=70 J. Parameters Vpp = 
30 kV, height ~1 mm. 
IV.2.3 DBD vs. Plasma-jet 
The comparison between the results of plasma-jet, DBD and the treatments with the 
artificial PAM is shown in Fig 111. The black dots represent the treatments made with 
the plasma-jet. Regarding the DBD, since the initial number of cells is double, it is 
necessary to divide the number of cells by two to obtain a valid comparison. So, the 
ordinate corresponds to the number of living cells in 500 μL of medium (red dots). It can 
be seen that the red dots are above the black ones for the same energy. This can be 
easily understood: since the volume of liquid is double, the concentration of ROS is twice 
smaller. In order to obtain a more relevant comparison, it is interesting to divide the 
energy of the treatments by two (green dots). The abscissa of green dots represents 
the amount of energy consumed by the DBD for 500 μL of liquid. With this correction, the 
points associated with the jet and the DBD have a similar effect on viability (comparison 
of black and green dots). 
The blue dots represent the result obtained with the artificial PAM. The points 
associated with several nitrite concentrations were pooled since there is no significant 
effect of nitrites. The three points (Untreated, [H2O2]=100 µM, [H2O2]=200 µM) are 
plotted as a function of the H2O2 concentration (blue and upper abscissa).  
The experiments of Chapter III show that the yield of H2O2 is close to 2 nmol / J for the 
DBD and the plasma-jet. This gives 4 μM / J regarding concentration in 500 μL of liquid. 
This information enables to match the two abscissas (energy and [H2O2]). The position of 
blue dots is consistent, again with the hypothesis that [H2O2] alone could explain the 
decreasing viability of the cells. 
 
Fig 111 Results of trypan blue diagnostic. Comparison of the number of living cells after a treatment 
made with the jet (black), the DBD (red and green) or and artificial PAM (blue) as a function of energy 
and the equivalent amount of H2O2. Error bars are the standard deviation of measurement. 
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The conclusions of this experiment are summarised here. They are valid in the studied 
ranges with experimental uncertainties. 
 [NO2-] have no significant effect on the viability of the cells. 
 The concentration of H2O2 could explain all observations on cell viability, 
irrespective of the source of H2O2:  DBD, plasma-jet, artificial PAM. 
 The representation of cell viability as a function of energy makes sense since the 
experiments of Chapter III have shown that the yield of H2O2 is of the order of 2 
nmol/J for the DBD and the single-channel jet (for this range of parameter). Since 
there are variations in the power of the sources (for this experiment: 
ܲ݋ݓ݁ݎ(݌݈ܽݏ݉ܽ − ݆݁ݐ) = 419 ± 100 ܹ݉, ܲ݋ݓ݁ݎ(ܦܤܦ) = 110 ± 40 ܹ݉); this 
representation is preferable to a representation of the cell viability as a function of 
the treatment time. 
 
IV.3 Comparison of the viability of two lines: NRS1 
and TC-1 
A group of experiments was carried out with another cell line: NRS-1. Since the rate of 
growth and the needs of this line are very close to those of TC-1, the number of cells and 
the conditions of incubation are the same for TC-1 and NRS-1 (schematic in Fig 112). 
The wells were treated with DBD and plasma jet. Wells containing TC1 were also 
treated, to compare the behavior of the two cell lines. The treatment takes place 24 h 
after the seeding of the wells. The duration of exposure is increased to reach one value 
of energy. The experiment is repeated in triplicate for each setpoint of energy. 
 
Fig 112 Diagram and schedule of DBD-dose-response experiment. Three wells are used for each 
concentration (triplicate experiments). 24-Wells plate: 30 000 cells/well in 500 µL of the medium. 12-
Wells plate: 60 000 cells/well in 1000 µL. 
The results of trypan blue diagnostic are shown in Fig 113. The trends are very similar 
for the two species since there is a significant reduction of the number of the cells when 
the energy reaches 10 J. There is a great similarity between the results obtain with the 
DBD and the plasma-jet regarding the viability of the NRS1. Once again, the number of 
cells represented was halved in the DBD-treated wells since the initial amount of cells is 
twice as big. The energy applied to the DBD-treated wells was halved because the 
volume of liquid is twice as large (RONS are diluted by two). 
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Fig 113 Results of trypan blue diagnostic. Number of living cells after 72 H of incubation. Errors bars 
= standard deviation. Triplicate experiments. Parameters of JET-NRS1: Vpp = 25.1 kV, height =5 mm, 
Helium=400 sscm, Power=352±51 mW. JET-TC1 Vpp = 24.9 kV, height = 5 mm, Helium=400 sscm, 
Power=495 ± 48 mW. DBD-NRS1: Vpp=29.3 kV, height~1-2 mm Power= 105±17 mW. 
 
The curve showing the normalized results as a function of the initial number of cells for 
500 μL is represented in Fig 114. The evolution of viability is very similar not only for the 
two devices but also for the two lines. For 20 J, however, we find that TC1s seem to be 
significantly less affected by plasma-jet than NRS1. This experiment should be repeated 
in this range of energy, to clarify this point. 
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Fig 114 Results of trypan blue diagnostic. Left: number of living cells after 72 H of incubation. Errors 
bars = standard deviation. Triplicate experiments. Parameters of JET-NRS1: Vpp = 25.1 kV, height =5 
mm, Helium=400 sscm, Power=352±51 mW. JET-TC1 Vpp = 24.9 kV, height = 5 mm, Helium=400 
sscm, Power=495 ± 48 mW. DBD-NRS1: Vpp=29.3 kV, Power= 105±17 mW. 
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IV.4 Discussion 
Our group is not the first to do experiments with this line (TC-1). Kim et al. have treated 
TC-1 cells with a micrometric sized plasma-jet [19]. Indeed, the hollow-core of an optical 
fibber was used as a gas pipe. The inners diameters of the fibbers were in the range 15 
– 200 µm. The frequency of the power supply was ~32 ݇ܪݖ. The power consumption 
was between 15 and 35 W. This is very different from our device. The single-channel 
plasma-jet has an inner diameter of 3 mm, is powered at 500 Hz, and consumes ~500 
mW.  
Moreover, the processing conditions are entirely different. Indeed, in the work of Kim et 
al. the medium overlying the cells was removed just before the treatment. In our 
experiment, the medium was not removed. 
Kim et al. observed that the percentage of viable, necrotic, and apoptotic or dead cells 
with Annexin V-FTIC assay and TUNNEL assay. One treatment of 6 × 10 ݏ (repeated in 
6 spots) reduces the viable cells of ~ 75%83 24h after treatment.  
It could be assumed that the oxidative stress is higher in the experiments of Kim et al. 
because they observed that the viability of the cells is below those of control group only 
after 24 hours of incubation (against 72 h for us). The smaller volume of the target and 
the greater power of the devices could explain this observation. However, in the absence 
of additional measures regarding the chemistry, it would be hazardous to do others 
comparisons. 
Regarding the comparison of the efficiency of artificial PAM with plasma treatment. 
Girard et al. conducted a much more extensive study than ours on the line HCT116 and 
LU1205 [69]. Contrary to what we saw in the previous sections, they proved the 
existence of an anti-tumor synergy between ܪଶܱଶ and ܱܰଶି in aqueous solution. In this 
respect, two important remarks must be made: 
 the viability assay was performed after 24 h of incubation (in our case no visible 
effect before 72h of incubation)  
 the concentration of H2O2 and NO2- is higher in the well treated by Girard et al. 
than in our experiments. For Φ(ܪ݁) = 50 ݏݏܿ݉, the device produce 400 μM of 
ܪଶܱଶ, 400 μM of ܱܰଶି and 100 μM of ܱܰଷି per minute. In our case, for the same 
volume, the single-channel plasma-jet produces 120 µM of ܪଶܱଶ and 60 µM of 
nitrites and nitrates per minute. Only the wells treated with 200 J have a final 
concentration (~ 800 μM in 500 µL) which is comparable. The rate of production 
of nitrite and nitrate of our device is lower than those of Girard et al. Beyond the 
fact that the cell lines are different in the two studies, this could explain why we 
do not see a very significant effect of plasma treatment before 72h of incubation, 
contrary to Girard et al. [69]. 
 
To conclude, it is also necessary to be very careful with the experimental biases that 
culture medium could elicit. For instance, sodium Pyruvate is frequently used in cell 
culture medium and is known to be a scavenger of H2O2. Some formulations of 
Dulbecco's Modified Eagle Medium (DMEM) contain pyruvate [194]. Fetal Calf Serum 
(FCS) contains a complex mixture of proteins that can also scavenge radical species. 
                                               
83 this result is difficult to appreciate, since error bars and uncertainties are not available 
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The same caution must be applied regarding the commercially kits for ROS 
measurements. For example, in the work of Girard et al. the nitrate/nitrite assay kit of 
Cayman is used in accordance with the manufacturer's instructions [69]. According to 
Sun et al. [195] (and the manufacturer's instructions), the kit of Cayman is based on 
Griess Reaction. In these conditions, it has been shown that H2O2 can react very 
efficiently with nitrites which can lead to underestimating the production of nitrites 
(Chapter II, section II.3.3., page 46). It would be interesting to test the kit in the presence 
of H2O2. If a chemical interference is found; the addition of catalase should enable the 
destruction H2O2 and so, avoid the interference. Of course, it must be checked that 
catalase itself does not distort the diagnostic with appropriate controls. 
According to  [195] and [196], the protein content of the samples could also bias the 
measurements. However, preliminary experiments of C.Duchesne (private 
communication) show that FCS content of culture media does not bias Griess 
diagnostics. Since these kits have not been designed to give accurate results in the 
context of plasma medicine; it would be wise to control all the sources of bias for each 
kit.  
Some attempts to couple plasma therapies with various therapies have been made in-
vitro. For example, [197] describes the use of air plasma coupled with antibody 
conjugated nanoparticles. On the other hand, without in-vivo studies, the results of this 
kind of studies seems very disconnected from the therapeutic applications. Indeed, it 
seems very unlikely that a biological tissue protected by several anti-oxidant defenses 
behave similarly in-vitro and in-vivo. 
IV.5 Conclusion 
The aim was to show that plasma treatment could have an anti-tumor effect. Since it is 
unlikely that a significant effect occurs in-vivo without a cytotoxic response in-vitro. Two 
cancerous lines were used; TC1, and NRS1 and deleterious effects have been shown in 
vitro. 
The conclusions of this chapter are summarised in the following points: 
 Plasma treatments performed with DBD and the single-channel plasma jet 
decrease the viability of the cells. The effect on viability is significant after 72h of 
incubation. The difference between treated and untreated wells is not significant 
after 24 or 48h, in the range of energy 0 -> 200 J. 
 Direct and indirect treatments (PAM) are not significantly different regarding cell 
viability after 24H or 48H of incubation. 
 After 72h of incubation, H2O2 added from the bottle has a similar effect than those 
of direct treatments. For one same energy, the viability is the same for these two 
conditions of treatments:  (height=1.7 mm, flux = 200 sscm) and (height = 9.7 
mm, flux = 400 sscm) 
 TC-1 cells have been exposed to increasing concentrations of H2O2 and nitrites, 
as well as combinations of both chemicals. The concentrations take the following 
concentrations: 
o [ܪଶܱଶ] ∈ {0, 100, 200 μܯ} 
o [ܱܰଶି] ∈ {0, 10, 50, 100, 150, 200, 600, 1000 μܯ} 
It appears that nitrites play no role in the toxicity of chemical mixtures. H2O2 alone 
explains the toxicity of the mixture. Moreover, with the experimental uncertainties, 
the production of H2O2 generated by the plasma explains the toxicity of the 
plasma treatments (DBD and plasma-jet). 
 There are slight differences between the mortality of NRS1 and TC1 lines. 
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 [NO2-] have no significant effect on the viability of TC-1 after 72h of incubation. 
 [H2O2] alone explain the decrease in viability whatever the source of H2O2: DBD, 
plasma-jet and artificial PAM. 
After such experiments, it appears logical to proceed to in-vivo studies. 
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Chapter V In-vivo experiments 
Five experimental campaigns have been carried out during the last three years. For the 
sake of clarity, the protocols and the specificity of each experiment are described before 
the presentation of the results. These campaigns involve treatments of two lines: TC-1 
implanted in the cheek or the flank of C57BL/6 mice and CT26 tumor implanted in the 
flank of BALB/C mice.  
The approach was to increase the power of the source to obtain an anti-tumor effect. 
This led us to observe the appearance of cutaneous lesions due to hyperthermia. It was 
therefore necessary to develop temperature monitoring. Finally, a refrigerated source 
was then used. A thorough discussion based on the literature takes place in Chapter VI. 
It is recalled that TC-1 cell line (CRL-2785; American Type Culture Collection [ATCC]) is 
an immortalized epithelial cell line of C57BL/6 mice that expresses HPV-oncoproteins E6 
and E7 [107]. If the tumor is located in the place of origin of the cells of the tumor line, 
the tumor model is orthotopic; otherwise, this model is called ectopic. TC-1 in the cheek 
is an orthotopic model of HPV cancers. CT26 tumors are subcutaneously implanted in 
the flank of the mouse; this is an ectopic murine colorectal carcinoma. 
In-vivo and in-vitro experiments are two classes of models. In other words simplifications 
of the disease occurring in humans and the biological responses accompanying the 
treatment. In-vivo models are better models than in-vitro models because the tissue and 
the whole organism are taken into account. Growing complexity is encountered when the 
experiments are done at the level of the cell, the tissue; the whole organism or the level 
of an organism disturbed by the disease. 
 
 
 
  
Since, the complexity increases, it is much harder to understand biological responses. 
On the other hand, the relevance of the treatment is more precisely questioned during an 
in-vivo than in-vitro experiments. For instance, the microenvironment of the tumor and 
the immune response are key parameters that cannot be taken into account with in-vitro 
experiments. 
Numerous in-vitro experiments describe cellular mechanisms that can lead to cell death 
by necrosis or apoptosis. However, if it is not possible to prove the existence of any in-
Complexity/relevance for therapeutical applications 
Understanding, ease of implementation 
Cells Tissue Organism 
Sick organism 
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vivo effect, these experiments are rather useless for therapeutic applications. In-vitro 
experiments aim to obtain more precise knowledge of cellular mechanisms and clues 
regarding what might happen in-vivo. However, it must be proved secondly, that these 
precise mechanisms intervene and play a key role at the scale of the organism by 
dedicated in-vivo experiments. 
Ultimately, this is the relevance and the strength of the in-vivo experiments which will 
give the extension of the medical applications of plasmas. The question is whether the 
benefit-risk ratio of this type of treatment will convince physicians to assign a function to 
plasma-medicine therapies (PAM and direct treatment) in the framework of modern 
oncology. 
V.1 Preliminary experiment: CT26-tumor of Balb/C 
mice treated with a DBD at low power 
This experiment took place between November and December 2014. This work was 
done in collaboration with Alexandre Dizeux, Ph.D. student in the team of Lori Bridal at 
the Laboratoire d’imagerie Biomédicale (LIB) in Cordeliers’ Research Center. 
V.1.1 Power supply and plasma source 
The AC-power supply has a frequency 610 Hz. The waveform is non-sinusoidal, and 
peak-to-peak voltage is 30 kV (Fig 115, right). It was the first version of the home-made 
power supply: voltage and frequency cannot be set precisely. The plasma source is a 
dielectric barrier discharge between the skin and the surface of the glass rod, in which a 
tungsten tip is embedded. Glass thickness is around 1.5 mm (± 0.2 mm). Several glass 
tips broke over the mice. The lack of flexibility of the power-supply and the lack of 
reliability of glass-tips have resulted in the evolution of the devices for subsequent 
experiments. 
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Fig 115 Left: Schematic diagram of glass-DBD and photography of the discharge above a metallic 
plate. Right: waveform of the voltage provided by the power supply. 
V.1.2 Treatment schedule 
Seven- to 8-week-old female mice from the Balb/C line were purchased from Janvier (Le 
Genest-Saint-Isle, France). The animals were housed at the CEF (Centre d’Explorations 
Fonctionnelles, Cordeliers’ Research Center). All experiments were conducted in 
laboratory animal house in accordance with the institutional guidelines and the 
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recommendations for the care and use of laboratory animals established by the French 
Ministry of Agriculture. 
 A  group  of  35  mice with subcutaneous CT26 colorectal tumor on the flank  was 
 divided  into three  homogeneous groups  in  terms  of  tumor  size:  a  placebo  group 
(ܰ = 11)  and  two groups that received, respectively, CAP  exposure  at  100  J/cm² 
(ܰ = 12)  and  300  J/cm²  (N  =  12) per  day  of therapy. Ultrasound diagnostic is time 
consuming (around 30 min per mouse). Therefore, the number of mice that can be 
treated and observed per day is limited. That’s why 35 mice are divided in two groups of 
17 (Gr1) and 18 mice (Gr2). Tumor implantation is made at two consecutive days for 
these two groups. Therapy was applied for 5 consecutive days, twelve days (Fig 116) 
after tumor implantation. 
 
Fig 116 Treatment schedule of the experiment. 35 mice are divided into two groups. CT-26 tumors are 
implanted at time D=-12 and D-11 for groups one and two respectively. 
V.1.3 Monitoring of tumor, ultrasonic diagnostics 
Baselines measurements were made at day 0 for Gr1 and day 1 for Gr2 with the three 
different imaging: B-mode, shear wave elastography (SWE), and Contrast-enhanced 
ultrasound (CEUS). 
Ultrasound imaging with B-mode was used for the calculation of volume. Tumor 
dimensions were assessed with two B-mode images. The first gave length and 
thickness. The second gave width and thickness (again). Tumor volume was 
approximated using the ellipsoid formula  ܸ = గ
଺
ܾܽܿ where  a  is  the  length,  b  is  the 
width  and  c  is  the  thickness. Surface of the ellipsoide that must be treated was 
calculated according to Knud-Thomsen formula: 
ܵ = ߨ ቆ
ܽ௣ܾ௣ + ܾ௣ܿ௣ + ܿ௣ܽ௣
3
ቇ
ଵ/௣
 
 where  ݌ ≈ 1.6075 yields a relative error of at most 1 %. 
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 We consider that the surface exposed to plasma is constant and equal to 9 mm² (It is 
based on photographs of the electric discharge). We also make the assumption that the 
half of the surface of ellipsoid can be exposed to plasma, the rest being inside. The 
number ௧ܰ of treatment points of each tumor is obtained by dividing S/2 by 9 mm²:  
௧ܰ =
ௌ(௠௠మ)
ଶ ×ଽ
. 
Then, shear-wave elastography measurements give the mean stiffness of this region of 
interest. After injection of contrast agent, CEUS enables to obtain the six functional 
parameters of tumor vascularization. Chapter II.5 summarises the definition of these 
parameters. 
V.1.4 Protocol applied to each mouse 
In the beginning, the general state of each mouse was checked. Particular attention was 
paid to the research of specific signs of pain and distress. The mouse was then 
anesthetized with 2 % (v/v) isoflurane in the medical air at 1 l/min. The temperature of 
the animal was maintained at 37 °C during anesthesia using heated support (Minerve, 
 Esternay,  France). The hair of the mouse was shaved around the tumor or the position 
of ECG electrode. The ECG electrode (whitesensor, distrimed) was then fixed on the 
flank; a small amount of the conductive gel (uni’gel, distrimed) was put between the skin 
and the electrode to improve electrical contact. At the beginning of treatment, the mouse 
was moved to an anesthetic device. This device was in plastic material to isolate the 
animal from the earth. The ECG electrode was then connected to the measuring 
capacitor Cm. The equivalent electrical circuit as described in Chapter II. 
The surface of the tumor was divided into several zones according to the number of 
treatments points Nt defined in previous section (Fig 117, left). The generator was 
switched on, and the power consumption was measured in real time by the oscilloscope. 
The processing time was changed to obtain the wanted energy per unit area. There were 
slight changes in the power consumption as a function of the position of the treated 
point. The glass tip was held securely attached about 1.5 mm from the skin. Once the 
point was processed, the generator was cut off, and the tip was moved to the next point. 
The measurements of the oscilloscope were reset between each point. 
 
Tumors are divided into several 
areas of approximately 9 mm ² 
Measuring 
capacitors 
Cm=9.6 nF 
BALB/c mouse 
Anesthesia system 
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Fig 117 Left: diagram of one tumor, the order of the treatments is indicated. Right: photography of 
experimental setup. 
At the end of the treatment, the mouse was moved to the heating plate. Its front and rear 
legs, and its tail are firmly taped to the surface of the thermostat plate. B-mode imaging 
is used to measure the transverse dimensions of the tumor (width and depth). If the 
tumor is large enough, three measurements of elasticity (using SWE) are made 
according to three transverse sections of the tumor. The same protocol was repeated 
along the longitudinal axis (1 image in B mode giving length and depth + 3 elasticity 
measurements). 
Then, another ultrasound transductor delivering greater power is fixed above the mouse, 
after the choice of a region of interest, which contains the tumor; the contrast agent is 
injected into the caudal vein of the mouse. The ultrasound power reflected by the 
bubbles is measured for a few minutes (CEUS diagnostic describe in Chapter II).The set 
of ultrasonic measurements take about 30 min for each mouse. The mouse was left to 
wake up on the hot plate; the state of health was checked after his awakening. 
V.1.5 Power measurements 
The section below describes the results of the electrical measurements carried out on 
the mice. As outlined in Chapter II, the measurement of two voltages enables the 
calculation of power consumption. The voltage provided by the generator (black curve) 
and the voltage at the terminal of the measuring capacitor (9.6 nF), which was connected 
in series to the mouse (red curve), are plotted in Fig 118. These voltages are called 
respectively “High Voltage” and “Ucm”. 
Peak to Peak Voltage of “High Voltage” signal was only 28 kV whereas it was 30 kV at 
the beginning. This drop in voltage is a consequence of the heating which occurs in the 
primary circuit of the transformer. After several tens of minutes, the increasing 
temperature of coil leads to increase the resistance of the primary circuit which elicits a 
decrease of the current flowing through the transformer. Since the output voltage is 
directly proportional to this current, the output voltage decreases to the observed value. 
This is one of the problems raised by this homemade generator. 
The waveform of “Ucm” is very similar to “High Voltage” signal. This is a consequence 
of capacitive currents. As explained in Appendix A, the circuit “mouse + capacitor+Cm” 
may be modeled as pure capacitance with a good approximation. Without plasma, the 
layer of air between glass rod and the skin is also a pure capacitance. Therefore, this 
circuit is a Voltage divider referenced to ground. Capacitive currents caused by the 
vicinity of high voltages are at the origin of a signal proportional to “High Voltage.” 
The changes of Ucm, however, are not only due to capacitive current but also to 
discharges currents. Discharges currents cause steps in the voltage across the 
capacitor. This is a result of an exchange of charges between the surface of the 
dielectric and the skin. This exchange is partly due to the charges transported in the 
head of streamers in the form of an ionization wave. Another part of discharge current 
occurs after the establishment of the ionized between the two surfaces. Steps in “Ucm” 
are shown in the right part of Fig 118, which is a zoom of signals plotted on the left 
between 2.6 and 2.9 ms. 
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Fig 118 Voltage of power supply (in black) and the voltage at the terminal of measuring capacitor (in 
red) as a function of time. Right: zoom of the waveform between 2.6 and 2.9 ms. The step of voltage 
observed on measuring capacitor corresponding to successive discharges are clearly visible. 
As explained in Appendix A, the capacitive currents do not contribute to the power 
balance, on average. On the other hand, the capacitive currents have a significant effect 
on the instantaneous power. The numerical calculation of the integral of power 
consumption is set out in Fig 119. The Visual Basic script, which enables the integration 
of power, use trapezoidal rule. This script was implemented in the oscilloscope. The 
energy consumed during the acquisition can be read directly into the interface. The 
benefit of this approach is that we know power consumption in real time. The black curve 
is the value of consumed energy between time t=0 and time in the range [2.6 ms ; 4.4 
ms]. The decrease in the energy consumed just after 2.7 ms, as well as the overshoot 
between 2.8 and 2.9 ms, is due to the transient capacitive currents. When the black 
curves decrease, it means that energy is released from the capacitor. The dipole 
equivalent to the circuit  “DBD + system of measurement” acts as a generator for a short 
time. By contrast, when energy consumption of the circuit “DBD+ measuring system” is 
higher than the damping values (dashed line, Fig 119 left), it means that energy is stored 
in a capacitive form.  
The instantaneous power gives no information regarding each discharge because of the 
response time of the system. This is shown very clearly by comparing the left and right 
parts of Fig 119. The four individual discharges cannot be distinguished on the left of, in 
contrast to the right. Instantaneous power, with this measurement method, is 
meaningless regarding physics of the discharge. Only the damped value of the energy 
gives physical information. 
The difference of the energy before and after discharge current, when the transient 
capacitive currents have been damped, represents the energy consumption due to the 
formation and maintenance of the plasma (as well as energy consumption due to the 
dielectric losses, see Appendix A). The red arrow represents this quantity in (Fig 119, 
left). We obtain that 98 µJ were consumed during these discharges.  
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Fig 119  Left: Detail of the integral of the power as a function of time. The decrease in the energy 
consumed just after 2.7 ms, as well as the overshoot between 2.8 and 2.9 ms is due to the transient 
capacitive currents (this is energy stored in capacitive form and then released). Right: XY 
representations of signals between t=2.6 ms and t=4.38 ms. 
Several periods of “High Voltage” signal are recorded during each acquisition. The 
purpose was to increase the precision of measurements of mean value. The using of 
long acquisition time is not the best choice. Appendix A shows that a wiser choice is to 
acquire only one period. This increases the speed of calculation of one acquisition and 
enables to acquire more samples. Moreover, uncertainties due to numerical integration 
decrease. 
The integral of power given by the oscilloscope is plotted in the left panel of Fig 120. 
Acquisition time is 20 ms, 2060 µJ is consumed. Each step corresponds to a half period 
of the power supply. The frequency of power supply is 610 Hz. For one treated point, a 
given position above the tumor, hundreds of acquisitions are made. Each dot in black 
plotted on the right of Fig 120 is the energy consumed during one acquisition. The 
dispersion is partly due to the respiration of the mouse or change in the distance 
between glass rod stems from respiration and movement of the mouse under 
anesthesia. The mean value of the 420 measurements (1555 µJ), is plotted in red and 
blue. Red error bar is the standard deviation of the set of measurements (167 µJ). In 
blue, error bar is the standard error of the mean equals to 8 µJ. The mean value of 
power is known much more precisely because more than 400 measurements are 
available. Since 1555 µJ are consumed in 20 ms, power is equal to 77.8 ± 0.5 mW. 
 
Fig 120 Left: Result of the calculation of the energy consumed during 20 ms. The black curve is the 
integral of the power consumption calculated by the oscilloscope. At each change of sign of the 
voltage, discharges leave glass-electrode. Right: each black dot is one measure of energy during 
one acquisition. Error bar in red is the standard deviation of the set of measurements (167 µJ). In 
98 µJ 
t = 2.6 ms 
t = 2.8 ms 
t = 4.38 ms 
Discharge
s 
No plasma 
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blue, error bar is the standard error of the mean: 8 µJ. mean value of energy consumption is 1555 µJ 
for 20 ms. Therefore power is 77.8 ± 0.5 mW. 
The measurement method described in the previous paragraph was used on each 
mouse and for each position of glass rod above the tumor. Following this treatment, 
energy was summed for all points of one tumor. This energy is divided by the S/2; this is 
half of the surface of the ellipsoid describing a tumor. The result, energy per unit area, is 
set out in Fig 121 as a function of time express in terms of the number of treatments 
undergone by one mouse. The black dots represent mice in 300J/cm² group. The blues 
dots correspond to 100 J/cm². Error bars are the standard deviation of the sets. 
Regarding 300 J/cm² group, energy per area is very close to the setpoint for the first 
three days of treatment. The energy applied to the mice was not precisely at the level of 
the setpoint because it was necessary to leave time for ultrasound diagnostics. The area 
of the tumor was estimated from caliper measurements. The last two treatments are far 
from the setpoint. The surface of the tumor became so large that it was impossible to 
treat the tumor in less than an hour, which is dangerous for animals. 
Regarding 100 J/cm² group, the first three treatments respect the setpoint. It was not 
possible to treat all mice in this group in the last two days due to the long handling times. 
 
Fig 121 Treatments (in J per cm²) effectively applied to the mice of different groups (black 300 J/cm², 
blue 100 J/cm²). After day 4 the surface was so high that it was not possible to treat mice in less than 
45 min. 45 min was the upper bound of treatment time. The time of anesthesia undergone by the 
mouse (1h15) is dangerous beyond that. 
Energy consumed by the DBD above each mouse is set out in Fig 122. The graph 
reveals that there has been a gradual increase in the consumption. It is merely due to 
the growth of the volume of the tumors which required longer treatment to comply with 
the setpoint values. The mean energy is between 170 J and 270 J for 300 J/cm² group. 
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Fig 122 Treatments (in J) effectively applied to the mice of different groups (black = 300 J/cm² group, 
blue = 100 J/cm² group). 
The energy consumed was summed for each mouse and all treatments. Fig 123 
provides the results for each group. On average, mice in 300 J/cm² group received 1020 
J, during five successive days. One mouse died during the first treatment. No other mice 
died or were sacrificed before the end of the therapy. 
 
Fig 123  Sum of energy consumed for all treatments. Each point is a mouse. On average, mice in 300 
J/cm² group received 1020 J.  Error bars represent the standard deviation. 
V.1.6 Treatment of CT-26Tumor: a negative result 
The following section is a brief description of results given by ultrasound diagnostics. 
No difference was visible between the skin of treated and placebo group. No mark, no 
sign of damage, no inflammation or crust was visible just after one or five treatments. 
The tumor volume (B--mode), tumor stiffness (SWE) and tumor vascularization (with 
CEUS) were measured at baseline and the end of the experiment (D=9). As presented 
in, the results did not reveal significant differences between size, stiffness or functional 
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parameters of the tumors Fig 124. Only results related to the placebo group and the 300 
J/cm² group are presented here (results of 100 J/cm² group are similar). This is clearly a 
negative result. 
 
Fig 124 Left: tumor volume as a function of time for placebo and 300J/cm² group. Center: 
comparison of 6 parameters describing vascularisation for placebo and 300 J/cm² group at day nine 
given by Contrast Enhanced Ultrasound imaging. Right: comparison of stiffness for placebo and 300 
J/cm² group at day 9. Ultrasound diagnostics show no differences between placebo and treated 
groups. 
V.1.7 Conclusion 
The results of this preliminary study are negative: no antitumor effect or changes in 
vascularisation was observed. This study, however, was rich in lessons regarding the 
limitation of the experimental setup. Furthermore, it enabled to refine the questions 
relating to the measurement of power consumed by the plasma above the mouse. 
After this first experiment, several changes appeared to be priorities: 
 Improve the power supply to obtain a generator whose peak to peak voltage and 
frequency can be set up. 
 Replace glass DBD by something more reliable and reproducible. The assemblage 
(glass rod fused around tungsten tip) broke several times above the animal (risk of 
electrocution) 
 Increase the area of the treated surface (9 mm² for glass-DBD) to shorten 
treatment time. 
 Increase the power consumption of the device. Indeed, the mean power of this 
device was around 100 mW. This is an order of magnitude smaller than the 
devices of others groups. It was assumed that this could explain the failure of 
treatment despite long treatment times. 
 Develop a transportable plasma-jet source, which could be installed and provide a 
comparison with DBD experiments. 
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V.2 Experiments with a Cheek-TC1 model of oral 
squamous cell carcinoma: toward more power 
This section describes experiments with a different tumor model than that used in the 
previous section. TC-1 cancer cells were injected in the cheek of mouse and formed a 
solid tumor, causing inflammations similar to those observed in humans [107], [108]. This 
is an orthotopic model of C57BL/6 mice. These experiments took place at the animal 
house of Pitié-Salpêtrière hospital between May and August 2016. The maximum 
volume before euthanasia84 is 800 mm3. This value is justified by the fact that growing at 
this location causes significant eating disorders and quickly reaches the eye. 
First, the results of  four modalities of treatments are described; (i) treatment during 30 
min with a DBD shown in section II.1.3; (ii) treatment time of 15 min or 30 min with the 
single-channel plasma jet described in II.1.4; (iii) injection of plasma-activated RPMI in 
the vicinity of the tumor. All plasma sources are powered by the high voltage power 
supply n°3 operating at 500 HZ described in II.2.1. 
The second subsection describes experiments with the multijet (described in Chapter 
II.1.5) made with the 10 kHz sinusoidal power supply. The power consumption is larger 
than those of the preceding experiments of one order of magnitude. Unlike previous 
experiments, the skin cannot sustain the treatment without damage beyond a given time 
of exposure. 
V.2.1 Single-jet and DBD experiments with 500 Hz power 
supply generator 
V.2.1.1 Treatment schedule 
 
 
Fig 125 Treatment schedule of the experiment. The injections took place at time D=0. There were 
three days of treatment at three-day interval after D11. 
For this experiment, the power supply n°3 described in II.2.1 was used. The waveform is 
non-sinusoidal, and peak-to-peak voltage can be set to 30 kV maximum. 
Regarding the experiment using DBD, peak to peak voltage was adjusted to 30 kV. The 
currents do not cause muscle contraction. By contrast, peak to peak voltage was limited 
                                               
84 according to the protocol accepted by ethics committee 
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to 22-23 kV with the single-channel plasma jet. A Higher voltage caused muscles 
contractions. The flow rate of helium was set at 400 sscm.  
Plasma activated medium was prepared by exposing one mL of RPMI-1640 to the 
plasma-jet during 1h15 or 1h 20 min. As evaporation occurs at a significant level, more 
than half of the fluid evaporates during treatment. The remaining volume is measured 
with the 1000 μL pipette.  
A group of 40 Seven- to 8-week-old female C57BL/6  mice were purchased from Janvier 
(Le Genest Saint Isle,France) and kept under specific pathogen-free conditions at the 
UMS28 animal facility (UFR 969, Pitié-Salpêtrière). 50, 000 TC1 cells were injected into 
the cheek of each of the 40 mice. After twelve days of growth, treatments begin. The 
group of 40 mice was divided into six homogeneous groups in terms of tumor size (Table 
5). For an exploratory study of several experimental conditions, it is necessary to reduce 
the size of the groups to the minimum to reduce the number of animals implies in the 
study. Consequently, the minimum group size was fixed at six. Mice were sacrificed if 
tumor volume was higher than 800 mm3. 
Table 5 Size of the groups. 
Group Number of mice 
Direct treatments Untreated 8 
DBD 30 min 6 
Single-channel jet 15 min 6 
Single-channel jet 30 min 6 
Indirect treatments 
injection of 40 µL 
Control group, injection of RPMI 6 
RPMI treated by the single-
channel jet (PAM) 
7 
 
The distance between the surface of the DBD and the skin ranged from 2 to 4 mm. This 
distance was not precisely fixed because the animal moved and breathed during 
anesthesia, Furthermore, the DBD was moved during processing so that the plasma 
touched the entire surface and the tumor. The same range of distance was used for the 
plasma-jet Two photography are shown on the top of Fig 126. At the right, we can see 
the ECG electrode, which is connected mouse torso to the measuring capacitance. 
Photos of Fig 126 illustrate another practical problem. In the presence of hair, the plasma 
discharges tend to strike the top of the hair rather than the surface of the skin. This could 
reduce the effectiveness of the therapy. It is, therefore, necessary to shave the surface 
of the skin at the level of the tumor. The two photos below represent a mouse before 
shaving treated with the single-channel plasma jet. This mouse was used for preliminary 
experiments. 
A conductive gel was applied on mouse skin to prevent the current from flowing through 
the internal organs. A conductive path was established from the ECG electrode to the 
surface of the tumor with this gel. The surface of the tumor was also covered by this 
hydrogel. The gel is removed from the tumor just before treatment, so the plasma was 
applied to a slightly moist skin (except for the first treatment of 30 min-plasma-jet group, 
Fig 128). 
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Fig 126 Top: treatment with the DBD. Bottom: right and left, hair and vibrissae are an issue when it is 
desired to direct the plasma discharge onto the skin. This figure enables to understand the problem 
caused by the presence of hair during plasma-treatment. 
V.2.1.2 Results of the electrical diagnostics 
The section below describes the results of the electrical measurements carried out on 
the mice. As outlined in 0, the measurement of two voltages enabled the calculation of 
power consumption. A capacitor of 100 nF was connected in series to the mouse (Fig 
127). 
5 mm 
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Fig 127 Left, photography of experimental setup, the tumor is implanted in the cheek of the mouse. 
Right, a schematic diagram of the single jet and electrical circuit devoted to power measurement. 
Power measurements regarding treatments with the single-channel plasma jet were 
summarised in Fig 128 (blue). The power is of the order of 400 mW. The first day of 
treatment of the group “jet 30 min” is different from those of group “jet 15 min”: the skin of 
the mice was dry. In this case, the power was significantly lower for this group at day 1. 
The average of the energy for the two groups is plotted in red and green. 
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Fig 128 Blue: power consumption of single-channel plasma-jet. Orange and green: energy 
consumption in J. The first treatment took place at day 11; the three treatments are at three-day 
interval. The first day of treatment of group « jet 30 min » is different: the skin was dry for all the 
mice. Consequently, the power was significantly lower for this group at day one. 
Power measurements regarding treatments with the DBD were summarized in Fig 129 
(blue). The power consumed, 150 mW, is considerably lower than that of the plasma-jet. 
It is also found that the reproducibility of one treatment to the other is ensured. The mean 
energy was 320 J for each treatment. 
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Fig 129 blue: power consumption of DBD during treatment. Orange: Energy consumption in J. The 
first treatment took place at day 11; the three treatments are at three-day interval. The reproducibility 
of power consumption and energy reached seems better than those of single-channel plasma-jet. 
Plasma activated medium (PAM) was prepared with the set of parameters specified in. 
The final volume was measured with 1000 µL pipette. The amount of H2O2 in the well 
was deduced from the measurement of energy and the fact that the yield was close to 2 
nmol/J for this parameter (Chapter III). 
Table 6 Plasma activated medium was prepared from RPMI-1640. One mL of liquid in 24 wells plate 
was exposed to the single channel plasma-jet for a time specified in the second column. He flow was 
400 sscm. Height above liquid was 2 mm. A significant part of the liquid was evaporated during 
plasma exposure. Consequently, height above the liquid is between 2 mm and 4.5 mm. 
Day of PAM 
injection 
Time of 
treatment (s) 
Final 
Volume 
µL ±10 µL 
Energy (J) 
± 15 J 
Amount 
of H2O2 
(µmol) 
Amount of 
H2O2 
injected in 
each mouse 
(µmol)  
D1 4830 565 3030 6 0.4 
D2 4805 440 4075 8 0.6 
D3 4521 440 4130 8 0.6 
 
V.2.1.3 The growth of TC1-tumor in the untreated group 
The size of the tumor was measured with a caliper (Fig 130). Tumor volume was 
approximated using the formula  ܸ = ଵ
ଶ
ܮ × ܹ ×  min (ܮ, ܹ) where L was the length and 
W  the width. It is an approximation of the volume of an ellipsoid, considering that the 
thickness of the tumor is of the order of magnitude of the width. Mean value and errors 
bars are plotted until the day of the first sacrificed mouse. The volume of tumors grows 
exponentially. 
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Fig 130 Tumor volume as a function of time for the untreated group. Black dots represent individual 
values. Red dot and errors bars are the mean value and the standard deviation of this group. The 
mean values and error bar no longer make sense when a mouse in this group had to be sacrificed. 
V.2.1.4 Tumor volume of DBD group 
Tumor volume of the group treated with the DBD was plotted on Fig 131 for each 
replicate. There is no significant difference in the size of untreated and DBD group. In 
these conditions, the plasma treatment does not affect tumor growth. 
 
Fig 131 Tumor volume as a function of time. Comparison between untreated and plasma DBD group 
for each mouse (left). Comparison between the mean value of each group: error bar represents the 
standard deviation of the groups. 
V.2.1.5 Effect of plasma jets treatments on tumor growth 
Tumor volume of the two groups treated with plasma-jet is plotted in Fig 132 for each 
replicate. There was no significant difference in the size of untreated and plasma jet 
groups. 
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Fig 132 Comparison of tumor volume of group “plasma jet 15 min” and “plasma jet 30 min” with the 
untreated group. There is no significant difference between the treated and untreated groups. 
The survival curve, however, shows a little effect for the group “plasma jet 30 min”. Such 
increase survival is not significant since there is only 6 mices in each group. 
 
Fig 133 Survival curve as a function of time for untreated(Black), single-channel plasma jet for 15 min 
(red), 30 min (purple). 
V.2.1.6 Effect of PAM injection on tumor growth 
Tumor volume of the group treated with the injections of PAM was plotted on Fig 134 for 
each replicate. There is no significant difference in the size of untreated and PAM group. 
The amount of H2O2 in each injection was 0.4 µmol for the first treatment and 0.6 µmol 
for the two others. These values are based on the assumption that the yield of H2O2 
production is of the order of 2 nmol / J. 
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Fig 134 Tumor volume as a function of time. Comparison of PAM (pink) and untreated group (red and 
black) 
V.2.1.7 Conclusion 
The main results are summarised in the following points: 
 No visible effects on mouse skin, no signs of damages. 
 Indirect treatment with PAM injection had no measurable effect.  
 Regarding tumor size, direct treatment with the DBD during 30 min and 
the single-channel plasma jet for 15 min had no measurable effect. 
 Perhaps a little effect regarding the survival of plasma jet groups 
V.2.2 Multichannel plasma jet experiments 10 kHz 
experiments  
These experiments took place at the animal house of Pitié-Salpêtriere hospital between 
August and October 2016. These experiments were done in collaboration with the team 
of François Lemoine from the Centre d'Immunologie et des Maladies Infectieuses (CIMI) 
in Paris. 
V.2.2.1 Protocol and electrical diagnostic 
The experiment is composed of two groups of six eight-weeks-old female C57BL/6. The 
orthotopic tumors were prepared as in the previous section. However, treatment began 
seven days after the injections (instead of eleven days). The 12 mice are divided into two 
homogeneous groups. The conditions of sacrifice are the same than in the previous 
experiment in term of tumor size ( ெܸ஺௑ = 800 ݉݉ଷ). 
The plasma source and the generator have been changed compared to the previous 
experiment. For this experiment, the power supply n°2 is used (described in II.2.1). The 
waveform is sinusoidal, and the peak-to-peak voltage was adjusted to 13 ± 0.3 kV. 
Higher voltages cause muscles contractions. The flow rate was set at Φ(ܪ݁) =
2250 ݏݏܿ݉, the minimum value, which provides a stable discharge. 
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Fig 135 The power consumption is plotted in black. Energy consumption is plotted in red. The 
treatment has a duration of 30 min. Mean power = 2371 mW, Mean energy = 4408 J. Error bars 
corresponds to the standard deviation of the treatments applied to the six mice. 
V.2.2.2 Results of the 30-min-treatment 
Just after the treatments of 30 min, no differences were visible between the skin of 
treated group and placebo group. No mark, no sign of damage, no inflammation or crust 
was visible right after the treatment (Fig 136, left). 
The state of skin was very different two days later. The skin of the treated area was 
destroyed. The damage is similar to that of a severe third-degree burn. Subcutaneous 
tissue was severely damaged, in some cases, muscle tissue is apparent. Ischemia 
accompanies the loss of substance. A significant loss of weight of the order of ~ 1.5 g is 
also observed, probably due to the difficulties that the mouse has to feed. Owing to the 
size of the damage, three mice were immediately sacrificed. 
The size of the damaged area spread until the third day. Wound healing occurred, and 
the mice started to gain weight again. The treatment was not repeated. After the 
cicatrization, two of the three mice developed the tumor at the same location. The tumor 
of the mouse shown in Fig 136, was removed entirely. This mouse was still alive 60 days 
after plasma-exposure. 
 
 
C) 15 day B) 2 days after A) Just after the 
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Fig 136 Picture of the cheek of the mouse n°A0. Picture A: just after the treatment. Picture B: 2 days 
after. Picture C: 15 days after. These massive damages entirely obliterated the tumor which did not 
re-growth. 
V.2.2.3 Discussion 
A) First, in-vitro experiments had shown that there was no heating of the liquid exposed 
to the multichannel jet (even for higher power consumption). The cooling of the liquid 
was observed and attributed to the evaporation of the liquid. The rate of evaporation is 
increased by the flow of dry helium.  
B) Moreover, the paper [80] (Kin-Pen experiments) use the same kind of assumption. 
The authors of this paper use the temperature obtained at the surface of their petri dish 
to assume that the maximum temperature reached by the tissues do not exceed 41 ° C. 
They assume an initial temperature of 37 °C for biological tissue. Then, they use their 
temperature measurements in 12-wells dishes (temperature rise of + 2.93 ° C + -0.40 ° 
C) to justify the fact that the temperature of the biological tissue does not exceed 41 ° C.  
C) Unfortunately, the infrared camera was not available. Consequently, the temperature 
was measured with a thermocouple applied at the surface of the skin few seconds after 
the end of the treatment. However, the time required by the moving of the mouse and the 
outcoming the thermal equilibrium with the skin (15-20 s) is sufficient to ensure that the 
temperature measured by the thermometer reaches a temperature range which seems 
tolerable (40 ± 1 °C). However, next experiments and simulations show that this 
temperature did not represent the temperature of the skin during treatment.  
Indeed in the framework of plasma-medicine the symptoms encountered could have 
three origins: an electrical burn, a thermal burn or a chemical burn.  
Electrical burns involve the destruction of tissues by Joule effect and dielectric rupture. 
They are fairly well characterized in the literature, especially to prove the existence of 
cases of torture by electricity [198]. In our case, this source of damage can be excluded, 
the value of the current involved exclude the possibility of damages produced by joules 
effects inside the body. In addition, precautions are taken (addition of conductive gel) to 
minimize the size of the tissues through which the current flows. 
The literature shows that the corrosive action of H2O2 (see toxicology section II.3.2) 
could be a source of damages. Regarding our case, it will appear that the damage is 
probably from thermal origin. At this point of the discussion, without the measurements 
given by the thermal camera, it is not possible to exclude that chemical effects play a 
role.  
Three needs emerge: 
1. Reliable data regarding the temperature of the treated surface. The link between 
these temperature measurements and the damage observed must be studied. 
2. The modeling and the simulation of the thermal behavior of the tumor exposed to 
plasma should bring precious information. 
3. experimental device that excludes the possibility that hyperthermia plays. 
V.2.3 Damage to the skin 
This discussion is devoted to the damage following the treatments of 1, 2 or 5 min. 
These experiments aimed to determine the maximum duration of treatment, which 
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enables the repetition of treatment every two days. The multijet powered by a sinusoidal 
source at a frequency of 10 kHz was used 
V.2.3.1 Orthotopic model 
Fig 137 shows the treatment of an orthotopic TC-1-model (tumor in the cheek) by the 
multi-channel jet. The distance between the center of the nozzle and the skin is of the 
order of 4-6 mm. The gas flow and the voltage are the same as in the previous 
experiment. In all cases, no mark is visible on the skin just after the treatment. In this 
context, the repetition of treatment which seems to induce a second- or third-degree burn 
is not acceptable. 
  
Fig 137 Picture of the mouse during the treatment of the orthotopic model. 
Fig 138 shows that one-minute treatments do not cause significant damage. Both photos 
are taken two days after the last mentioned treatment. The two photos were taken with 
the same mouse.  After one treatment of one minute, no difference can be observed 
between the untreated skin and treated area.  After three treatments, the skin seems to 
have peeled (on a very small area). It is not even possible to describe this as a burn of 
the first degree: the treated zone has the same color than the untreated area. 
 
Fig 138 Left: two days after the first treatment. the four yellow objects are gravel, which has stuck to 
the skin. Right: two days after three treatments of 1 min 
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Fig 139 shows the skin of the mouse two days after one treatment of 5 min (Left), and 
two days after one treatment of three minutes (Right). It appears that the five min 
treatment induces a rather severe burn, relatively thick (second or third degree) and 
relatively extensive. From an ethical point of view, it would not be acceptable to treat this 
mouse again. Three-minute treatments induce visible but limited damage (slight 
irritation). It seems ethically acceptable to repeat these treatments. 
 
Fig 139 Left: two days after one treatment of five min. The scar and the depth of the damage are like 
a second or third-degree burn. Damage is limited. However,  from an ethical point of view, it would 
not be acceptable to treat this mouse again. Right: 3 min of treatment is a good compromise between 
toxicity and treatment time. 
The proximity of the eye is a difficulty for this type of model. It is ethically unacceptable 
that a mouse loses an eye during treatment. It is also necessary to protect the eye of the 
mouse from the flow of Helium which could cause its drying. 
The ectopic tumor models developing in the flank enables to reduce the number of 
experimental precautions to be taken and enables to monitor tumors growth over a 
longer time since the mice must be sacrificed when the volume reaches 2000 mm3 (800 
mm3 for the orthotopic model). 
V.2.3.2 Ectopic model: damages and surface temperature after one or 
several treatments 
Fig 140 shows two mice bearing an ectopic model of cancer (TC1-tumor in the flank). It 
can be seen that the multijet achieves its objective: the possibility of treating a large area 
without moving the mouse. The discharge takes the form of several filaments starting 
from each of the channels and sweeping the surface over time. If the nozzle is too far 
from the surface, the filaments become a single, more intense filament, which may cause 
burns. 
The treatment conditions were slightly optimized compared to the previous case. The 
flow of Helium has been increased up to 2600 sscm to decrease the voltage of ignition. 
This enables to be away from the tension causing muscular reactions. 
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Fig 140 Photo of a C57BL/6 mouse bearing an ectopic TC1 tumor. During this treatment, the power 
consumption is around 2 W. The generator has a frequency of 10 KHz. Sinusoidal voltage, peak to 
peak voltage is 13 kV peak to peak. 
Fig 141 shows three infrared images of a tumor. They were taken at the end of the 
treatment. The first picture, on the left, was taken around 5 s after the end. The two 
others are taken respectively 33 s and 57 s after the first picture. The rate of 
thermalization of the surface can be observed. The generalization of this kind of 
measurements is presented in section V.3.2.5; they are interpreted by a model described 
in Chapter VI. In this precise measurement, the surface of the skin reaches a maximum 
temperature of 45 ° C after 3 min. The temperature after 5 min of treatment is not so 
different. To summarize, the surface temperature is systematically measured between 45 
and 48 ° C at the end of a treatment of 3 or 5 min. Exposure of the cells to a temperature 
above 42 ° C induces irreversible damage to the cells. The damage increases 
exponentially with temperature. The modeling of damage is described in Chapter VI. 
 
Fig 141 Temperature of the treated area acquired with the infrared camera. From left to right: the 
maximum temperature is 44.7, 36.1 and 34.4 ± 0.1 °C. The picture in the center is taken 33 s after the 
left one, the picture on the right, 57 s after the left one. The left image was acquired about 5 seconds 
after the end of treatment. This kind of measurement was repeated during the experiment described 
in section 0. The results of measurements are compiled in section V.3.2.5 and interpreted in Chapter 
VI. 
As previously, damage caused by treatments lasting 3 min were evaluated. The following 
tables show the damage to the skin of two mice. The damages shown are representative 
of those of a group of 12 mice, which has undergone a similar treatment. The pictures 
1 cm 1 cm 
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were taken two days after each treatment. Significant damages always appear after two 
or three treatments. 
Table 7 Damages two days after repeated treatment of 3 min. Peak to peak voltage and power which 
was measured two days before the picture was taken are written below the picture.  Orange column = 
the two pictures are taken two days after the first treatment of 3 min. Green column = the pictures are 
taken two days after the second treatment. The damages after one treatment are relatively small. The 
black area is parts of the skin with different coloration: this is not a carbonized area.  For the mouse 
n°374 (First line), significant damages appear after only two treatment (probably a second-degree 
burn). Whereas the extension of damage is more limited for mouse n°362 (probably a first degree-
burn). The blue arrow is the spatial scale of the wound. 
 One treatment of 3 min Two treatments of 3 min 
Mouse number = 
374 
઴ = ૛૟૙૙ ࢙࢙ࢉ࢓, 
height=4-6 mm 
  
 1500 mW, Vpp =  12.3 kV 1200 mW, Vpp = 11.8 kV 
   
Mouse number = 
362 
઴ = ૛૟૙૙ ࢙࢙ࢉ࢓, 
height= 4-6 mm 
 
 
 1660 mW, Vpp = 12.7 kV 1000 mW, Vpp =  10.4 kV 
 
All the experimental observations of damage and temperature measurements are 
summarized in the four following points. 
 Skin temperature after one treatment of 3 min or 5 min was around 45-48 °C. 
 Treatment of one min gave no damages. Repetition of 1-min therapy does not 
produce damage. 
 One treatment of three min gave no damages, but the repetition of this treatment at 
two days intervals gave damages after two or three treatments. 
 Treatment of 5 min systematically causes damages. The damage probably 
corresponds to a second or third-degree burn. 
These observations are the set of facts that the simulations of Chapter VI must 
reproduce, it enables to constrain the model and the simulations. 
~ 5 mm 
~ 3 mm 
~ 4 mm 
~ 7 mm 
Chapter V—In-vivo experiments  
 
149 
 
V.3 Systematic experiments with refrigerated 
plasma-jet: treatment of CT-26 and TC-1 tumors line 
The discussions of the previous section and the results of the experiments provided 
treatment conditions that minimized damage to the skin. The addition of a cooling system 
reduced the damages considerably. A preliminary experiment missed due to a failure of 
the control group, suggested that a decrease in the size of TC-1 tumors could be 
observed with non-refrigerated plasma-jet. In this experiment, however, the temperature 
of the skin was between 45 and 48 ° C after plasma treatment. Consequently, It is not 
excluded that hyperthermia plays a role. 
The purpose of the experiments described in following sections is to cancel this bias by 
cooling the skin. The refrigerated plasma-jet is a 3D-printed plasma source described in 
section II.1.6, which includes a tank for containing liquid nitrogen. The boiling point of 
liquid nitrogen is −195.8 °ܥ at atmospheric pressure. This very low temperature could 
lead to mechanical stress and breakdown of plastic material. The design85 of the source 
guarantees the good mechanical strength of the device and solves this issue. Since 
liquid nitrogen was removed from the device before treatment, the cooling was not 
excessive or able to cause frostbite. Infrared images show that the skin temperature is 
around 10 ° C when the treatment begins.  
This solution was chosen due to his practical interest86. Unfortunately, the chemistry of 
this source is less well characterized, but preliminary measurements suggest that yield of 
nitrites and H2O2 (in nmol per J) has the same order of magnitude than the single-
channel jet. 
It would have been possible to choose another technological solution. For instance, in 
dermatology, micro-droplets of a cryogenic fluid are projected on the skin [199]. Their 
evaporation elicits a cooling of the upper layer of the skin and enables to use 
dermatological treatments based on the heating of the tissues while preserving the upper 
layers of the skin. It is also possible to use the Joule-Thomson expansion of argon gas at 
high pressure to obtain a fast cooling of biological tissue for the treatment of prostate 
cancer by cryotherapy [200]. 
Let's go back to our device. 
Since the device cool the skin, are we creating a new bias? 
The review [201] describes the effect of cold on several tissues. The rate of refrigeration 
and warming seems to play a key role. Necrosis occurs when ice is formed within the 
cells. The paper [202] explains how to quantify the damage caused by the cold. The 
temperature has to be below 0°C to damage the tissue.  
With our device, since the minimum temperature of the skin is between 7 and 9 °C87, it 
can be considered that the device is safe regarding the low-temperature side. Moreover, 
cryotherapy required a temperature of - 40 °C to kill the cancers cells in one treatment 
[203] [204]. 
                                               
85 i.e. the choice of plastic thickness ~several millimeter 
86 The device was designed, manufactured and tested in a single week thanks to 3D printing. 
Moreover, the use of liquid nitrogen is credible from a practical point of view. Indeed, all 
laboratories and hospitals have liquid nitrogen to store biological samples. 
87 see section V.3.2.5 
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The first experiment consisted of treating BALB/C mice with CT-26 tumors implanted in 
the flank. The second was to treat C57BL/6 developing TC-1 tumors in the flank. 
V.3.1 CT26- treatment with refrigerated multi-channel jet 
This experiment took place between November and December 2016. This work was 
done in collaboration with Jerôme Griffon, a Ph.D. student in the team of Lori Bridal at 
the Laboratoire d’imagerie Biomédicale (LIB) in Cordeliers’ Research Center. 
V.3.1.1 Power supply and plasma source 
The power supply of this experiment produced a sinusoid waveform with a frequency of 
10 kHz. Plasma source was the multichannel plasma jet described in section II.1.6. Mass 
flow controllers (Brook’s instruments) provided a helium flow of 2600 sscm. This flow 
was the minimal value of flow that enables the ignition of plasma for a peak to peak 
voltage around 11 or 12 kV. For lower flow rates, the ignition occurs at higher voltage 
(16-17 kV). Moreover, the ignition occurs suddenly when the voltage of the generator is 
increased. The current flowing through the skin caused a rather violent muscular 
reaction. 
To avoid a waste of gas, we do not choose a gas flow rate higher than this value. 
Second, we know from our chemicals experiments, that the yield of nitrite production 
decrease for increasing value of Helium flow. Consequently, the choice of helium flow is 
a compromise between mouse health and the production of reactive species from 
nitrogen. The best operating point of the device is achieved by a flow of 2600 sscm. 
The choice of the distance between the output of the refrigerated plasma-jet and the skin 
is also the result of compromises. Too close, the output of plasma-jet which is at a 
temperature below -20 ° C may touch the skin, which, while freezing, may stick to the 
device and induce frostbite. Moreover, chemistry experiment from chapter IV, show that 
the yield of production of nitrogen species decrease when the distance decrease. This is 
probably due to a less efficient mixture of nitrogen from the ambient air with He flow 
leaving the plasma jet. Too far, the stability of ignition is not ensured. Second, the 
cooling of the skin due to cooled He is ineffective because He is less dense than air, the 
range of distance for cooling is limited by the characteristics of Helium flow at the output 
of the plasma-jet. Third, If we increase the distance too much the aspect of the discharge 
changes, instead of having about ten plasma filaments, striking the surface of the tumor 
in ten different points, we have a single discharge, Much brighter, probably warmer, 
since huge damages were instantaneous observed on the skin of mice (carbonization). 
V.3.1.2 Treatment schedule 
Seven- to 8-week-old female mice from the Balb/C line were purchased from Janvier (Le 
Genest-Saint-Isle, France). The animals were housed at the CEF (Centre d’Explorations 
Fonctionnelles, Cordeliers’ Research Center). All experiments were conducted in an 
animal house in accordance with the institutional guidelines and the recommendations 
for the care and use of laboratory animals established by the French Ministry of 
Agriculture. 
 A  group  of  39  mice with subcutaneous CT26 colorectal tumor on the flank  was 
 divided  into four  homogeneous groups  in  terms  of  tumor  size (a) untreated group 
 (N  =  10) (b)   (N  =  10) (c)   (N  =  10) per therapy (d). Ultrasound diagnostic requires 
much time (around 30 min per mouse). Therefore, the number of mice that can be 
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treated and observed per day is limited. That is why 39 mice are divided into two groups 
of 20 (Gr1) and 19 mice (Gr2). Tumor implantation was made at two consecutive days. 
Therapy was applied to each mouse for two weeks at two days interval, seven days after 
tumor implantation. 
Table 8 Description of the four groups. 
Group Number of mice Description  
Untreated 10 Control group  
PAM 10 Prepared from PBS1X, injection in 
6 points 
Plasma 10 Direct exposure of the tumor to the 
refrigerated multi-channel plasma-
jet 
Plasma-inhibitor 9 Tumor was exposed to a catalase 
inhibitor during 10 min before 
plasma  treatment (Hydroxylamine 
NH20H 10%w in DMSO) 
 
V.3.1.3 Tumor monitoring 
The set of diagnostics used for the monitoring of the tumor is the same than those of 
previous experiments done at LIB laboratory. The monitoring protocol was described in 
section V.1.3. The tumor size was measured with a caliper. Tumor volume was 
approximated using  the approximation:  ܸ = ଵ
ଶ
ܾܽܿ where  a  is  the  length,  b  is the 
width  and  c  the  thickness.  
V.3.1.4 Protocol applied to each group 
Untreated group 
The ten mice of this group undergo only the manipulations necessary for the acquisition 
of ultrasound measurements. 
Direct-plasma group 
First, the plasma source filled with liquid nitrogen. The cooling took about 10 min. Photos 
of the tumor were systematically taken before treatment. The size of the tumor was 
measured with a caliper. A small amount of gel was spread on the surface of the tumor. 
The gel was removed with paper towels before treatment. The purpose of this was to 
treat a slightly moist skin in the hope that this could promote the formation of ROS. 
The mouse was moved to a plastic anesthetic device to isolate the animal electrically. 
The ECG electrode was then connected to the measuring capacitor Cm. Liquid nitrogen 
was removed from the plasma sources (otherwise the cooling is too strong) 
The health of the mouse was checked a few minutes after his awakening. This group 
contained ten mice. Measurements made with the ultrasound diagnosis are performed 
for approximately 30 min. 
Catalase-inhibitor group 
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The skin of mice was exposed to hydroxylamine (NH2OH), a catalase inhibitor, for 10 min 
before plasma treatment. The 10% by weight solution of Hydroxylamine was prepared by 
dissolving the solid in DMSO. Since the DMSO has an excellent cutaneous absorption, 
the idea was to promote the passage of the product through the skin of the mouse. In the 
protocol, 40 μL of solutions are applied to the surface of the skin for 10 minutes. Then 
the skin is dried before being treated with plasma. This group contains ten mice. 
PAM group 
The conditions regarding the preparation of PAM are summarized in Table 9 and its 
legend. The PAM is prepared by exposing PBS1X to the plasma source for more than 30 
min. 30 μL of liquid is injected into each mouse every two days. These injections take the 
form of 6 injections of 5 μL in the vicinity of the tumor (less than 1 mm outside the tumor). 
The injections are not done in the tumor itself to avoid the breaking of the outer layer of 
the tumor and the spread of metastasis. 
Unfortunately, the chemistry generated by this plasma source has not been studied 
precisely, however measurements made with semi-quantitative diagnostics (Quantofix®, 
test strip for H2O2, nitrites, nitrates) show that the yield of chemical species (in nmol/J) is 
at least as high for this device than for the single-channel plasma jet. The yield could be 
even higher (up to an order of magnitude higher). It is certain that a rigorous chemical 
characterization work must be done with this plasma source. The estimation of the 
quantity of H2O2 contained in the 30 μL of injected liquids (last column of Table 9) is 
based on the low assumption that the yield is around 2 nmol / J. The amount of H2O2 
injected has a significant variability. The sum of the total quantity of H2O2 injected is of 
the order of 7.2 or 7.9 μmol. This group contains nine mice. 
Table 9 Plasma activated medium was prepared from PBS 1X.  The liquid contained in 6 wells plate 
was exposed to the multichannel plasma jet for a time specified in the second column. He flow was 
2600 sscm, mean value of peak to peak voltage was 12.7 kV. Height above liquid was 6 mm. A 
significant part of the liquid was evaporated during plasma exposure. 
Day of PAM 
injection 
(after 
implantation) 
Time of 
treatment 
(s) 
Initial 
Volume 
(µL) 
Final 
Volume 
µL ±20 µL 
Energy (J) 
± SD 
Amount of H2O2 
injected in each 
mouse (with the 
assumption of a yield 
equals to 2 nmol/J) 
(µmol) 
7 Gr1 1860 1500 270 7988 15 1.8 
7 Gr2 1824 1700 500 10086 25 1.2 
9 Gr1 2551 2000 460 10255 16 1.3 
9 Gr2 1937 1500 280 10314 22 2.2 
11 Gr1 1833 1500 790 10704 9 0.8 
11 Gr2 1882 2000 700 11047 16 0.9 
       
14 Gr1 2220 2000 680 11510 70 1.0 
14 Gr2 1869 2000 580 12335 15 1.3 
16 Gr1 1800 2000 950 9549 14 0.6 
16 Gr2 2100 2000 ~ 550 13471 52 1.5 
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18 Gr1 2105 2000 520 14745 19 1.7 
18 Gr2 1823 2000 890 11393 7 0.8 
 
V.3.1.5 Results of electrical diagnostics 
The section below describes the results of the electrical measurements88. The measuring 
capacitance had a value of 104 nF. Fig 142 shows the power of the plasma source 
during direct treatments. Compared to non-refrigerated devices, we found that the power 
of the devices is twice higher. This increase in power could be attributed to the fact that 
the refrigeration dries the gas. In non-refrigerated devices, it was likely that the 
desorbption of water adsorbed inside the gas tubes contributes to decrease the power of 
the device. 
 
Fig 142 Power consumption of the multichannel plasma-jet. In red: power consumption of “plasma” 
group. In black: power for “plasma+inhibitor” group. Error bars represent standard deviation. The 
mean value for the merged group was close to 4 W. 
Fig 143 shows the energy consumed during direct plasma treatments. It appears that the 
energy consumed by the plasma is constant from one day to another (average value of 
785 J). The error bars show the dispersions of measurements. The primary sources of 
variability are the structure89 of the flow in the vicinity of the surface of the tumor or the 
variability of the electrical properties of the skin. 
                                               
88 method is described in Chapter II 
89 laminar or turbulent 
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Fig 143 Energy consumption of the device during one treatment. In red: “plasma” group. In black: 
“plasma+inhibitor” group. Error bars represent standard deviation. The energy consumption is 785 J 
(average value of pooled groups) 
 
Fig 144 shows the sum of energy and time over the six treatments of the experiment 
campaign. It appears that each mouse was treated during 1300 seconds (total energy 
consumption ~5400 J). There is considerable progress compared to the first experiments 
in terms of applied energy and therefore the quantity of chemical species produced in the 
skin. 
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Fig 144 sum of energy (black dots) and treatment time (blue dots) during the six treatments of the 
experiment campaign. The nine mice of “plasma+inhibitor” are plotted in the left part of the graph. 
The ten mice are drawn in the right part.                                                                                                                             
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V.3.1.6 Treatment of CT26-tumor 
Tumor volume (calliper measurements) is plotted as a function of time in Fig 145 for 
each group. It appears there is no significant difference between treated and controls 
groups.  
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Fig 145 Tumor volume plotted as a function of time for the four different groups. Error bars represent 
the standard deviation of measurement. Each group contained ten mice. 
Even ultrasound measurements show no effects. The results of the preliminary results of 
ultrasound measurements (mode B, CEUS, contrast-enhanced ultrasound) show similar 
results. The results of shear wave elastography are visible in Fig 146. There is no 
difference between treated and untreated groups. 
  
Fig 146 Stiffness of the tumor (in kPa) as a function of time. Pink = treated group. Green = Control 
group. Error bars = standard deviation of measurement. Each group contains ten mice. 
   7        9             11          14    16         18 
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V.3.1.7 Conclusion 
This experimental campaign was the first to use a cooled plasma-jet device. The device 
was developed on isolated mouse during the previous experiment. It was found that the 
amount of damage to the skin decreased considerably. The following points emerge from 
this experiment 
 The refrigeration system of the plasma sources is effective; there was less 
damage. 
 The plasma treatments done with the refrigerated-multijet have strictly no 
observable effect on tumor growth. Even measurements taken with ultrasound 
showed no difference between the untreated group and the group exposed to the 
plasma. 
 The addition of an inhibitor of catalase, the hydroxylamine dissolved in the DMSO 
(10 %w) does not enable to obtain a slowdown of tumor growth. The catalase 
inhibitor is applied to the skin overlying the tumor for ten minutes. 
 PAM injections (6 injections of 5 µL around the tumor, every two days) have no 
significant effect compared with untreated group. 
V.3.2 TC-1 Treatment with refrigerated multi-channel jet 
 This experiment took place between February and March 2017. This work was done in 
collaboration with the team of François Lemoine, in the Centre d'Immunologie et des 
Maladies Infectieuses (CIMI) at the hospital of Pitié-Salpêtrière. 
V.3.2.1 Power supply and plasma source 
The power supply is the same as in the previous study. Plasma source was the 
multichannel plasma jet described in section II.1.6. The choice of processing parameters 
(peak to peak Voltage, height above the skin, Helium flow) follow the constraints 
described in the previous section (section 0). 
V.3.2.2 Treatment schedule 
A group of 30 Seven- to 8-week-old female C57BL/6  mice were purchased from Janvier 
(Le Genest Saint Isle,France) and kept under specific pathogen-free conditions at the 
UMS28 animal facility (UFR 969, Pitié-Salpêtrière). 5 × 10ସ TC1 cells were injected into 
the flank of each of the 30 mice. After seven days of growth, treatments began. 
After seven days, only 25 mice had palpable and measurable tumors. The 25 mice were 
divided into three homogeneous groups in terms of tumor size. There were ten mice in 
the untreated group. The ten mice of the group “plasma 3 min” were exposed during 3 
min. The treatments take place during three weeks90. The majority of mice in this group 
had eight treatments. One of the mice had only six treatments. Indeed, for ethical 
reasons, the state of the skin was not considered favorable for repeated treatment. The 
total treatment times of each animal and power measurement are described in the next 
section. 
In addition to these two groups, the group “plasma 6 min” with five mice had treatments 
of increasing duration: first of 5 min and then of 6 min. These treatments started slightly 
                                               
90 Monday, Wednesday and Friday of each week 
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later than those of the group “plasma 3 min”. Consequently, the majority of mice in this 
group had only six treatments. 
A mouse is sacrificed if the volume of the tumor exceeds 2000 mm3 or if signs of pain are 
observed. Fig 147 summarizes the experiment schedule. 
Table 10 Number of mice for each group of this experiment. 
Name of group Size of group 
Untreated 10 
Plasma 3 min 10 
Plasma 6 min 5 
 
 
Fig 147 experimental Schedule. At day one, 50 000 cells had been injected into the flank of C57BL/6 
mice. Tumors grew until day seven without treatment. At day seven, mice are divided into 
homogeneous groups in terms of tumor size. There were ten mice in the groups “plasma 3 min” and 
untreated. There were five mice in the group “plasma 6 min”. Treatments took place after day seven 
at two days intervals during three weeks. A mouse is sacrificed if the volume of the tumor exceeds 
2000 mm3. 
V.3.2.3 Protocol applied to each mouse 
First, the plasma source was cooled. The plastic tip shown in Chapter II was placed in a 
horizontal position and filled with liquid nitrogen. Due to evaporation, it was necessary to 
fill the tank with liquid nitrogen three times. It was refilled when there were less than 3 ml 
of liquid nitrogen. The cooling took about 10 min.  
The general state of each mouse was checked. Particular attention was paid to the 
research of specific signs of pain and distress. The mouse was then anesthetized with 2 
% (v/v) isoflurane in the medical air at 1 l/min. The temperature of the animal was 
 maintained at 37 °C during anesthesia using a heated support (Minerve,  Esternay, 
 France). The hair of the mouse was shaved around the position of the tumor and those 
of ECG electrode. The ECG electrode (whitesensor, distrimed) was then fixed on the 
flank; a small amount of the conductive gel (uni’gel, distrimed) was put between the skin 
and the electrode to improve electrical contact. 
Photos of the tumor were systematically taken before treatment. The size of the tumor 
was measured with a caliper. Tumor volume was  approximated using  the ellipsoid 
 formula  ܸ = గ
଺
ܮ × ܹ ×  min (ܮ, ܹ) where  L  was  the  length and W  the width. It is an 
approximation of the volume of an ellipsoid, considering that the thickness of the tumor is 
of the order of magnitude of the width. A small amount of gel was spread on the surface 
of the tumor. The gel was removed with paper towels before treatment. The purpose was 
to treat a slightly moist skin in the hope that this could promote the formation of ROS. 
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The mouse was moved to a plastic anesthetic device to isolate the animal electrically. 
The ECG electrode was then connected to the measuring capacitor Cm. Liquid nitrogen 
was removed from the plasma sources and fixed in a vertical position. The generator 
was switched on, and the power consumption was measured in real time by the 
oscilloscope. The output of the jet was held about 3-4 mm from the skin. An infrared 
image of the skin was acquired (with camera testoo® 868, resolution of 0.1 °C) few 
seconds after the end of treatment. 
The total anesthesia time was about 17 min for each mouse. This time is quite 
acceptable for their health, and no mice died because of anesthesia. The mouse was left 
to wake up on the hot plate. His state of health was checked a few minutes after his 
awakening. 
The first treatments took place seven days after the injection of TC1. Mean value of 
tumor volume was around 14 mm3 (Fig 148). 
 
Fig 148 volume of the tumors in the three groups seven days after the injection of TC1. Mean volume 
is around 14 mm3. Day seven is the first day of treatment. The groups are homogeneous. 
V.3.2.4 Results of electrical diagnostics 
The section below describes the results of the electrical measurements carried out on 
the mice. We use the same method in the previous section. 
The power consumption is plotted in Fig 149. The left part of the graph shows that mean 
value of power is close to 4 W± 300 mW for each group. This uncertainty is much higher 
than the uncertainties which come from measurement method (under 40 mW). The 
dispersion comes purely from experimental conditions. The output of the jet is not exactly 
at the same distance from the skin from one treatment to another. Moreover, chemistry 
experiments from Chapter III show that distance is likely the main parameter that 
contributes to the dispersion of power. It can be seen that the power was very low during 
four treatments (below 2 W). This was due to the presence of moisture inside the plasma 
source91. When the plasma jet is cooled, water solidifies on its surface. After several 
thaws, water can contaminate the nozzle. A systematic drying of the nozzle was done 
after each treatment to prevent this problem. 
                                               
91 Our own experiments and the literature shown that water admixture reduces power. 
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 The right part of the figure shows the mean value and standard deviation of power for 
each mouse during all the treatments. It is clear that there is no significant difference in 
power from one mouse to another. No mice were exposed to a discharge whose 
production required a very different power. 
 
Fig 149 Left: power consumption of the device for each mouse and each treatment. Mean value of 
power is 3600mW in “plasma 3 min” group and 3900 mW “plasma 6 min” group. The power was very 
low during four treatments. This was due to the presence of moisture inside the plasma source. 
When the plasma jet is cooled, water solidifies on the surface. After several thaws, water can 
contaminate the nozzle. Precautions were taken subsequently to prevent this problem from 
recurring: systematic drying of the nozzle after treatment. Errors bars are the standard deviation of 
power.  Right: power consumption for all treatments as a function of mouse ID.  All treatments are 
equivalent in terms of power consumed; there is no major difference from one mouse to another 
despite the fact that the tumors have slightly different sizes and locations. 
 
Treatment times are shown in the left of Fig 150. Mice from group “plasma 3 min” had 
only treatment of 3 min. In some cases, the discharge went off for a few seconds. In 
order to compensate, treatments were longer. That is why there is a small dispersion 
around 3 min. Fives mice of “plasma 6 min” had treatments of increasing duration: two 
treatments of five min and four of 6 min. At the right of this figure, energy consumption 
was plotted as a function of treatment time. As we have already noted, the energy 
consumed in 3 min is of the order of magnitude of the energy consumed by the single-
channel jet in 30 min. 
It is also observed that choosing fixed processing times is accompanied by a significant 
dispersion in the energy consumed. Chemistry experiments show that the energy 
consumed in plasma is a better parameter than time to account for the production of 
chemical species. Perhaps it would be appropriate to fix the energy consumed by each 
treatment, to increase the reproducibility of treatments? For that, it would, of course, be 
necessary that it is the chemistry produced by the plasma that is at the origin of anti-
tumor effects. 
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Fig 150 Left: treatment time for each mouse in the groups and for each treatment. In the group 
“plasma- 3 min, one mouse was not treated two times (pink dot at t= 0s). Mice of “plasma groups” 
were treated 5 min two times and then 6 min. Right: energy consumption of the multichannel plasma-
jet for each treatment as a function of time. 
The sum of the treatment times during the experimental campaign is plotted at the left of 
Fig 151. Each column is associated with one mouse. Mouse 117 had only six treatments 
of 3 min. The others had eight treatments of 3 min in the group “plasma 3 min”. Mice 107 
and 130 had one treatment more than the others. Mouse 130 survived a little longer; 
mouse 107 was treated two days before the others to check that the treatment was 
tolerable. The graph on the right represents the sum of energy consumption for all 
treatments. Mean value of total energy was 5500 J for “plasma 3 min group”and 8800 J 
for “plasma 6 min” group. These value should be compared with the order of magnitude, 
2000 J, of energy consumption observed with the single-channel plasma jet when used 
for 30 min. 
 
Fig 151 Left: the sum of the treatment time during the experimental campaign. Each column is 
associated with one mouse. Mouse 117 had only 6 treatments of 3 min. The others had 8 treatments 
of 3 min in the group “plasma 3 min”. Mice 107 and 130 had one treatment more than the others. 
Mouse 130 survived a little longer; mouse 107 was treated two days before the others to check that 
the treatment was tolerable. Right: the sum of energy consumption of plasma source for all 
treatments. Mean value of total energy was 5500 J for “plasma 3 min group”and 8800 J for “plasma 6 
min” group. 
V.3.2.5 Skin temperature 
During this experiment, the temperature of the skin was systematically measured few 
seconds (less than 5 s) after the end of treatment. At the end of the processing, the high-
voltage generator was switched off, the mouse was quickly removed from the sources, 
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and an infrared image was taken. Infrared images were acquired with an infrared camera 
testoo® 868 (thermal resolution of 0.1 °C).  
Some infrared images were taken from the mouse during treatment. These images, 
however, were taken at grazing incidence, and from far enough (due to high voltage). 
Consequently, it is conceivable that this could cause errors. Nevertheless, it was found 
that the temperature measured before the plasma generator was stopped and after the 
mouse had been removed (less than 5 s) were almost the same. It seems that the skin 
did not cool significantly in 5 s. 
Fig 152 shows infrared images of mice under anesthesia or not. Under anesthesia, skin 
temperature decrease and reach a value of between 28 °C and 30 °C. This drop comes 
from the slowing of metabolism due to anesthesia. 
 
Fig 152 Left: the infrared image of mice. The temperature of the skin was just below 37 °C. Right: 
infrared picture of a mouse under anesthesia. The animal was placed on a heating plate. The mean 
temperature of the skin was around 25 °C. The metabolism of the mouse slows down during 
anesthesia and causes this drop. 
The kind of images acquired with the infrared camera is shown in Fig 153. These 
pictures were taken only 5 seconds after the end of treatment. The images of the center 
(B and C) were taken after one treatment of 3 min. The blue zone, colder than the rest of 
the body, represents the upper part of the tumor exposed to the flows of cooled helium. 
Picture D was acquired after one treatment of 6 min. The tumor was slightly heated 
compared to the rest of the body. Tumor temperature is around 34 °C, thus below the 
threshold of thermal damage. 
 
Fig 153  part A : picture of the mouse sleeping on the heating plate. part B: infrared picture of the 
mouse on the heating plate (at 39 °C) after a treatment of 3 min with the refrigerated plasma jet. The 
A B C D 
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area exposed to the device is colder than the rest of the body. The temperature on the top of the 
tumor is around 19 °C. Part C: another mouse exposed during three minutes. The photo was taken 
while the mouse was still on the plastic anesthesia device (non-heating). This explains why the 
background temperature is around 14 °C. For this mouse also the temperature of the treated zone is 
of the order of 19 ° C. Part D: This mouse was treated during six minutes. In this case, the 
temperature of the tumor is higher than the temperature of the body. The maximum temperature of 
the tumor is 34 ° C. This average temperature should exclude the onset of thermal damage. 
The infrared camera enables to obtain the maximum temperature at the position of the 
tumor and at the end of treatment. This value is plotted as a function of groups and 
energy in Fig 154. It appears that mean temperature was respectively 17± 7 °C and 32 ± 
6°C after 3 and 6 min of treatment. This proves that the cooling system is efficient, and 
has avoided the hyperthermia in the majority of cases. Only one treatment gave a final 
skin temperature of 43 °C. Only two treatments gave temperature between 39°C and 
42°C (mild hyperthermia). It should also be noted that these temperatures were reached 
at the end of treatments, so the time spent above the limits was probably short. The 
pictures of the skin associated will be described just below. 
The temperature is higher after 6 min because the device does not contain liquid 
nitrogen during processing (which could cause excessive cooling), so the plasma source 
heats up during processing. Consequently, helium coming out of the nozzle becomes 
less and less cold. In addition, infrared pictures show that the temperature of the heated 
area at the beginning of the treatment had a mean value of 10°C. This should avoid the 
overcome of frostbite. 
The dispersion of the results on skin temperature could be explained by the fact that 
many factors play in the thermal transfer of helium and plasma to the surface of the skin. 
And that some of these parameters are difficult to control. Distance to the nozzle of the 
jet is probably a key parameter. 
The shape of the tumor, which could modify the gas flows and thus the heat exchanges, 
has a significant effect. The nature of the gas flow: turbulent or not is probably very 
important. 
The surface condition of the tumor should modify heat exchange coefficient and 
conduction of the heat (what if there is a crust or holes in the skin?). The blood 
perfusion92 of the tumor itself should modify the ability of the tumor to exchange heat, 
and it could be different from one tumor to another. 
Furthermore, heating depends on how the filamentary discharges spread over the 
surface. It should be mentioned that the mechanism at the origin of thermal transfer is 
not well known during the plasma-skin interaction. 
 
                                               
92 About blood perfusion, see Chapter VI, section VI.1.5.3, page 189 
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Fig 154 Skin temperature was measured from the data acquired with an infrared camera (less than 5 
s after treatment). The maximum temperature of the treated area was read on the acquired images. 
This value was plotted as a function of groups (Left) and energy consumption during the treatment 
(right). The dispersion of the results is quite important. This is due to the fact that the cooling 
undergone by the biological tissue depends on many parameters among which: distance to the 
nozzle of the jet, shape of the tumor (Is the tumor aerodynamic or not?), surface condition of the 
tumor (is there any crust?) and how the filamentary discharges spread over the surface during 
processing. The threshold of mild hyperthermia and irreversible damage are represented by dotted 
lines. All available data are represented on both graphs. Only one treatment gave a final skin 
temperature of 43 ° C. Only two treatments gave temperature between 39°C and 42 °C 
The skin condition was monitored during the experiment. Each day of treatment, notes 
are taken on the condition of the skin: depth and condition of the lesions if any. A photo 
of the tumor was taken before each treatment.  
Table 11 presents the skin of three mice at seven, nine and eleven days after injection. 
This corresponds to the first, second and third treatment of each mouse. These mice 
were representative of the whole “plasma-3 min” group. 
As in the previous experiment93 the damage are considerably limited compared to the 
treatments done without cooling. After three treatments of three minutes, most of the 
tumors presented a few crusts of very small sizes (~ 1-3 mm²) and of low thickness 
(estimated below 200 µm). This level of damage is acceptable from the ethical point of 
view and corresponds to the specifications that would be achieved by a treatment 
applied to humans. With these processing times, and for equivalent plasma powers, the 
level of damage appears to be less than that of the previous experiment: either because 
this mouse line is less sensitive or because the refrigeration procedure is better 
controlled.  
Table 12 summarizes treatments conditions of these three mice. There is no obvious link 
between the occurrence of damage and the power applied or the energy consumed. 
Table 11 Pictures of treated area as a function of time for 3 mice of “plasma 3 min” group. Pictures 
were taken before each treatment (blue marks allowed to target the tumor). No differences were 
visible between a picture taken before treatment and 1 hour after. Treatments begin at day 7. Since 
the effects of one treatment are not visible instantaneously (A) at day seven, the skin without 
treatment was observed, (B) at day 9, the effect of treatment of day seven can be seen. (C) At day 
eleven, the sum of the effect of day seven and nine was observed. These three mice were chosen 
because the condition of their skin is representative of that of the other seven mice of the group. 
Regarding mouse 123 at day seven, the short red line was probably a scratch or a bite of another 
mouse. At day 9 very small crusts (~ 1 mm²) were found in mice 123 and 121: brown and black areas 
at the top of the tumor. These areas are wider on the mouse n°108: length~2-3 mm width~1 mm. 
These small crusts had a very low thickness (<200 µm). At day 11, the appearance of the crusts had 
not changed fundamentally but had slightly expanded. 
 Mouse n°123 Mouse n°121 Mouse n°108 
Day 
7 
 
 
                                               
93 regarding the treatment of BALB/C mice bearing CT-26 tumor (sectionV.3.1 page 149) 
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Day 
9 
 
Day 
11 
 
 
 
 
Table 12 Summary of processing conditions. Peak to peak voltage was not exactly the same from 
one treatment to another (max difference in the order of 1 kV). The voltage is difficult to reproduce 
from one treatment to the other because the primary winding heats up during the experiment, which 
tends to decrease the output voltage. No obvious link appears between deposited energy or power 
and extension of damage. Damage has a very limited extent quite similar in all mice in the group (at 
least for the first week of treatment). 
He flow = 2600 
sscm 
Mouse n°123 Mouse n°121 Mouse n°108 
Day 7 Vpp=13.7 kV 
Power=4.30 W 
Energy=790 J 
Vpp=13.2 kV 
Power=3.3 W 
Energy=589 J 
Vpp=14.4 kV 
Power=4.27 W 
Energy=777 J 
Day 9 Vpp= 14.1 kV 
Power=3.5 W 
Energy= 734 J 
Vpp=13.5 kV 
Power=2.7 W 
Energy=485 J 
Vpp=13.3 kV 
Power=2.10 W 
Energy=432 J 
Day 11 Vpp=13.2 kV 
Power=2.82 W 
Energy= 507 J 
Vpp=13.8 kV 
Power=3.75 W 
Energy=675 J 
Vpp=14.5 kV 
Power=3.80 W 
Energy=684 J 
 
As reported in the previous paragraph: only three treatments gave temperature between 
39°C and 43 °C. It is interesting to observe the skin condition of these mice before and 
after treatment. This is a way to assess the sensitivity of the skin to hyperthermia. Photos 
of tumors were grouped in Table 13. The mouse subjected to the highest hyperthermia 
(43 ° C, Mouse n°128) had a fairly extensive crust (4 ݉݉ ×  3 ݉݉). For the other two 
mice, damages were distributed over a larger surface but are more superficial. Again, 
electrical diagnostic (power and energy) did not predict hyperthermia and the occurrence 
of damage. For example, the greater power used does not lead to greater temperature 
and damage. It appears that the damage observed on these skins after two days is more 
important than those of the other mice of the group. 
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To conclude, this refrigeration system seems efficient to avoid the damages. It would be 
useful to generalize this system to other plasmas sources to extend their conditions of 
use and optimize the production of chemicals species without thermal damages. The 
Table 14 recalled the damages obtain after 5 min of treatment without refrigeration. 
Of course, the changes that these refrigeration systems induce on the chemical 
production of plasma should be studied. We know from semi-quantitative experiments 
that the production of hydrogen peroxide and nitrite had the same order of magnitude 
with or without refrigeration. In any case, the approach which consists in the separation 
of the thermal effects from the chemical effects seems useful for in-vivo experiments.  
 
Table 13 The first column describes the parameter of the treatment leading to mild hyperthermia at 
the position of the tumor and after treatment of 6 min. The second column contains the infrared 
images that allowed to observe the hyperthermia. The third column contains the photos of the 
tumors taken the same day. The fourth column contains a photo of the tumor two days later. A 
clearly defined crust appears on the skin of the mouse subjected to the highest hyperthermia (43 ° 
C). For the other two mice, damages seem distributed over a larger surface but are more superficial 
 Infrared image and this picture were taken the 
same day 
two days after the 
previous column 
Mouse n°128 at 
Day 18 
 
Time = 6 min 
Vpp =14.5 kV 
Power= 4.5 W 
Energy = 1620 
J 
Tmax= 43 °C 
 
  
Mouse n° 125 
at day 16 
Time= 6 min 
Vpp = 15.4 kV 
Power=5.34 W 
Energy=1922 J 
Tmax= 38.2 °C 
 
  
 
Mouse n°110 
At day 223 
Time =6 min 
Vpp=15 kV 
Power= 5.1 W 
Energy=1930 J 
Tmax=39.1 °C 
 
  
 
Table 14 Very serious damage after one  treatment of 5 min, without refrigeration. Right, the second 
or third-degree burn of 7 mm diameter observed two days after one treatment of five min. 
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5 min,  
Vpp = 14.5 kV 
Power = 2160 ± 10 mW 
E = 647 ±3 J 
 
Just after treatment 
 
Two days after 
V.3.2.6 Effect of cooled multi-channel jet , tumor volume 
This section describes the observations made on the tumors during the last two weeks of 
treatment. In some of the treated mice, large size holes occurred in the tumors. These 
holes have developed from what appears to be surface necrosis. This kind of necrosis 
occurs naturally for this type of tumor as shown in Fig 155, left (this mouse was in the 
untreated group). Conversely, some of the mice of the treated groups have the skin of 
the tumor relatively intact with very few lesions at the end of the protocol (Fig 155, right). 
 
 
Fig 155 Left: mouse from the untreated group which develops a bleeding open wound 18 days after 
the injection of TC1 cells. Surface necrosis occurs naturally with this tumor model. It was necessary 
to kill this mouse (Mouse n°127). Right: tumor of one of the mouse n°113 of “plasma 3 min group” at 
day 25, last day of treatment. 
It appears, however, that treatment of three or six min causes the formation of hollows 
much deeper and wider, than those observed in the untreated group. Table 15 merge 
photos of the skin of the tumor taken each day of treatment during the last two weeks of 
treatment (between day 14 and day 25). At days 14 16 and 18, there was probably the 
growth of a necrotic and weakened area below the crust. From day 25, the hollow itself 
was appearing. The following days, the hollow continues to spread, but the tumor 
growths rapidly and tends to bend the cavity. 
 
 
 
 
 
Tumor 
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Table 15 Monitoring of the formation of holes in the mouse tumor 130 ("plasma 6 min" group) 
20/02- Day 14 22/02-Day 16 
 
 
24/02- Day 18 27//02 Day 21 
  
01/03-Day 23 03/03 – Day 25 
  
 
The size of the tumor was measured with a caliper. Tumor volume was  approximated 
 using  the formula  ܸ = గ
଺
ܮ × ܹ ×  min (ܮ, ܹ) where  L  was  the  length and W  the 
width. It is an approximation of the volume of an ellipsoid, considering that the thickness 
of the tumor is of the order of magnitude of the width. These measurements, however, 
do not take into account the formation of hollows in the tumor, since the hypothesis is 
that the tumor is an ellipsoid. According to this formula, tumor volume was plotted as a 
function of time on Fig 156 for each group. Error bars were the standard deviation of the 
set. Once again, the results of the groups show no statistically significant differences 
between them. 
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Fig 156 Volume of TC1 tumor as a function of time. There was no significant difference between the 
different experimental groups. Methods of measurement, however, did not take into account the 
holes created in some tumor. 
What if the volume of hollow was taken into account? 
The size of the hollow was likely between 6 and 8 mm of diameter, with the assumption 
of spherical holes, the volume of these was between 110 and 190 mm3. Even in this 
case, error bars are large enough to exclude the eventuality of an anti-tumoral effect. 
Table 16 summarizes the results for each mouse at day 22. 
Table 16 Summary of the state of the tumor TC1 and the skin located above at day 22. The first 10 
mice are in the group “plasma 3 min”. The last five are in the group “plasma-6 min”. Only two mice of 
the untreated group develop surface necrosis: one was sacrificed. Regarding the second, the hole 
induce was small (around 4 mm in diameter). “NO” means, there were no holes in the tumor. “N0 + 
no damage” means that there were no holes and no (or very small) scar and crust. “YES” means that 
there was a big hollow that cannot be explained by the usable surface necrosis. 
“plasma 3 
min” 
Mouse n° 
119 117 121 123 103 
NO YES YES + crust YES YES (small) 
Mouse n° 
101 113 126 102 108 
NO NO + no damage 
NO 
+ no damage YES 
NO 
+No 
damages 
“Plasma 6 
min” 
Tox n°107 Tox 128 Tox 110 Tox 125 Tox 130 
NO 
+ no 
damages 
YES (small) NO YES (small) YES 
 
V.4 Conclusion 
The objective of this chapter was to develop protocol of plasma treatment. We have 
evaluated:  
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i. The anti-tumor effects 
ii. Skin damages 
During the five experimental campaigns, the device and the protocol have evolved 
towards powerful device. The experiments were performed on two types of tumors that 
have never been treated with plasma: TC-1 and CT-26 tumors. The experiments were 
carried out with two DBD devices, the single-channel plasma jet and multi-channel jet 
devices (refrigerated or not). The efficacy of PAM has also been tested in-vivo. It has 
also been attempted to expose the skin to catalase inhibitor, to see if it is possible, 
thereby increasing the efficiency of plasma treatments. The processing conditions 
(power, source type, the probable concentration of PAMs, range of energy) are 
summarized in the table below. 
Device/protocol In-vivo target Power Range of 
energy/ H2O2 
Glass DBD/500 Hz CT-26, flank ~75-100 mW 100 & 300 
J/cm² 
DBD/500 Hz TC-1, cheek ~ 140 mW 400 J 
Single-channel jet/500 Hz TC-1, cheek ~ 400 mW 500-800 J 
PAM injection TC-1, cheek  0.6 µ݉݋݈ 
Multichannel plasma jet/ 
10 kHz 
TC-1, cheek & 
flank 
1000-1500 mW 180-3000 J 
Refrigerated multichannel 
plasma jet/ 10 kHz 
CT-26 flank ~ 4000 mW ~800 J 
Refrigerated multichannel 
plasma jet/ 10 kHz + an 
inhibitor of catalase 
(hydroxylamine in DMSO) 
CT-26 flank ~ 4000 mW ~800 J 
PAM injection CT-26 flank  ~1-2 µmol 
Refrigerated multichannel 
plasma jet/ 10 kHz 
TC-1, flank ~ 4000 mW 800-1600 J 
 
These experiments highlight negative results of our tissue-tolerable plasmas sources. 
These results, although negative, are useful. For example, it is reasonable to think that 
an experimenter wishing to treat these tumors should use a source producing different 
chemistry from those produced by our device. For this reason, the results presented in 
Chapter IV could guide his choice. It could also be tempted to remove the skin before the 
treatment of a subcutaneous tumor (for example, with a micro-punch. Since the skin is 
an anti-oxidant barrier, we can hope for better results. Although showing no anti-tumor 
effect, the last experiment with the refrigerated multijet showed that the plasma treatment 
promotes the extension of pre-existing surface necrosis. 
The only positive results (up to tumoral ablation) were obtained with sources causing a 
heating of the skin (final temperature between 45 and 48 °C). This tumor ablation result 
most probably from thermal burn: since the refrigerated devices produce less damages 
and are close in terms of chemical production. It turns out also that the measure of the 
temperature of biological tissue is not necessarily something obvious. In particular, the 
question of the spatial resolution of the diagnostic is a crucial point which can lead to 
biases. 
The experimental observations related to the link between heating due to plasma-
treatment and damages are summarized by the following points: 
 Skin temperature after treatment of 3 or 5 min was around 45-48 °C. 
 Treatment of one min gave no damages. 
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 One treatment of three min gave no damages, but the repetition of this treatment 
at two days intervals gave damages after two or three treatments. 
Treatment of 5 min systematically gave damages. 
The following chapter is dedicated to these methodological questions. It addresses the 
issues related to hyperthermia and it's biological effects, the simulation of heat-
propagation through tissue. 
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Chapter VI Modelling and simulation of the 
thermal aspects of plasma-tissue interaction  
The primary objectives of this chapter are 
 The development of a model of the thermal properties of mouse skin and tumors. 
The model should describe (a) the propagation of heat by conduction (b) heat 
exchange by convection and radiation with the external environment (c) heat 
exchange with the blood flow. Finally, the model should provide a quantitative 
approach of the thermal damages affecting the tissues and blood vessels. 
 The implementation of this model in a simulation using the finite element method. 
The results given by the simulation should be consistent with all the experimental 
observations. This includes temperature measurements on the surface of the 
tumor and all qualitative observations regarding the state of the skin after one or 
several treatments. For example, the simulation should reproduce the kinetics of 
heating and cooling of the tumor. 
 There is no guarantee that each mouse has exactly the same thermal properties 
or even that they are precisely known during the experiment. It is necessary to 
know in what extent the simulated damage (represented by the field ષ(࢘ሬ⃗ )) evolve 
when the treatment or the thermal properties of the biological tissue are changed. 
For example, what happens if the rate of blood perfusion of the tumor, the 
thermal conductivity, the parameters which defined  ષ or the area of plasma-skin 
interface are changed? The scientific literature indicates in which intervals these 
parameters vary. Fortunately, this problem is constrained by temperature 
measurements. The precise question is “In what extent are the damage different? 
knowing that this simulation correctly predicts the temperature field. 
 The simulations should cover a wide range of cases of practical interest: 
o Non-refrigerated multijet, refrigerated multijet, single-jet (our own 
devices). 
o What information can be obtained from simulations on the accuracy of 
measurement methods? What is the required spatial resolution of 
measurement methods? 
o What happens if the skin is covered with a gel or is slightly moist? How to 
model the mass transfer of water? 
o What happens when a short treatment (~few s) that induces heating of the 
tissue is repeated? 
 Propose a critical approach of the scientific literature regarding in-vivo plasma-
cancer studies. 
 
VI.1 describes the different biological effects of hyperthermia and the content of the 
model. Finally, its numerical implementation is described. There is particular emphasis 
on the biological effects that can be induced by moderate hyperthermia (T ~ 39-44 ° C). 
The effects of hyperthermia are not purely local. The following table summarizes what 
moderate hyperthermia can induce at the level of an organism or tissue. 
VI.2 gives the results of the simulations obtained in various experimental configurations 
(not only our experiments but also those of T. Freeman's group). The measurement 
methods and the pitfalls that can lead to underestimation of temperature are presented in 
VI.2.6. The accuracy that can be expected from measurements made with thermometer-
gun, infrared cameras, and invasive devices are modeled and discussed in the context of 
plasma medicine. 
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The section VI.3 is a critical approach of in-vivo plasma-medicine experiments. We 
proceed to a new reading of the published in-vivo experiments which regards the 
treatment of B16 melanoma. For each paper, there are two simple questions: 
 Does the published information really exclude the possibility that tissues have 
been subjected to hyperthermia, depending on the measurement method used? 
 In what extent the results obtained could be attributed to hyperthermia? 
The question of the reliability of measurement methods used in the papers is addressed 
by the section VI.2.6. The principles that guided the construction of this critical approach 
are listed below: 
The calculations were done with Freefem++, a software developed by Frederic Hecht 
and his team at UPMC [205]. Visualization is done with Matlab®. The code that 
represents the physical content of the simulation in Freefem++ is in Appendix I. The 
code of visualization is in Appendix J. 
VI.1 What is hyperthermia? How to model and 
simulate it? 
Several groups produced works related to the quantification of thermal damage since the 
end of the forties [206]. The objective of these studies was to predict the lesions that 
appear on the skin depending on the temperature exposure. Quantifying the biological 
effects of heat is also essential for treatments that explicitly involve hyperthermia. In 
oncology, heat can be used to destroy tumors. This heat can be produced by focusing 
microwaves, ultrasound or laser. In some cases, the heat applied is so intense that it 
makes it possible to carry out the instantaneous ablation of the treated zone. For most 
treatments, the heat produced induces tissue necrosis and not their vaporization. This 
necrosis occurs several hours after treatment. Cells may die directly from heat because 
excessive temperature causes the denaturation of vital proteins. They can also die 
because they are in a hypoxic environment. Indeed, blood vessels are very sensitive to 
the damages induced by heat. For example, coagulation occurs at 60°C, and small 
capillaries are sensitive to lower temperature. The destruction of blood network bringing 
oxygen and nutrients to the cells induce ischemia and lead to strong hypoxia.  It must be 
noticed that hypoxic environment is not systematically associated with anti-tumor effect. 
Hypoxic environment can leads to the selection of the more aggressive cells clones 
among the different population of cells in competition. 
Heat exposure has less destructive applications in the field of dermatology: laser-heating 
can be used for the remodeling of tissue [207]. Fortunately, the literature concerning the 
simulation of thermal damage is rather extensive, since reliable models were needed to 
optimize the applications in the field of health. 
Most papers modeling thermal damage consider human skin. It appears that human skin 
and mouse skin are significantly different. Since mouse skin is thinner, it is easier to elicit 
hyperthermia and second-or third-degree burns in mice than in humans. The first section 
of this chapter is a comparison of the structure of human and mouse skin.The second 
enables to precise the ideas regarding thermal diffusion, the threshold of hyperthermia. 
The discussion is conducted with calculations of orders of magnitude. The third 
describes how to quantify and predict thermal damage. The fourth paragraph describes 
the physical content of the simulation: what are the physical phenomena to be taken into 
account and how to model them. The fifth section gives the numerical values which 
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define the model used in most of the simulations. The sixth briefly describes the 
implementation of the finite element method. How to choose spatial and temporal 
resolution, what are the boundary conditions? 
VI.1.1 Human and mouse skin structure 
This section is a quick overview of the structure of the skin. For the sake of brevity, the 
main components are only mentioned. This discussion does not address the biological 
properties and functions of the skin and how these could be affected by plasma. The 
antioxidant functions of the skin in humans and mice were quickly discussed at the end 
of Chapter III. This point indeed requires further discussion. It would be interesting that a 
biologist leads this kind of discussion. Since the composition of the skin, for example, the 
kind of immune cell and so the type of immune response triggered, should be very 
different in mice and humans [208]. Similarly, the mechanisms of wound healing are 
considerably different for mice and humans [209]. 
The structure of skin consists of three main layers: epidermis, dermis, and subcutaneous 
tissue (Fig 157). The thickness of layers depends on the localization of the skin on the 
body [210]. For instance, the skin of the foot is thicker. 
The stratum corneum (20 µm- 40 µm of thickness) is the most out layer of the epidermis 
(75 µm- 150 µm of thickness). Stratum corneum is made of dead cells, which is an 
impermeable barrier between environment and organism. The epidermis is 
nonvascularized and stratified. The most frequent cells are keratinocytes. In the 
epidermis, the non-keratinocytes cells that can be found are melanocytes (pigment 
forming), Langerhans cells (immunological functions) and Merkel cells, which are 
involved in the immune response. 
 
Fig 157  simplified structure of human skin. The thickness of different layers: Stratum corneum (from 
10 µm to 40 µm), epidermis (from 75 µm to 150 µm), dermis (from 1 mm to 4 mm), hypodermis. 
The dermis is much thicker (1∼4 mm for humans) than the epidermis and is mainly 
composed of two fibrin proteins: collagen and elastin. Blood vessels, nerves, and lymph 
vessels are included in the dermis. Hair follicles, sebaceous and sweat glands are held 
together by collagen. 
Collagen is a rather stiff and hard protein which is a major constituent of the extracellular 
matrix of connective tissue and provides structural strength in soft tissues. In the dermis, 
collagen is the major constituent and accounts for approximately 60%∼80% of dry 
weight of fat-free skin and 18%∼30% of the volume of the dermis  [210]. This molecule 
also serves to quantify the thermal damage (see section VI.1.4). 
The ground substance contributes to 20% of the dry weight of skin and to 70%~90% of 
the skin’s volume. This is a gel-like substance, which contains proteins like 
Stratum corneum 
Epidermis 
Dermis 
Hypodermis 
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glycoproteins, proteoglycans and glycosaminoglycans and hyaluronic acid [210]. The 
hyaluronic acid chain has proteoglycans side-chain, which are cross-linked by 
glycoproteins to others structures such as collagen or elastin fibrils. 
The third layer is the hypodermis is mainly composed of fat. This layer is made of fatty 
connective tissue and has thermal insulation functions. The fatty tissues have a lower 
thermal conductivity than the rest of the tissues. This layer carries major blood vessels 
(and nerves) to the overlying skin. 
The thickness of mouse skin is described in [162]. Fig 158 compares the thickness of the 
four layers separated by strains and gender. This study aimed to prove that gender of 
mice is a major factor for biophotonics experiments. The value of the left column (‘gray’) 
is particularly useful because this species (C57BL/6 - female) was used for each 
experiment involving TC1-cancer cells. It appears that the thickness of stratum corneum 
is close to 20 µm. The dermis is thinner (180 µm) in mice than in humans.  Therefore, 
thermal damage reaches the deeper layers of the skin faster in the mice than in humans. 
Moreover, the spread of chemical species produced by plasma at the surface through 
the skin could be less effective in humans than in mice.  
 
Fig 158 Averaged values of the epidermis, dermis, and hypodermis thicknesses as measured by 
histology, separated by strain and gender. Gray refers to C57Bl/6 mice, and White refers to CD-1 
mice. Variation in the thickness of the dermis is the most significant difference between genders. 
Error bars correspond to the standard error of the mean. Figure and legend are from [162] 
 
Table 17 Mean and SEM values of the thickness of epidermis, dermis, adipose tissue and muscle 
layer quantified by histology in [211] 
 BALB/c C57BL/6 
 Female Male Female Male 
Epidermis 12.08 ± 3.14 10.19 ± 3.29 13.08 ± 3.50 12.53 ± 3.97 
Dermis 156.65 ± 55.23 343.44 ± 100.09 162.02 ± 15.12 226.33 ± 36.86 
Adipose tissue 168.01 ± 52.31 40.17 ± 9.65 189.37 ± 64.14 103.05 ± 61.24 
Muscle 91.68 ± 21.95 90.47 ± 51.96 83.34 ± 27.14 90.53 ± 18.23 
 
The difference in thickness and in the nature of the biological response (e.g., wound 
healing or immune response) should be an issue. For example, the cicatrization of 
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mouse skin does not take place exactly in the same way in mice as in humans or pigs 
[209]. 
The layers of the skin are used to assess the severity of damage to the skin. Burns are 
classified as first, second, third degree based on the extent of damage to the different 
layers of skin. The degrees of skin burns are described by Parsons [212], as shown in 
Table 18. 
Table 18 Classification of burns according to [212] 
Burn 
degree 
 Description 
First degree Partial 
thickness skin 
destruction 
Characterized by redness in the burned region. 
Discomfort is temporary, and healing is rather quick, 
with no permanent damage. 
Second 
degree 
 Also referred to as partial thickness burns. The 
epidermal layer is damaged, and injury extends into the 
dermal layer as well. There is damage to sweat glands 
and hair follicles. Blisters, severe pain, reddening, and 
swelling characterize these burns. 
Third 
degree 
Whole 
thickness skin 
destruction 
Burns destroy all the epidermal and dermal layers. 
There is tissue damage below the hair follicles and 
sweat glands into the subcutaneous tissue. The burned 
area will appear charred or dry, white color. There is no 
possibility for spontaneous healing, so skin grafting is 
required. 
 
VI.1.2  Orders of magnitude related to hyperthermia 
This section aims to present the framework of the simulations using the orders of 
magnitude. 
VI.1.2.1 Space and time scales of thermal diffusion 
First, the numerical values of the characteristic times of thermal diffusion ߬஽  are 
calculated. 
Thermal properties of the skin for human, pig, and rabbits are described in [213]. The 
specific heat is very close for all of these species. It is assumed, for this calculation, that 
the tissue has a specific heat  ܥ௣ = 3600 ܬ. ݇݃ିଵ. ܭିଵ). The thermal conductivity is 
ߣ = 0.235  W. mିଵ. Kିଵ which corresponds to the conductivity of the epidermis. The 
density is assumed to be ߩ = 1500 ݇݃. ݉ିଷ. 
The thermal diffusivity is then 
ߙ =
ߣ
ߩܥ௣
=
0.235
1500 ∗ 3600
≅ 4.4 × 10ି଼݉ଶ. ݏିଵ 
The characteristic time of diffusion ߬஽ on the scale ܮ஽ is  ߬஽(ܮ஽) = ܮ஽
ଶ /ߙ 
Consequently, the time of diffusion through a thickness of the order of magnitude of the 
size of a cell is: 
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߬஽(ܮ஽ = 20 μ݉) ≅ 9.1 ݉ݏ 
Regarding the time of diffusion through a layer with a characteristic size of the order of 
skin thickness~ 300 μ݉ (݉݋ݑݏ݁):  
߬஽(ܮ஽ = 300 μ݉) ≅ 2.1 ݏ 
It is recalled that the power supplies have a frequency of 500 Hz and 10 KHz. So, with 
the assumption of one discharge per half-period, we obtain the characteristic times of 
߬௥௘௣(500 ܪݖ) = 1 ݉ݏ and  ߬௥௘௣(10݇ܪݖ) = 0.05 ݉ݏ. 
This means that thermal diffusion is a slow phenomenon, compared to the characteristic 
time scale of discharges frequency. Consequently, 9 and 182 discharges had time to 
occur, before the heat had the time to diffuse of the thickness of a single cell. Thus, in 
the simulation, the heat transfer due to the plasma-skin interaction of many filaments 
striking the skin is correctly modeled by a continuous function of time and space. 
It is now assumed that the discharges are evenly distributed over a surface S depending 
on the distance output-skin. Closes to the surface, the discharges spread over ଵܵ =
1 ܿ݉ଶ. Far from the surface, the discharges form a single filament strinking an area  ܵଶ =
1ܱିଶ ܿ݉ଶ. It is assumed that 100 μ݉ × 100 μ݉ is the order of magnitude of the plasma-
skin interfaciale area for a single filament. In fact, this area is likely larger, and it seems 
obvious that filaments are not distributed evenly. The number of electrical discharges 
striking the same spot during the characteristic times of diffusion is summarized in Table 
19. This enables to understand that the most dangerous is obtain with the power supply 
at 10 kHz and ܵଶ = 10ିଶ ܿ݉ଶ. A quasi-instantaneous carbonization of the skin was 
observed on very small spots (even when the source was refrigerated). The input of 
thermal energy is so high that the thermal diffusion does not have the time to act 
effectively before the damage occurs. In all other experimental situations, no damage 
was observed, instantaneously after treatment. On the contrary, thermal diffusion has 
had time to play its role; the damaged zones extend beyond the zones immediately 
affected by the plasma. 
 
Table 19 Orders of magnitude of the number of discharges striking one spot of area ૚૙૙ μ࢓ ×
૚૙૙ μ࢓  over a total area ࡿ૚ or ࡿ૛ during ࣎ࡰ(૛૙ μ࢓) and  ࣎ࡰ(૜૙૙ μ࢓). 
Frequency of 
the power 
supply 
area 
Number of discharges 
striking the same spot of 
area ૚૙૙ μ࢓ × ૚૙૙ μ࢓ 
during the time  
࢚ = ࣎ࡰ = ૢ. ૚ ࢓࢙ 
 
Number of 
discharges striking 
the same spot of 
area ૚૙૙ μ࢓ ×
૚૙૙ μ࢓ during: 
time ࢚ = ࣎ࡰ(ࡸࡰ =
૜૙૙ μ࢓) ≅ ૛. ૚ ࢙ 
 
10 kHz ଵܵ = 1 ܿ݉
ଶ 0.018<1 4.2 
  ܵଶ = 1ܱିଶ ܿ݉ଶ. 1.8 420 
500 Hz ଵܵ = 1 ܿ݉
ଶ 9 × 10ିସ<1 0.2 
  ܵଶ = 1ܱିଶ ܿ݉ଶ. 0.09<1 20 
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VI.1.2.2 Order of magnitude of surface heat flux 
In the first place, it is interesting to have an order of magnitude of the value of the 
maximum heat transfer due to plasma-skin interaction. The purpose is to compare the 
thermal flux obtained to those which are known causes of thermal damage. It is recalled 
that the mean power consumption of the plasma-source (see 0) is described by 
 ૝૙૙ ࢓ࢃ for the single channel jet + 500 Hz power supply 
 2-4 W for the multichannel jet + 10 kHz power supply. 
So for this calculation, it is assumed that  ૚ ࢃ is the order of magnitude of the total 
thermal power crossing the interface skin-plasma of area S. Two cases are studied: 
 ࡿ૚ = ૚ ࢉ࢓૛, the order of magnitude of the area covered by plasma when the skin 
is treated with the multi-channel jet, and when there are several filaments striking 
the surface in a random way. 
 ࡿ૛ = ૚ࡻି૛ ࢉ࢓૛, when all the filaments are grouped into a single stronger filament 
striking the surface of the skin (this discharge regime is obtained by slightly 
removing the plasma source from the surface of the skin). 
Consequently, the power per unit of surface is 
઴૚ = ૚૙૝ ࢃ. ࢓ି૛  and  ઴૛ = ૚૙૟ ࢃ. ࢓ି૛ 
Let us now compare these orders of magnitude with known thermal fluxes. 
 The solar radiation received by the earth is equal to 340 ܹ. ݉ିଶ on average 
[214]. 
 Flashfires result from the inflammation of combustible gas. The radiative heat flux 
of these fireballs causes burns, sometimes several km. These fires involve heat 
fluxes of the order of several ܹ݇. ݉ିଶ for less than 5 s. The modelling of these 
fires is particularly important for the design of protective clothing for firefighters. 
For instance, [215] describes a finite element model of skin subjected to flashfire. 
[215] and [216] show that an incident flux of 4.18 ܹ݇. ݉ିଶ for 34 s is high enough 
to induce blistering or second degree burn. The time to obtain a second degree 
burn is only 2.78 s when the incident flux is 24 ܹ݇. ݉ିଶ ([215]). According to 
[217], theses fireballs causes second and third degree burn when the absorbed 
heat is approximatively equal to 23 ݇ܬ/݉ଶ and 113 ݇ܬ/݉ଶ respectively. 
 An example of a clinically used photothermal treatment is described in ([210], 
p240).The laser-skin interaction is divided into three categories depending on the 
temperature of the tissue and the duration of heating  i) the mild hyperthermia is 
due to a slight increase in temperature in the range 41-44 °C for some tens of 
minutes. In this case, cell death is induced by changes in enzymatic pathway ii) 
strong hyperthermia occurs when the temperature is in the range 50-100°C for 
few seconds. The death of tissue stems from extensive necrosis caused by the 
coagulation. Indeed, the destruction of the blood vessels deprives the cells of 
their intake of oxygen and nutrients. iii) The photoablation of tissue occurs when 
the tissue is heated above 100°C. The tissues are vaporized. For the most 
powerful pulses (laser fs, mJ to cite a personally tested example), the upper part 
of the skin forms a plasma plume. The skin bursts, shock waves are emitted. In 
addition to these three categories, non-thermal effects were observed, due to 
photochemical reactions. According to ([210], p240),  a pulse at 1064 ݊݉, whith 
an intensity of 150 ܹ. ܿ݉ିଶ = 1.5 ܯܹ. ݉ିଶ during 0.1 s induce a temperature of 
90 °ܥ in the upper part of the dermis. At the wavelength  532 ݊݉, the same 
intensity causes the photo-ablation. 
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Finally, the orders of magnitude of thermal fluxes and duration of heating described in 
the previous paragraph induce damages or at least biological responses associated with 
mild-hyperthermia. These values are similar to those that can be imagined for plasma 
treatments. In this context, it is pertinent to ask whether plasma treatments can inflict 
thermal damage or not. The way in which the damages are quantified is specified in the 
next section. 
VI.1.2.3 What are the thresholds of hyperthermia? 
The term “mild-hyperthermia” regards tissue exposed to a temperature between 39 and 
42 °C. The mild-hyperthermia has biological effects which regard, for instance, the 
chemical reactivity of intracellular ROS and the heat shock protein HSP70. This point will 
be discussed at the end of this chapter. 
Hyperthermia, in the strict sense, occurs when it is possible to observe deleterious 
effects (cells necrosis or apoptosis) that are the consequence of an exposure to the 
temperature Th during a reasonable time t (up to several hours, not days). The most 
frequently reported value in the literature is 43 °C. 
For example, [218] describes the clinical use of thermal dosimetry. It is a matter of 
predicting the way in which energy is deposited (by microwave treatments) to ensure that 
the tumor is in a state of hyperthermia. The target temperature of the tumor is between 
42 or 43 ° C (p125, p146, p161). However, at 43 °C, the time to obtain complete necrosis 
could be quite long (several hours). However, the time required decrease with increasing 
temperature. The paper [219], which describes  bio-heat transfer which occurs during 
laser exposure, argue that an exposure of 56 ° C for 1 s is enough to kill cancer cells. 
Moreover, the three following papers, [220] [221] [222], respectively from 2015, 2014 and 
2011 discuss the concept of thermal dose called “Cumulative Equivalent Minutes at 43 
°C (CEM43)”. The damages are represented by the time needed to obtain the same 
damage at  T =  43 ° C. It is then possible to know the time t required to elicit the same 
amount of damages at another temperature T. 
CEMସଷ = t × Rସଷି୘ where R is a constant for T>43°C 
The paper [221], [222] contains discussions of the relationship between CEM43 and the 
quantification of damages by a first order Arrhenius law (explain in next section). The 
damage can be modeled by a chemical reaction of the first order; [222] has collected the 
values of the kinetic coefficients for some tissue/cells. [221] and [223] also give an order 
of magnitude of the depth of damage as a function of the surface temperature: 
ܤݑݎ݊ ݀݁݌ݐℎ (݅݊ ݉݉, ܶ ݅݊ °ܥ, ݐ ݅݊ ݏ) =  −2.9302 + 0.0473ܶ − 0.0317ݐ + 0.000913ܶݐ 
The results given by this expression are poorly consistent with the results obtain with the 
non-refrigerated multichannel jet after the treatments of 3, 5 and 30 min. It is recalled 
that the final surface temperature was observed between 45 and 48 ° C. For the 
calculation, 46 ° C is chosen. 
Burn depth (T = 46°C, t = 3 min) = 1.1 mm  
 
Burn depth (T=46°C, t=5 min) =  2.4 mm  
 
Burn depth (T = 46°C, t = 30 min) = 18 mm  
This expression tends to overestimate the depth of the damage inflicted. This failure was 
predictable; since this expression is fitted to the human skin, heated by hot water in the 
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range 60-90 °C. The laws apply only to restricted temperature ranges. This is one of the 
pitfalls of the quantification of thermal damage; others are described after. 
Caveat 1 Steepness of the dose effect,  
In fact, the relationship between damages and time and the temperature is really steep. 
The paper [224] give an example. At 43.5 °C, the fraction of mice developing necrosis of 
the ear is 0% after 40 min and 100% at 60 min. Experiments can quickly lead to widely 
dispersed results. The paper [225] also affirm that the cytotoxicity increased rapidly as 
temperatures were increased from 42°C to 45°C. This review also affirms that cancer 
cells are more sensitive to moderate increases in temperature (42-45°C) than normal 
cells. This paper also discusses the correlation between immunotherapy and 
thermotherapy. 
Caveat 2 Mouse skin vs. human skin 
The review [224], show that the sensitivity to thermal damages depends on the species 
(see Fig 159). It appears that the mouse is more sensitive than humans (several °C). It is 
potentially a huge bias for plasma-medicine. Treatments that induce an anti-tumor effect 
via a hyperthermia-type response at 45 °C in the mouse may be ineffective for humans. 
Moreover, the results presented in this figure Fig 159 is consistent with the fact that the 
skin of the mouse was completely destroyed after a treatment of 30 min with the non-
refrigerated multichannel-jet (final temperature between 45 and 48 °C). Indeed, this 
curve gives a time of the order of ~15 min for mouse skin necrosis. 
 
Fig 159 the points represent the time to obtain epidermal necrosis as a function of temperature for 
human, pig and mouse skin. The figure is from the review [224]. The data itself were derived from 
papers [226] and [227] 
An additional difficulty, the damage also depends on the type of biological tissue. The 
differences between tissues are considerable, several °C (see Fig 160) 
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Fig 160 The figure is from the review [224]. Time-temperature relationships to achieve isoeffective 
damage in several mouse tissues. 
Moreover, there is no obvious ranking by type of tissue. Regarding the nervous system, 
for instance, peripheral nerves appear heat resistant, whereas the brain is very sensitive 
[224]. 
Caveat 3 the heating rate 
Under the effect of a moderate increase in temperature (mild-hyperthermia 39-42 °C), 
the cells develop temperature tolerance mechanisms (involving, among others, the heat 
shock proteins HSP70). HSP proteins play the role of chaperones, helping the folding of 
the proteins emerging from the ribosomes, enabling to avoid the defect of folding and 
denaturation that could result from the mild-hyperthermia. The review [224] assume that 
the heating rate is a significant factor because  the thermotolerance develops to a 
greater degree during slow versus fast heating rates. The example discussed in [224] 
regards damage to vascular systems. These damages play a key role in the tumoricidal 
effects. It appears that the threshold for arteriolar stasis (respectively venular stasis) that 
was between 45-46°C (respectively 43.4 °C) for heating rates in the range 0.1-0.7 °C/min 
dropped to 42°C (respectively 42.1 °C) at a heating rate of 1 °C/min. Since the heating 
rates due to plasma treatment are still higher than 1 °C/min, the damage should be 
greater than what the simulations might suggest. 
Not to leave with a pessimistic impression. Quantification of thermal damage, although 
problematic, is an area of active research, promising results of phase III clinical trials are 
presented in the paper [220] from 2015. 
VI.1.2.4 Can the plasma-skin interaction produce damage at short time 
scales?  
“short timescale” mean the time scale of the interaction of a single discharge with the 
skin. it has been found, by acquiring images with the ICCD camera and a plasma-jet, 
that the plasma has a lifetime of the order of 200 ns above a glass surface. We will take 
this value as the time scale. In 200 ns, the thermal diffusion takes place over a very short 
distance: 
ܮ஽ = √ߙ × 200 ݊ݏ = ඥ4.4 × 10ି଼ × 200 × 10ିଽ = 94 ݊݉ 
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The only thing that could happen is possibly an ablation of the first cells of the stratum 
corneum. Two kinds of experiments are known to produce this type of effects to the skin. 
First, the paper  [228] describes the ablation of the skin at a microsecond timescale. The 
device produces hot steam jets that interact with the skin during approximatively  10 μݏ. 
The purpose of these devices is to pierce the corneum stratum to facilitate transdermal 
passage of drugs. The external parts of the skin are heated to a temperature of the order 
of several hundred °C. According to the authors, the thermal effects (not the mechanical 
effets due to the impact of the jet) are the cause of tissue ablation. Unfortunately, we do 
not have sufficient time-resolved skin temperature measurements to know if the plasma 
treatments are approaching this case or not. The temperature measurements were 
acquired with the thermal camera which has a limited temporal resolution of ~100 ms. 
On the other hand, the amount of energy consumed during each discharge is known. At 
maximum, each microdischarges represents energy of the order of 100 μJ. This gives an 
upper limit to the thermal transfer due to plasma-skin interaction. 
It is assumed that the area of interaction of a single filament is: 
S= ૚૙૙ μ࢓ × ૚૙૙ μ࢓ = ૚ࡻିૡ ࢓૛, 
100 µJ in 200 ns, this is a flux Φ = ଵ଴଴×ଵ଴
షల
ଶ଴଴×ଵ଴షవ
ଵ
ଵ଴షఴ
= 5 × 10ଵ଴ ܹ. ݉ିଶ  
Then, we consider, the volume of epidermis define by the thickness of epidermis (e~15 
µm), multiplied by a square of area S. This volume has the volumic specific heat: 
ܥ = ߩܥ௣ܵ݁ = 1500 ∗ 3600 ∗ 10ି଼ ∗ 15 ∗ 10ି଺ = 8.1 × 10ି଻ܬ. ܭିଵ 
Consequently, the addition of 100 µJ of thermal energy should increase the temperature 
of this volume by: 
Δܶ =
100 × 10ି଺
8.1 × 10ି଻
= 123 ܭ 
It seems unlikely that a substantial part of the skin can be ablated with the heating 
caused by a single discharge. Firstly, because it is below the temperatures described in 
the paper [228], secondly, we are assuming that all the energy is transferred the skin and 
in the thermal form which is probably false. However, the heating caused by a single 
discharge should be detectable by a triggered infrared camera with a temporal resolution 
lower than the ms. It would be an interesting to do the experiment with a thin film (50 µm) 
of material which could mimic the skin. Measuring the temperature of the two sides of the 
film could provide valuable information on the kinetics of the thermal energy deposit, and 
indirectly on the plasma surface interaction. 
 
The other type of experiments known to ablate the upper part of the skin involves laser 
pulses. Very short pulses (ns-fs) can cause damage by dielectric breakdown of materials 
(especially optical glasses). However, thermal damage is the main risk for pulses longer 
than 1 µs. There are medical treatments for the skin using the thermal energy released 
by the absorption of lasers. The process is called photo-thermolysis. One of the goals of 
this treatment may be the removal of skin defects or its rejuvenation. The paper [207] 
describes the treatment of the skin which consists in the thermolysis of zones of 
micrometric sizes. The treated volume is a cylinder of diameter 100 µm and depth 300 
µm. The depth is limited by the phenomena of absorption and diffusion. The infrared 
pulse has a duration in the range 1.5-5 ms and energy in the range 6-12 mJ. 
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Thus, the optical intensity is in the range, 0.15-1  ܩܹ. ݉ିଶ  
The temperature increase would be Δܶ, in the cylindric volume of the skin: 
Δܶ =
6 × 10ିଷ
ߩܥ௣ܵ݁
=
6 × 10ିଷ
1500 ∗ 3600 ∗ ߨ × (50 × 10ି଺)ଶ ∗ 300 ∗ 10ି଺
= 470 ܭ 
This order of magnitude is consistent with the value evoked in the paper [228], which 
describes the thermo-ablation by hot steam at a timescale of 10-100 µs. The conclusion 
is the same with respect to the comparison with the energy deposited by a single plasma 
filament. It is likely that a single discharge does not cause ablation. 
In the following, the damages occurring at longer time scales (seconds) is studied. At this 
scale, the thermal diffusion is a key factor. 
VI.1.3 Biological effects of hyperthermia 
Long-term cellular changes 
Lepock et al. reviewed the molecular and cellular changes related to hyperthermia [229]. 
Higher temperature increases the metabolism 94and elicits transitions95 in cellular 
structures, particularly membrane and macromolecules. The orders of magnitude of 
time/temperature mentioned in section VI.1.2.3 are confirmed. The protein denaturation96 
occurs at a temperature as low as 40-45°C (mammalian cells) [229]. However, the 
temperature of denaturation is only ~40°C in rodent cells and 41-42°C for human cells 
[229]. This could be an issue since most in-vivo plasma-medicine experiments are done 
with mouse models. 
Hyperthermia also alters the fluidity of the membrane97 and increases cell 
permeabilization [229]. De Andrade Mello et al. exposes the link between changes in the 
fluidity of the membrane due to hyperthermia and the promotion of tumor death [230]. 
Leyko et Bartoz. compare the effects of ionizing radiation and hyperthermia on the 
membranes [231]. 
The existence of thermotolerance shows that the metabolic path is modified in a fairly 
durable way (at least several days) by moderate hyperthermia and that mild-
hyperthermia (e.g., temperature in the range 39-42 °C) change the behavior of the cells. 
Lepock et al. describe the mechanism of thermotolerance [229]. It has been shown that 
relatively short exposure to 40-41°C can inhibit growth and changes the activity of 
cellular pathways. 
                                               
94  in particular, the reaction rate of enzyme involved in cellular life 
95 The changes in molecular structures, for example, unfolding of the proteins (also called protein 
denaturation) are characterized by high activation energy (“100–200 kcal/mole”), which reflects 
the strong temperature dependence of this kind of process. Metabolism reactions have activation 
energies of one order of magnitude lower. Since thermal damages are characterized by higher 
activation energy, it is the reactions of structural transitions, and not the accelerated reactions of 
the metabolisms which explain the kinetics of thermal damage. 
96 Lepock et al. distinguish two effects of protein denaturation at the origin of cells killing [229]  . 
First direct loss of essential functions of the metabolism (“Inactivation of enzyme 
activity,membrane receptors, and ion transporters”). Second, the structural damages to the 
membrane, the cytoskeleton, the nuclear matrix. 
97 directly due to the denaturation of the structural protein of the membrane 
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It should be noted that there are sensitizing chemical substances (methanol, ethanol, 
propanol, butanol) or protective substances (glycerol) with regard to the denaturation of 
cellular proteins [229]. 
Hyperthermia and thermal ablation (ࢀ ≥ ૝૛°࡯) 
Borasi et al. study the coupling of strong hyperthermia induced by focalized ultrasound 
with radiotherapy [232]. The tissues reach a maximum temperature of 58 °C. They also 
found activation of the immune system due to hyperthermia. Several models of glioma98 
were treated. 
Ahmed et al. and Appelbaum et al. describe tumor ablation at high temperature 
(T>50°C), with radiofrequency heating in combination with doxorubicin chemotherapy ( 
[233] [234]). They prove that the combined effect of treatments is much better than 
treatments alone. Hyperthermia enables to improve drug delivery. 
Rossman et al. review the effects of hyperthermia on the tissues properties [235]. 
Regarding the electrical properties, the conductivity increase with tissue temperature. 
whereas the permittivity is rather constant. Regarding thermal properties, thermal 
conductivity and specific heat increase with the temperature for ܶ ≤ 80 °ܥ. Regarding the 
blood perfusion it appears that generally99 mild-hyperthermia increase blood flow 
whereas excessive heating elicit vascular stasis. This paper raises also an important 
issue: hyperthermia would be less effective on large animals (humans) than smalls 
(mice). 
Sun et al. have shown that a treatment which consists in  an alternation of heating (~60 
°C) and cooling  (with liquid nitrogen) is efficient against tumor [236]. It appears that 
damaged was increased when the cooling precedes heating. 
The damage elicited by hypothermia is beyond the scope of this section. However, 
information can be found in the papers [237]–[240]. 
Mild hyperthermia and tumor 
Stewart et al. show that mild hyperthermia (42.5 °C/30 min) have long-term effects on 
tumor blood perfusion [241]. One day after treatment, the blood perfusion decreases 
considerably. Contrary to what is observed in normal skin. Reduced blood flow and 
hypoxia leads to tumor starvation and decrease the pH of the tissue. The combination of 
radiotherapy and chemotherapy should be avoided at this time. On the other hand, the 
drugs will be diffused less effectively within the tumor, on the other hand, because the 
low oxygenation increases the radioresistance of the cells. It is, therefore, better to apply 
chemotherapy and radiotherapy before hyperthermia. 
Grile et al. show that hyperthermia (44 °C from 30 to 40 min) and radiation have 
synergistic effects on tumor [242]. It appears that big tumors are more sensitive to heat 
than the small ones, while the smaller ones are more sensitive to radiotherapy. It's 
consistent with the results presented in the paper [241] since the small tumor benefit 
from good oxygenation, while large, less oxygenated will be more radioresistant and 
more sensitive to additional hypoxia. This paper also shows that serotonin injections 
increase the sensitivity to heat. 
                                               
98 including U-87 which was also treated by Vandamme et al. [84] 
99 there are exceptions… It happens that blood perfusion decrease at the begining of 
hyperthermia. 
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Sun et al. show that one-third of the lethal dose of heat induces thermoresistance. It 
appears that the tissues are not damaged by a dose that should destroy them [241]. 
Song et al. have studied the modifications of blood  flow induced by mild-hyperthermia. It 
turns out that the effect is complex, in some cases, blood flow increase, in another case 
it decreases [243]. Song et al. also observe a decrease in tissue pH (by 0.2 unit of pH) in 
addition to an increase in tissue oxygenation due to mild hyperthermia [244]. 
Vujasckovic et al. observe the oxygenation and pH of the in-vivo canine tumor [245]. The 
tumor oxygenation (pO2) and blood perfusion are described after hyperthermia (24 h). 
Oxygenation increases when the temperature is lower than 44 ° C, on the contrary, it 
decreases when the temperature is above 44 ° C. Regarding blood perfusion, mild 
hyperthermia significantly increase blood perfusion. On the contrary, there is no change 
in perfusion when ܶ ≥ 44 °ܥ. On average, the pH decrease of 0.1 after hyperthermia. 
Song et al. also observe an increase in oxygenation of tumors due to hyperthermia. The 
combined use of hyperthermia and nicotinamide increases radiosensitivity of the skin 
and tumor [246]. 
Mild hyperthermia and immune response 
Tempel et al. describe how the immune system is activated by mild-hyperthermia [247]. 
The heat shock proteins in particular HSP70 is crucial. Heating cells to 41.5 °C also 
increased the phosphorylation of histone H2AX. And it turns out that γH2AX is 
considered as a marker of DNA breaks (double strand breaks) which also triggers 
immune responses 
The first effect of hyperthermia on immunity is localized to the heated tumor, but, 
secondly, local hyperthermia can also stimulate a systemic antitumor reaction that can 
strike tumor cells that are distant from the heated tumor. Indeed: 
[247]. “At 39°C, heat increases the MHC class I polypeptide-related sequence A (MICA), a molecule which 
increases cell sensitivity to natural killer cells. At a temperature of 43 °C, heat will increase the level of 
MHC class I molecules, which attract cytotoxic T-cells.” 
[247]. “Moreover,Hsp70s can stimulate the adaptive immune system by transferring chaperoned tumor 
proteins to antigen-presenting cells, which evokes a tumor-specific T-cell response [69,85–87]. This T-cell 
response presumably has the ability to target all tumor cells, including metastases.” 
Regarding this topic, the following references contain more information about this topic. 
[248]–[251] and [252]. 
Mild hyperthermia and oxidative stress 
Lord-Fontaine et al. show that hypothermia increases the toxicity of ROS, especially 
H2O2 [253] and proves that protection systems against ROS can be deactivated by 
hyperthermia [254]. The review of Bettaieb et al. summarize the link between 
hyperthermia and oxidative stress [255] with the following statement: 
 Elevated temperatures can increase the rates of biochemical reactions, this 
would increase cell metabolism and increased oxidative stress 
 This increase is seen below (at 40°C) and above 42 °C. 
 This stress is likely due to a dysfunction of the mitochondrial respiratory chain 
 Hyperthermia could increase the reactivity of reactive oxygen species. For 
example, the toxicity of H2O2 is higher at 41-43°C compared to the physiological 
temperature. 
 Hyperthermia inactivated cellular antioxidant defenses 
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The thermosensitivity depends on species and organ 
Some tissues and organs are more sensitive to hyperthermia than others: this question 
was illustrated by the comparison of human and mouse skin and mouses organs (see 
section VI.1.2.3). According to [255], the nervous and gastrointestinal tissues are most 
sensitive100 to hyperthermia. 
Hyperthermia and wound healing  
It turns out that mild-hyperthermia can promote wound-healing [257]. It may be 
interesting to take this into account for dermatological applications of plasmas [258]. 
Mild hyperthermia and photodynamic therapy 
This difficulty in separating the effects of hyperthermia has arisen in other domains, for 
example, that of photodynamic101 therapy. As this is beyond the scope of this study, the 
relevant papers will be quoted without further comment: [259]–[262]. 
in-vivo experiments have shown that mild hyperthermia causes: 
Long-term cellular changes: thermotolerances, expression of several 
heat shock protein, HSP70 
oxidative stress 
pH decrease 
pO2 increase (vasodilatation) 
membrane permeabilization  
Radio and chemosensitization of chemoresistant lines  
Innate and adaptive immune responses 
 MHC class I ↗  =  attract cytotoxic T-cells  
 Hsp70s stimulate the adaptive immune system  
 abscopal effect/systemic response  
 
 
VI.1.4 Quantification of thermal damage 
Collagen is the major component of skin [210]. Consequently, the state of collagen can 
be used as a marker of thermal damage. Moritz & Henriques ([206], [263])described a 
way to quantify thermal damage, which is widely accepted and used by communities 
interested in the quantification of thermal damages. The purpose is to link the degree of 
burns with temperature history of the skin.  
                                               
100 see also Yarmolenko et al. discusses the susceptibility to hyperthermia of several organs and 
tissues [256] 
101 According to [259] “Photodynamic therapy (PDT) have been shown to be synergistic with sub-
lethal hyperthermia. The greatest effect in vivo is when hyperthermia is applied immediately prior 
to light irradiation. In many of the earlier clinical studies of PDT, it was not realised that, at high 
enough incident light power, the absorption of light by the target tissue could itself produce 
significant temperature rise, even to the extent of causing coagulation or charring. … Conversely, 
hyperthermia could be applied deliberatelywith PDT,either using the light itself or by independent 
RF, microwave or ultrasonic irradiation, to enhance the tumoricidal effects of PDT” 
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Skin damage can be modeled as a chemical reaction of collagen. This reaction, called 
denaturation, is the transition of collagen structure from triple helix configuration to a 
randomly coiled conformation. The reaction rate ݇(ܶ) depends on the temperature.  
 
The temperature of thermal denaturation strongly depends on (a) the water content in 
collagen (b) the degree of cross-linking between the molecules [264]. In fact, the 
denaturation of collagenous tissue is even more complex and depends not only on the 
temperature history but also on mechanical loading during heating, pH variations and 
preheating.  
This modeling assumes that the denaturation is of order one and follows the law of 
Arrhenius. The damage function, Ω, is dimensionless and defined by: 
k(T) =
dΩ
dt
= Aexp ൬−
Ea
k୆T
൰ 
Where A and Ea are constants; A has the dimension of a frequency, interpreted as a 
parameter related to the frequency of molecular collision. Ea is the activation energy of 
the reaction (J). When the thermal energy exceeds this energy, the reaction occurs at a 
significant rate. The damage function Ω is also expressed in an integrated form for each 
time and each position: 
Ω(x, y, z, t) =  න A × exp ൬−
Ea
k୆T(x, y, z, τ)
൰ dτ
୲
଴
 
The reaction is faster with larger values of T for the same Ea. The two constants A and 
Ea were obtained experimentally. The meaning of Ω is explained in [265]. This number is 
the logarithm of the relative concentration of undenatured collagen. 
Ω(ݐ) = ln (
େ(଴)
େ(୲)
). 
Where C(t) is the concentration of undenatured collagen at time t. The percentage of 
denatured collagen is: 
%ܿ݋݈(ݐ) =
ܥ(0) − ܥ(ݐ)
ܥ(0)
= 1 − exp (−Ω(ݐ)) 
Thus, Ω = 1 corresponds to the transformation of 63.2% of collagen into damaged 
collagen. Damage function can be calculated in each position:  Ω(x, y, z, t). Three 
thresholds of damages, which corresponds to the three degrees of the burn are generally 
used (Table 20, according to [266] and [210]) . Ω is calculated at the position of the basal 
layer of the epidermis (the living cells at the boundary of dermis and epidermis). The 
value Ω = 104 at the same location represents a third-degree burn (for human), which 
mean that the damages reach subcutaneous tissues. 
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Table 20 Link between the degree of burn and the value of the damage function. 
Degree Description Quantification 
1 Transepidermal damage Ω = 0.53 at the basal layer 
of epidermis 
2 transepidermal necrosis Ω = 1 at the basal layer of 
epidermis 
3 Third-degree burn Ω = 104 at the basal layer of 
epidermis 
 
Ea and A are obtained for several species and location of the skin on the body. The 
value Ω = 1 corresponds to the same amount of damage for all species and kind of skin 
because Ea and A are chosen for this purpose. 
The damage function Ω is an integral over time. The consequences of single 
hyperthermia are well known. The effects of repeated hyperthermia with an interval of 
several days have been less studied. It is likely that the damage does not have time to 
be fully repaired in two days when the tissue is significantly damaged. 
VI.1.5 Physical content of the simulation 
In this section, the physical significance of the parameters used to model the thermal 
behavior of the tumor is explained. The numerical values of these parameters are given 
in next section (VI.1.6). The parameters related to the plasma source are given in the 
sections devoted the results. 
VI.1.5.1 Conduction through living tissue 
The heat transfer by conduction takes place as soon as there is a temperature gradient. 
It represents the global effect of the transport of energy by the elementary carriers: 
molecules, phonons, electrons. The conductive surface flux jc is proportional to the local 
temperature gradient સܶ, according to the Fourier law in the case of a homogeneous and 
isotropic medium. 
࢐ࢉ = −ߣ(ܶ)સܶ 
ߣ(ܶ) depends on temperature, but is considered to be constant in the temperature range 
that is concerned. The different layers of the skin will be considered as homogeneous 
and isotropic media (Otherwise it would be possible to consider conductivity as a tensor). 
The minus sign comes from the second principle of thermodynamics. The Fourier law is 
the approximation of the response to a disturbance at first order. This is a linear 
response, only the first derivative of the temperature appears in this equation. This law 
postulates an instantaneous response to a thermal disturbance. This means that the 
heat flux occurs instantaneously in response to a temperature gradient, at a given point. 
This hypothesis holds true as long as the time scales are large compared with the 
timescale of collisions ࣎ࢉ࢕࢒ between the elementary carriers. The Fourier law ceases to 
be valid for the modelling of thermal transfer due to the interaction of a short laser pulse 
(scale of the ps or below) with a solid medium.  
Some authors (see reference book  [210]) propose non-Fourier simulations of thermal 
transfer through the skin using expressions like  ࢐ࢉ(ݐ + ߬௤) = −ߣ(ܶ)સܶ(ݐ + ்߬). The 
argument for these approaches is that the non-homogeneous of the skin, the presence 
of sub-structure (cells, blood vessels…) could give relaxation times between 0.1 s and 
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100 s (instead of 10-11 s for crystal lattice). This relaxation time that characterizes 
exchange between each sub-structure would be an equivalent of the time of collisions 
between energy carriers in crystal. This description is strongly controversial. The 
observation of thermal waves has not been clearly proved for biological tissues. 
Moreover, these generalizations of the Fourier law pose fundamental problems for non-
equilibrium thermodynamics and could lead to strange physical behaviours like negative 
thermal-temperature [267]. Furthermore there is few data on the values of coefficients ߬g 
and ߬T regarding the skin. That’s why it was decided to describe conduction only on the 
basis of Fourier propagation equation. 
Some authors also use the notion of “effective thermal conductivity” ([268], [269], [270]). 
In fact, the tissue studied is often irrigated by multiple blood vessels. The displacement 
of the blood is accompanied by a convective transfer of heat. Consequently, a 
description which assumes that the transfer of heat is of pure conductive form is 
necessarily incomplete. Effective conductivity is a mean to deal with the convective 
transport of heat by assuming that the tissue has a thermal conductivity (ߣ௘௙௙), several 
times higher than the real conductivity of the tissue. In what extend this approah can 
correctly mimic the thermal behavior of the tissue is still an open question. There is much 
less information available on the values of thermal conductivities that could be attributed 
to tissues. The Appendix F gives the results of simulations based on the theory of 
effective thermal conductivity. 
VI.1.5.2 Metabolic heat generation 
The activity of the cells generates heat. This can be modeled by a constant volumic-
source in the equation of heat propagation. Heat generation, however, depends on 
several parameters: ambient temperature, physical activity of the mouse. 
Thermoregulation can be maintained at ambient temperature in the range -5°C, 30°C 
[271]. Rodents cannot sweat; they adjust their temperature by changing their metabolism 
and behavior. Metabolic activity of awake mouse was measured at 30 kJ/day (for a body 
weight of 30g). With the assumption of a density of 1 for the whole mouse, this gives 
7700 W/m3. Deng et Liu [272] choose the value of 4200 W/m3 for normal human tissue 
and 42 000 W/m3 in the tumors. Consequently, the metabolic heats of humans and mice 
have the same order of magnitude. 
However, the following paragraph will show that the heating due to metabolic heat is not 
preponderant compared to the effect of blood perfusion. The effect of metabolic heat is 
relevant at the scale of the whole organism, not as the scale of a centimetric tumor. This 
statement is true for small animals but not necessarily in humans.  
VI.1.5.3 Heat exchange with blood 
Blood flow coming from the artery acts as a damping system for temperature variations. 
In most models, the blood enters the tissue at the arterial temperature which matches 
the internal temperature of the mouse. The blood exits at the tissue temperature. It is 
assumed that blood transfers its thermal energy to the tissue. Dermis and tumor tissue 
are highly vascularised. The fat layer is poorly vascularized. The epidermis is not 
vascularized. Arterial blood temperature is 37 °C when the mouse is conscious. During 
anesthesia (with isofluorane) and for this strain, the internal temperature is 35 °C [273]. 
Internal temperature strongly depends on the number of heartbeats per minute, the 
duration of the anesthesia and the concentration of anesthetic gas. We assume that this 
temperature is the same for C57BL/6 and BALB/C strain. Volumic source term of heat 
has the following expression: 
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ݍ௣௘௥௙ = ߱ߩ௕௟௢௢ௗܥ௕௟௢௢ௗ (ܶܽ − ܶ) 
Where ܶܽ is the arterial temperature; T the temperature of the tissu; ߩ௕௟௢௢ௗܥ௕௟௢௢ௗ  the 
volumetric specific heat of blood; ߱ the perfusion rate. Perfusion rate is often express 
with unit ml/s/ml, which expresses the number of ml of blood flowing per s per ml of 
perfused organ. Blood perfusion has a magnitude of 0.001 ml/s/ml for the dermis and 
this kind of tumor. 
Numerical example: 
With ࣓ = ૙. ૙૙૚ ml/s/ml, ߩ௕௟௢௢ௗ = 1060 kg/m
3, ܥ௕௟௢௢ௗ = 3770 J/kg/K and Ta-T=5 K (for 
example if the tissue has a temperatureܶ = 40 °ܥ). Consequently, ݍ௣௘௥௙ = 20 000 W/m
3. 
That’s why metabolic heat, whose mean value is around 7000 W/m3 does not have a 
preponderant effect. 
VI.1.5.4 Effect of temperature and damage on blood perfusion 
The organism reacts to temperature variation. In particular, blood perfusion is 
temperature and damage-dependent. When the temperature increases blood flow begins 
to increase until reaching a maximum. The blood flow then decreases with increasing 
damage and vanishes entirely above 60 ° C due to blood coagulation [210]. This effect 
was modeled by Schutt and Haemmerich [274] by using the “degree of stasis function.” 
The degree of stasis is defined with: 
ܦܵ = 1 − exp (−Ω୮ୣ୰୤) 
Where Ω୮ୣ୰୤ is a damage function defined by coefficient A = 1.98 10
106 s-1, Δܧ = 6.67 105  
J/mol. 
Ω୮ୣ୰୤ = න ܣ݁ି୼ா/(ோ்)݀ݐ
௧
଴
 
Perfusion rate is linked to the degree of stasis with four linear approximations: 
߱ = ߱଴(1 + 30 ܦܵ)   ݂݋ݎ ܦܵ ߳ [0,0.02] 
߱ = ߱଴(1.86 − 13 ܦܵ)   ݂݋ݎ ܦܵ ߳ [0.02,0.08] 
߱ = ߱଴(0.884 − 0.79 ܦܵ)  ݂݋ݎ ܦܵ ߳ [0.08,0.97] 
߱ = ߱଴(3.87 − 3.87 ܦܵ)  ݂݋ݎ ܦܵ ߳ [0.97,1] 
߱ = 0  ݂݋ݎ ܦܵ ≥ 1 
Where ߱଴is the blood perfusion of the undamaged skin. The same model of damage is 
used in our model. Since the volumes destroyed are generally small, this effect does not 
play a key role. 
VI.1.5.5 Radiation 
The physics of heat exchange at the skin interface is described in the four following 
sections. Exchange of heat by radiation takes the form: 
ݍ௥௔ௗ = ߪ(ܶݏସ − ܶ݁ݔݐସ) (with the assumption of emissivity = 1= black body, in reality the 
emissivity of the skin is around 0.95) 
With Ts the skin temperature, Text The temperature of the surface which emits the 
radiation seen by the surface of the tumor, ߪ = 5.67 × 10ି଼ ܹ. ݉ିଶ. ܭିସ the constant of 
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Stefan-Boltzmann and ݍ௥௔ௗ  the value of the power which leaves the body per surface 
unit (W.m-2).  
Numerical example:  
With Ts = 33 °C and Text = 20 °C, heat flow is ݍ௥௔ௗ ~ 78 ܹ. ݉ିଶ. 
In the condition of natural convection (see next section), heat exchange for the same 
difference of temperature is  ݍ௖௢௡௩  ~ 91 ܹ. ݉ିଶ. Radiative exchanges are a significative 
part of heat exchange. It is necessary to take them into account. In the simulation, the 
part of the tumor which is not exposed to plasma is exposed to  ܶ݁ݔݐ = ܾܶܽ݉ = 20 °ܥ. 
The part of the tumor exposed to plasma jet, is exposed to Text = Temperature of Helium 
gas = Temperature of the plasma source. The tumor is in the nearby of plasma-source, 
and we assume that the plasma source (at least his head) is in thermal equilibrium with 
gas. This point is particularly crucial in the case of treatment with refrigerated multijet 
since the initial temperature of the device is below -30 ° C and represents a significant 
part of the visible surface from the treated zone. 
VI.1.5.6 Convection 
The convection is modeled by a heat exchange coefficient h.  
ݍ௖௢௡௩ = ℎ(ܶݏ − ܶ݃ܽݏ) 
Where Ts is the temperature of the surface of the skin; Tgas is the temperature of the 
fluid; h is the heat transfer coefficient (W/m²/K);  ݍ௖௢௡௩ is the amount of heat transferred 
per unit area. The coefficient h depends strongly on the nature of the flow, which is 
conditioned by the value of the dimensionless numbers of the fluid mechanics. Three 
cases are studied: (a) the case of a skin exposed to air at room temperature (natural 
convection) (b) the skin under the helium jet orthogonal (c) case of an argon jet. Plasma-
specific effects are not taken into account. Plasma can act on the turbulence of the 
overall flow. The thermal conductivity ߣ of the plasma is quite high; thus, the effusivity of 
the plasma ඥߣߩܿ௣ can be expected to be much higher than that of the air. 
Thermal effusivity ۳ = ඥૃૉ܋ܘ is the parameter which fixes the surface temperature when 
two semi-infinite bodies 1 and 2, initially at temperatures T1 and T2 are brought in perfect 
conductive thermal contact. This value is only true for short duration, those for which the 
approximation of semi-infinite media is valid. In this case surface temperature is: 
ܶݏ = ଵܶ
ܧଵ + ଶܶܧଶ
ܧଵ + ܧଶ
 
It is, therefore, possible to assume that the presence of plasma could increase the value 
of the heat transfers. 
It would be interesting to have an idea of thermal conductivity of this cold plasma at 
atmospheric pressure, in the conditions of plasma-medicine experiments. The lifetime of 
these plasmas on the surface of the solid and the unsteadiness of their thermal 
properties at short time scales requires the use of simulations. The following three 
sections describe heat exchanges by assuming that heat exchanges are made with hot 
(or cold) helium if the device is refrigerated. 
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VI.1.5.6.1 Natural convection 
Natural convection of the skin (i.e., without imposing a flow of fluid) is modeled in the 
works [210], [275], by that of an isothermal cylinder of diameter D=10 cm. It seems 
relevant since these works seek to model the skin at human scale. In this framework 
ݍ௖௢௡௩ = 2.44 (ܶݏ − ܶܽ݅ݎ)ଵ.ଶହ ܹ. ݉ିଶ  (ࡱࢗ ૚) 
In our situation, the relevant dimension is rather D = 1 cm (~ size of the tumor). It is 
therefore necessary to recalculate an expression of the heat transfer coefficient elicited 
by natural convection with this hypothesis. Insofar, we use a tabulated expression linking 
some of the adimensioned numbers which characterized the problem. Let's start by 
calculating these numbers 
The heat transfer coefficient h is related to the number of Nusselt with 
Nu =
୦ ୈ
஛౗౟౨
, 
where D is the diameter of the cylinder; and ߣ௔௜௥ the thermal conductivity of air. Morgan 
[276] shows that Nusselt number is a function of Rayleigh number Ra. This number 
characterises the relative importance of heat transfer by conduction or convection. If the 
Rayleigh number is below a critical value, heat transfer is in the form of conduction. This 
number is the product of Grashof number and Prandtl number  Ra = Pr Gr. 
Prandtl number is defined by   Pr =
஝
஑
=
୫୭୫ୣ୬୲୳୫ ୢ୧୤୤୳ୱ୧୴୧୲୷
୲୦ୣ୰୫ୟ୪ ୢ୧୤୤୳ୱ୧୴୧୲୷
, this number depends 
only on the fluid characteristic. For small Pr, the heat diffuses quickly compared to 
diffusion of momentum. 
Grashof number is defined by    ܩݎ = ݃ ߚ(ܶݏ−ܶܽ݅ݎ)ܦ
3
ߥ2
, where g is acceleration due to 
earth’s gravity; ߚ is the coefficient of thermal expansion (1/T for ideal gases); ߥ is the 
momentum diffusivity (i.e the kinematic viscosivity). The Grashof number compares the 
value of viscous force and buoyant force which is a consequence of the difference of 
density due to gas heating. Gas parameter are given in [277] (French edition). 
νୟ୧୰ = 1.589 × 10ିହ mଶ/s at 300 K 
αୟ୧୰ = 2.25 × 10ିହ mଶ/s  at 300 K 
Pr = 0.707 at 300 K 
diameter D=1 cm, Ts=33°C ,Tair =20 °C and ߚ = ଵ
்
= 1/(273.15 + 33) give 
Gr(D = 1cm) =  
g β(Ts − Tair)Dଷ
νଶ
=
9.81 × 1/306.15 × 13
(1.589 × 10ିହ)ଶ
Dଷ = 1649 × 10଺ ×  Dଷ 
 
Thus, ܩݎ(ܦ = 1ܿ݉) = 1649 and ܴܽ = ܲݎܩݎ = 0.707 ∗ 1649 =1166 
 
According to [276] and [277], ܰݑ = ܣܴܽ௡ with A=0.850 and n=0.188, for Ra in the 
interval [102, 104]. 
Thus,    h = ஛౗౟౨୒୳
ୈ
=
ଶ.଺ଷ×ଵ଴షమ×୅ୖୟబ.భఴఴ
଴.଴ଵ
= 5.21 × (Ts − Tair)଴.ଵ଼଼ W/m²/K 
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For example, with Ts=33 °C and Tair= 20 °C, ℎ = 8.4  W/m²/K. This is relevant for 
natural convection according to [277]. 
Furthermore, thermal transfer leaving the surface takes the form: 
qୡ୭୬୴  = h(Ts − Tair) =  5.21 ×  (Ts − Tair)ଵ.ଵ଼଼ ܹ. ݉ିଶ 
At this point, we have found the expression which provides the value of power loss per 
unit of surface relevant with the size and curvature of mouse tissue. The following note 
explains how to obtain Eq1 with our own calculations. 
Additional note: 
Briefly, for D = 10 cm, ܩݎ(ܦ = 10 ܿ݉) = 1.649 × 10଺, thus ܴܽ = 1166 × 10ଷ which is in 
the interval [104, 107]. Consequently,  ܰݑ = ܣܴܽ௡ with A=0.480 and n=0.250. Thus,  
qୡ୭୬୴ =
2.63 × 10ିଶ × 0.480 × ቌ0.707 × 9.81 ×
1
300
(1.589 × 10ିହ)ଶ
10ିଷቍ
଴.ଶହ଴
0.1
(Ts − Tair)ଵ.ଶହ 
qୡ୭୬୴  = h(Ts − Tair) =  2.20 ×  (Ts − Tair)ଵ.ଶହ଴ W. mିଶ 
The heat flux is a polynomial function of (Ts-Tair), with the same power than the 
expression given in [210], [275] (ݍ௖௢௡௩ = 2.44 (ܶݏ − ܶܽ݅ݎ)ଵ.ଶହ ܹ. ݉ିଶ). The proportionality 
factor differs from 8%. Unfortunately, I was unable to access the references used in 
[210], [275] to investigate this small difference. 
VI.1.5.6.2 Helium jet 
The study of the thermal transfer of a jet of gas to the surface of a solid is a problem of 
applied physics that is studied since the mid-fifties. Many industrial applications involve 
gas jets for (a) drying surfaces (b) cooling hot surfaces in particular during welding (c) 
heating parts or furnaces  with the flames of a burner in the most efficient way possible 
[278]–[289]. 
Most applications, however, involve relatively high Reynolds number (above 10,000) 
whereas the number characterizing the gas flow is relatively small (around 100). 
Fortunately, some studies contain results for small Reynolds number. The influence of 
the turbulence and the shape of the treated substrate were explored experimentally and 
numerically. In particular, following configurations were studied: (a) plate (b) concave or 
convex surface (c) multi-jet configuration. 
On the other hand, no paper describing the thermal exchanges of a gas stream lighter 
than air was found in this experimental configuration. It seems reasonable to think that 
this configuration should probably increase the level of turbulence of the flow, even at 
low Reynolds number. The formation of the boundary which contains helium and air 
possessing different hydrodynamic and thermal properties could be a source of 
instability. Especially since the thermal and physical properties of the air-He mixture are 
more complex than an elementary weighting related to the partial pressure of the gases 
[290]. 
The heat transfer coefficient is evaluated from the information found in the literature. 
Before this, the flow was characterized by the values of dimensionless numbers. The 
geometry of the tip is visible in Fig 161. The total flow rate is 2600 sscm. Each of the ten 
channels has a size of 1.5 mm × 1.5 mm. 
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Fig 161 Nozzle of the multi-channel jet is made of ten channels with sizes of 1.5 mm X 1.5 mm. 
Helium flow was around 2600 sscm during experiments. 
Consequently, gas velocity is: 
Uୌୣ =
2600
10
10ି଺
60
1
(1.50 × 1.50 × 10ି଺)
= 1.93 m/s 
Thus, Reynolds number is Re = ୙ౄ౛୐
஝ౄ౛
=
ଵ.ଽଷ ×ଵ.ହ×ଵ଴షయ
ଵଶ.ଶ×ଵ଴షఱ
= 15.8 
Where Uୌୣ, the flow velocity is defined at the exit of the nozzle; L is the characteristic 
size of flow at the exit; νୌୣ the kinematic viscosity. Numerical values of gas properties 
were found in [277] . 
νୌୣ = 12.2 × 10ିହ mଶ/s at 300 K 
αୌୣ = 18 × 10ିହ mଶ/s  at 300 K 
ߣு௘ = 12.2 × 10ିଶ ܹ/(݉. ܭ) at 300 K 
Pr = 0.680 at 300 K 
 
The calculation of Rayleigh and Richardson number give a better view of the flow. 
ܴܽ =
௚ ఉ(்௦ି்௛௘)௅య
ఔఈ
~0.24, where Ts-The = 50 K and ߚ = ଵ
்
 is taken at 40 °C. 
Richardson number, Ri is defined by ܴ݅ = ீ௥
ோ௘మ
=
ோ௔
୔୰ ோ௘²
=
଴.ଶସ
଴.଺଼଴×ଵହ.଼²
= 1.4 × 10ିଷ ≪ 1. 
Since Ri characterize the importance of natural convection compared to the forced 
convection, it appears that natural convection is negligible. 
Fig 162 shows the structure of a jet impinging a free surface. The literature describes the 
evolution of Nusselt number (and therefore h; thermal transfer coefficient) along the plate 
as a function of the distance from the point of impact. The results giving the Nusselt 
number are taken only in the stagnation region. This region is located at the point of jet 
impact; its size is related to the size of the flow exiting from the nozzle. In this region, the 
heat transfer coefficient takes its greatest value. Moreover, the farther, the less the 
model will be valid, due to the rise of the helium and the curvature of tumor surface. 
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Fig 162 Structure of the flow of an impinging jet given by Viskanta et al. [282]. 
[283] gave an expression of the Nusselt number at the stagnation point by using the 
results obtained in the paper of Brdlik et Savin [286]. 
ܰݑ = ܴ݁
ଵ
ଶܲݎ
ଵ
ଷܽଵ ቀ
ݖ
݀
ቁ
ି଴.ଵଵ
ቌ1 −
ቀݎ݀ቁ
ଶ
ቀݖ݀ቁ
ି଴.ଶ
ܾ1
ቍ
ଵ.ଶ
 
Where, d is a characteristic size of the flow (1.5 mm); z is the distance between nozzle 
and surface; r is the distance between the center of impact region and the point where 
the local Nusselt number is calculated; coefficients a1 and b1 depends on z/d. This 
expression applies to stagnation region (r/d<1) and has been validated experimentally for 
Re ≥ 3800. This expression was obtained with the hypothesis of a laminar layer and 
should be valid at lower Reynolds number.  
For z/d=4, close to our own experimental situation ܽ1 = 1.42 and ܾ1 = 3.2 
And Nusselt number at stagnation point is 
ܰݑ(ݎ = 0) = ܴ݁
ଵ
ଶܲݎ
ଵ
ଷܽଵ ቀ
ݖ
݀
ቁ
ି଴.ଵଵ
= 15.8
ଵ
ଶ0.680
ଵ
ଷ × 1.42 × (4)ି଴.ଵଵ = 4.26 
Sahoo et al. [285], described slot-jet at Re = 100. This paper describes the behavior of 
the gas leaving a long slot (compared to its width). In the impingement region, depending 
on the aspect ratio and the geometry chosen, the number of Nusselt is between 4.5 and 
6. The two orders of magnitude are consistent. 
The Nusselt number describing the thermal transfer of a sphere in a forced heat 
convection flow is known for a larger range of Re. According to [277], for 1<Re<25, 
Nu = (2.2 + 0.48 × Re଴.ହ)Pr = 2.8      with Re = 15.8     
Line of ϐlow around sphere
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This number is a global Nusselt number; it describes the thermal transfer over the entire 
surface of the sphere. This is a mean value taking into account the lower heat transfer 
occurring in the downstream of the flow, that’s why this Nusselt number has a smaller 
value than in the previous configuration. 
According to these three experimental configurations, the Nusselt number has likely 
magnitude of few units. 
Finally, in simulations involving the convection of helium, the value ܰݑ = 5  was chosen. 
Thus, the value of heat transfer coefficient is given by:  
ℎ௖௢௡௩ =
ߣு௘ܰݑ
ܮ
=
15.2 × 10ିଶ × ܰݑ
1.5 × 10ିଷ
= 101.3 × ܰݑ 
But this heat coefficient is relevant only for the region of stagnation (i.e., an area of ~ 
1.5 × 1.5 = 2.25 mm²). Since there are ten channels, the total area for which this heat 
transfer coefficient occurs is 22.5 mm². 
In the simulation, however, the treated area represents the size of the treated area which 
is experimentally observed. This size is of the order of the size of the nozzle ~ 0.5-1 cm. 
More precisely, the treated area is the portion of a sphere of radius 5 mm defined by a 
half-angle at the top of 50 °. This area is 2ߨ × 5ଶ × (1 − cos(50°)) = 56.11 mm². 
In the simulation, we consider that incident flux is uniform over the boundary. 
Consequently, an equivalent heat transfer coefficient is defined over the entire boundary 
with 
ℎ௦௜௠௨ = ℎ௖௢௡௩ ×
"ܵݑ݉ ݋݂ ݐℎ݁ ܽݎ݁ܽ ݋݂ ݏݐܽ݃݊ܽݐ݅݋݊ݏ ݎ݁݃݅݋݊ݏ"
"ܾ݋ݑ݊݀ܽݎݕ ܽݎ݁ܽ"
= ℎ௖௢௡௩ ×
22.5
56.11
= 40.6 × ܰݑ 
For example, with Nu = 5, hୱ୧୫୳ = 203  W. mିଶ. Kିଵ. 
The heat transfer coefficient is higher than those of natural convection; this is consistent. 
VI.1.5.6.3 Argon jet 
What happens with a different gas? This section contains the calculations for Argon by 
using the same approximations. The thermophysical properties of Argon were found in 
Handbook [291]. 
U୅୰ =
2600
10
10ି଺
60
1
(1.50 × 1.50 × 10ି଺)
= 1.93 m/s 
Re =
U୅୰L
ν୅୰
=
1.93 × 1.5 × 10ିଷ
1.418 × 10ିହ
= 204 
ν୅୰ = 1.418 × 10ିହ mଶ/s at 300 K 
λ୅୰ = 17.84 × 10ିଷ W/(m. K) at 300 K 
ρ୅୰ = 1.603  kg/mଷ at 300 K 
Cp୅୰ = 521.5  J. kgିଵKିଵ  at 300 K 
 
Thus, α୅୰ =
஛ఽ౨
஡ఽ౨େ౦ఽ౨
= 2.14 × 10ିହ mଶ/s  at 300 K and Pr = ఔ
ఈ
= 0.66 at 300 K 
Regarding Rayleigh and Richardson number: 
ܴܽ =
௚ ఉ(்௦ି்௛௘)௅య
ఔఈ
~17.4, where Ts-The = 50 K and ߚ = ଵ
்
 is taken at 40 °C. 
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ܴ݅ =
ீ௥
ோ௘మ
=
ோ௔
୔୰ ோ௘²
=
ଵ଻.ସ
଴଺଺×ଶ଴ସ²
= 6.3 × 10ିସ ≪ 1 natural convection is negligible. 
For z/d=4 and a1 = 1.42 and b1 = 3.2, the Nusselt number at stagnation point is: 
ܰݑ(ݎ = 0) = ܴ݁
ଵ
ଶܲݎ
ଵ
ଷܽଵ ቀ
ݖ
݀
ቁ
ି଴.ଵଵ
= 204
ଵ
ଶ0.66
ଵ
ଷ × 1.42 × (4)ି଴.ଵଵ = 15.2 
Then,    ℎ௖௢௡௩ =
ఒಹ೐ே௨
௅
=
ଵ଻.଼ସ×ଵ଴షయ×ே௨
ଵ.ହ×ଵ଴షయ
= 11.9 × ܰݑ W.m-1.K-1 
and  ℎ௦௜௠௨ = ℎ௖௢௡௩ ×
"ௌ௨௠ ௢௙ ௧௛௘ ௔௘௥௔ ௢௙ ௦௧௔௚௡௔௧௜௢௡௦ ௥௘௚௜௢௡௦"
"௕௢௨௡ௗ௔௥௬ ௔௘௥௔"
= ℎ௖௢௡௩ ×
ଶଶ.ହ
ହ଺.ଵଵ
= 4.77 × ܰݑ 
Thus, with the assumption Nu=15.2, hୱ୧୫୳ = 72.4  W. mିଶKିଵ 
Considering all other parameters constant elsewhere, heat transfer is 64% less efficient 
with argon than with helium. This is essentially due to the smaller thermal conductivity of 
argon. Obviously, beyond this consideration, the physics of argon plasmas and in 
particular the metastable-chemistry will be considerably different from those of Helium 
plasma. Regarding the comparison between Helium and argon plasma. It would be 
simplistic to say that argon plasma generates less or more heat transfer than He plasma. 
VI.1.5.7 Evaporation 
Evaporation takes place if the there is moisture at the surface of the skin. A quantity of 
thermal energy equivalent to the latent heat of evaporation multiplied by the quantity of 
evaporated water is removed from the surface of the skin. Sweating is a very efficient 
means for some animals (like humans) for evacuating the heat. However, it turns out that 
rodents do not sweat since rodents have not sweat gland  [292]. The evaporation is not 
taken into account for most simulations. 
An expression of the evacuated power per unit area is given in [293] and Wilson & 
Spence [275]  for human skin 
qୣ୴ = 9.66 × 10ି଼ (Ts − Text)଴.ଶହ × (10଴.଴ଶ଺ହ ୘ୱ − RH × 10଴.଴ଶ଺ହ ୘ୣ୶୲) W.m
-2 
Where Ts is the temperature of the skin; Text is the temperature of the air in contact with 
the skin; RH is the relative humidity of the ambient air. 
The following orders of magnitude help to understand the efficiency of the sweating in 
the cooling of the skin. 
Numerical example:  
With ܂ܛ =  ૜૙ °۱ and Text = 20 °C, RH=0%, ݍ௘௩  ~ 19 ܹ. ݉ିଶ 
with ܂ܛ =  ૝૞ °۱ and Text = 20 °C, RH=0%,  ݍ௘௩  ~ 58 ܹ. ݉ିଶ  
with ܂ܛ =  ૠ૙ °۱ and Text = 20 °C, RH=0%, ݍ௘௩  ~ 318 ܹ. ݉ିଶ (order of magnitude of 
natural convection at this temperature ~ 324 W.m-2. The losses by radiation, natural 
convection and evaporation are compared in Fig 163. In the case of human skin, and 
when the humidity is 50%, the radiation losses are predominant (red curve). 
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Fig 163 Thermal flux coming out of the skin (algebraic value) according to the temperature. Case of 
human skin, when RH=50%. ࢗࢉ࢕࢔࢜ = ૛. ૝૝ (ࢀ࢙ − ࢀࢇ࢏࢘)૚.૛૞ ࢃ. ࢓ି૛. ࢗ࢘ࢇࢊ = ࣌(ࢀ࢙૝ − ࢀࢋ࢚࢞૝)ࢃ. ࢓ି૛, 
ܙ܍ܞ = ૢ. ૟૟ × ૚૙
ିૡ (܂ܛ − ܂܍ܠܜ)૙.૛૞ × ൫૚૙૙.૙૛૟૞ ܂ܛ − ܀۶ × ૚૙૙.૙૛૟૞ ܂܍ܠܜ൯܅. ܕି૛ 
Several expressions are given in the literature. Deng et al. [293] provide another 
expression of heat transfer by evaporation: 
qୣ୴ = Qdif + Qrsw 
with    Qdif = 16.7hW୰ୱ୵(0.256Tୱ − 3.37 − Pୟ) W. mିଶ 
with    Qrsw = 0.354 ∗ (0.256Tୱ − 3.37 − Pୟ) W. mିଶ 
Where ௥ܹ௦௪ is the skin humidity (0 mean that the skin is dry, 1 mean that the skin is 
entirely wet); ௔ܲ is the vapor pressure (in kPa) of water in ambient air. ௦ܶ is skin 
temperature. h is the heat transfer coefficient (W/m²/K), as defined in previous section. 
ܳௗ௜௙ represents the heat loss which already occurs (even if the skin is dry). ܳ௥௦௪ 
represents the heat loss added when the skin is wet. Unfortunately, the review [210] 
does not provide information on the validity of either expression. Fig 164 shows that the 
two models predict very different values (even for several values of Wrsw). A more recent 
study [294] indicates a value of the order of 350 ܹ. ݉ିଶ (nude and wet human skin at 30 
°C). Which could be compatible with the model of Deng et al. Regarding the evaporation 
of the gel located on the surface of mouse skin, it would be necessary to propose our 
own model since the geometry is slightly different. 
Chapter VI—Modelling and simulation of the thermal aspects of plasma-tissue interaction  
198 
 
Fig 164 Comparison of heat loss by evaporation at the surface of human skin, according to the two 
model of evaporation. 
VI.1.5.8 Plasma source 
This section describes how thermal transfers caused by plasma treatment are taken into 
account in simulations. There are some studies which describe thermal energy balances 
during plasma-surface interactions ([295] and [296]). Unfortunately, it describes plasma 
at low pressure, and very little is known about thermal transfer for cold plasma at 
atmospheric pressure. 
Consequently, the thermal transfer is modeled either by a constant surface term or by 
the convective transfer of heat described in the previous section. No experimental data 
on gas temperature were acquired during these experiments. We do not know what the 
origin of thermals transfers is. Are they due to the impacts of charged particles on the 
surface or to the convective heat transfer? It could be a mixture of the two terms. The 
available data do not enable to differentiate the two source terms.  
One of the following two assumptions is made; in order to propose gas temperatures and 
heat flux which enable to reproduce surface temperature over time.  
 Thermal transfer due to plasma is constant over time as long as the plasma is 
turned on. q୮୪ୟୱ୫ୟ = Constant W. mିଶ on skin boundary, if plasma is on, else 
q୮୪ୟୱ୫ୟ = 0. We assume that gas temperature (if study regards plasma jet) is 
ambient temperature. Thus, convection contributes to decrease the temperature 
of the skin. 
 Thermal transfer is only caused by convection of hot gas. qେ୭୬୴ = hୱ୧୫୳(T୥ୟୱ −
Tୱ୩୧୬) W. mିଶ at skin boundary when plasma is on. Gas temperature is constant. 
 
With more information on the dynamics of heating, for example, more data on the 
evolution of surface temperature as a function of time, it would be possible to quantify 
the importance of the two terms (one will be constant over time, the other evolve with the 
surface temperature). With gas temperature measurements given by spatially resolved 
spectroscopic measurements, for example, it would be possible to refine convective 
transfer models. It would be possible to reproduce the evolution of surface temperature 
by simply projecting helium heated without plasma. 
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With a better experimental knowledge of convective transfers, it would be possible to 
identify the contributions specific to the plasma. This information on the origin of thermal 
transfers would make possible to control them better: one could choose to amplify or limit 
thermal transfers by playing on the nature of the flow (for example by introducing vorticity 
and playing with nozzle geometry and turbulence) 
Regarding damages predictions, we have enough data to model and simulate the field of 
temperature and thus the field of damage. 
The approach consists of reproducing the evolution of surface temperature either by 
choosing the value of q୮୪ୟୱ୫ୟ  or by choosing the gas temperature. Since surface 
temperature is somewhat sensitive to these parameters, observations constrain the 
values of q୮୪ୟୱ୫ୟ or gas temperature in restricted ranges. Then, we observe if the 
thermal damage corresponds to the experimental observations. 
The main source of uncertainty in this model is the value of h. However, this uncertainty 
will not affect the ability of the model to predict damage, since, for a given h, qplasma or 
gas temperature are constrained in such a way that experimental observations of surface 
temperature are respected. Tgas and qplasma are simulation products in this approach. 
q୮୪ୟୱ୫ୟ  and h are also constrained by the measurements of power consumption. 
Chapter VI—Modelling and simulation of the thermal aspects of plasma-tissue interaction  
200 
VI.1.6 Physical properties of living tissues 
This paragraph summarizes the numerical values used to model the tumor according to 
the physical model made in the previous section. Unless otherwise stated, the values 
below were used to perform the simulations. The exact properties of the tissues are not 
always known for the mouse. However, the range of values they can take is often very 
limited. Finally, the results section contains a paragraph dealing with the effects of 
changes in biological parameters. We show that these modifications have little effect on 
the prediction of the zones affected by the thermal damage. 
Tumor and the skin above it are modeled as a sphere of radius 5 mm. This is an 
axisymmetrical 2D-Simulation. We defined four layers, which have constant thermal 
properties. Table 21 gives the value of parameters regarding conductive heat transfer. 
The last column contains references. When experimental values for mouse skin were not 
found, the value for human skin was used. Regarding the specific heat of the fat layer, 
instead of using the value of [210] (~2500 J.kg-1.K-1 ) which corresponds to human or 
obese C57BL/6 mouse (~40 g [297]), we use the value of specific heat for lean C57BL/6 
mouse (20.79+ 3.58 g) found in  [297]. Conductivity, specific heat, and volumetric density 
of the dermis and the tumor (and generally those of soft tissue) differ little from that of 
blood for the mammals. Thermal conductivity is in a range between 0.2 and 
0.6 ܹ. ݉ିଵ. ܭିଵ. Thermal conductivity is below the thermal conductivity of water: 
0.591   ܹ. ݉ିଵ. ܭିଵ [298]. 
Table 21 Thermal properties and size of this four model describing C57BL/6 subcutaneous tumor. 
Parameter 
unit 
Layer Value Reference 
Thickness 
µm 
epidermis 13 [211] C57BL/6 female 
dermis 162 [211] C57BL/6 femal 
fat layer 189 [211] C57BL/6 female 
tumor 4636 Substraction 
Volumetric 
mass density 
kg.m-3 
epidermis 1500 [210] [213] 
dermis 1116 [210] [213] 
fat layer 971 [210] [213] 
tumor 1050 Assumption =Blood 
density. Same 
assumption in [293] 
Specific heat 
J.kg-1.K-1 
epidermis 3600 [206][210] 
dermis 3300 [206][210] 
fat layer 3660 [297] (lean) 
tumor 3770 Assumption =Blood 
specific heat 
Conductivity 
W.m-1.K-1 
epidermis 0.235 [210] 
dermis 0.445 [210] 
fat layer 0.21 [299] 
tumor 0.561 [300]  
 
Metabolic heat generation was described with the set of parameters given in Table 22. 
This term is negligible at this scale (small tumor of a small animal: a half-sphere with a 
diameter of 5 mm). Metabolic heat plays at the scale of the whole body (for the small 
animal). 
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Table 22 Parameters of metabolic heat generation. 
Parameter Layer Value Reference 
Metabolic heat 
generation (W.m-3) 
epidermis 0 [275] 
dermis 200 [275] 
fat layer 5 [275] 
tumor  7700 (conscious) [271] 
 
The value of the perfusion rate is a critical parameter for evaluating the stationary and 
dynamic thermal response. With the conduction term, it is the term that leads to limiting 
thermal damage, by decreasing the temperature of the superheated tissues. 
Blood perfusion in humans 
Deng et al. study the possibility to detect tumor with thermal techniques [293]. In their 
simulation, they used a perfusion rate of 5 × 10ିସ  ݈݉/ݏ/݈݉ for normal tissue and 
2 × 10ିଷ ݈݉/ݏ/݈݉ for human tumoral tissue. Holmes et al. provide the value 0.25 ݈݉/
݉݅݊/݃ (~ 4 × 10ିଷ ݈݉/ݏ/݈݉) for one human tumor [300]. This is consistent. Torvi et al. 
propose a model of human skin subjected to fire and use a perfusion rate of 1.25 ×
10ିଷ  ݈݉/ݏ/݈݉  in dermis and fat layer of human skin [215]. 
Blood perfusion and mice 
Stott et al. describe the distribution of blood flow in each organ of the mouse [301]. 
Regarding skin, the paper show that perfusion rate is 0.07  ݈݉/݉݅݊/݃  (i.e. 1.2 ×
10ିଷ݈݉/ݏ/݈݉). For comparison purposes, the heart, the best-irrigated organ has a 
perfusion rate of 3.6 ݈݉/݉݅݊/݃ (i.e. 0.06 ml/s/ml). 
The book of Orr et al. report the rate of perfusion for mouse skin and mouse tumors 
[302]. Perfusion rate of the skin and muscle are respectively around 0.08 ml/min/g and 
0.11 ml/min/g. This is consistent with the paper cited above. Perfusion rate of the small 
tumor is between 0.03 and 0.22 ml/min/g. Small tumors have better blood irrigation. Big 
tumors have a perfusion rate in the range 0.01 and 0.08 ml/min/g. We choose the value 
0.08 ml/min/g ~ 1.3 × 10ିଷ  ml/s/ml for the simulation of dermis and tumor tissue102. 
Order of magnitude 
The Mean Transit Times (MTT) of contrast agent was measured by CEUS (see Fig 124) 
during the experiments regarding the treatment of mice bearing CT-26 tumors. It turns 
out that the rate of perfusion can be obtained from this parameter if the volume of blood 
contained in the tumor is known. Montet et al. have determined the Vasculature Volume 
Fraction (VVF) of the CT-26 tumor, during experiments on angiogenesis [303]. The value 
of the VVF taken from this paper: VVF~ 3% means that only 3% of the tumor is made of 
blood vessels. Note however that this value may not correspond to that of our 
experiments since the experimental conditions are slightly different. In addition, because 
the fluorescence diagnostic has a depth of detection limited to few mm, this value 
represents the VVF only in the upper layer of the tumor. 
Anyway, this value is used to obtain an order of magnitude and check if this value is 
consistent with the range 0.01 − 0.22  ml. minିଵ. gିଵ, reported in the book [302]. 
According to the experimental results described in Fig 124: MTT ≅ 40 ±  10 s  for CT-26 
tumor. Consequently, if the tumor has a radius of 5 mm  
                                               
102 Except during reliability study where blood perfusion vary in the range 
0.01 − 0.22  ml. minିଵ. gିଵ reported in the book [302]. 
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௧ܸ௨௠௢௥ =
ସ
ଷ
ߨݎଷ =
ସ
ଷ
ߨ(5݁ − 3)ଷ = 0.52 ݉ܮ, 
and blood volume is close to       ௕ܸ௟௢௢ௗ = ௧ܸ௨௠௢௥ × ܸܸܨ = 15.6 µܮ. 
Thus, perfusion rate is obtained with 
߱஼்ଶ଺ =
௕ܸ௟௢௢ௗ
ܯܶܶ × ௧ܸ௨௠௢௥
= 7.5 × 10ିସ  ml. sିଵ. mlିଵ  
The experimental value is consistent with the values given in the bibliographic references 
(an order of magnitude 10ିଷ ݈݉/ݏ/݈݉). We will consider that TC1 and CT26 tumors have 
the same perfusion rate and the same thermal properties. 
Table 23 Properties for the computation of heat exchange due to blood perfusion, blood damages, 
and tissue damages. 
Parameter Layer Value Reference 
Volumetric mass density of blood 
kg.m-3 
1050 [213] [210] 
Specific heat of blood 
J.kg-1.K-1 
3770 [210] 
Blood perfusion ml/s/ml ࣓૙ 
(value before the effect of 
temperature add damages on 
blood vessels) 
epidermis 0 [293] 
dermis 0.0013 [301] [302] 
fat layer 0.0005 [293] 
tumor 0.0013 [302] 
Tblood (°C) mouse awake  37 [273] 
Tblood (°C) under anesthesia  35 [273] 
Damage function of blood 
vessel and degress of stasis 
(as described in VI.1.5.4) 
A = 1.98 10106 s-1, Δܧ = 6.67 105  J/mol. 
Ω୮ୣ୰୤ = න ܣ݁
ି୼ா/(ோ்)݀ݐ
௧
଴
 
ܦܵ = 1 − exp (−Ω୮ୣ୰୤) 
߱ = ߱଴(1 + 30 ܦܵ)               ݂݋ݎ ܦܵ ߳ [0,0.02] 
߱ = ߱଴(1.86 − 13 ܦܵ)        ݂݋ݎ ܦܵ ߳ [0.02,0.08]  
߱ = ߱଴(0.884 − 0.79 ܦܵ)   ݂݋ݎ ܦܵ ߳ [0.08,0.97]  
߱ = ߱଴(3.87 − 3.87 ܦܵ)     ݂݋ݎ ܦܵ ߳ [0.97,1]  
߱ = 0                                         ݂݋ݎ ܦܵ ≥ 1 
 
[274] 
Damage function of tissu A = 2.984 1080 s-1, Δܧ = 5.064 105  J/mol. 
Ω = න ܣ݁ି୼ா/(ோ்)݀ݐ
௧
଴
 
[274] 
 
VI.1.7 How to formulate and solve the partial differential 
equations of the model? 
VI.1.7.1 Weak formulations of a problem defined by partial differential 
equation 
The equation which defined heat transfer in living tissue is known as Pennes-Bioheat 
equation ([304]). This equation describes the thermal diffusion in the presence of blood 
perfusion. 
ߩܿ
߲ܶ
߲ݐ
= ݀݅ݒ(ߣ∇ܶ) + ߱ߩ௕௟௢௢ௗܿ௕௟௢௢ௗ( ௔ܶ − ܶ) + ݍ௠௘௧ 
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Where ߩ is the density; c the specific heat;  ߣ the thermal conductivity; ߱ the perfusion 
rate; ߩ௕௟௢௢ௗ  and ܿ௕௟௢௢ௗ  are density and specific heat of blood at arterial temperature Ta; 
qmet is the metabolic heat generation in W.m-3. 
The software does not solve this equation directly. The software solves a variational 
formulation of this partial differential equation. For example, if we want to solve the 
problem of conductive heat transfer on the domain Ω with only one boundary called  ߲Ω 
and a surface heat flux defined by ℎ(ܶ − ௔ܶ௜௥). Strong formulation of this problem mean 
that we want to find the field of temperature T defined on Ω such that 
ߩܿ
డ்
డ௧
− ߣΔܶ = 0 ݅݊ Ω 
ݓ݅ݐℎ ܶ ݅݊݅ݐ݈݈݅ܽݕ:  ܶ(ݔ, ݕ, ݖ, 0) = ݂(ݔ, ݕ, ݖ) 
ߣસࢀ. ࢔ + ℎ(ܶ − ௔ܶ௜௥) = 0   ݋݊  ߲Ω  
 
with ࢔ the unit vector normal to the surface and oriented towards the interior. 
On the contrary, a weak formulation of this problem consists of finding the function T 
such that: 
∀ ݃ ∈ ܪଵ(Ω)      න ߩܿ
߲ܶ
߲ݐ
݃ −
 
ஐ
න λΔܶ݃ + න ߣસࢀ. ࢔ ݃ +  න ℎ(ܶ − ௔ܶ௜௥)݃
 
பஐ
= 0
 
பஐ
 
ஐ
 
Where ܪଵ(Ω) is the Sobolev space of functions of ܮଶ(Ω) whose first weak derivatives are 
also in ܮଶ(Ω). 
ܪଵ(Ω) = ܹଵ,ଶ(Ω) = {ݑ ∈ ܮଶ(Ω)|∀ ߙ ݏݑܿℎ ݐℎܽݐ |ߙ| ≤ 1, ܦఈݑ ∈ ܮଶ(Ω)} 
But, by using Green's identity ∫ Δܶ݃
 
ஐ = ∫ સࢀ. ࢔ ݃ − ∫ સࢀ. સࢍ
 
ஐ
 
பஐ  
Thus,    ∀ ݃ ∈ ܪଵ(Ω)      ∫ ߩܿ
డ்
డ௧
݃ +
 
ஐ ∫ λસ܂. સࢍ + ∫ ℎ(ܶ − ௔ܶ௜௥)݃ = 0
 
பஐ
 
ஐ  
Note that with this form, it is quite easy to add the boundary conditions which consist of 
known heat flux. Of course, this equation is discretized according to time. If dt is the time 
step; ܶ௡ the field of temperature at time t; ܶ௡ାଵ the temperature t+dt. The weak 
formulation becomes: 
∀ ݃ ∈ ܪଵ(Ω)      න ߩܿ
ܶ௡ାଵ − ܶ௡
݀ݐ
݃ +
 
ஐ
න λસ܂. સࢍ + න ℎ(ܶ − ௔ܶ௜௥)݃ = 0
 
பஐ
 
ஐ
 
VI.1.7.2 Space and time resolution 
Finite element methods solve the partial differential equation at discrete points. The 
choice of the mesh defining the size of the finite element is crucial for the accuracy of the 
results. The differential equations are solved for each vertex which defines a triangle and 
for the midpoints of each side of the triangle.  The other points are interpolated with a 
quadratic polynomial function. 
The Mesh is refined in the region of interest. This region contains mouse skin which has 
a total thickness of 364 µm. A thickness of 500 µm is added to the region of interest to 
correctly describe the propagation of heat and damage inside the tumor. The region of 
interest is clearly visible on Fig 165. Our main objective is to determine whether the 
thermal damage can reach the tumor or not. In that purpose, a spatial resolution of the 
order of 20 µm is required (small compared to the size of the layer of the skin). With the 
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mesh shown in Fig 165 and Fig 166, the spatial resolution is even better in the dermis 
and the epidermis to take into account the differences in thermal properties between the 
two layers. It would not make sense to increase the spatial resolution further since it 
would mean to calculate in an increasingly precise way an environment that is modeled 
as homogeneous and isotropic, whereas this is false at this scale (for example the size 
of a cell is around 10 μm). Temporal resolution is directly imposed by the desired spatial 
resolution. The characteristic length on which the heat diffuses must be of the same 
order of magnitude as the size of a finite element. 
For example, in the dermis, thermal diffusivity is   ߙௗ௘௥௠௜௦ =
ఒ
ఘ஼
= 1.2 × 10ି଻ ݉ଶ. ݏିଵ . 
Thus, diffusion time on a length L = 20 µm is ߬ = ௅
మ
ఈ
= 3 ݉ݏ. On the other hand, it is quite 
expensive in terms of calculation time. We use time a step of 10 ms for most simulations 
which corresponds to a spatial resolution of 35 µm. A decrease of the resolution from this 
point does not alter the representation of the damaged areas. 
  
Fig 165 Triangulation of the region of interest modeling tumor and the different layers of the skin. 
The entire region of interest is visible on the left-hand side of the figure. Right zoom on an area of 
thickness 1 mm. The positions of the different layers are clearly visible because mesh resolution is 
increased at the level of the outermost layers to precisely describe the field of temperature. Size of 
epidermis, dermis, and fat layer are respectively, 13, 162, 189 µm. 
Chapter VI—Modelling and simulation of the thermal aspects of plasma-tissue interaction  
 
205 
 
 
Fig 166 Triangulations applied to the outermost layers of mouse skin. For epidermis and dermis, the 
size of each triangle is below the size of the cell itself (order of magnitude d~10 µm).  The mesh 
enables to describe temperature and damage field in a precise manner. At this spatial resolution, it is 
not the resolution of the simulation that is lacking, but the physical model which ceases to be valid. 
It doesn't make sense to perform calculations of the field of temperature at the subcellular or cellular 
scale because the medium is far from being isotropic and homogenous. 
VI.1.7.3 Physical fields in finite elements method 
Finite element method approximates all functions u as: 
ݑ(ݔ, ݕ) ≅ ෍ ݑ௜߶௜(ݔ, ݕ)
ெ
௜ୀଵ
 
Where ߶௜(ݔ, ݕ) are the basis functions of a space of polynomial functions which are 
defined on triangle describing the mesh. The basis functions of this space are continuous 
piecewise and quadratic functions of space coordinate. The support of each function ߶௜ 
is defined on triangle ௜ܶ and is zero on other triangle. Six coefficients define each 
function. The software does an exact resolution in the center of each side and at each 
vertex which define a triangle. These six values enable to find the six coefficient of the 
polynomial interpolator. 
VI.1.7.4 An axisymmetric problem 
Problem is axisymmetric with axis ݎ = 0. This has consequence regarding the definition 
of boundary conditions and the equations. It is necessary to multiply all the function 
under the integral by 2ߨݎ to take the effect of axisymmetry into account. 
 
 
 
 z 
r 
Axis of 
axisymetry 
ur 
uz 
∀ ݃ ∈ ܪଵ(Ω)      න ߩܿ
ܶ௡ାଵ − ܶ௡
݀ݐ
݃2ߨݎ݀ݎ݀ݖ +
 
ஐ
න λસ܂. સࢍ2ߨݎ݀ݎ݀ݖ + න ℎ(ܶ − ௔ܶ௜௥)݃2ߨݎ݈݀ = 0
 
பஐ
 
ஐ
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VI.1.7.5 Dealing with nonlinearity 
We have seen that radiative exchanges are not negligible. Thermal transfer depends on 
temperature to the fourth power (ߪܶସ). This nonlinear problem can be solved iteratively 
after a semi-linearization. Boundaries conditions take the form: 
ߣસࢀ. ࢔ + ߪ൫ܶସ − ௔ܶ௜௥
ସ ൯ = 0 = ߣસࢀ. ࢔ + ߪ(ܶ − ௔ܶ௜௥)(ܶ + ௔ܶ௜௥)(ܶଶ + ௔ܶ௜௥
ଶ ). 
The problem is solved at iteration index m+1 (for a given time), by using surface 
temperature calculated at iteration m. 
ߣસࢀ࢓ା૚. ࢔ + ߪ(ܶ௠ାଵ − ௔ܶ௜௥
 )(ܶ௠ + ௔ܶ௜௥
 )൫ܶ௠ଶ + ௔ܶ௜௥
ଶ ൯ = 0 
Convergence seems quite fast; we used only two iterations. No significant difference was 
found between a solution obtained with 2 or 3 iterations (the difference was only of the 
order of 10ିସ ܭ). Heat exchanges due to evaporation are solved in the same way. The 
solver UMFPACK was used for the resolution. 
VI.1.7.6 Initial conditions 
For the simulation of a conscious mouse, the initial temperature is constant at 33°C. 
Regarding the mouse under anesthesia, final skin temperature was observed between 
25°C and 30 °C. In the simulation, it is considered that the cooling of the mouse just 
begins. The initial temperature is chosen as a constant at 30°C. 
VI.1.7.7 Boundary conditions 
Fig 167 describes the position and kind of boundary conditions which was chosen to 
solve the problem. The region of interest is the area defined by the boundary red, green, 
yellow and orange n°2. No heat transfer occurs through Red boundary (perfect 
insulation). This mirror boundary represents the fact that axis r=0 is axisymmetrical. 
The green boundary defined the surface of plasma-surface interaction. Half angle to the 
top, θ, defined a portion of sphere of area  ૛ ࣊࢘૛(૚ − ࢉ࢕࢙(ࣂ)). Heat transfer through 
green boundary occurs by radiation, convection, evaporation and plasma surface 
interaction. 
On yellow boundary, heat transfer occurs by radiation and natural convection with 
ambient air at room temperature. 
The function of the square delimited by orange line is to mimic an infinite medium on the 
boundary n°2 of the region of interest. This choice enables to obtain a realistic 
description of the temperature field located up to few mm below the green boundary. 
Boundary n°1, 4 and 3 are also mirror boundary, but they are too far to have any effect 
on the region of interest. The imposition of a Dirichlet condition at boundary n ° 2 leads to 
an unrealistic temperature distribution. The surface temperature is imposed by choice of 
the temperature at the border. This must be adjusted to match the surface temperature. 
While the surface temperature of the mouse without treatment reappears naturally in the 
simulation with a semi-infinite medium. 
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Fig 167 Description of boundary conditions. The region of interest is the area defined by boundary 
red, green, yellow and orange n°2. The red boundary is a mirror boundary; no heat transfer occurs 
through = isolative boundary. This enables to use the symmetry of the problem which is 
axisymmetric of axis r = 0. The green boundary defined the surface of plasma-surface interaction. 
Half angle to the top, θ, defined a portion of sphere of area ૛ ࣊࢘૛(૚ − ࢉ࢕࢙(ࣂ)). Heat transfer through 
green boundary occurs by radiation, convection, evaporation and plasma surface interaction. At 
yellow boundary, heat transfer occurs by radiation and natural convection with ambient air at room 
temperature. The function of the area delimited by orange line is to mimic an infinite medium at the 
boundary n°2 of the region of interest. Boundary n°1, 4 and 3 are also mirror boundary. This choice 
enables to obtain a realistic description of the temperature field located up to few mm below the 
green boundary. 
VI.2 Results of numerical simulations 
The first objective of these simulations is to correctly predict the thermal damage induced 
in the skin and in the tumor. Unfortunately, the heat flux due to the plasma-skin 
interaction is not known. This is one of the unknowns of the model. 
We know the temperature and its evolution over time. Our experiments provide the 
temperature on the surface of the skin. The experiments performed by the team of T. 
Freeman [79] provide measurements acquired inside the tissues. The modeling of heat 
propagation enables to find the temperature field inside the tumor and to know the 
severity of the damages. 
As the thermal flux incident on the plasma-skin interaction surface is strongly related to 
the evolution of the temperature field, it is possible to find constraints on the value of the 
thermal flux. Simple models of the plasma-surface thermal interaction are proposed: we 
assume, for example, that the thermal flux is constant and uniform in the area affected 
by the plasma. This model has only two unknowns, the size of the plasma-surface 
interaction zone and the value of the incident thermal flux. For example, for a large area 
of plasma skin interaction, it is not always possible to determine an incident heat flux 
value respecting the heating kinetics. 
As the model regards living tissue, we could fear that the results have a weak validity. 
For example, because of the biological variability of the thermal properties and the 
uncertainties regarding the blood perfusion of the tumor. Fortunately, this is not the case, 
the link between the damage and the temperature distribution is particularly robust (see 
Appendix E). We have varied the thermal properties of the tumor at the extremities of 
known ranges. For example, the conductivity of soft tissue cannot be anything; it is 
necessary between 0.1 and 0.7 W / m / K for the most insulating and most conductive. 
The first thing to do is to simulate a situation for which there is an analytical solution. This 
enables to know the precision that can be expected from the numerical calculation 
1 
2 
3 
4 
θ 
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depending on the temporal and spatial resolutions chosen. This comparison is made in 
Appendix D for the sake of brevity. 
The next simulation regards the behavior of the skin of a mouse under anesthesia 
without plasma-skin interaction. In this case, when a steady state is reached, the losses 
due to convection and radiation are compensated by heat exchanges with the arterial 
blood at 35 ° C. This enables to check that heat exchange due to the blood perfusion are 
realistic. 
Then, the thermal behavior of the non-refrigerated multijet, the single jet, and the 
refrigerated multi-jet is simulated. A study is dedicated to the rate of cooling of the skin at 
the end of the treatment. 
We then propose a discussion of methods of temperature measurements. Which ones 
are adapted, which ones should be avoided? The simulations illustrate how specific 
methods give biased results: especially those with insufficient spatial resolution. 
We then propose a simulation of all the experiments described in Chernets et al. [79] and 
performed by the team of T.Freeman. 
We are then interested in more open questions. To begin, we analyze the damage that 
can cause fractional treatments, e.g., repeated sequences of heating due to plasma and 
cooling in ambient air. Then we have found the maximum heat flux that can sustain the 
skin without damages. 
Then a summary of the results developed in Appendix E is presented. Appendix E is a 
discussion of the reliability of the simulation when the thermal properties of the tumor are 
changed. It would be interesting to describe what happens when the skin is wet or 
covered with gel (comparison with the experiments of Chernets et al. [79]). 
VI.2.1 Skin temperature under anesthesia 
The first step is to simulate the skin of the mouse under anesthesia without treatment. 
Our experiments show that skin temperature is between 25°C and 30°C. Of course, the 
more the mouse waits under anesthesia, the more the skin cools down. The initial 
temperature of 33°C is selected for the entire simulation domain. The skin exchange 
heat by natural convection with air at ambient temperature Tamb = 20 °C. When a steady 
state is reached, the losses due to convection and radiation are compensated by heat 
exchanges with arterial blood at 35 ° C. All the properties of the tumor and of the 
boundaries are as described in the sections VI.1.6 and VI.1.7. The simulation lasts 600 
s. Fig 168 shows that temperature is not significantly different from the initial temperature 
below one cm depth. A surface temperature compatible with the experimental 
observations emerges naturally, without the need to impose an arbitrary Dirichlet 
condition at the boundaries defined by (z = −15 mm). 
Chapter VI—Modelling and simulation of the thermal aspects of plasma-tissue interaction  
 
209 
 
 
Fig 168 map of temperature on the whole area of simulation after t=600s. ࢀ࢏࢔࢏ = ૜૙ °࡯, ܂܉ܕ܊ = ૛૙ °۱. 
No plasma. 
The left Fig 169 shows the map of temperature at the same time. The temperature of the 
tumor is fairly uniform and of the order of 30 ± 0.5 °C. The right-hand side of this figure is 
a graph which represents the temperature as a function of time. Several points were 
chosen on axis r=0 with different depth. Of course, the deeper is the point, the higher is 
the temperature. Cooling kinetic seems realistic. 
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Fig 169 Left: map of temperature at time t=600 s for the region of interest which contains the tumor. 
Right: temperature as a function of time for points on axis r=0 and at different depth under 
the surface of the skin. 
VI.2.2 Non-refrigerated multichannel jet 
Now we will simulate the evolution of the temperature of the skin which undergoes the 
treatment of multi-channel plasma jet. What do we know from our experiments? What do 
thermal images show? 
 Skin temperature after treatment of 3 or 5 min was around 45-48 °C. 
 Treatment of one min gave no damages. 
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 One treatment of three min gave no damages, but the repetition of this treatment 
at two days intervals gave damages after two or three treatments. 
 Treatment of 5 min systematically gave damages. 
The tumor model is the same as in the previous paragraph. The initial temperature is set 
at 30 ° C. What are the unknown parameters? 
 If the effect of plasma-surface interaction is modeled by a constant heat 
transfer ݍ௣௟௔௦௠௔ = ܥݏݐ  ܹ. ݉ିଶ. The value of ݍ௣௟௔௦௠௔ must be set to respect what 
we know from the experiment. He temperature is set to ambient temperature = 20 
°C. Convective transfer cools down the skin. 
 If the effect of plasma-surface interaction is modeled by a convective heat 
transfer due to Helium at the temperature  ுܶ௘ . The value of  ுܶ௘ must be set to 
respect what we know from the experiment. 
 
VI.2.2.1 Constant heat transfer, Helium temperature = Tamb 
For ݍ௣௟௔௦௠௔ between 6750 W/m² and 7750 W/m², the value of surface temperature 
obtained after three and five min of treatment is consistent with the experimental 
observations. The prediction of damages enables to further refine. When  ݍ௣௟௔௦௠௔ =
7000 ܹ. ݉ିଶ, the simulation does not predict sufficient damage (after 3 min of treatment 
Fig 170). Indeed, the maximum value of the predicted damage is Ω = 0.2. 
 
Fig 170 Field of temperature and damage after 3 min of treatment. ࢗ࢖࢒ࢇ࢙࢓ࢇ = ૠ૙૙૙ ࢃ. ࢓ି૛. 
 
For ݍ௣௟௔௦௠௔ = 7500 W/m², the damages would be too severe (Fig 171). A significant part 
of the surface of the skin would be burned to the second degree, which does not 
correspond to the observations. 
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Fig 171 Field of temperature and damage after 3 min of treatment. ࢗ࢖࢒ࢇ࢙࢓ࢇ = ૠ૞૙૙ ࢃ. ࢓ି૛ 
ݍ௣௟௔௦௠௔= 7250 W/m² is a good compromise. Fig 172 shows that there are no damages at 
t = 1 min, the damages and the temperature at 3 and 5 min are consistent with 
experimental results. 
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Fig 172 from top to bottom: field of temperature and damage after one three and five min of treatment 
with  ࢗ࢖࢒ࢇ࢙࢓ࢇ = ૠ૛૞૙ ࢃ. ࢓ି૛. 
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Temperature and damages are plotted as a function of time on Fig 173 and Fig 174. 
Several points located on axis r=0 are chosen. The legends show the depth relative to 
the surface. The accumulation of damage ceases as soon as the plasma is stopped due 
to the rapid cooling of the surface. From 0 to 200 μm of depth, Ω is greater than 1. It 
means that the dermis is totally destroyed after 5 min (third-degree burn). Damage is 
more limited at 1 mm depth but would be problematic if the treatment was repeated.  
Regarding treatments of three minutes, the damage is in the range from 0.35 to 0.58 for 
the outermost layers of the skin. The observation of damage after multiple plasma 
exposures could be explained by the progressive accumulation of damage that the 
mouse could not totally heal in two days. 
 
Fig 173 Temperature as a function of time for several points located on axis r=0. The legend 
designates the depth relative to the surface. The red curve is the surface temperature. 
 
Fig 174 Damages as a function of time for several points located on axis r=0. The legend designates 
the depth relative to the surface. From 0 to 200 μm of depth Ω is greater than 1. It means that the 
dermis is totally destroyed (third-degree burn) after 5 min. For 3 minutes of treatments, the damage 
is between 0.35 and 0.58 for the outermost layers of the skin. Damage is limited at 1 mm of depth 
since  ષ = ૙. ૙ૡ. 
The treated surface has an area  ܵ = ૛ ࣊࢘૛(૚ − ࢉ࢕࢙(ࣂ)) with ߠ = 50 ° and ݎ = 5 ݉݉. 
Thus ܵ = 56.11 ݉݉ଶ,  and the total thermal power take the form:  
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௣ܲ௟௔௦௠௔ = ݍ௣௟௔௦௠௔ܵ = 7250 × 56.11 × 10ି଺ = 407 ܹ݉ 
This is consistent with the fact that the total power of the device is of the order of 4W > 
407 mW. Only 12% of total energy would take the form of thermal heating. Of course, 
with the assumption that the incident heat flux is constant: for example, this could be due 
to the impact of electrons and ions on the surface. 
The consequences of a 30-minute treatment are also simulated (Fig 175). It is found that 
serious damage extends up to 4 mm deep. Since the tumor ablated by the plasma 
treatment had an initial diameter smaller than 4 mm (~ 1-2 mm at day seven), it is 
coherent that the plasma treatment of 30 min resulted in the total thermal ablation of 
some tumors (as seen in Fig 136, section VI.2.2.1). 
 
Fig 175 Field of temperature and damage after a treatment of 30 min, with  ࢗ࢖࢒ࢇ࢙࢓ࢇ = ૠ૛૞૙ ࢃ. ࢓ି૛. 
VI.2.2.2 Constant helium temperature 
For ுܶ௘ between 50 and 57 °C, the value of surface temperature obtained after three and 
five min of treatment is consistent with the experimental observations. The prediction of 
damages enables to further refine. The simulation does not predict sufficient damage 
after 3 min of treatment with  ுܶ௘ = 54 °ܥ (Fig 176). Indeed, the maximum value of the 
predicted damage is around Ω = 0.3. 
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Fig 176 Field of temperature and damage after 3 min. ࢀࡴࢋ = ૞૝ °࡯. 
On the contrary, with  ுܶ௘ = 56 °ܥ, the damages would be too severe (Fig 177). A 
significant part of the surface of the skin would be burned to the second degree, which 
does not correspond to the observations. 
 
Fig 177 Field of temperature and damage after 3 min. ࢀࡴࢋ = ૞૟ °࡯. 
 ுܶ௘ = 55 °ܥ is a good compromise. Fig 178 shows that there are no damages at t = 1 
min, the damages and the temperature at 3 and 5 min are consistent with the 
observations. 
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Fig 178 Field of temperature and damage after 1, 3 or 5 min. ࢀࡴࢋ = ૞૞ °࡯. 
As explained in the previous section, the accumulation of damage ceases as soon as the 
plasma is stopped due to the rapid cooling of the surface (Fig 179). Regarding 
treatments of three minutes, the damage is in the range from 0.35 to 0.55 for the 
outermost layers of the skin (Fig 180). The observation of damage after multiple plasma 
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exposures could be explained by the progressive accumulation of damage that the 
mouse could not totally heal in two days. 
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Fig 179 Temperature as a function of time for several points located on axis r=0. The legend 
designates the depth relative to the surface. The red curve is the surface temperature. 
 
Fig 180 Damages as a function of time for several points located on axis r=0. The legend designates 
the depth relative to the surface. From 0 to 200 μm of depth Ω is greater than 1 after 5 min. It means 
that the dermis is totally destroyed (third-degree burn). Regarding 3 minutes of treatments, the 
damage is between 0.35 and 0.55 for the outermost layers of the skin. at 1 mm, the damage is limited 
since  ષ = ૙. ૙ૡ. 
The power required to heat the helium at 55 ° C flowing with a flow rate D of 2600 sscm 
is 
ுܲ௘௔௧௜௡௚ = ܦߩு௘ܥு௘( ுܶ௘ − ௔ܶ௠௕) =
2600 × 10ି଺
60
× 0.1625 × 5193 × (55 − 20) = 1.3 ܹ 
Where ߩு௘ = 0.1625 ݇݃. ݉ିଷ is the density of Helium at 300K [277]; 
ܥு௘ = 5193 ܬ. ݇݃ିଵ. ܭିଵ is the specific heat of helium at 300K [277]. This is consistent 
with measurements of the total power consumption of the device, which is of the order of 
4 W > 1.3 W. Only 32% of total energy would take the form of thermal heating according 
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to the assumption that heat mainly comes from convective transfer. The convective 
transfer model leads us to assume that helium has a temperature of 55 ± 1 °C. 
It can also be noted that the cooling curves are different when heat transfer is due to 
plasma-surface interaction with ݍ௣௟௔௦௠௔ = ܥݏݐ or when it comes from convectives 
transfer. This is probably due to the fact that the temperature distribution inside the tumor 
is slightly higher in the second case than in the first. 
VI.2.3 Refrigerated multi-channel jet 
Now we will simulate the evolution of the temperature of the skin which undergoes the 
treatment of refrigerated plasma jet. Relevant experimental results are summarized 
 At the beginning, the temperature of the skin is between 8 and 10 °C. 
 The mean temperature is 17 °C after 3 min. 
 The mean temperature is 31 °C after 6 min. 
We assume that thermal transfers are essentially caused by convective transfers 
between the gas and the skin. The problem then is to model how the temperature of the 
gas evolves over time. First, it is necessary to know the characteristic length needed to 
reach thermal equilibrium between gas phase and the wall. We consider the forced 
convection in a square pipe with sides of length a = 1.5 mm (representing one of the 
channels of the multichannel jet). When the profile of the velocity inside the pipe is 
established, ([277], p376) gives the length to establish the thermal equilibrium. This is 
the length that the fluid must travel to lose the memory of its initial conditions. The 
temperature is imposed by the temperature of the wall (here a constant surface 
temperature). 
ܮ௧௛ = 4.1 × 10ିଶ × ܽ × ܴ݁ × ܲݎ 
Using the same flow description as in VI.1.5.6.2, ܴ݁ =15.8 and ܲݎ = 0.680. Thus  ܮ௧௛ =
0.7 ݉݉. The fluid reaches the temperature of the wall in a few mm. Heat transfer to the 
wall are very effective since the channels are small and the flow is relatively slow. 
Now we will model the evolution of wall temperature by those of a semi-infinite medium 
subjected to a constant heat flux ߶. According to ([277], p62), this approximation is true 
as long as: ݐ ≪ ௅
మ
ఈ೛೗ೌೞ೟೔೎
, where L is the characteristic size of the medium; ߙ௣௟௔௦௧௜௖ is the 
thermal diffusivity of the medium. Thermal diffusivity of PET is given in [305]:  ߙ௣௟௔௦௧௜௖ =
0.16 × 10ି଺ ݉ଶ. ݏିଵ and ܮ =  1 ܿ݉. Consequently, ௅
మ
ఈ೛೗ೌೞ೟೔೎
= 625 ݏ. The approximation 
may be considered as true for the first few minute and false after. This is consistent with 
experiments; the thermal camera images show that the device warms up to 31 ° C in 6 
min. 
According to this model, surface temperature takes the form 
௦ܶ(ݐ) =
ଶథ√௧
ඥఒఘ஼
+ ଴ܶ, 
For PET, ඥߣߩܥ = 586 (according to [305]). Now, if we assume that the thermal flux ߶ is 
of the same order as the thermal flux which would be at the origin of the heating of the 
skin (see previous experiment with non refrigerated multichannel jet). We should have: 
߶ = 7250 ܹ. ݉ିଶ. Surface (and Helium) temperature takes the form: 
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௦ܶ(ݐ) = 24.7√ݐ + ଴ܶ = ுܶ௘ , 
With this assumption, however, the heating of gas and skin is too fast (even assuming 
the initial temperature is 196 ° C, Fig 181). The result is totally inconsistent with 
experimental results. The predicted temperature is too low at the start and too high at 
360 s. 
 
Fig 181 Left: gas temperature. Right: skin temperature for several depths. With the 
assumption  ࢀࡴࢋ = ૛૝. ૠ√࢚ − ૚ૢ૟ °࡯ until  ࢀࡴࢋ = ૞૞ °࡯. 
Since it is difficult to imagine that the heat flux due to the plasma-surface interaction is 
lower in the plasma source than on the surface of the skin, it is perhaps a sign that the 
modeling of thermal effects by a constant heat transfer ݍ௣௟௔௦௠௔ = ܥݏݐ is inconsistent. 
To obtain a skin warm-up curve compatible with the experimental observations, it must 
be assumed that ுܶ௘ = 3.5√ݐ − 31 °ܥ, which corresponds to ߶ = 1000 ܹ. ݉ିଶ. In this 
case, the temperatures given in Fig 182 are obtained. On the right side, the red curve 
represents the temperature at the surface of the skin. It is 17 ° C after 3 min and 31 °C 
after 6 min. few seconds after the start, skin temperature stabilizes between 7 and 9 ° C, 
This is consistent with the experiments. The simulation does not predict damage (Fig 
183) 
Fig 182 Left: gas temperature. Right: skin temperature for several depths. 
With the assumption  ࢀࡴࢋ(ܜ) = ૜. ૞√࢚ − ૜૚ °࡯. 
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Fig 183 Field of temperature and damages. Top: time t= 60s. Bottom: time t=360s. 
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VI.2.4 Surface cooling after plasma-treatment 
The purpose of this section is to compare the experimental results which regard the 
cooling of the tumor with the simulations. Several infrared images of the tumor were 
acquired at different times during the cooling of one tumor. For each image, the 
maximum temperature of the tumor is recorded. Table 24 shows three pictures of a 
mouse during the cooling, which follows a 6-min exposure to the refrigerated plasma-jet. 
This temperature will be compared with the maximum surface temperature given by the 
simulation (the temperature of the point defined by r = 0 and z = 5 mm). 
Table 24 Infrared picture of a tumor treated during 6 min with the refrigerated multi-channel plasma 
jet. The picture of the second line is acquired 8 s after that of the first line. Picture of the third, 12 
seconds later. The three images have the same orientation. The maximum temperature is visible in 
the third column. 
Time Infrared image Maximum 
temperature 
 
 
 
The first 
image defines 
the time 
t =0 s 
 
 
 
 
 
43 °C 
 
 
 
t = 8 s 
 
 
 
 
38.5 °C 
 
 
 
 
t = 12 s 
 
 
 
 
37.4 °C 
 
Head 
anesthesia 
system 
Tumor 
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Unfortunately, this type of use of infrared images was not foreseen when the experiment 
took place. The infrared images were used to attest that the tissues were not subjected 
to hyperthermia. Consequently, there is not many usable data, because it is necessary to 
have at least two successive pictures of the same tumor. Moreover, there is uncertainty 
regarding the time between the end of plasma-exposure and the acquisition of the first 
picture. This time is of the order of five seconds or less, but, without the exact value, it is 
not possible to use the first image. Only the interval of time between two images 
(provided by the image metadata) can be exploited. Ideally, it would have been 
necessary to film the cooling of the skin. 
Fig 184 shows the maximum temperature as a function of time for several mice. The first 
image defines the time ݐ = 0 ݏ . It can be seen that among the measurements which start 
from the same temperature at ݐ = 0  gives dispersed measurements after cooling. 
Several factors could explain this dispersion:  
 Differences in the distributions of temperature ܶ(ࡹሬሬሬ⃗  ) from one mouse to another 
due to the inhomegeity of the treatment, area of plasma-skin interaction. 
 Differences in biological parameters of the tumor from one mouse to another 
߱௧௨௠௢௥ , ௕ܶ௟௢௢ௗ .   Differences in thermal environment, enhancement of the natural convection...  
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Fig 184 Maximum temperature of the surface of the skin as a function of time. The pictures were 
acquired during the in-vivo experiments described in section V.3.2. These experiments concern the 
cooling of the skin after an exposure of 6 min to the refrigerated multichannel plasma-jet. 
Fig 184 shows that the speed of cooling is of the order of several103 °C for 5 s when 
T>30 °C. Now, we compare this observation with the simulations. The first point (at time 
t=0 s in Fig 184) of each set of measurements is positioned on the curve which 
represents the temperature as a function of time. 
For the sake of clarity: 
 The experimental data are represented by different sets of dots (from A to J). 
Each set corresponds to the data acquired on one mouse. 
 The results of the simulation are represented by a continuous line. 
                                               
103 that why it is assumed that final skin temperature was between 45-48°C during non 
refrigerated multichannel-jet experiments.. 
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 The first point of each set (from A to J) is positioned on the curve. Then, the other 
points are positioned with respect to the first point according to the measured 
intervals Fig 184.  
The kinetic of the cooling depends on the temperature reached at the end of plasma 
treatment. However, the treatments were slightly different from one mouse to another 
since after treatment (< ~ 5 ݏ), the temperature is 31 ± 6°C  (see Fig 154 in V.3.2). 
Therefore, the initial conditions of the cooling are different from one mouse to another. 
The total time of simulation is shown in the panel A of Fig 185. The treatment time of 
duration tc (indicated in the legend) is followed by cooling. The panel B shows the 
cooling from the moment the plasma is off. Fig 185 (panel A and B) proves that the rate 
of cooling at a certain temperature T, for instance, 31 °ܥ, depends on the history of 
cooling/heating since it depends on tc (see the slope of the curve at 31 °C). The lower 
the maximum temperature reached by the skin, the higher the cooling rate at 31 ° C. This 
observation enables to obtain simulations results consistent with experimental results 
with reasonable assumptions about blood temperature/perfusion rate. The panel C 
shows the cooling curves for two treatment times and three blood temperatures. 
It is therefore somewhat futile to try to obtain a curve on which all the points of 
measurement would be distributed since they correspond to several initial conditions. On 
the other hand, the approximation should be correct for similar initial conditions. In this 
case, it means that the initial conditions are within a temperature range with a width of 
less than 5 ° C. It appears in sub-figure D that: 
 The black curve (ݐܿ = 390 ݏ, ܾܶ = 30 °ܥ) is a good fit for the sets of data I and J. 
These treatments are characterized by the lowest initial temperature. 
 The blue curve (ݐܿ = 460 ݏ, ܾܶ = 30 °ܥ) fit the sets A, B, D, E, F, G, and H. These 
sets have an initial temperature between 33 and 38 °C. 
 The set C is fitted by the red curve (ݐܿ = 600 ݏ, ܾܶ = 30 °ܥ). (this result does not 
have a profound meaning: there is only two points in the set ...) 
 The assumption  ௕ܶ௟௢௢ௗ = 30 °ܥ  enables to obtain simulations that explain the 
rate of cooling. This is a more realistic assumptions than ௕ܶ௟௢௢ௗ = 25 °ܥ. 
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Fig 185 Temperature as a function of time, દ = ૛૞°.  A) for severals time of heating (tc = 390, 410, 460 
and 600 s) and two depth (1 mm and 0 mm = surface). Only the phase of cooling is represented in the 
following figures. Blood temperature = ࢀ࢈ = ૜૞ °࡯   B)  zoom on the cooling phase. The rate of 
cooling at 31 °C is different for the different durations of heating. C) skin temperature for two 
durations of treatment and three different temperatures of blood. D) The dots represent the 
experimental data. The three simulations are made with Tb = 30 ° C and three processing times (tc = 
390, 460, 600 s). 
In conclusion, the studies of the cooling show that: 
1. The mains parameters imply in the cooling are the conduction and the thermal 
effect of blood perfusion (For the sake of brevity, these points are shown in 
Appendix G). A mistake in the evaluation of natural convection cannot explain 
the cooling rates. 
2. The area on which the heat transfer takes place is likely smaller than what was 
previously imagined (see Appendix G). The simulations could be easily 
generalized to distributions of incident flux of any form. 
3. Another interpretation is that the rate of perfusion, ߱, is higher than previously 
modeled. 
4. The cooling is a non-steady problem which strongly depends on the initial 
temperature. This enables to propose more realistic simulations of the cooling 
according to the range of initial surface temperature. 
5. Very simple experiments would make possible to improve the comparisons 
between simulations and experiments. In particular, the recording of the cooling 
of the tumor with the thermal camera over time.  
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To conclude, it appears that dynamics of the cooling is particularly sensitive to the 
parameters of the model. In contrast, the reliability of the model regarding the prediction 
of the damage still remains (see Appendix E, where the parameter are modified for a 
constant surface temperature). 
VI.2.5 Single channel jet 
The purpose of this section is to simulate the thermal aspects of the single-channel jet. It 
is assumed that the proportion of consummed energy which heats the tumor is the same 
for single jet and multijet (without refrigeration). We must also consider that the surface 
treated is much smaller and that gas flow rate (thus convective heat loss) is smaller. We 
will begin by studying the convection. 
This section uses the same line of arguments and notations as paragraph VI.1.5.6.2. The 
flow rate is 400 sscm, and the pipe is a cylinder of diameter 3 mm. We assume that the 
treated area is a portion of sphere defines by half angle to the top  ߠ = 19.5 °. The 
boundary has an area of  2ߨݎଶ(1 − cos(ߠ) ≅ 9 ݉݉ଶ. 
Uୌୣ = 400
10ି଺
60
1
π(1.5 × 10ିଷ)ଶ
= 0.94 m/s 
Re =
UୌୣL
νୌୣ
=
0.94 × 3 × 10ିଷ
12.2 × 10ିହ
= 23.2 
With z/d=1 which corresponds to this experimental situation; [283] gives  ܽ1 = 1.2 and 
ܾ1 = 4.6  in the expression of Nusselt number at stagnation point. 
ܰݑ(ݎ = 0) = ܴ݁
ଵ
ଶܲݎ
ଵ
ଷܽଵ ቀ
ݖ
݀
ቁ
ି଴.ଵଵ
= 23.2
ଵ
ଶ0.680
ଵ
ଷ × 1.2 × (1)ି଴.ଵଵ = 4.4 
ℎ௖௢௡௩ =
ߣு௘ܰݑ
ܮ
=
15.2 × 10ିଶ × ܰݑ
3 × 10ିଷ
= 50.7 × ܰݑ 
ℎ௦௜௠௨ = ℎ௖௢௡௩ ×
"ܵݑ݉ ݋݂ ݐℎ݁ ܽ݁ݎܽ ݋݂ ݏݐܽ݃݊ܽݐ݅݋݊ݏ ݎ݁݃݅݋݊ݏ"
"ܾ݋ݑ݊݀ܽݎݕ ܽ݁ݎܽ"
= ℎ௖௢௡௩ ×
ߨ(1.5)ଶ
9
= 39.4 × ܰݑ  W. m². Kିଵ 
If we assume Nu = 5, thus ℎ௦௜௠௨ = 197 W. m². Kିଵ. From the point of view of convective 
transfers the, situation is very similar with those of the multijet (197 instead of 203 
W.m².K-1). 
Mean electric power consumed by the multijet was measured at 4 W. In this case, the 
simulation enables to find the incident heat flux.  ݍ௣௟௔௦௠௔ =  7250 ܹ. ݉ିଶ on 56 mm² 
reproduce the surface temperature and the observed damage. 
Since the power consumption of the single jet is around 400 mW. Plasma-surface 
interaction should be modeled by  ݍ௣௟௔௦௠௔ =
଴.ସ
ସ
଻ଶହ଴∗ହ଺
ଽ
= 4510 ܹ. ݉ିଶ by using the 
assumption that same proportion of electrical power gives thermal transfer. 
The temperature increases slightly at the border (Tmax=36°C), but not enough to cause 
damage (Fig 186). This is consistent with the experiments. 
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Fig 186 Field of temperature and damages after 30 min. 
 
 
VI.2.6 Traps of temperature measurements 
The purpose of this section is to show that many pitfalls can skew temperature 
measurements in the context of plasma medicine. The traps are listed one after the 
other; their existence is proved and quantified by calculation or by the result of 
simulations. 
VI.2.6.1 Spatial resolution 
The spatial resolution of a diagnostic describes the distance between two points below 
which the temperature of the two points cannot be separated. Temperature differences 
occurring at a smaller spatial scale are spatially averaged. This is an issue in the context 
of plasma medicine since the sources of heat can be very localized. For example, 
regarding the single-channel plasma jet, if the target and the source are immobile, it can 
be estimated that the surface of the skin in contact with the plasma is of the order of 1 
mm². 
In these circumstances, the spatial resolution of the diagnostics should be small enough; 
otherwise, the temperature measurement may be biased. Let's examine what happens 
with three measurement methods, i) infrared thermometer ii) a probe implanted in a 
biological tissue iii) an infrared camera. 
An infrared thermometer provides averaged measurement on a surface called “Field of 
View”. The size of this surface depends on how far the thermometer is from the surface 
(see Fig 187). Often a laser is added, to visualize the area on which the measurement is 
acquired. Generally, the area viewed with the laser corresponds to a surface containing 
90% of the signal acquired by the sensor (Fig 187). The minimum resolution is between 
a few mm and several cm for most infrared thermometers. 
Chapter VI—Modelling and simulation of the thermal aspects of plasma-tissue interaction  
 
227 
 
 
Fig 187 Link between the field of view and the distance between the object and the thermometer. The 
size of the spot represents 90% of the signal received by the sensor in front of a surface having a 
uniform temperature (manufacturer's data). 
To evaluate the extent of the experimental error, we used the results of the simulation 
program. The parameters of the simulation are really close to those described in section 
VI.2.5 (simulation of the single jet). It is considered that the treated surface has a radius 
of 1 mm on the surface of the tumor. The tumor has a diameter of 1 cm. The half-angle 
to the top is therefore: 
ߠ =
1
5
×
180
ߨ
≅ 11.46 ° 
The heat transfer is therefore done on a total surface of: 
2π(1 − cos(θ))rଶ = 3.13 mmଶ 
The surface power is equal to  15 000 W/m². Consequently, the total thermal power is 
around 47 mW. The surface temperature is plotted after 10 minutes of treatment (Fig 
188, red curve). The steady state has been reached. This surface power is chosen 
because it enables to exceed the temperature beyond which the damages are 
irreversible (42 °C). It can be seen that at 1 mm, the temperature is 42 ° C. This is also 
the maximum radius of the heated area. Two mm from the center, the temperature is 
equal to 35.1 ° C. 
The black curve represents the temperature measured by a gun-thermometer, whose 
the spot of measurement has a radius of 2 mm. Since the temperature is averaged over 
the surface of the spot, it is considerably underestimated in the hottest area of the tumor. 
The blue curve represents the averaged temperature on the surface whose radius is 
indicated in abscissa. This is the value that would provide a thermometer whose spot 
would have this area. If the thermometer spot has a diameter of 4 mm, the measured 
temperature is only 39.4 ° C. Under these assumptions, the temperature measurement is 
biased and hyperthermia is invisible. 
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Fig 188 Left: surface temperature after 10 min of treatment (red curve). The incident thermal power is 
equal to  ܙܘܔ܉ܛܕ܉ = ૚૞ ૙૙૙ ܅. ܕି૛.  The heated area is defined by ી = ૚૚. ૝૟ ° (the heated area has a 
radius of 2 mm). The gun-thermometer averages the temperature by a spot of radius 2 mm. The black 
curve  is the temperature given by gun-thermometer as a function of the position of the spot on the 
surface of the tumor. The average, leads to greatly underestimate the temperature in the hottest area 
of the tumor. Right: the blue curve represents the temperature measured in the center of the heated 
surface as a function of measurement spot radius.  
The spatial resolution is also an issue for a probe implanted in a biological tissue. The 
size of the probe is related to the spatial resolution of the measurement. Just below, the 
biases that can induce the introduction of a probe into a tissue is discussed. 
Regarding an infrared camera, the spatial resolution is much higher. It depends on the 
number of pixels present on the sensor, the optics, the angle under which the object is 
observed, its distance, the dispersion of the optics... We can estimate the spatial 
resolution of the image by noting that, on most acquired images, the observed surface 
has a size of about 5 cm. Since the cameras give an image of 480 by 640 pixels, a single 
pixel corresponds to approximately 78 μm. This order of magnitude illustrates the fact 
that thermal imaging has a much better spatial resolution than gun-thermometers. 
VI.2.6.2 The time of measurement 
The moment at which the measurement is made is a critical point; the previous 
discussion on the cooling time (section VI.2.4) has shown that the cooling occurs quickly 
after the end of the plasma treatment. 
For example, the experimental results of Table 24 show that the temperature goes from 
43 to 38.5 in 8 s. If a measurement is made at the end of the treatment, it is therefore 
crucial to know exactly when this measurement takes place. Otherwise, there is a risk of 
underestimating the maximum temperature reached by the tissues. 
VI.2.6.3 Thermal conduction smearing 
One of the essential qualities of a good sensor is that it does not disturb the measured 
object. As such, the sensors inserted in the body can induce several biases ([306], p 42 
and  [307]). One of them is related to the thermal conductivity of the inserted probe. If the 
inserted probe is too large and provided that the thermal gradients are significant, the 
thermal conductivity of the probe can lead to a significant underestimation of the tissue 
temperature. The role of thermal conductivity of the thermocouple leads and the errors 
Chapter VI—Modelling and simulation of the thermal aspects of plasma-tissue interaction  
 
229 
 
they can induce is shown in [308] and  [309]. In particular, these two papers provide 
comparisons of the measurements made with thermocouples and fluorometric probes 
fixed at the end of optical fibers. This last measurement technique is much more reliable 
and has been used by the team of T. Freeman [79]. The operation of these probes is 
detailed in the review [310]. 
The thermal behavior of a mouse skin under which a temperature probe has been 
inserted is simulated. It is considered that the probe used in the work of Vandamme et al. 
[84] is inserted under the skin of a C57BL/6 mouse. The specifications of the probe are 
available on the website of the manufacturer and resellers (Fig 189). 
 
Fig 189 Specifications of the probe Ret-1, (Physitemp Instruments) used in [84]. Manufacturer’s data. 
The operation of the thermocouples is based on the Seebeck effect [311]. In this sensor, 
two wires of copper and constantan (copper-nickel alloy) are brought into electrical 
contact at the end of the sensor (the ball). This pair of metals is used since the sensor is 
a thermocouple of type T. The two leads of the sensor are electrically and thermally 
insulated from the outside environment. The thermal properties of cooper and 
Constantan are described in [311] and [312]. 
 
Unfortunately, the exact structure of the probe is not known; neither the metal 
constituting the ball nor the thickness of the plastic layer (vinyl) covering the sensor. 
However, this lack of information is not really crucial to realize the simulation since the 
response time of the sensor is specified (5 s). The response time is the time required for 
the measured temperature to reach 63% of the maximum value when a temperature step 
is applied to the sensor. It is sufficient to verify that the simulated sensor has this 
response time, to simulate how this sensor could disturb the measurements (at least in 
first approximation). 
It is assumed that the sensor is a sphere of diameter 5 32⁄ " ≅ 3.97 ݉݉. The plastic 
lasyer has a thickness of 400 µm, the metal part is a sphere of radius 3.17 ݉݉. At 
time  ݐ =  0, the sensor which has an initial temperature of 20 ° C is immersed in water at 
30 ° C. The thermal properties attributed to the metal and to the plastic layer correspond 
to those of copper and vinyl. The thermal properties and the initial temperature field are 
below: 
(ߩ, ܥ, ߣ, ௜ܶ௡௜) = (8900, 385, 390, 20)       for     r ≤ rୱ − dplas 
                         = (1200, 900, 0.14, 20)      for    rୱ − dplas ≤ r ≤ rୱ 
                         = (1000, 4180, 0.59, 30)    for    rୱ ≤ r ≤ r୵ୟ୲ୣ୰ 
With, the density ߩ in ݇݃. ݉ିଷ, the specific heat C in ܬ. ݇݃ିଵ. ܭିଵ, the conductivity ߣ in 
ܹ. ݉ିଵ. ܭିଵ, the thickness of plastic layer ݀݌݈ܽݏ = 400 ߤ݉, the radius of the sensor 
ݎ௦ = 1.985 ݉݉, the radius of the sphere which contains the water ݎ௪௔௧௘௥ = 3 × ݎ௦. ݎ௪௔௧௘௥ 
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delineates the boundaries of the model (dirichlet boundary ܶ = 30 °ܥ). The other 
boundary condition is provided by the symmetry of the problem (perfectly isolating 
boundary). Fig 190 shows the initial value of the temperature field. 
 
Fig 190 Field of temperature at the beginning of the simulation. Z axis is an axysymetrical axis. The 
blue zone corresponds to the volume occupied by the thermocouple (metal part + vinyl layer). The 
whole has an initial temperature of 20 ° C. The red zone represents the water in which the 
thermocouple is immersed (temperature of 30 ° C). 
Fig 191 shows the field of temperature at time  t = 5 s. The metal part of the 
thermocouple has a temperature of the order of 26.4 ° C. This value would be displayed 
by the sensor if we assume that there are not additional thermal losses (due to the 
thermal conductivity of the leads). 
 
Fig 191 Field of temperature at the time t = 5 s. The metal part of the thermocouple has a temperature 
of the order of 26.4 ° C. Since the thermocouple has been subjected to a step of 10 ° C, this means 
that the response time of the sensor is 5 s. 
The value of the temperature measured by the thermocouple is represented as a 
function of time in Fig 192. Subject to a temperature step of 10 ° C in water. It is proved 
that the response time at 63% is 5 s when the thermocouple is subjected to a 
temperature step of 10 ° C. This value is in accordance with the manufacturer’s 
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specifications. Finally, the knowledge of the response time of the sensor is sufficient to 
model its interaction with its thermal environment (at least in first approximation). 
 
Fig 192 Temperature measurement provided by the simulated thermocouple. It is assumed that the 
thermocouple which has an initial temperature of 20 ° C is immersed in water at 30 ° C at the time 
࢚ = ૙ ࢙. The temperature is an average of the temperature of the metal part. Since the conductivity of 
the metal is much greater than that of those of the biological tissue or the layer of vinyl, the 
temperature of the metal part is almost uniform. 
We will now look at the result that this implanted sensor would give under a mouse skin. 
Does the measurement given by this sensor correctly represent the thermal conditions 
that the tissue undergoes in the absence of an implanted probe? 
 
Here, the simulation is based on the one presented in section VI.2.2 (non-refrigerated 
multijet). The structure of the mesh used is shown in Fig 193. The spatial resolution is 
increased in the skin and the plastic layer surrounding the thermocouple. The metal part 
does not require a precise description; the thermal gradient will be very low in the metal 
compared to that of the surrounding tissue, because of its high thermal conductivity. 
The thermocouple is implanted just below the skin, the plastic layer of the sensor 
touches the lower fat layer of the skin at the z-axis. The thermocouple has the 
dimensions presented above: total diameter of 3.97 mm, including a layer of vinyl of 
thickness 400 μm. All the other properties of the materials and heat exchanges with the 
outside: source plasma and convection in the ambient air are already described in VI.2.2 
(non-refrigerated multijet) and VI.1.6. 
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Fig 193 Mesh used in the finite element modeling of a subcutaneously implanted thermocouple. 
It turns out that the presence of the thermocouple significantly changes the temperature 
distribution. Fig 194 shows the field of temperature with (left) or without (right) the 
thermocouple after 5 minutes of simulation. The heat transport with the surface is 
changed, which has a significant influence on the value of the surface temperature. 
Indeed, the maximum temperature is only 45.4 ° C with the thermocouple, against 46.9 ° 
C. In addition, the temperature measured by the probe (40.8 ° C) is much lower than that 
of the skin above. 
 
Fig 194 Field of temperature with (left) or without (right) the thermocouple after 5 minutes of 
simulation. The position of the metal part of the thermocouple is clearly visible on the left side of the 
figure. The temperature is constant in this semi-circular zone. The maximum temperature reached by 
the tissue is 1.5 ° C lower in the presence of the probe. After 5 min the thermocouple gives a 
temperature which is 6.1 °C than surface temperature.   
The temperature is plotted at different depths under the skin on the z-axis (Fig 195). The 
dotted lines represent the simulation made in the presence of thermocouple. It is noted 
that the probe decreases the temperature of several degrees. This is very significant 
since the time required for thermal damage to occur is divided by two or three for each 
degree of hyperthermia added. The dashed black curve represents the temperature that 
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the thermocouple would measure; it is the average temperature of the metal part of the 
sensor. The temperature measured by this probe never exceeds 42 ° C. This means 
that, with this thermocouple, we would never be able to conclude that hyperthermia can 
play a role. 
 
Fig 195 Simulation of the temperature field measured in several depths. Non-refrigerated-multijet 
The damages (continuous curves in Fig 196) are therefore much greater than what 
would be expected according to thermocouple measurements. Moreover, the 
thermocouple itself causes a decrease in temperature which causes a reduction of the 
damage. 
 
Fig 196 Damages at several depths along z-axis (࢘ = ૙). The presence of the thermocouple 
decreases the temperature, therefore the damage to the tissues. 
 
The study precedence concerns our multi-channel plasma. A significant area of the 
tumor was covered by plasma. But what happens if the plasma source is slightly 
smaller? What will be the influence on the temperature measured after the 
thermocouple? 
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In the following simulation, we consider that the area of skin in contact with the plasma is 
defined by the half-angle to the top ߠ = 30° (in the previous simulation 50°). The 
diameter of the disk delimiting the plasma-treated surface is 5.2 mm. Its area is: 
ܵ = 2ߨݎଶ(1 − cos(ߠ)) = 0.21 ܿ݉ଶ 
It is assumed that the incident thermal power is constant during 12 min: ݍ௣௟௔௦௠௔ =
4000 ܹ. ݉ିଶ. The surface exchanges heat by natural convection with the outside. Fig 
197 shows the field of temperature after 10 min. As before, we find that: 
 The presence of the thermocouple has a significant influence. With the 
subcutaneous thermocouple, the maximum temperature reached by the tissues is 
only 45.5 ° C (49.5 °C without) 
 The temperature measured by the thermocouple does not give a true picture of 
the temperature actually reached by the tissues. Without a thermocouple, a 
significant part of the skin and subcutaneous tissue has undergone hyperthermia 
(ܶ ≥ 42 °ܥ), while the thermocouple measures a temperature of 38.6 ° C 
 
Fig 197 Field of temperature with (left) or without (right) the thermocouple after 10 minutes of 
simulation. The position of the metal part of the thermocouple is visible: the temperature is constant 
in this semi-circular zone. The maximum temperature reached by the tissue is 4° C lower when the 
thermocouple is present. The thermocouple measures a temperature of 38.6 ° C. It is much lower 
than the temperature that reaches a good part of the tissues in the absence of a thermocouple. 
Fig 198 shows the temperature at several depths along the z-axis (ݎ = 0). Continuous 
lines represent temperatures in the absence of a thermocouple. The dotted lines 
represent the temperatures in the presence of a subcutaneous thermocouple. The 
dashed black curve is the temperature measured by the thermocouple. This temperature 
does not exceed 40 ° C while the subcutaneous temperature (at the border fat/tumor = 
continuous blue line) exceeds 42 ° C after 81 s. 
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Fig 198 Temperature at several depths along z-axis (࢘ = ૙).  ࢗ࢖࢒ࢇ࢙࢓ࢇ = ૝૙૙૙ ࢃ. ࢓ି૛, ࣂ = ૜૙ °. The 
experimental situation corresponds more or less to that of a DBD treating a surface of 0.21 cm². The 
diameter of the disk delimiting the plasma-treated surface is 5.2 mm. 
With this plasma source, the difference between the temperature measured by the 
thermocouple and the surface temperature is greater than those measured in the 
simulation of the non-refrigerated multi-jet. About 10 ° C difference here, 4.6 ° C with the 
multijet. 
The damages (continuous curves in Fig 199) are therefore much greater than what 
would be expected according to thermocouple measurements. Moreover, the 
thermocouple itself causes a decrease in temperature which causes a reduction of the 
damage. 
 
Fig 199 Damages at several depths along z-axis (࢘ = ૙). The presence of the thermocouple 
decreases the temperature, therefore the damage to the tissues. 
In conclusion, the subcutaneous implantation of thermocouple does not necessarily give 
a true picture of the temperature that the tissues can undergo in the absence of this 
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thermocouple. The error will be greater if the thermocouple has a large volume, or if the 
thermal source is localized. The smallest possible thermocouples should be used; a 
better solution is to use fluorometric probes placed at the end of optical fibers implanted 
in the tissues. 
VI.2.6.4 Summary of methodological issues 
The previous sections discuss methodological issues that are directly specific to plasma-
skin interaction. 
To conclude, we have to check: 
 The range of detection and the accuracy of measurements 
 The probe should be placed at a known and measured depth. The Fig 194 and 
Fig 197 show that the thermal gradients are sharp ~5 °ܥ/݉݉. 
 It must be checked that the electric field and / or the deposited charges do not 
distort the measurements of the sensor. This is another argument in favor of the 
optical sensors used by the team of T. Freeman [79] . On the other hand, 
changes in temperature could distort the values provided by an implanted 
electrochemical probe (pH, O2, H2O2, …) 
 An invasive sensor should alter as little as possible the field of temperature. In 
addition, it must be verified that the temperature measured by a subcutaneous 
sensor represents a true picture of tissues below which it is implanted. Large 
thermocouples should be avoided. 
 The surface temperature must be measured by a diagnostic that has a suitable 
spatial resolution. Thermometer-gun should be avoided. At least, in any case, it is 
necessary to indicate the spatial resolution of the method. It is the same for 
measurement acquired inside the tissue. The error induced by the thermocouple 
can also be seen as a problem due to a lack of spatial resolution. 
 If a measurement is made after the plasma has been stopped, it is essential to 
know precisely when. 
To conclude, if an invasive measurement method is employed, it is probably better to 
use the fluorometric method (fluorophore placed at the end of optical fibers) than 
thermocouples. The ideal would be obvious to use non-invasive methods. Regarding the 
surface temperature, it is better to use a thermal camera, which provides higher spatial 
resolution than gun-thermometers. 
VI.2.7 Simulation and Modelling of the experiments of 
Chernets et al. [79] 
In this section, the results regarding the simulation of the experiments of Chernets et al. 
[79] are presented. This team carried out temperature measurements with the method 
evocated in section VI.2.6. 
VI.2.7.1 Temperature in the center of postmortem mouse tumors 
Let's start from what has been measured. In the first experiment, the fiber optic sensor 
was implanted in the center of the 6 mm tumor. The three mice bearing this tumor were 
freshly sacrificed before the experiment and treated with the ns-pulsed DBD described in 
the paper. The temperature was measured each minute. The paper specifies that the 
area of the surface electrode of the DBD is equal to 0.83 cm². This corresponds to the 
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surface of a 5.14 mm diameter disc. The surface of the skin affected by the plasma is not 
specified in the paper, but it is reasonable to think that the area of plasma-skin 
interaction is less than or equal to the surface of the electrode. It is therefore chosen to 
simulate the skin on a radius 3 times larger so that the boundary condition “ݎ = 15 ݉݉” 
does not disturb the result. The results of the paper also show that the plasma treatment 
causes a considerable heating of the tissues including the center of the tumor located at 
3 mm of depth. 
The experimental results (Table 3, [79]) show that the temperature measured at the 
center of the tumor reaches a plateau value of 27 ° C higher than the ambient 
temperature of the tissue. As in the foregoing, a sufficient depth of tissue is simulated so 
that the thermal disturbance produced by the plasma treatment never reaches the 
boundary (z = -15 mm) of the simulated domain. Otherwise, it would be necessary to 
impose a temperature value at the border. Fig 200 and Fig 201 presents the mesh 
choosen for each layer of the skin. The inner tissues are on the left; the skin is on the 
right. Apart from the right-hand boundary that takes into account heat losses by 
convection and radiation, all boundaries are perfectly thermally isolated. 
Of course, the thermal properties of the subcutaneous tissues (tumor or normal) are 
probably different from those modeled. To go further, it would be necessary to take into 
account the thermal properties of the organs located in the simulated zone. However,  
Appendix E shows that the thermal properties of the tumor do not fundamentally change 
the extent of damage in the superficial layers. 
In this simulation, the tissue temperature reaches values above 60 °C, which changes 
the thermal properties of the tissue (thermal conductivity and specific heat). For example, 
the phospholipids of the membranes undergo phase changes (an increase of specific 
heat). Generally, this effect is not taken into account, due to the lack of information 
available in the literature. 
  
Fig 200 structure of the mesh for the simulation of mouse tumor. The  Z axis is an axysymetrical axis. 
The mesh resolution is increased inside the skin. The tumor has a diameter of 6 mm. The tissues are 
simulated up to 1.5 cm radius from the center of the tumor. 
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Fig 201 Structure of the mesh. From the outside to the inside: blue = epidermis, green = dermis, 
yellow = fat layer, orange+black+green = subcutaneous tissues. The thermal properties of 
subcutaneous tissue are assumed uniform. 
The simulation has a total duration of 520 s; the plasma is on for 7 min = 420 s. The 
initial temperature is 20 °C (thermal equilibrium with the ambient temperature). The 
plasma-skin interaction is modeled (regarding the thermal aspect) by a constant and 
uniform heat flux ݍ௣௟௔௦௠௔. The contribution of radiation and natural convection is taken 
into account in the cooling of the surface. Several values of the plasma-skin interaction 
surface and  ݍ௣௟௔௦௠௔ are tested. It is assumed that the postmortem tissue have the 
same thermal properties than alives tissues. The heat exchanges due to blood perfusion 
are disabled. 
Of course, the way in which heat exchange is modeled is most likely false, especially the 
assumption of uniformity. Additional dedicated experiments would help to provide 
answers. The model is simple: it depends on the size of the treated area and the incident 
heat flux. The question is whether it is possible to obtain simulation results compatible 
with the experiments by combining the two parameters. 
Fig 202 illustrates that the area of the plasma-skin interface has been modified. On the 
left and in the center, this area is larger than the surface of the tumor. On the right, the 
surface is defined by the half-angle to the top ߠ. 
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Fig 202 Visualization of the part of the skin that is in contact with the plasma. Left, the treated area 
has a radius of 5.14 mm. Center, the radius is 3.14 mm. Right, the treated area is defined by  ࣂ = ૟૙ °. 
The red cross corresponds to the center of the tumor. The temperature at this point is compared with 
the reported experimental results. 
Fig 203 shows the results of simulations made with large areas of contact (radius  = 5.14 
or 3.14 mm). The results of the simulations are not very compatible with the experimental 
measurements. Indeed, the orange and red, green simulations are compatible with the 
measurement made at ݐ = 60 ݏ. The same simulations do not respect the experimental 
measurements at ݐ ≥ 120 ݏ. By reducing the incident flux, the temperature at time 
ݐ ≥  120 ݏ is acceptable (4500 W / cm², blue curve), but the temperature at 1 min, is 
seveal degrees colders than the experiments. This proves that no thermal flux is 
compatible with the experimental measurements once the area is defined by the radius 
of 5.14 mm. The result is similar when the radius is 3.14 mm, even if a significant 
improvement is visible. 
 
Fig 203 Temperature in the center of the tumor as a function of time. The black dots are the 
experimental results; the errors bars represent the standard deviation. The solid lines represent the 
temperature at the center of the tumor, for several values of qplasma. and when the surface of the 
skin interacting with the plasma has a radius of 5.14 mm. Dotted line = the surface is defined by a 
disk of radius 3.14 mm. 
+ 
θ 
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Fig 204 shows the results obtained for smaller areas on which the heat flux is applied. 
No perfect agreement is obtained with the experimental results. But the surface fluxes 
equal to 7000, 11000, or 23000 makes it possible to obtain the best compromises 
respectively for theta = 80, 60 and 40 °. 
 
Fig 204  Temperature in the center of the tumor as a function of time. The angle ࣂ defines the surface 
exposed to the plasma. Simulations performed with the angle ࣂ and incident fluxes are specified in 
the legends. On the right, zoom between 110 and 130 s. 
It is possible that this discrepancy is due to an underestimation of thermal conductivity. 
Since the mouse has been freshly sacrificed, it is likely that the tissues were soaked with 
blood that has not coagulated. Even in the absence of cardiac activity, this blood will be 
able to increase the thermal transport by its convection in the irrigated tissues. Some 
papers used this notion of effective thermal conductivity (see section VI.1.5.1 and 
Appendix F). 
The results obtained by a slight increase in the conductivity of the inner tissues (an 
addition of 0.1 ܹ. ݉ିଵ. ܭିଵ to standard value of 0.56 ܹ. ݉ିଵ. ܭିଵ) are more compatible 
with the experimental results (not shown here). But without measure, it is difficult to 
justify this choice of modeling that would be tinkering. Consequently, the properties of 
the tissues used are retained. The following simulation is made with the parameter pair 
ݍ௣௟௔௦௠௔ =  7000 ܹ. ݉ିଶ and ߠ =  80 ° (see Fig 205). 
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Fig 205  Temperature field.  ࢗ࢖࢒ࢇ࢙࢓ࢇ =  ૠ૙૙૙ ࢃ. ࢓ି૛ , ࣂ = ૡ૙ ° Left after 1 s of simulation. It enables to 
vizualize the surface in contact with the plasma. Right: temperature field after 7 min. The red cross is 
at the center of the tumor, the temperature is 50.1 ° C after 7 min. 
Fig 206 shows the temperature as a function of time at several depths along the Z-axis. 
The increase of temperature of the superficial layer of the tumor is considerably high, to 
obtain an increase of 27 ° C in the center of the tumor. This model predicts that the 
temperature at the fat/tumor interface is around 77°C, while the surface temperature 
would be of the order of 80 ° C. Heat damage is expected to be devastating in a short 
time. 
 
Fig 206 ࢗ࢖࢒ࢇ࢙࢓ࢇ =  ૠ૙૙૙ ࢃ. ࢓ି૛ , ࣂ = ૡ૙ °. The temperature as a function of time at several depths 
along Z axis. Black  dots = experimental data from [79]. the blue curve represents the temperature at 
the dermis-hypodermis interface. 
+ + 
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VI.2.7.2 Living mice 
Previous simulations were done in dead mice. What if the animal is alive? 
First, it is considered that the initial temperature of the tissue 30 ° C instead of 20 °C. 
Then we consider that the blood circulation works. With such an initial temperature, an 
increase of 12 ° C is sufficient to enter in the range of irreversible damages. Fig 207  
shows that the damage function Ω  reaches the value of Ω = 1 at the center of the tumor 
after only 87 seconds. It also means that all the tissues above are also severely 
damaged.Ω = 1 is reached at the fat-tumor interface only after 22 s. Fig 208 enables to 
view the spatial extension of the damages as a function of time. After 7 min of treatment, 
a large part of the tumor tissues will die from the consequences of hyperthermia. Only a 
thin crescent of tumor tissue seems to have been spared. 
However, the team of T. Freeman observes total remissions. This observation is 
compatible with the simulation since the unafected part of the tumor will be touched by 
heat-induced vascular damages. These damages will induce hypoxia and nutrient 
depletion of the entire neighborhood, which could die from vascular damages, without 
even mentioning all the other biological reactions related to hyperthermia (described and 
discussed in the last section of this chapter). 
 
Fig 207 ࢗ࢖࢒ࢇ࢙࢓ࢇ =  ૠ૙૙૙ ࢃ. ࢓ି૛ , ࣂ = ૡ૙ °. Damages and temperature as a function of time at several 
depths along Z axis. the damage axis is logarithmic. 
Other simulations of the experiments of Chernets et al. could be treated by finite element 
model. The thermal behavior of pork skin can be simulated104.  
                                               
104 It coud be show that the structure of pork skin cannot explain why the temperature of pig skin 
increases so little compared to mouse skin in the work of Chernets et al. The simulations could 
also show that a layer of gel with a thickness ≥ 300 ߤ݉ have a very significant effect on the 
signals of the sensors located 2 mm below the pig skin surface. The simulations are compatible 
with the experimental results if the gel layer is less than 300 μm thick. Otherwise, the two signals 
(with / without gel) have a delay incompatible with that reported. Finally, the role of water-
evaporation coud be quantified with a modelling of the mass transfer. The damage that a mouse 
with or without a gel undergoes are compared. 
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Fig 208 Temperature and damage field after 1, 3 and 7 minutes. ࢗ࢖࢒ࢇ࢙࢓ࢇ =  ૠ૙૙૙ ࢃ. ࢓ି૛ , ࣂ = ૡ૙ °. In 
just one minute a considerable part of the tumor has been destroyed. 
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VI.2.8 In what extent fractioned treatments can be 
dangerous? 
In plasma medicine, it is generally sought to prevent the tissues from heating. The 
scientific community is aware that hyperthermia can play a biological role. Since the goal 
is generally to question the working hypothesis according to which it is the chemical 
species or ,at least, a non-thermal action of cold plasmas which is at the origin of the 
therapeutic effects; the experimenters seek to get rid of hyperthermia. 
Several strategies are possible to avoid hyperthermia. experimenters working with the 
Kin-Pen09 [313] chose to move the plasma device over the skin to avoid the overheating 
of the tissues. The addition of a cooling system is another solution. This “cooling 
strategy” was adopted to carry out the last two experimental campaigns (see sections 
V.3.1 and V.3.2). 
An obvious strategy to prevent hyperthermia is to reduce the duration of plasma 
exposure. However, it is necessary to maximize the total time of contact of the plasma 
with the skin to increase the amount of chemical species deposited on the surface. The 
strategy of fractional treatments is to repeat plasma treatments of a few seconds 
separated by a cooling time. 
The scientific question is to know in what condition this strategy works. We work with the 
same parameters as those of the previous simulation (Simulation of a tumor treated with 
the DBD of Chernets et al. with ݍ௣௟௔௦௠௔ = 7000 ܹ. ݉ିଶ and Θ = 80 °).  
First we consider the case of a fractional treatment characterised by the sequence 
{plasma on = 5 + cooling by natural convection = 10 s}. 
The damages after 15 min are shown in Fig 209. Consequently, the total time of plasma-
skin interaction is equal to 5 min. The damage extends significantly up to 2 mm depth 
and therefore would have led to severe damage. Note, however, that the damage is 
much less severe than that produced in 180 s by the device operating continuously (see 
previous figure, e.g., Fig 208). 
 
Fig 209 Field of temperature (left) and damage (right) for  ࢗ࢖࢒ࢇ࢙࢓ࢇ = ૠ૙૙૙ ࢃ. ࢓ି૛.  At time t = 900s, 
with fractional treatment (plasma on =5 s and cooling = 10 s). 
Fig 210 represents the temperature as a function of time at several depths along the Z-
axis. The temperature does not increase as much in-depth as on the surface. This 
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damping is visible as a function of depth. The period of 15 s is clearly visible on the right 
part of the figure. The left side shows that on average, tissues heat up with the 
accumulation of the sequences of heating and cooling. The equilibrium between the 
average incident power and the thermal exchange (conduction, radiation, convection, 
blood perfusion ...) is obtained after a transient regime (~ 200 s). The accumulation of 
heat between several treatment sequences is the cause of the damage. 
Fig 210 Temperature as a function of time at several depths. The legend designates the depth relative 
to the surface. The red curve is the surface temperature. ࢗ࢖࢒ࢇ࢙࢓ࢇ = ૠ૙૙૙ ࢃ/࢓². It can be seen that 
there is a temporal response at a timescale longer than the period. The period of 15 seconds is 
clearly visible. The damping of temperature step is also observed as a function of depth. 
In a second step, we consider the case of a DBD fractional treatment characterized by 
the sequence {plasma on = 5 + cooling by natural convection = 15 s}. We consider, 
as previously, that the total duration of plasma treatment is 5 min (+15 min of cooling by 
natural convection). Fig 211 is relatively similar from a qualitative point of view. The 
longer cooling time decreases the maximum temperature of 2 °C at all depths. 
 
Fig 211 Temperature as a function of time at several depths. The legend designates the depth relative 
to the surface. The red curve is the surface temperature. ࢗ࢖࢒ࢇ࢙࢓ࢇ = ૠ૙૙૙ ࢃ/࢓². It can be seen that 
there is a temporal response at a timescale longer than the period. The period of 20 seconds is 
clearly visible. The damping of temperature step is also observed as a function of depth. 
The damage map is plotted in Fig 212. The damages are reduced compared to the 
previous simulation (1 mm of depth along Z axis, 2 mm in the previous simulation). 
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However, the damage remains severe since the skin is completely destroyed and the 
tumor is directly damaged105. 
 
Fig 212 Field of temperature (left) and damage (right) for  ࢗ࢖࢒ࢇ࢙࢓ࢇ = ૠ૙૙૙ ࢃ. ࢓ି૛.  At time t = 1200s, 
with fractional treatment (plasma on =5 s and cooling = 15 s). 
If the cooling time is 10 or 15 s, the strategy which consists of splitting the treatments 
into fractions of 5 seconds, doesn't enable to avoid severe thermal damage. What 
happens if the cooling time is increased? 
Simulations were carried out with cooling times between 10 s and 35 s to answer that 
question. The next two pages contain figures describing the temperature at the 
beginning of the treatment (Fig 213) and the accumulation of damage during 1000 s 
106(Fig 214). The figures representing the temperature during all the treatment are visible 
in the Appendix H (p 367). It is noted that the surface temperature reached after the first 
5-second treatment exceeds the threshold of 42 °C for less than 100 ms. On the other 
hand, the temperature does not return to its initial value. After the transient regime, the 
temperature of the biological tissues oscillates around a mean temperature depending 
on the depth and the cooling time. The higher the average temperature, the more the 5s 
of plasma will inflict deep damage. 
Beyond 25 s of cooling, the damage function ષ is less than 1 after 1000 s. In particular ષ 
is less than 0.1 for the upper layer of the tumor. However, damage function is still higher 
than 0.1 in the dermis with 25 and 30 s of cooling. The dermis is therefore likely to 
undergo mild hyperthermia. This can cause significant biases since the inflammation of 
the skin can have side-effects on the anti-tumor response. 
The figures in Appendix H show that even with a cooling of 35 s, the 5 minutes of plasma 
ON, spread over 40 min (2400 s) of operation would cause severe damage to the 
dermis. The damage function remains below 0.1 at the fat-tumor interface. The solution 
would then be to have less than 5 s of plasma on. Note that the results obtained here are 
not intuitive. If an experimenter measures the skin temperature after only 5 seconds and 
sees that the surface temperature is only 40-42 °C. He might be tempted to use this to 
justify that his treatment does not heat significantly. This would be an error since this 
temperature is measured at the beginning of a transient regime. This approach is not 
                                               
105 Since skin thickness ~360 µm 
106  This is a realistic treatment time for an animal under anesthesia... 
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fundamentally exotic in the field of hyperthermia; indeed Kolios et al. [269]  conducted a 
similar study on the damage induced by repetitive heating induced by ultrasound. 
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Fig 213 Temperature at the beginning of fractioned treatment. The temperature is measured at 
several depths along Z axis: surface (red), interface between fatty and dermis layer (pink), 1 mm 
below the surface (grey), 2 mm below (blue), 3 mm = in the center of the tumor (black). From one 
sequence to another, the average temperature increases with time. With a longer cooling time, the 
average temperature reached by the tissues is lower. Even with 35 s of cooling, the temperature 
reached by the skin is in the regime of moderate hyperthermia for a few seconds. 
Chapter VI—Modelling and simulation of the thermal aspects of plasma-tissue interaction  
 
249 
 
 
Fig 214 Damage during fractioned treatment. The damage is measured at several depths along Z 
axis: surface (red), interface between fatty and dermis layer (pink), 1 mm below the surface (grey), 2 
mm below (blue), 3 mm = in the center of the tumor (black). Beyond 25 s of cooling, surface damage 
is less than 1 after 1000 s of treatment. With 10 s of cooling, very significant damage (ષ =  ૚) reaches 
a depth of between 2 and 3 mm. With 15 s of cooling, very significant damage (ષ =  ૚) still reaches 
the depth of the tumor. Significant damage still reaches the dermis with 20 and 25 s of cooling. This 
can cause significant biases since the inflammation of the skin can have side-effects on the the anti-
tumor response. 
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VI.2.9 What is the maximum heat flux that a mouse can 
sustain without damage? 
We will now determine the limiting conditions of the incident heat flux (and gas 
temperature) that can sustain the skin without damage. Even for the long treatments. 
The experimental configuration of the non-refrigerated multijet is used. It is assumed that 
there are no damages if  ௠ܶ௔௫ ≤ 42°ܥ after 20 min of treatment; with  ௠ܶ௔௫, the maximum 
temperature. 
Fig 215 represents the field of temperature and damages after 20 min of continuous 
treatment. Plasma surface-interaction is modeled by a constant incident flux qplasma = 
5500 W/m². It is considered that the flow of Helium is at room temperature and therefore 
cools the surface of the skin ( ௛ܶ௘௟௜௨௠ =   ௔ܶ௠௕ = 20 °ܥ). The maximum temperature is 
41.95 °C. It is unlikely that the skin suffer thermal damage, when the thermal flow is less 
or equal to qplasma = 5500 W/m². 
 
Fig 215 Field of temperature and damage after 20 min with qplasma = 5500 W/m². The convection of 
helium cools the skin at plasma-skin interface  ࢀࢎࢋ࢒࢏࢛࢓ =   ࢀࢇ࢓࢈ = ૛૙ °࡯. 
Fig 216 represents a very similar experimental situation. Except that it is assumed that 
there is no flow of helium to cool the surface. Cooling is ensured by natural convection 
only with ambient air at ௔ܶ௠௕ = 20 °ܥ. This experimental situation is closer to that of a 
DBD. 
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Fig 216 Field of temperature and damage after 20 min with qplasma = 1250 W/m². Natural convection 
cools the skin at the plasma-skin interface. It is recalled that   ࢀࢇ࢓࢈ = ૛૙ °࡯. 
In a similar way, the maximum temperature of helium which does not cause damages 
can be found. Fig 217 represents the field of temperature and damages after 20 min of 
treatment. Plasma surface-interaction is modeled by convective transfer due to Helium at 
temperature  ுܶ௘ = 46 °ܥ. 
 
Fig 217 Field of temperature and damage after 20 min. The convection of Helium heats the skin at the 
plasma-skin interface. Helium temperature of impinging jet is ܂۶܍ = ૝૟ °۱ 
To summarize, we found the treatment conditions to avoid damage to mouse skin. Since 
the structure of the human skin is different (in particular the epidermis is much thicker, 
and the blood perfusion is superior), it is likely that the human skin can withstand higher 
thermal flows. Sweating also enables to evacuate a consequent quantity of heat (absent 
in mouse). 
The influence of the gas flow rate cannot be easily guessed. In one hand, by increasing 
it, we can expect that gas temperature decreases since our experiments show that the 
power consumption reaches a plateau when flow rate increases. In other hand, the 
turbulence at the point of stagnation could considerably increase the value of heat 
transfer coefficient h (which already increases in ܴ݁଴.ହ in laminar regime). Experiments 
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combining heat transfer and turbulence studies in the presence of plasma discharges are 
therefore necessary. Spatially resolved diagnostics of plasma should be coupled to 
optical diagnostics. Fig 218 shows an example of an interferometric figure obtained at 
the beginning of this work with a Mach-Zehnder interferometer and a pulsed laser at 532 
nm. Optical diagnostic should enable the quantification of the turbulence. 
 
Fig 218 Interferometric image of the flow obtained with a Mach-Zender interferometer. ࣅ = ૞૜૛ ࢔࢓ 
VI.2.10 What is the reliability of damages predictions 
This paragraph summarizes the results presented in Appendix E. The reliability of 
simulations has been studied by modifying the four main parameters involved in the 
prediction of thermal damage. 
 Blood perfusion inside the tumor ߱௧௨௠௢௥  
 the thermal conductivity of the tumor ߣ௧௨௠௢௥  The value of the kinetics parameters A and Ea, which defines the damage 
function Ω = ∫ ܣ݁ݔ݌ ቀ−
ாೌ
ோ்
ቁ ݀ݐ
௧
଴  
 The area of the plasma-skin interface. The portion of sphere defined by half-
angle to the top Θ has an area of  ܵ = 2ߨݎଶ(1 − cos(Θ)). 
Studies were carried out with the previous experimental situation of a DBD operating 
during 5 s, whereupon the skin cools for 15 s by natural convection and radiation. These 
treatment sequences are repeated during 20 min so that the total processing time is 5 
min. This experimental situation is chosen because the transient responses play a key 
role in this context. The position and extent of damage are more sensitive to parameter 
changes than continuous processing by the multijet. Consequently, it would be a 
stronger result to prove that the damages prediction is quite independent of the model. 
As previously, the heat flux  q୮୪ୟୱ୫ୟ  at the plasma-skin interface is chosen in order to 
reproduce the temperature field at steady state. Secondly, the map damage is simulated 
in the case of an intermittent regime with the value of ݍ௣௟௔௦௠௔ found in first step. The 
depth reached by the damage is then compared. 
Whatever the parameter among the four considered, the simulation of a “fractioned DBD” 
always predicts damage that completely destroys the skin. This could be a bias for anti-
tumor. Since inflammation and immune reactions are triggered by the thermal damage 
(see the references and the discussion on thermal effects in the context of antitumor 
studies, concluding Chapter VI). In all realistic cases, significant damage also occurs in 
1 mm 
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the upper layers of the tumor (below 4636 µm on r axis). Thus, this reliability study 
proves undoubtedly that such treatment would induces a thermal bias during in-vivo 
experiments. The simulations are remarkably insensitive to the values of perfusion rates 
and thermal conductivity. 
In all cases, it was assumed that the heat flux is uniform on the treated surface. This 
hypothesis is probably false. It would be interesting to find experimentaly the heat flux as 
a function of the angle θ: q୮୪ୟୱ୫ୟ(θ). Measurements of the temperature field on half-
spheres of materials having different radii and a known thermal conductivity should 
enables to obtain  q୮୪ୟୱ୫ୟ(θ). The problem with this kind of experiment will be to know to 
what extent it enables to deduce the heat flux above a biological tissue which has a 
different electric conductivity (which could modify the plasma discharge and  q୮୪ୟୱ୫ୟ(θ)). 
The passage from the simple isotropic inert model to the anisotropic inhomogeneous 
material requires precautions. The further step of modeling would be to consider the 
effects of discharges inhomogeneitie to evaluate if the function q୮୪ୟୱ୫ୟ(θ) has a strong 
effect to the depth reached by thermal damage at constant incoming power. 
VI.2.11 What if the skin is slightly moist? 
The case of wet skin could be treated by finite element method. The addition of a gel 
layer would probably reduce the temperature of the skin and therefore the damages in 
three different ways. 
First, the gel layer adds a thickness of material which adds thermal inertia to the skin. A 
thermal gradient is established through the gel layer which constitutes a thermal 
resistance. Second, the diffusion which is orthogonally to the surface significantly 
reduces the temperature at gel-skin interface, since the thermal conductivity of the gel is 
greater than that of the epidermis. Finally, the evaporation of the gel considerably 
reduces the temperature at the surface of the gel (and below) since the specific latent 
heat of water is of the order of 2500 J per gram of water. 
VI.3 Plasma-medicine and hyperthermia, a critical 
approach of in-vivo experiments. 
In this section, we will focus on few in-vivo plasma experiments. In particular, those that 
involve treatment of melanoma B16. For each paper, there are two simple questions: 
 Do the published studies really exclude the possibility that tissues have been 
subjected to hyperthermia depending on the measurement method used? 
 In the event of a negative answer. In what extent the results obtained could be 
attributed to hyperthermia? The question of the reliability of measurement 
methods is addressed by the section VI.2.6. The questioning of the published 
results is based on the discussions presented therein. 
VI.3.1 In-vivo experiments involving B16-F10 melanoma 
Four recent studies present in-vivo results involving plasma treatment of B16 melanoma 
models. This line of melanoma is well known in the scientific community of hyperthermia. 
Consequently, the first part of this discussion describes what is known from the effect of 
hyperthermia alone on this specific line. Then, the four papers are discussed according 
to the principles discussed above. 
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VI.3.1.1 What are the effects of the temperature on B16 melanoma 
growth? 
First of all, the temperature is far from being a negligible parameter even below the limit 
of irreversible damage, especially regarding the anti-tumor response. For example, 
Kokolus et al .2013 [314] show the effect of the thermal environment of an anti-tumor 
response. Most animal houses keep mice at a temperature between 20 and 26 °C, which 
elicits cold stress of the animals. The temperature, called “thermoneutral”, which do not 
induce thermal stress would be rather of the order of 30-31 °C. The experiments 
compare the tumor growth of mice housed at thermoneutral temperature (TT) or classic 
sub-thermoneutral (ST) temperature. Fig 219 show that the tumors grow significantly 
faster when mice are exposed to cold stress [314]. Tumor growth is delayed at 
thermoneutral temperature by 10 days for almost all the lines studied (especially the 
B16-F10 line). Using immunodeficient lines, the authors were able to show that this 
behavior is related to a better immune response in the case of thermoneutrality (TT). 
It is obvious that this situation has no analogy with hyperthermia experiments (implying 
moderate or strong hyperthermia during few minutes) in terms of exposure time and 
temperature. This is an illustration of the strong link between temperature and immune 
response. For someone with a physicist background, this links seems counter-intuitive at 
first glance whereas immune response greatly alters tumor growth. 
 
Fig 219 Legend and figures of Kokolus et al. [314]. Maintaining mice at thermoneutral temperature 
(TT) slows tumor growth in immunocompetent mice but not in immunodeficient mice compared to 
the mice exposed to sub-thermoneutral temperature (ST). Tumor growth was monitored following 
injection of (A) 1 × 105 B16. F10 cells into C57BL/6 mice, (B) 1 × 104 4T1 cells into BALB/c mice, (C) 1 
× 105 CT26 cells into BALB/c mice or (D) 1 × 105 Pan02 cells into C57BL/6 mice, (E) 1 × 104 4T1 cells 
into SCID mice, and (F) 1 × 104 CT26 cells into NUDE mice. Data presented as mean ± SEM (n = 5–10; 
*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001; Two-way ANOVA with Bonferroni posttests). (G) 
Tumor incidence was monitored in mice after injection of 1 × 104 CT26 into BALB/c mice or 1 × 103 
CT26 cells into SCID mice. Data presented as percent of mice tumor-free (n = 5; #P <0.05; Mantel-Cox 
test). 
Now the discussion will focus on three articles proving and quantifying the sensitivity of 
B16-F10 melanoma to hyperthermia. These results all relate to in-vivo experiments. The 
modes of exposure to hyperthermia are different in the three cases discussed. 
In Li et al. [315], the melanomas are heated at a temperature between 46°C and 55 °C. 
The tumors are heated with a hot steam flow. The temperature is measured in the center 
of the tumor with a 0.1 mm thermocouple. This thermocouple size is small enough not to 
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disturb the measurement (contrary to the case discussed in the section VI.2.6.3 “Thermal 
conduction smearing”). The tumors are heated for 15 minutes at 46 ° C, 48 °C and 50 ° 
C (and 10 minutes at 55 ° C). The two figures of [315], Fig 220 and Fig 221, show the 
tumor volume and survival rates of the groups exposed to hyperthermia compared to 
control group. The treatments were performed on 5-6 mm tumors. 
It appears that tumor growth is considerably slowed down. The survival time of all groups 
is increased. The groups treated at 50 and 55 ° C contain cases of remission/tumor 
removal. The group treated at 46 ° C is particularly remarkable since the survival is 
increased by 15 days. 
 
Fig 220 Legend and figures from Li et al. [315] Tumor growth following hyperthermia treatment. All 
data are expressed as mean ± standard deviation (SD) (n=6) 
 
Fig 221 Legend and figures from Li et al. [315] Survival curve over a period of 60 days following 
hyperthermia treatment. n=6 mice/group, T=0 corresponds to the time of hyperthermia. 
 
Kostenich et al. [316] describe hyperthermia treatment of B16 melanoma by intense light 
pulses (xenon flash, incoherent broadband 400-800 nm). The pulses have a duration of 
2 ms; each pulse deposits 0.6 J / cm² on a disc of diameter 2 cm. The light dose is 
between 60 and 120 J/cm². Tumors were treated when their diameter was 5 mm. The 
temperature was measured at different depths with thermocouples: 
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 “Temperature in the tissue during photoirradiation was measured by a quick-response (0.025 s) TEFLON 
PFA-insulated thermocouple probe coupled to a DigiSense digital thermometer (Cole–Parmer, Niles, 
Illinois). The thermocouple was inserted into a 21G needle and fixed to three positions in the tissue: under 
the skin above the tumor surface, and in the tumor at depths of 2 and 4 mm.” 
The thermocouples are small enough, therefore, the temperature measurement was not 
biased (see VI.2.6.3 “Thermal conduction smearing”). Four groups were treated with light 
doses of 60, 72, 90 and 120 J/cm². The figure below shows the results of temperature 
measurements, as well as the volume of melanomas. 
It appears that tumors in the 72 J / cm² group have a significantly slower tumor growth 
rate than the control group. In this group, the maximum temperature reached 
respectively at the surface, 2 mm and 4 mm depths are 44-45 ° C, 41 ° C and 39 ° C. 
Compared to previous paper, melanomas were subjected to much lower hyperthermia. 
In addition, the dose of 72 J / cm² was delivered in 2 min, since the pulses have a 
frequency of 1 Hz. The heating time of the tissues is shorter than in previous paper. It 
may also be noted that the surface tissues reach the temperature of 42 ° C only for a 
dose of 30 J, so all tissues spend slightly more than one minute at a temperature higher 
than 42 °C. Even with such small times and temperature, a significant effect is obtained 
on tumor growth. 
It should also be noted that, in two cases, only the upper tissues were exposed to high 
hyperthermia (ܶ ≥  42 ° ܥ). This concern a small volume since the temperature at 2 mm 
depths is below 42 °C. However these doses of 60 and 72 J / cm² are sufficient to induce 
a significant effect on the total tumor volume. The paper shows also that a light dose of 
120 J/cm² (which corresponds to a temperature of 43 ° C at 4 mm depths after 200) 
prevent the regrowth of the tumor. The sensitivity to hyperthermia of melanomas is 
stronger than the first paper could suggest. It is likely that the immune responses 
associated with mild hyperthermia play a predominant role in these experimental 
situations. 
 
 
Fig 222 Legend and figures of Kostenich et al. [316] Left: Temperature-time profiles in melanoma 
B16 tissue above the tumor (square), at depths of 2 mm (circle) and 4 mm (triangle) during pulsed 
photoirradiation with pulse energy density 0.6 J/cm² and frequency 1 Hz. Five mice in each group 
were examined. Error bars, SE. Right: B16 melanoma growth curves after pulsed Photothermal 
therapy. 1 Hz-photoirradiation (0.6 J/cm² per pulse) was performed with light doses of 60 J/cm² (open 
circle), 72 J/cm² (closed circle), 90 J/cm² (open triangle) and 120 J/cm² (closed triangle). (closed 
square), untreated control. Ten mice in each group were examined. Error bars, SE. 
In the experiments of Werthmöller et al. [317], the hyperthermia is induced by microwave 
heating. This study presents a comparison of the effect of hyperthermia, irradiation and 
the combination of both on B16-F10 tumors. 
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“Treatment of B16-F10 melanomas with ionising radiation and hyperthermia On days 8, 9 and 10 the 
irradiation was performed. The tumours were locally irradiated with a clinically relevant single dose of 2 
Gy using a PRIMART linear accelerator (6MV, Siemens, Munich, Germany). Local hyperthermia was 
delivered on days 8 and 10, in each case 4 h after RT. To do so the mice were anaesthetised and the 
tumours were heated locally with microwaves to 41.5 C for 30 min using a BSD50 Hyperthermia System 
(BSD Medical, Salt Lake City, UT)” 
It appears that hyperthermia greatly increases the effect of irradiation. Radiotherapy 
alone does not enable to induce a difference in tumor growth. The immune response 
induced is particularly interesting, since B16 melanomas are known to be poor 
immunogens. 
“This suggests that RT in combination with HT induces a tumour microenvironment which is immunogenic 
and characterised by apoptotic and necrotic tumour cells, presence of the danger signals HMGB1 and 
HSP70, enhanced infiltration of CD8+ T cells, DCs, and NK cells, and concomitantly decreased infiltration 
of Treg and MDSC. HT combined with RT can therefore be regarded as a potential in situ tumour 
vaccinator” 
The immune response of B16 melanoma induced by hyperthermia is specifically studied 
by Kubes et al. [251] and T. Takada et al. [318]. In the first paper, the tissue is heated 
with microwaves, in the second by magnetite nanoparticles. 
More general information on the immune response induced by hyperthermia can be 
found in section VI.1.3 (Biological effects of hyperthermia) and in the papers [248], [249] 
and  [251] which give a good idea of the number of signaling pathways involved in the 
response to hyperthermia. 
VI.3.1.2 Chernets at al. [79], 2015, melanoma B16/F10 
The results presented in [79] are clearly in a range of temperature which elicit anti-tumor 
response due to hyperthermia. To be convinced, let us recall that the treatment causes a 
temperature rise of 27 ° C at the center of the tumor of the dead mice. In addition, the 
simulations show that the temperature rise will be substantially the same in the tumor of 
living mice, which leads to a temperature of the order of 57 °C. The treatment has a total 
duration of 7 min. The discussions of the paragraph VI.3.1.1. (especially the papers of Li 
et al. [315] and Kostenich et al. [316]) show anti-tumor response very similar to those 
obtained with plasma-treatments. Moreover, these experiments are in a range of 
temperature containing the temperatures reached by the tumors of Chernets et al. It has 
even been found that tumor slowing can even be obtained at lower temperatures and for 
shorter treatments than those induced by plasma-skin interaction. These studies are 
carried out under biological conditions which are very similar to those of Chernets et al. 
and are therefore fully valid to make a comparison (mouse species, melanoma line, 
tumor size, and even position of temperature probe). 
The next figure (Fig 223) enables to compare the results of Li et al. [315] with those of 
Chernets et al. At first glance one could say that the experiments of Li et al. expose the 
tumors to hyperthermia for a longer time (10 min at 55 °C). But, it is recalled that the time 
required to inflict a given amount of damage (related to the denaturation of structural 
proteins) is divided by 2-3 for each additional degree (see VI.1.2 “Orders of magnitude 
related to hyperthermia”). So, the damage inflicted during plasma-experiment are 
therefore probably larger. Both results, however, are quite comparable. 
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Fig 223 Left, legend and figure 1C from Chernets et al. [79]. Survival for nsP DBD 
treated tumors (red triangle) and control untreated tumors (black diamond) as a function of time 
post-injection (n = 6 each)  Right: Legend and figures from Li et al. [315] Survival curve over a period 
of 60 days following hyperthermia treatment. n=6 mice/group, T=0 corresponds to the time of 
hyperthermia. 
The comparison of the results of Chernets et al. and Kostenich et al. [316] is shown in 
Fig 224. Indeed, in the work of Kostenich et al., tumor ablation is obtained with a light 
dose equal to 120 J/cm². This corresponds to 200 s of treatment, leading to a 
temperature at the center of the tumor of 43 °C at the end of the treatment. This thermal 
stress is lower than that caused by plasma treatment according to the measurements 
done by Chernets et al. 
 
Fig 224 Left, legend and figure 1C from Chernets et al. [79]. Survival for nsP DBD 
treated tumors (red triangle) and control untreated tumors (black diamond) as a function of time 
post-injection (n = 6 each). Right: legend and figures of Kostenich et al. [316]  B16 melanoma 
growth curves after pulsed Photothermal therapy. 1 Hz-photoirradiation (0.6 J/cm² per pulse) was 
performed with light doses of 60 J/cm² (open circle), 72 J/cm² (closed circle), 90 J/cm² (open triangle) 
and 120 J/cm² (closed triangle). (closed square), untreated control. Ten mice in each group were 
examined. Error bars, SE. 
As a result, the non-thermal effects are entirely masked by the response due to 
hyperthermia. It turns out that arguments proposed by the authors to justify that 
hyperthermia plays no role are questionable. However, it leads to very interesting 
physical questions involving pig-skin and the gel layers covering the differents skins. 
To begin, what is the argument proposed by Chernet et al. which leads them to 
affirm that they observe an effect due to plasma chemistry? 
 First, they observed that the anti-tumor response is less efficient when a layer of 
gel is applied at the surface of the tumor 
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 Then, they observed that the addition of H2O2, to the gel, enables to restore the 
anti-tumor effect at a level which is similar to those of direct treatment. 
 To justify that hyperthermia does not play a role, they do experiments on pig skin. 
At 2 mm depth, it turns out that the presence of gel does not significantly change 
the dynamics of heating. 
What conclusions do they draw from these observations? 
Since the gel does not change the temperature in the center of the pig's skin, they 
assume that this is also the case for the mouse. So they deduce that the gel only slows 
the diffusion of the chemical species from the plasma. Then in the experiment with the 
H2O2 gel, it also assumes that the addition of H2O2 does not modify the thermal 
properties, and makes it possible to restore some efficiency to the plasma treatment. 
It could be shown by finite element model that: 
First of all, the temperature increase is very different in the case of pigskin (+6 °C) and in 
the case of the freshly sacrificed mouse (+27 °C). The simulations could probably show if 
the incident thermal flux caused by plasma-surface interaction is very different for the 
simulation of pig or mouse skin. In a second step, the effect of the gel layer on the skin 
can be modeled. For low concentrations of glycerol, the thermal properties differ little 
from those of water [319]. The simulations could probably show that the temperature 
reached by the skin depends a lot on the thickness of gel. 
 
Fig 225 Legend and figure 1C from Chernets et al. [79]. Measurement of temperature 2 mm below the 
pig skin surface during nsP DBD treatment for 2 min, with or without gel, showed no significant 
differences (with gel – red triangles; without gel – black diamonds). 
Thus the depth of damage depends considerably on gel-layer thickness. Nothing 
indicates that the thickness has been controlled in the work of Chernets et al. [79]. The 
difference between survival rates of the “gel” or “gel+H2O2” groups with “control group” 
could be attributed to a lack of control of gel thickness in the experiment. It also turns out 
that an addition of H2O2 increase the thermal conductivity of the gel, which could 
increases the heating of the skin. 
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VI.3.1.3 Keidar et al. [12], 2011, melanoma B16/F10  
In [12], Keidar et al. report positive results regarding B16-melanoma (C57/BL6) and 
SCaBER tumor (nude mice). They report that tumor growth rates of B16-melanoma is 
significantly decreased after cold plasma treatment. They claim that their source does 
not cause heating of the tissue with the following argument: 
“The skin temperature during plasma treatment was measured using an infra-red thermometer (Traceable, 
Model no. 4470, Control Company, Friendswood, TX, USA) to assess whether the cold plasma effect on 
cancer tissue is associated with thermal damage. Cold plasma treatment produced an increase in skin 
temperature of approximately 2°C above room temperature, which is below the temperature needed for 
thermal damage.” 
With this instrument, obtaining a spatial resolution of less than 1 mm would require a 
distance to use the thermometer at less than of 1.1 cm. Moreover, the spatial resolution 
of this measuring instrument cannot be made arbitrarily small. Before reaching the 
diffraction limit, the aberrations of the optics, in particular, their dispersions, generally 
limit the spatial resolution to a few millimeters, this could lead to an underestimation of 
surface temperature as explained in section VI.2.6.1 (page 226). 
Moreover, the mouse skin shows the presence of damage, just after treatment (see Fig 
226). This kind of damage is usually associated with a burn as stated in the paper of 
Dobrynin et al. [78]. 
 
Fig 226 From [12] 
If mild-hyperthermia occurs during this treatment, the positive effects of plasma 
treatment, namely a slowing of tumor growth (Fig 227), could be attributed to thermal 
effects. 
As previously discussed in VI.3.1.1, the thermal sensitivity of B16 melanoma to mild-
hyperthermia is so high that a moderate increase in temperature for a relatively short 
time is enough to slow tumor growth of 10-15 days. The same plasma device was used 
in another study (Walk et al. [81]). 
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Fig 227 Legend and figure from [12]. Left: cold plasma treatment effect on the growth of established 
tumour in a murine melanoma model. Right: Cold plasma treatment effect on the mice survival in a 
murine melanoma model. 
The paper of Walk et al. [81] describes the treatment of an in-vivo murine model of 
neuroblastoma (Neuro2a).This paper begins by defining the operating conditions of 
plasma-device and refers to the paper of Shashurin et al. [320]: 
 “The CAP device utilized for these experiments was previously described  [320] and additionally modified 
for handheld application of the CAP. All treatments, both in vivo and in vitro were administered at 4 kV 
using industrial-grade helium at a flow rate of 4l/min 
So let's look in the paper of Shashurin et al.  [320]. Unfortunately, this paper does not 
contain temperature measurement. However, Shashurin et al. writes that 
“Short-time up to 10 s exposition of the finger to the jet results in a mild sensation of heat in the treated 
area.” 
Several remarks can be made about this statement: 
It is recalled that human skin is very different from mouse skin (see section VI.1.1, page 
173). The thickness of the epidermis is considerably higher for humans (mean value 75 
µm-150 µm) than mice (~13 µm). In addition the thickness of the epidermis is greater in 
body parts exposed to mechanical stress (like the fingers). According to [321], the 
epidermis of the fingertip has a thickness of 369 ± 111 μ݉. However, the cells signaling 
the pain or the impression of heat are located in the dermis [210]. Consequently, these 
cells are protected from heat flow by a particularly thick and insulating layer in humans 
compared to the mouse. It should also be noted that the sweat phenomenon can 
consume a large part of the incident heat flux in humans. It turns out also that mice do 
not have sweat glands (as discussed in section VI.1.5.7, page 196). Because of this, the 
temperature is necessary greater in mouse skin than in humans for the same treatment. 
Consequently, the following argument: "I put plasma on my finger, I do not feel heat, 
thus the skin of the mouse will not experience hyperthermia" is false. 
The fact that Shashurin has reported a sensation of heat after only 10 seconds may raise 
concerns that plasma treatment will heat the skin of the mouse beyond 42 ° C. 
Now let's go back to the commentary of Walk et al. [81]. This paper does not contain 
temperature measurement. The absence of heating is justified by a reference to the 
paper of Keidar et al. [12]. 
“CAP therapy provides a unique method of treatment. Unlike argon plasma, cryoablation, or 
electrocautery, this treatment is atraumatic to the tumor and surrounding tissue. A prior paper utilizing our 
device investigated surface temperatures during treatment and found a 2°C rise from room temperature 
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[12]. There is no evidence of thermal damage to skin following treatment. Application of the beam to one's 
skin is tolerable and pain-free” 
We have shown that the temperature measurement used in  [12] could be significantly 
biased. It also turns out that the treatment conditions used on neuroblastoma are 
different from those used in [12]. Indeed, the helium flow is lower in this studies than that 
used in  [12] (4 l/min versus 11 l/min). However, it is likely that a decrease in flow will 
lead to an increase in gas temperature, as seen by the users of kINPen09 107. 
 
Fig 228 Legend and figure from [81] . (A) Female A/J mouse with a tumor on the right hind leg 
(arrowhead). Mice were selected for treatment once tumors reached 5mm in any dimension. (B) The 
tumor was treated through the skin with CAP for five minutes. (C) View of tumor immediately 
following treatment. (D) View of right hind leg 25days after CAP therapy demonstrating ablation of 
the tumor. 
VI.3.1.4 Daeschlein et al. [76], 2013, melanoma B16/F10 
Daeschlein et al. [76] compare the effects of two plasma sources described below: 
1) “Atmospheric pressure plasma jet (APPJ), kINPen 09 (Institute for Plasma Science and 
Technology Greifswald, Greifswald, Germany). For a detailed characterization of the APPJ, see 
Weltmann et al. [323]. Argon as the feed gas flows through the capillary (gas flow rate of about 8 
l/min). A radio frequency (RF) voltage (1–5 kV, 1.5 MHz) is coupled to the centre electrode. The 
temperature at the tip of the beam with a length of up to 12 mm did not surpass 37 °C as a result of 
the cooling effect by the argon stream together with the electronic regulation when the device 
works with 60 V [324].” 
2) “Dielectric barrier discharge (DBD, CINOGY GmbH, Duderstadt, Germany). The second 
plasma source was a dielectric barrier discharge device. The DBD generates high-voltage pulses 
(14 kV) across small gaps with the high-voltage electrode being covered with a dielectric barrier 
made of Macor [325]. The application electrode measures 20 mm. The pulse repetition rate is 
adjustable between 100 and 400 Hz, which leads to electric powers dissipated in the gas discharge 
in the range of 167–237 mW [325].” 
The tumors are significantly larger (~8 mm) than those of the experiments of Freeman 
[79] and Keidar [12]  (~5 mm) and are exposed to plasma every day. The conditions of 
plasma-exposure are specified by: 
1) “Tumors were treated with cold plasma once they were 8 mm in diameter. All treated mice 
received 2 ×  3 min of cold plasma treatment with DBD (30 s interruption after 3 min of 
treatment) and 5 min with APPJ” 
                                               
107 See [322], however the plasma jet used in this paper (kINPen04) is different in terms of 
frequency, voltage, and gas flow. 
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2) “Treatment with plasma Treatment with DBD (D) was manually performed at a distance of 1–2 
mm between electrode and skin. The APPJ (J) treatment was carried out with the tip of the jet just 
touching the surface and being continuously moved over the whole tumor surface.” 
Curiously, the results are not given directly in terms of tumor volumes. The conclusions 
are drawn from derived quantities: tumor growth acceleration (TGA) and daily volume 
progression (DVP) in ݉݉ଷ/݀ܽݕ. TGA is the quadratic coefficient of the curve that fit 
tumor volume as a function of time  ܸ(݀ܽݕ) = ܾ0 + ܾ1 ∗ ݀ܽݕ + ܾ2 ∗ ݀ܽݕଶ. 
The results show a weaker effect than those observed by the Freeman's and Keidar’s 
teams. 
 “DBD (D) alone caused no and APPJ (J) alone a non-significant (3.6 days) effect on survival” 
[76] 
 “Regarding TGA, both plasmas J and D as single treatment caused significant delay of TGA (P = 
0.035, respectively 0.063; one-sided t-test) (J with slightly more efficacy than D)” [76] 
 “In conclusion, CP (J or D) alone can significantly delay melanoma skin tumor growth“[76] 
Now, what data are available regarding the thermal aspect of the two plasma-device. 
VI.3.1.4.1 What about hyperthermia and the DBD device used in the paper of 
Daeschlein et al. [76]? 
 
The paper does not report any measurements made on the tissue itself and is based on 
the results presented by Kuchenbecker et al. [325]. This paper is a very precise 
characterization of the thermal and electrical aspects of this plasma source. The 
measurement method is described by the following statements. 
 “The temperature of the treated surface is measured using a probe consisting of thin round Al-
plate.” 
 “The heating of the treated object is studied using probe measurement. The mass of the probe is 
0.46 g. The probe is hung on the thin wires with a diameter of 0.27 mm and length of 100 mm. The 
ends of the wires are connected to the ground. The probe is heated in the discharge for 10 min (see 
Fig 229). The temperature of the probe is measured with an accuracy of ±0.5 K.” 
 “By means of steady-state temperature difference (T ) and the value of the h · A parameter, the 
heat input is determined. The heat input is calculated by assuming that cooling efficiency of the 
probe during discharge is equal to that in afterglow. But the gas temperature in the gas gap is 
clearly higher than outside. Therefore, during active phase of discharge, cooling occurs mainly 
from one side of the probe plate. The real value of the heat input is in between the values obtained 
by assuming both sides and one side cooling. We take into account this effect and calculate the 
heat input for both electrodes assuming that the heating of those are equal. The heat input 
increases with interelectrode distance (see figure) because averaged current is approximately 
constant for the discharge in the gas gap broader than 1.0 mm and at the same time the ignition 
voltage increases” 
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Fig 229 Legend and figures 18 and 19 from Kuchenbecker et al. [325]. Left: Temporal dependence of 
the probe temperature by heating during 10 min in DBD discharge. Right: Electric power consumed 
for heating of the electrodes via interelectrode distance (black square). Total electric power 
dissipated in discharge (star) and in excitation of chemically active species (hollow circle). 
 
Note that the maximum temperature reached by the probe is about 314 K (41 °C). A 
tissue at this temperature would undergo the modifications associated with moderate 
hyperthermia (modification of the blood flow, oxygenation ...). In addition, the initial 
temperature of the probe is 25 ° C, which is 5 ° C lower than the temperature of the skin 
at the beginning of treatment (30 °C, temperature of the skin after few minutes of 
anesthesia). If the increment of temperature is the same on the skin, the skin would 
reach a temperature of 46 ° C. 
With the information cited so far, it is not possible to know if the skin will be in a state of 
hyperthermia or not. Fortunately, the thermal characterization was continued. The paper 
describes a measurement of the incident heat flux. We will use it to guess the 
temperature of the skin during the treatment described in Daeschlein et al. [76] 
Unfortunately, in the absence of measurement of tissue temperature, the result will be 
more uncertain. We assume that the incident heat is the same as that given in Fig 229 
(~80 mW).  
The plasma is on for 3 minutes, off for 30 seconds and on for 3 minutes again as in 
Daeschlein et al. [76]. It is assumed that the tumor has a diameter of 8 mm. The 
simulation code used is the same as in section VI.2.7.2 (“Living mice”, p 242). The 
thermal properties of the tissue are those summarized in the tables of the section VI.1.6 
(p 200). It is considered that the skin is heated by a constant incident heat 
flux   ݍ௣௟௔௦௠௔   =  ܥݏݐ  ܹ. ݉ିଶ, and cooled by natural convection. 
Unfortunately, the area of the plasma-skin interface is not known. Numerical simulationd 
are done with the two following assumptions:  
 Either the surface covered by the plasma has the same dimensions as the inner 
electrode of the DBD (radius of 9 mm).  
 Either the treated area covers only the tumor (radius of 4 mm). 
The power per unit area is such that the total power of the incident heat is 80 mW in both 
cases. Fig 230 shows that the temperature reached by the upper layers of the skin is 
below the limit of mild-hyperthermia (39 °C). Of course, if the 80 mW were distributed on 
a smaller area, the temperature increase could be higher. 
Note that the surface temperature of the skin is lower than that measured by the probe 
(32 and 38 ° C against 41 ° C for the metal probe). This is consistent with the fact that 
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the skin evacuates the heat towards the interior of the body by thermal conduction and 
thermal exchanges with the blood (In addition to the cooling due to convection and 
radiation which are also present above the probe). Regarding the paper Kuchenbecker 
et al. [325], the temperature sensor is not really mentioned (a thermocouple ? a fluoroptic 
sensor ? only the target is described). Moreover, the proposed modeling does not take 
into account radiative thermal losses. Without more information about the metal target, it 
is difficult to know if radiation loss is negligible or not. Indeed, the emissivity of aluminium 
varies between 0.02 and 0.9 depending on the surface state, the thickness of the oxide 
layer and alloy. It is recalled that the losses depend on the fourth power of the 
temperature. The equations representing the cooling of the metal probe must therefore 
take the form: 
߲(ܥ௛Δܶ)
߲ݐ
=
߲ܳ
߲ݐ
− ℎ. ܣ. Δܶ − ߳஺௟ߪ൫ܶସ − ௔ܶ௠௕
ସ ൯. ܣ 
The linearization of the radiative term is valid only when: 
൫ܶଶ + ௔ܶ௠௕
ଶ ൯(ܶ + ௔ܶ௠௕) varies little on the range of temperature. The minimum 
temperature is 25 °C; the maximum temperature is 41 ° C.  
Numerical application 
With   ௔ܶ௠௕ = 25 °ܥ, 
݂݅ ܶ = 25 °ܥ        ൫ܶଶ + ௔ܶ௠௕
ଶ ൯(ܶ + ௔ܶ௠௕) = 1.059 × 10଼ Kଷ 
݂݅ ܶ = 41 °ܥ        ൫ܶଶ + ௔ܶ௠௕
ଶ ൯(ܶ + ௔ܶ௠௕) = 1.147 × 10଼ ܭଷ 
which represents a relative error of only 7%. Consequently, the integration of a term of 
radiative losses in the term of convection (linear terms) does not cause a significant 
error. Consequently, these measurements are likely valid, and the simulations confirm 
that the skin of mice has not been subjected to hyperthermia provided the area exposed 
to the plasma is sufficiently large, and heat transfer is the same above the skin and 
above the metal probe. 
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Fig 230 the color map indicates the size of the heated surface during the simulation. On the left, the 
surface below an 18-mm disc, on the right, only the tumor. The temperature along the z-axis is 
plotted for two depths: surface = red curve, fat-tumor interface (depth = 364 μm) = black curve. In 
both cases, the power per unit area is such that the total power of the incident heat is 80 mW. In both 
cases, the temperature increase experienced by the tissues is lower than the threshold of mild-
hyperthermia (39 °C). It depends on the area over which the 80 mW of heat is distributed. The 
sequence consists of 3 min of plasma on, followed by 30 s plasma-off, the skin cools, followed by 
another 30 s of plasma 
 
VI.3.1.4.2 What about the kINPen09 used in the paper of Daeschlein et al. 
[76], (2013)? 
 
The paper [76]  of Daeschlein et al. does not report any measurements made on the 
tissue itself with the kINPen09 and is based on the results of a previous paper. 
The statement “The temperature at the tip of the beam with a length of up to 12 mm did not surpass 37 
°C” has been proven in another paper of the same author [326].  
It appears that the operating conditions of the kINPen09 are the same as those of the 
anti-tumor study. Gas flow, operating Voltage and distance are the same. The green 
curve (60 V) of Fig 231, describes the temperature in the plasma plume. It is also noted 
that it is necessary to control the distance of the tip to better than 2 mm since at 10 mm 
the temperature reaches the threshold temperature of 42 °C. 
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Fig 231 Legend and figure from the paper of Daeschlein et al. (2012) [326]. Temperature profile of the 
plasma beam. 
The paper [323] explains in what operating conditions the kINPen09 can generate 
excessive heat (In continuous mode, with a flow of 5 slm). The temperature 
measurement was performed by placing a temperature probe at the center of the gas 
flow. This probe is fluoroptic: as said before, this probe works by measuring the 
decreasing fluorescence of molecules placed at the end of the probe108. The response 
time of such probes is generally short109. Moreover, they are insensitive to 
electromagnetic disturbances since the signal is optical. 
The only remark that can be made is the size of the probe: its diameter is of the order of 
0.8 mm, it means that the measured temperature is averaged over this distance, and 
therefore the central temperature may be slightly higher than what is claimed (Fig 232). 
 
Fig 232 Legend and figure from the paper of Weltmann et al. [323]. Radial temperature profile of the 
APPJ (Kin-Pen09 parameters: P=3.2 W, U=65 V). 
Note also that the size of the plasma corresponds to that of the heating zone simulated 
in VI.2.6.3. Another criticism concerning this type of measurement is that the nature of 
the discharge is not necessarily the same above the temperature probe or a mouse. 
                                               
108 . The results of this probe can be distorted if the fluorophores are exposed to laser IR 
irradiation  [327]. Here, this is probably not relevant. 
109 Since the time needed to thermalize the thin layer of fluorophore can be short. 
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Under these conditions, the authors claim that it is possible to limit the damage by 
moving the plasma source quickly above the skin. This is certainly true, for a single 
passage, but it would be necessary to know how often the plasma source goes back to 
the same point. Indeed, in a similar way than fractioned treatment, slow heating of the 
tissues could lead to thermal damage (as explain in VI.2.8, page 244). The APPJ could 
also be used in burst working mode to reduce the temperature. This seems a very 
effective way of reducing the temperature, but this is probably done to the detriment of 
the production of reactive chemical species. 
Unfortunately, the following information is missing: 
 The temperature measurements of a substrate exposed to the treatment 
conditions precisely used above the tumor (and not only in the plasma plume). 
 As the source is moved manually, it would be interesting to know the pattern 
described on the surface of the tumor and its frequency of repetition. And the 
height above the tumor in each point. 
Among the plasma sources used, the kin-pen is probably the best thermally 
characterized. But in the absence of published subtract temperature measurement of 
temperature under the conditions specifically used by Daeschlein et al., it is not possible 
to conclude that there is no hyperthermia, strictly speaking. 
In a very clever way, the heat flux leaving the plasma has been studied in [323] by 
measuring the temperature of a copper target (floating electrode). The heat flux is 
estimated at about 75 mW. Since the plasma is modeled by a cylinder with a radius of 1 
mm, we can estimate the value of the incident thermal flux:  
ݍ௣௟௔௦௠௔ =
75 × 10ିଷ
ߨ(10ିଷ)ଶ
≅ 23 900 ܹ. ݉ିଶ 
which is an order of magnitude greater than the thermal flux we have determined in 
VI.2.9 (maximum heat flow without damage for long treatment). This order of magnitude 
is ultimately very similar to that of laser treatments presented in (VI.1.2 page 175). This 
is not surprising since, in the absence of displacement, kINPen09 actually causes 
damage in these operating conditions (continuous mode, 8 L/min). And that’s why it was 
chosen to move the device above the skin. 
VI.3.1.5 Mashayekh et al. [77], 2015, melanoma B16/F10  
Mashayekh et al. describe treatment of mice bearing melanoma B16/F10 [77]. To ensure 
that the melanoma has not heated up, an image acquired with a thermal camera is 
presented. This image is visible on the left side of Fig 233. The target used during this 
measurement is not specified in the paper. After discussion with one of the authors, 
A.Mashayekh, it appears that the target is a piece of wood (private communication of 
A.Mashayekh). As the temperature measurement is done with a thermal camera, it is 
likely that the spatial resolution is adapted. 
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Fig 233 Pictures from Mashayekh et al. [77] 
The heating of the wood found on the surface is very low in all the treatment conditions 
envisaged. A simulation was carried out by modeling the wood with the following thermal 
properties: 
ߩ = 650 ݇݃. ݉ିଷ 
ߣ = 0.16 ܹ. ܭିଵ. ݉ିଵ 
ܥ = 1600 ܬ. ݇݃ିଵ. ܭିଵ 
When the plasma-surface interaction surface is modeled by a filament with a diameter of 
1 mm (private communication), the temperature at steady state (33°C) is reproduced by 
the simulation with an incident heat flux 2800 W/m². In these conditions, the total power 
is equal to 2.2 mW. 
On the other hand, it is likely that the nature of the discharge is different above the 
mouse compares to those above the wood. Indeed the mouse is relatively conductive 
while dry wood is a good electrical insulator. It is well known that the electrical properties 
of the target play a key role, for example, on the helium density of the metastable and 
the entire discharge [39]. It is reasonable to imagine that the same goes for thermal 
behavior. 
The paper shows that plasma treatment is effective against B16 melanoma. However, 
tumor volumes are given only in standardized form (as shown in Fig 234). 
 
Fig 234 Legend and figures of Mashayekh et al. [77]. In-vivo comparison of different groups 
Regarding the condition of the tumor, the author told me that no damage was visible 
(necrotic or burning damage) at the surface of the tumor (private communication of 
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A.Mashayekh). In addition, interestingly, the treatments were done on conscious mice 
that showed no signs of pain (private communication of A.Mashayekh). 
Since no temperature measurement was made on the mouse itself, it is not possible to 
exclude the possibility that the temperature is higher than those measured above wood 
(since the electrical properties of the two targets are different). The absence of pain and 
the absence of visible burn should exclude strong hyperthermia. However, mild-
hyperthermia (as explain in VI.3.1.1) could explain the slowing of tumor growth. 
VI.3.2 Summary of the critical approach 
Finally, few papers rigorously control the hyperthermia induced by plasma treatments. 
Often it is not possible to know if the temperature played a role or not in obtaining the 
therapeutic effects obtained. 
However, the literature concerning the treatment of B16 melanoma shows that mild-
hyperthermia can have a significant effect on tumor growth without necessarily producing 
visible damage. Sometimes some papers are based only on the following statement to 
exclude the role of hyperthermia: "I put my finger under the plasma-jet, and I did not feel 
any warm up ". We have shown how false this statement is because of physiological 
differences between our skin and those of mice. 
We need to measure systematically110 the temperature of the skin during and after the 
treatment. The simplest solution is to use an infrared camera with sufficient spatial 
resolution. It is only under these conditions that it will be possible to prove that cold 
plasmas have a non-thermal antitumoral effect. 
On the other hand, if cold plasmas have a thermal effect, it might be interesting to 
recognize it and exploit this fact to kill cancer. 
In the paper of Chernets et al. the temperature is measured with admirable precision at 
the center of the tumor showing that the hyperthermia cannot be excluded (contrary to 
what is stated by authors) [79]. 
In the next two paragraphs and to conclude this critical approach, we will consider which 
non-thermal biases could also play. 
Therapeutic versus preventive treatment 
Tumors in humans are not detected until they reach a certain size. However, the 
effectiveness of therapy will depend significantly on the initial tumor size at which it 
starts. Consequently, an in-vivo model is considered as representative of the effect that 
would be obtained during therapy, if the tumors have reached few mm before the first 
treatment. Otherwise, the experience represents the effect of a preventive approach. 
Wound healing and Low-Level Laser Therapy (LLLT) 
According to the review of Avci et al. [328], LLLT/phototherapy/photobiomodulation 
refers to the use of photons to alter biological activity, but with light intensity that 
excludes the possibility of thermal effect. The exact mechanism remains essentially not 
understood but could be related to the absorption of light by some chromophores located 
in the mitochondria [328]. LLLT could accelerate wound healing and promote skin 
rejuvenation. It would be interesting to see if the light produced by plasma discharges 
                                               
110 on each mouse and during each treatment. 
Chapter VI—Modelling and simulation of the thermal aspects of plasma-tissue interaction  
 
271 
 
could produce such effects and contribute to the improvement of wound healing. More 
information can be found in the following papers: [328]–[332]. 
VI.4 Conclusion 
The development of this chapter started from the observation that, sometimes, cold-
plasma experiments involved significant heating of the biological tissue. “Significant” 
means high enough to induce biological changes in the behavior of the cells constituting 
the tissue. This chapter contains three main parts: 
i. Description of the biological effects of hyperthermia 
ii. Modeling of power transfer  from plasma to living tissues and subsequent 
damages. 
iii. Compaison of model with in-vivo experiments presented in Chapter V as well as 
with few article published by other group dealing with the treatment of B16 
melanoma 
This term deliberately imprecise of “biological changes,” covers a wide variety of 
modifications regarding the enzymatic activity, the denaturation of proteins, the 
production of thermo-induced oxidative stress... 
Let us briefly summarize the consequences of hyperthermia detailed in section VI.3. 
 At the scale of one cell, these changes can lead to its death by a great variety of 
mechanisms. If the cell survives, it can develop a thermotolerance, making it 
resistant for several hours to another thermal stress. It is noteworthy that these 
changes induce radiosensitization of the cells for several hours. This is 
particularly useful against chemoresistant cancer. 
 At the scale of the tissue, the changes vary from a slight increase in tissue 
oxygenation associated with vasodilatation of blood vessels and slight changes in 
tissue pH, to the complete destruction of living tissues by necrosis or apoptosis 
and the total annihilation of the blood network as a result of blood coagulation. 
 At the scale of the organism, thermal stress can trigger systemic responses of the 
immune system. 
On purpose, we have not yet spoken of temperature. It is obvious that these phenomena 
do not occur at any temperature, or with the same amplitude. However, the threshold 
temperatures delimiting the temperature intervals that defined the magnitude of 
phenomena depend on several parameters. Among these, I would like to draw attention 
to the fact that the effects of hyperthermia strongly depend on the species, and organs, 
and even of the cell type considered. 
 mouse skin is more sensitive to hyperthermia than human skin [224], which is 
important since the majority of in-vivo experiments use mice... 
 Some organs are subject to greater damage for the same exposure to 
hyperthermia 
 All the different cells of the same organ do not have the same thermosensitivity. 
This greatly complicates the definition of limit temperature. T>~ 45°C is the threshold to 
obtain a significant ablation in relatively short time (~min).  
It appears that there are great similarities between the effects induced by hyperthermia 
and the effects that the plasma-medicine community has shown in the last ten years.  
Since plasma-skin interaction can be at the origin of a warm-up of the skin, a model for 
studying the propagation of heat through the skin of a mouse has been developed and 
validated with experimental results. Conversely; this model specifies the characteristic 
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that a thermal diagnostics must have to obtain reliable measurements of temperatures. 
The methods of temperature measurement and their scientific description are crucial 
points. In particular, the spatial resolution of certain infrared thermometers could lead to 
minimize the measurements of surface temperature 
In the present work, the tissues damages are modeled with the denaturation reaction of 
collagen, the major component of skin. The rate of reaction strongly depends on the 
temperature. An increase of only 1 ° C divides the time to obtain the same amount of 
damages by 2 or 3. The degree of burns is linked with the temperature history of the skin 
with the damage function [210],  Ω(t) = ∫ ܣ݁ݔ݌(−
ாೌ
௞್்(௧)
)
௧
଴ ݀ݐ,  which enables the 
simulation of thermal damages. Where t is the time, ܶ(ݐ) the temperature as a function of 
time, A (in ݏିଵ) is a constant which depends on the specie and tissue, ܧ௔  is the energy of 
activation of the denaturation. This simulation gives the volume of a subcutaneous tumor 
subjected to mild hyperthermia. It also describes tissues subjected to higher 
temperature, which can lead to tissue ablation. Heat burns may affect epidermis, dermis 
or subcutaneous fat (1st to 3rd-degree heat burn).  The severity depends on the time and 
temperature of exposure.  
 The model provides a quantitative approach of the thermal damages which 
corresponds to the current state of the art. The model takes into accounts 
o The thermal diffusion of heat 
o Radiative exchange 
o Natural and forced convection of heat with ambient air and Helium 
o The effect of blood perfusion 
o The effect of metabolic heat generation 
o The effect of temperature on blood circulation 
 The model can reproduce the kinetics of heating and cooling of the surface of the 
tumor. The sensitivity of the cooling rate to various parameters is studied. The 
thermal conductivity (not the convection) is the main factor of cooling (see 
Appendix G). 
 The simulation takes into account the specificity of mouse skin compared to 
human skin, in terms of thickness. 
 The heat source due to plasma-skin interaction has been modeled either by the 
assumption that only hot helium ( ுܶ௘ =  55 °ܥ assumption), or the bombardment 
of energetic particules (ݍ௣௟௔௦௠௔ = ܥݏݐ (ݐ) assumption) is at the origin of the 
heating. 
 We have benchmarked the code  by comparison between computational results 
with time temperature measurements presented in Chapter V. The simulations 
are consistent with the totality of the experimental observations regarding the 
temperature and the severity of the damages. 
o Regarding the non-refrigerated multichannel-jet: Skin temperature after 
treatment of 3 or 5 min was around 45-48°C. Treatment of one min gave 
no damages. One treatment of three min gave no damages, but the 
repetition of this treatment at two days intervals gave damages after two 
or three treatments. Treatment of 5 min systematically gave damages. 
o The simulation of refrigerated multichannel-jet reproduces the evolution of 
the surface temperature correctly. 
o The treatment with the single jet does not cause any damage. 
 The prediction of damages is a reliable result (see Appendix E). In the framework 
of fractionated treatment, the change in the settings111 of the model does not 
                                               
111 i.e. the thermal conductivity of the tumor, the area of plasma-skin interaction, the value of 
blood perfusion, the two parameters defining the damage function (A and B) 
Chapter VI—Modelling and simulation of the thermal aspects of plasma-tissue interaction  
 
273 
 
modify the result in a qualitative way; in the sense of the tumor is always 
damaged as long as the simulation correctly reproduces the temperature in 
the center of the tumor in continuous regime. 
 The simulation can give the conditions for which a plasma treatment can cause 
mild-hyperthermia without significant thermal damages. This could potentially 
elicit an additional therapeutic response. 
 Particular attention has to be paid to the accumulation of damage during 
fractioned treatments at high temperature. It appears that the device used by 
Chernets et al. [79] should be used with a cooling time greater than 25 
seconds112, to avoid the formation of thermal damage in less than 1000 seconds. 
 Finite element simulations could show at which point the evaporation over a 
slightly moistened skin can decrease the damages. For instance, a layer of 100 
μm thick decreases the surface temperature reached by the skin by more than 15 
° C (for DBD treatment). The temperature at the center of the tumor loses only 
7°C. 
 
As a conclusion, temperature of tissues exposed to non-thermal plasmas should be 
controlled by appropriate thermal probes associated with models in order to i)  
discriminate the “plasma effect” such as RONS and electric field, from the effects of 
hyperthermia, ii) possibly take advantage of a controlled hyperthermia (mild or high) to 
increase the “plasma effect” , iii) avoid biased experiments when effects of hyperthermia 
have been neglected. 
 
                                               
112 The repeted sequence is : {cooling=25 seconds +  plasma-on =  5 seconds} 
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General conclusion 
The main motivation of this Ph.D. was to evaluate the potentialities of Cold Plasmas 
sources for cancer treatment. This is a long-term objective; to the date, only few 
published papers have evidenced antitumor effect of Cold Plasma Treatment. In our 
work, the priority given to in-vivo experiments underlies the whole architecture of this 
dissertation. 
 
Chapter III is dedicated to the chemistry of plasma-liquid interaction. The plasma-device 
have been characterized with respect to the amount of H2O2, NO2-, NO3-, and HO° that 
the device produces per second (production rate in pmol/s) or per J (yield in nmol/J). 
Regarding, the quantification of HO°, it was found that the yield of the reaction between 
terephthalic acid (TPA) and hydroxyl radical depends on TPA concentration. In fact, the 
reaction producing the fluorescent compound is most likely in competition with the 
recombination reaction of the radicals HO° into H2O2. This experimental problem was 
transformed into a mean to acquire data on the incident flow of HO° by performing 
measurements with several values of [TPA]. 
The aim of the parametric studies was not only to understand the plasma-liquid 
interactions but also to choose the set of parameters which optimize the production of 
chemical species. The underlying idea is to maximize the biological effect by increasing 
the amount of species produced. These experiments show that it is possible to optimize 
the amount of nitrite and nitrate produced in liquid phase by the single-channel jet by 
choosing   Φ(ܪ݁) = 300 ݏݏܿ݉, when peak to peak voltage is 27.4 kV and height is 5.5 
mm. In such condition, the production rate of nitrite is ~750 ݌݉݋݈. ݏିଵ and the yield is 
~1.2 ݊݉݋݈. ܬିଵ. By comparing the production rate of nitrites and nitrates for all the 
devices, it appears that the ratio of the two seems relatively constant: about 4 molecules 
of nitrate are measured for one molecule of nitrite.  
Regarding the single-channel plasma jet113, the production rate of H2O2, NO2-, NO3- and 
HO° were measured in the range: 300-1500, 50-1500, 20-4000 and 100-400 pmol.s-1 
respectively; the yields were in the range 0.7-4, 0.03-1.5, 0.2-9, 0.2-1.1 nmol.J-1 
respectively. 
The question of the chemical dose was also discussed from the point of view of the 
antioxidant defenses of the tissue. The results obtained suggest that the antioxidant 
defenses of the skin can considerably limit the ability of H2O2 to diffuse deeply into the 
living tissues. Incidentally, we also explain how the studies [176] and [169] which present 
an opposite result could have been biased. 
Chapter IV described in-vitro experiments made with two cell lines TC1 and NRS1. An 
energy-dependent effect of plasma treatments has been shown on cell viability. It 
appears that the DBD and the single-channel plasma jet decrease the viability of the 
cells. The effect on cell-viability is significant after 72h of incubation. Moreover, TC-1 
cells have been exposed to increasing concentrations of H2O2 (~10-200 µM) and nitrites 
(10-1000 µM), and a combination of the two. It appears that nitrites play no role in the 
toxicity of the chemical mixtures. The concentration of H2O2 alone explains the decrease 
in cell viability observed after 72h of incubation. Finally whatever the origin of H2O2; 
DBD, plasma-jet or PAM; the decay of cell viability seems to be identical. 
Chapter V describes the results of five in-vivo campaigns. Plasma-device and the 
protocol have evolved towards powerful device. The experiments were performed on two 
                                               
113 at 500 Hz 
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lines of tumors: TC-1 and CT-26 tumors. The experiments were carried out with two 
Dielectric Barrier Discharge (DBD), the single-channel plasma jet and several multi-
channel jets (refrigerated or not). The efficacy of PAM has also been tested in-vivo. It 
has also been attempted to expose the skin to catalase inhibitor, in the hope that it could 
increase a ROS-mediated effect of cold plasma. These experiments highlight negative 
results of our tissue-tolerable plasmas sources. Although the last experiment was done 
with the multi-channel plasma jet show no anti-tumor effect, it was observed that plasma 
treatment promotes the extension of pre-existing surface necrosis. The only positives 
results; up to tumoral ablation; were obtained with the plasma device which increases 
the temperature of the skin (final temperature between 45 and 48 °C). 
Chapter VI was dedicated to the thermal aspect of plasma-skin interaction. It addresses 
the issues related to hyperthermia and its biological effects. Since plasma-skin 
interaction can be at the origin of a warm-up of the skin, a model for studying the 
propagation of heat through mouse skin has been developed and validated with 
experimental results. Conversely; this model specifies the characteristic that a thermal 
diagnostics must have to obtain reliable measurements of temperatures. The methods 
chosen to measure the temperature is a crucial point. The spatial resolution of some 
infrared thermometers could lead to minimize the measurements of surface temperature 
by several degrees. 
To sum up, The temperature of tissues exposed to non-thermal plasmas must be 
controlled by appropriate thermal probes associated with thermal-simulations to : 
i) Check the absence of bias regarding the temperature measurements. 
ii) Discriminate the “plasma-chemical-action” which would be caused by RONS 
and/or the pulsed electrical field, from the effects of hyperthermia, 
iii) take advantage of controlled hyperthermia (mild or high) to increase the effect 
of cold plasma.  
Regarding hyperthermia and plasma-cancer, one of these two statements is true: 
Either hyperthermia contributed significantly to the “plasma-effect” reported in the 
published in-vivo experiments showing positive anti-tumor effects of cold plasma. In this 
case, it is interesting to study and understand the precise role of hyperthermia in plasma 
treatment. 
Either hyperthermia played no role. Consequently, it would be interesting to study the 
combination of cold-plasma and hyperthermia. Since such path could considerably 
increase the effect of cold-plasma treatment. 
In both cases, the modeling and the study of hyperthermia in relation to plasma 
treatments is a positive contribution. 
Perspectives 
It appears that plasma-medicine is not only an interdisciplinary field full of major scientific 
challenges such as i) the quantifications of highly reactive radicals, ii) the biochemistry of 
living organisms, iii) the interpretation of in-vivo experiments. Plasma-medicine is also an 
epistemological trap. 
Since cold-plasma treatments can induce biological responses via several modalities: 
heat, UV, pulsed electrical pulse, charge deposition, reactive oxygen and nitrogen 
species. It is necessary to increase the level of control of our experiments (particularly 
regarding thermal aspects among others). The scientific objective is to separate the role 
of each contribution. However, even the effect of heat, UV or RONS alone is not always 
detailed in the literature. The data available in the literature often do not correspond 
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exactly to the experimental situation encountered with plasma medicine. For example, 
studies concerning hyperthermia and cancer rarely114 involve small thermal sources 
located at the surface of the skin. 
Consequently, it would be interesting not only to do experiment implying the 
comparisons of several well-characterized (electrically, chemically...) plasmas-device but 
also to do in-vivo experiments with chemical species, heat, UV, pulsed field alone. 
 
                                               
114 since it is an inefficient way to heat the entire tumor. 
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Contribution details 
Abbreviation of contributors’ name: 
LPP 
B.H = Bruno Honnorat 
A.R = Antoine Rousseau 
C.D = Constance Duchesnes 
B.L = Bo Liu 
T.D = Thierry Dufour 
S.T = Sébastien Thomassier 
LIB 
A.D = Alexandre Dizeux  
J.G = Jérôme Griffon 
L.B = Lori Bridal 
D.G = Delphine Le Guillou 
CIMI 
M.D = Maude Delost 
A.G =  Aurélien Gaubert,  
A.L  = Aline Le-Moignic 
G.L = Géraldine Lescaille 
F.L = François Lemoine. 
R.B = Réda Bouras 
 
Engineering 
S.T designed and manufactured all the power supply.  The Glass-maker of 
Polytechnique, Jean-Michel Wierniezky, prepare glass-DBD. B.H designed and 
manufactured all of the other plasma-device: DBD, single-channel plasma jet, multi-
channel plasma jet. The high voltage tests, as well as the electrical characterization of 
the devices, were carried out by B.H. All the mechanical supports made by 3D printing 
were designed (Openscad) and printed by B.H with a Creat-HS double extrusion 
(Leapfrog). The program for automatic discharges and energy consumption calculation 
detection has been coded by B.H. 
Chemistry experiments 
The procedures for the chemical diagnostics of H2O2 (amplex-red + TioSO4) and nitrite 
(Griess) were developed, calibrated and tested for chemical interference in the 
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framework of plasma-liquid interaction by B.H. The modified diagnostic of nitrate was 
developed, tested and used by B.H, C.D and B.L. The development of HO° diagnostic by 
TPA was developed by B.H. Preliminary experiments showing an effect of [TPA] on final 
[TPA-OH] were made by B.H. The systematic measurements of [TPA-OH] as a function 
of variable [TPA] were made by  C.D and B.L (results shown in fig  87). The 
interpretation in term of competition between probing and recombination reaction was 
proposed and developed by B.H. 
The systematic experiments presented in section III.1, III.2 and III.5.3 were done by B.H. 
The experiments of sections III.3 and III.4 were done by B.H, C.D and B.L.  
B.H, A.R, C.D and B.L participated in the interpretation of the results 
In-vitro experiments 
The preliminary experiments were made by B.H and M. D. M.D prepared, observed and 
count the cells. B.H treated the wells. M.D, B.H, A.R and L.B participated in the design of 
the experiments and in the interpretation of the results. 
Regarding the systematic experiments presented in section IV.1 and IV.2, M.D prepared, 
observed and count the cells. B.H treated the wells and measured the energy 
consumption of the device. M.D, B.H, A.R and L.B participated in the design of the 
experiments and in the interpretation of the results. 
R.B prepared the cells of the three differents cell lines treated during the last in-vitro 
experiment (only two were presented in this manuscript). B.H, G.L and R.B participated 
in the interpretation of the results. 
In-vivo experiment 
LIB 
D.G, A.D and J.G prepare the CT26 cells, and the implantation of tumor fragment. A.D 
and J.G performed Ultrasound diagnostics. A.D and J.G performed the injections of 
PAM. B.H prepared the PAM and performed the other treatments. A.D and J.G 
performed the analysis of ultrasound data. A.D, J.G, B.H, A.R, L.B participated in the 
interpretation of the results. 
CIMI 
M.D, A.L prepared the cells and performed subcutaneous injections into the cheek or 
flank of the mice. A.L and A.G monitored the size of the tumors (caliper measurements). 
B.H proceeded to the treatments and performed tissue temperature measurements. A.L, 
B.H, G.L, A.G, A.R and L.B participated in the interpretation of the results. 
Finite element methods applied to hyperthermia 
All the simulations by finite elements methods and the instructions enabling to represent 
them in Matlab were written, tested, benchmarked and implemented by B.H. B.H and 
A.R participated in the interpretation of the results. 
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Appendix A Electrical and power measurements 
This section describes the results obtained related to the electrical characterization of the 
device. The first section regards the single-channel jet. The number of discharges, the 
amount of charges transferred were deduced from the signal acquired with the 
oscilloscope. The characteristic of the discharge are studied as a function of two 
parameters: the height above liquid and the helium flow, the other parameter being 
constant. Significant difference appears according to these two parameters. Such 
differences are correlated with the change in the chemical properties of the liquid. 
However, with such result, no causal link can be demonstrated. Perhaps electrical 
measurement could enable to obtain insight on target chemistry? Significant differences 
appear between positive and negative discharges. 
The second section regards the modeling of the dielectric losses. These loss are often 
negligible and neglected in plasma-device  and depends on the voltage, the frequency 
and the angle of loss of the dielectric. However, there is some case of practical interest 
where they can count for almost 10% of the total power consumption (DBD at “High 
Voltage” and “low” power115). Neglecting these losses could lead to an underestimation 
of the power of some plasma-medicine device. In contrast, the measurement of the 
angle of loss enables to characterize the aging of the dielectric barrier. This could useful 
to prevent the electrocution of a patient treated by a reusable device. 
In the last section, the consequences of the presence of a living organism are discussed. 
Experimental results of the equivalent series capacitance and resistance of the mouse 
are presented. 
A-1) Statistical count of discharges, correlation with 
RONS production. 
A-1-1) Method, characteristic times 
In the main document, the power consumption of the devices was calculated with the 
integral of ܷ × ܫ over an entire period of the power supply. As explained in section V.1.5 
(page 129), even if the time of the response of measurement systems is slow, power 
measurement are correct at the time scale of a period116 since the response time of the 
measuring system is small compared to one period. 
The measurement system is equivalent to a capacitance C = 11.5 pF placed in parallel 
with a resistance of 10 MΩ (see Chapter II). The response time is therefore of the order 
of ߬ = 10 ܯΩ × 11.5 ݌ܨ ≅ 0.12 ݉ݏ ≪ 2 ݉ݏ 
Actually, what is called one "discharge" in the rest of this section may be the occurrence 
of several microdischarges occurring at a time scale smaller than the temporal resolution 
of our device. When it is found that 90 nC are transferred in a “one” discharge, a current 
probe with a better temporal resolution117 could enable to specify if it is several 
discharges or a “big” single discharge. 
                                               
115 ~30 kV peak to peak and 100 mW at 500 Hz 
116 Indeed, what is important is to know the amount of charge transferred and measure the 
voltage across the plasma device at the time of the discharge. 
117 Rogowski coil, inductive groove… 
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In our condition, with theses plasma-devices118 and at low frequency (~500 Hz), it turns 
out that the plasma is not present over a significant part of power supply period (see Fig 
235, for instance). The discharges are separated by an interval of time119 during which 
the plasma is not present. 
 
Fig 235 Charge measured at the terminal of the measuring capacitor (࡯࢓ = ૚૙૝ ࢔ࡲ). 500 µL of 
desionised water exposed to the single-channel plasma jet (di=4, H=60 mm, e=1.5) with the set of 
parameter (helium flow = 350 sscm, Height = 9 mm, Peak to peak voltage = 26.6 kV). Sinusoid power 
supply of frequency ࢌ = ૞૙૙ ࡴࢠ 
The discharges stop because the surface of the dielectric has been neutralized by the 
currents circulating in the plasma or the highly conductive medium post streamer. It is 
interesting to evaluate the characteristic time to replenish the charge of the dielectric. For 
this, we consider the circuit presented in Fig 236: 
 
Fig 236 Schematic of the electrical circuit. There is a  high voltage resistor between High Voltage 
power supply and the cable which is connected to the plasma device (the dielectric layer of the 
device is shown, the rest was not modeled here) We have shown in Chapter II that the capacitance of 
dielectric layer is ~1 pF (DBD or single-channel plasma-jet). The cable has a length of about 1 m and 
therefore a capacity of the order of 100 pF (measured and consistent with the manufacturer's data). 
                                               
118 i.e the different plasma-jet and the DBD (not shown) 
119 During this, the voltage of the measuring capacity evolves only because of displacement 
current 
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Two characteristic time of charge replenishment appears. First, the time needed to 
charge the capacity of the dielectric layer of plasma-device from the cable which acts as 
a tank of charges: 
߬ଵ~1Ω  × 1 ݌ܨ = 1 ݌ݏ (ݐℎ݅ݏ ݒ݈ܽݑ݁ ℎܽݏ ݊݋ ݌ℎݕݏ݈݅ܿܽ ݉݁ܽ݊݅݊݃ ℎ݁ݎ݁) 
The time obtained is so small, that the AEQS and the modeling in term of electric dipole 
cease to be valid (it would be necessary to use the equations of the electromagnetism 
here to obtain realistic times). The time ߬ଵ is more likely of the order of few ns. Roughly it 
means that the voltage at the position P1 of the dielectric is quickly equal to the voltage 
of the cable. 
At 10 kV the amount of charges stored in the cable is of the order ~ 1 µC. The next 
sections show that this value is very large in front of the quantity of charge conveyed by 
“one” discharge (~100 nC maximum). The cable, therefore, remains almost at a 
constant120 voltage.  
Moreover, the characteristic time of cable replenishment is  
~߬ଶ = 250 ݇Ο݉ × 100 ݌ܨ = 25 μݏ 
These characteristic times explain why voltage measurements are the same whatever 
the position of measurement (P1 or P2) (observed but not shown in this document). This 
also explains why the drop in voltage is not visible when this cable is connected to the 
DBD (߬ଵ ≪ ݎ݁ݏ݌݋݊ݏ݁ ݐ݅݉݁ ݋݂ ܲܲܧ20 ܸ݇ ݌ݎ݋ܾ݁), but visible when the DBD is connected 
with a simple electric wire (in this case cable capacitance is small, and the time of charge 
replenishment ~߬ଶ and bigger than the response time of PPE20 kV probe
121). 
The two following sections describe statistical count of the discharges produced by the 
single-channel jet described with the parameter (di=4 mm, e=1.5 mm, H=60 mm, see 
Chapter II). The waveform is sinusoidal. The electrical circuit corresponds to that 
described in Fig 236. The target is identical to that used for chemistry studies (in Chapter 
III): 500 µL of deionized water in 24-wells plate. 
The voltage of the power supply was acquired with an oscilloscope (WaveRunner 6 Zi, 
band-pass =2.5 GHz, Lecroy) connected in P1 with a probe PPE20kV (÷ 1000 Lecroy). 
Passive probes PP08 (÷ 10) was connected in P3 to measure the voltage of the 
measuring capacitance Cm (C = 104 nF). The time to obtain 200 acquisitions122 is ~ 6 
min. The power calculated from the integral of ܷܫ݀ݐ, is represented in Fig 237 for the two 
experiments defined with the parameters: 
 Helium Flow= 100-600 sscm. Height= 9 mm, peak to peak Voltage is 26.6 kV 
 Helium Flow= 400 sscm. Height= 2-11 mm, peak to peak Voltage is 26.6 kV 
                                               
120 at a time scale larger than ߬ଵ and smaller than the period of power supply… 
121 Bandwith (-3 dB) ~ 100 MHz according to manufacturer’s data 
122 This number of acquisitions was chosen because it enables to perform statistics, and because 
the variation of height due to evaporation is not excessive during the required time. 
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Fig 237 Power (in mW) as a function of Helium flow (left, in sscm) and height (right in mm). Each 
point represents a single treatment; error bar is the standard error of the mean over 200 acquisitions. 
Left: height = 9 mm, peak to Peak Voltage= 26.6 kV, helium flow = 100-600 sscm .Right: height = 2-11 
mm, peak to Peak Voltage= 26.6 kV, helium flow = 400 sscm. 
The power was also calculated by summing the energy consumed by each discharge. 
The energy of a “single” discharge is calculated by multiplying the amount of charge 
transferred by the voltage of the power supply when the discharge takes places. It is 
correct to do this because, in this case, the voltage across the gas is almost identical to 
that measured at the position P2 before the discharge. Indeed, it is due to the fact that 
plasma exists only intermittently and that between discharges, the capacitance of the 
gas is very small compared to that of the dielectric layer. 
Indeed, the impedance of the dielectric is ܼௗ௜௘~
ଵ
௝஼ఠ
= −݆
ଵ
ఠ×ଵ ௣ி
, |ܼௗ௜௘| ≅ 3.2 × 10଼ Ω 
While the impedance of a cylinder (diameter = 4 mm, length e = 60 mm) of gas is 
approximately:  
ܼ௚௔௦ =
1
݆ܥ߱
= −݆
݁
߳଴ܵ߱
, ݐℎݑݏ หܼ௚௔௦ห ≅ 1.7 × 10ଵଵ Ω   
The voltage across the gas, ௚ܸ௔௦,is given by a voltage divider circuit
123 (almost a 
capacitive divider): 
௚ܸ௔௦ =
ܼ௚௔௦
൫ܼௗ௜௘ + ܼ௚௔௦൯
× ܸ(ࡼ૚) ≅ ܸ(ࡼ૚) 
The experimental results presented in the next two sections confirm the validity of this 
alternative means of calculating power (Fig 239 and Fig 243). The data were processed 
with a Matlab® program to detect the discharges (see section A-5-1), page 308). This 
code uses the functions of the “Signal Processing Toolbox”. 
                                               
123 Moreover,the voltage of the target is small (~100 mV) compare to the voltage accross the gas 
~ several kV 
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A-2-1) Adjustable parameter: helium flow 
This section regards the results acquired with variables helium flow, the other 
parameters being constant. The acquisition parameters have been previously described. 
The single-channel plasma jet operates according to the parameters: 
 helium flow = 100-600 sscm 
 height = 9 mm 
 peak to peak Voltage = 26.6 kV. 
The power consumption is shown in the left panel of Fig 237. Automatic waveform 
processing enables to obtain the distribution  of the discharges in terms of transferred 
charge (abscissa) and initiation voltage of the discharge (ordinate). Each point 
represents one discharge, the discharges of 200 periods of the power supply were 
added for each helium flow (Fig 238). 
 at 100 sscm, there are mainly less than 10 nC per discharge. Positive or negative 
discharges have the same behavior. 
 The asymmetry between positive and negative charges appears for the flow 
higher than 200 sscm. Negative discharges carry more charges per event. 
 At 550 or 600 sscm, there is a large number of “small” negative discharges which 
carry less than -10 nC and start between 6 and 13 kV. This population is not 
found in positive discharges (small number of positive discharges which carry a 
large number of charges). 
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Fig 238 Each point represents “one” discharge. The abscissa is the amount of charges transported 
during “this” discharge. The ordinate represents the voltage of the power supply at the time of the 
discharge. Single-channel plasma jet, height = 9 mm, peak to peak Voltage= 26.6 kV, Helium flow = 
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100-600 sscm. Waveform = sinusoidal, frequency = 500 Hz. Target = 500 µL of deionized water in 24-
wells plate. Each figure contains the concatenation of the data of 200 acquisitions. Each acquisition 
has a duration of 2 ms = one period of the power supply. 
It would be interesting to compare this behavior with the simulations of the positive and 
negative streamer. The accumulation of more results would enable to know the 
probability of triggering one discharge in each coordinate (amount of charge, Voltage). 
Note that the difference between positive and negative discharge is not due to an artifact 
of the program of detection since the peaks are detected from the absolute value of the 
current. 
Fig 239 shows a comparison of the two methods to calculate the power124 as described 
in the previous section. Both methods give very similar results; since the mean value 
differs by less than 3 % for all the flow (except one). It means that almost all the 
discharges were detected and that the number of false detection remains low. It is also 
experimental evidence of the validity of the approximation related to the relative 
impedance of gas (without plasma) and the dielectric layer. 
 
Fig 239 Left: energy consumed per acquisition (average on 200 acquisitions) as a function of Helium 
flow. Red sum of the energy of each peak detected, Blue: energy consumption is calculated over the 
entire period = ∫ ࢁࡵࢊ࢚
ࢀ
૙
. The error bars represents the standard deviation of the measurements. Right: 
percentage of difference between the sum of the energy counted during one period of the power 
supply for the two methods = ૚૙૙ × (܁ܝܕ ܗ܎ ܘ܍܉ܓܛ − ۷ܖܜ܍܏ܚ܉ܔ )/۷ܖܜ܍܏ܚ܉ܔ. It appears that the results of 
the two methods are similar and consistent. 
The amount of positive charge transferred per period of 2 ms is presented in red in Fig 
240 (respectively negative in blue). On average, the amount of positive and negative 
charge is the same (net charge ~ 0). 
 
 
                                               
124 since power is proportional to the energy summed over an entire period 
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Fig 240 Left: the amount of charge transferred during one acquisition (mean over 200 acquisitions) 
as a function of helium flow. Blue = total amount of negative charge transferred during one 
acquisition.Red = total amount of negative charge transferred during one acquisition. Black = sum of 
the absolute value of the charge transferred. Right: net number of charge transferred during one 
period of the power supply. The error bars represent the standard deviation. 
The left panel of Fig 241 shows the number of positive and negative discharge which 
take place on average during one period of 2 ms. There is less negative discharge but 
each negative discharge transport more charge (except for flow =550 or 600 sscm). So 
the increase in power should be attributed to an increase in the amount of charge 
transported per discharge, rather than an increase in the number of discharges. 
 
Fig 241 Left: number of discharges per period of the power supply (2 ms) as a function of He flow: 
Red = this discharge transport a positive amount of charges, Blue = a negative amount, Black: all the 
discharges. Right, red = mean value of the charge per positive discharge, Blue = mean value of 
transferred charge per negative discharge. Average on 200 acquisitions. Error bars represent the 
standard deviation of the mean. 
A-3-1) Adjustable parameter:  height above liquid 
This section regards the results acquired with variables height above liquid, the other 
parameters being constant. The acquisition parameters have been previously described. 
The single-channel plasma jet operates according to the parameters: 
 helium flow = 400 sscm 
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 height = 2-11 mm 
 peak to peak Voltage = 26.6 kV. 
The power consumption is shown in the right panel of Fig 237. Automatic waveform 
processing enables to obtain the distribution  of the discharges in terms of transferred 
charge (abscissa) and initiation voltage of the discharge (ordinate). Each point 
represents one discharge, the discharges of 200 periods of the power supply were 
added for each height (Fig 242). 
 The asymmetry between positive and negative charges appears for all the height. 
Negative discharges carry more charges per event. 
 At small height (2 and 3 mm), the majority of the negative discharge carry ~ -65 
nC and start at any negative voltage. Between 4 and 6 mm the distribution of the 
negative discharges seems to form two families: one at -65 nC and the others in 
the interval [–20 nC, 0 nC]. 
 at a great height (10 or 11 mm), the distribution looks like that observed at low 
helium flow. Perhaps that the composition of the gas phase play a significant role 
in the pattern of the discharge. On the other hand, perhaps is it possible to adjust 
the parameter of the device above the patient, in order to reproduce a pattern of 
reference and then obtain similar chemistry? 
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Fig 242 Each point represents “one” discharge. The abscissa is the amount of charges transported 
during “this” discharge. The ordinate represents the voltage of the power supply at the time of the 
discharge. Single-channel plasma jet, height = 2-11 mm, peak to peak Voltage= 26.6 kV, helium flow = 
400 sscm. Waveform = sinusoidal, frequency = 500 Hz. Target = 500 µL of deionized water in 24-wells 
plate. Each figure contains the concatenation of the data of 200 acquisitions. Each acquisition has a 
duration of 2 ms = one period of the power supply. 
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Once again, it would be interesting to compare these results with the simulations of the 
positive and negative streamer. Fig 243 shows a comparison of the two methods to 
calculate the power. Both methods give very similar results; since the mean value differs 
by less than 3 % for all height. 
 
Fig 243 Left: energy consumed per acquisition (average on 200 acquisitions) as a function of height. 
Red sum of the energy of each peak detected, Blue: energy consumption is calculated over the entire 
period = ∫ ࢁࡵࢊ࢚
ࢀ
૙
. The error bars represents the standard deviation of the measurements. Right: 
percentage of difference between the sum of the energy counted during one period of the power 
supply for the two methods = ૚૙૙ × (܁ܝܕ ܗ܎ ܘ܍܉ܓܛ − ۷ܖܜ܍܏ܚ܉ܔ )/۷ܖܜ܍܏ܚ܉ܔ. It appears that the results of 
the two methods are similar and consistent. 
The amount of positive charge transferred per period of 2 ms is presented in red in Fig 
244 (respectively negative in blue). On average, the amount of positive and negative 
charge is the same (net charge ~ 0). 
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Fig 244 Left: amount of charge transferred during one acquisition (mean over 200 acquisitions) as a 
function of the height. Blue = total amount of negative charge transferred during one acquisition.Red 
= total amount of negative charge transferred during one acquisition. Black = sum of the absolute 
value of the charge transferred. Right: net number of charge transferred during one period of the 
power supply. The error bars represent the standard deviation. 
The left panel of Fig 245 shows the number of positive and negative discharge which 
take place on average during one period of 2 ms. There is less negative discharge but 
each negative discharge transport more charge. The small decrease in power for large 
height should be attributed to a decrease in the number of charges transported per 
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discharge, rather than a decrease in the number of discharges (which increase slightly 
with height). 
 
Fig 245 Left: number of discharges per period of the power supply (2 ms) as a function of height: 
Red = this discharge transport a positive amount of charges, Blue = a negative amount, Black: all the 
discharges. Right, Red = mean value of the charge per positive discharge, Blue = mean value of 
transferred charge per negative discharge. Average on 200 acquisitions. Error bars represent the 
standard deviation of the mean. 
A-4-1) Correlation with RONS production 
The production rate of HO° was studied with the reaction which occurs between 
terephthalic acid (TPA) and hydroxyl radical for several [TPA] during plasma-liquid 
interaction (Chapter III, section III.5). 
The order-of-magnitude presented in section III.5.2 (page 85) propose the value of 16 
pmol per second for the production rate of hydroxyl radical when there is only one 
discharge per half period. According to the previous section, the number of discharge per 
half period is ~2.5 discharge which would lead to predicting a production rate of 40 
pmol/s. 
This value is five times below those observed with the single jet studied in Chapter III 
(~200 pmol/s  at 27 kV). However, the comparison is not valid since the power supply 
are not the same (“square with resonance” for HO° study versus sinusoidal for the 
statistical study of the discharges). It would be necessary to do additional experiments to 
go further. 
However, since the number of discharge slightly increase with height at (almost) 
constant power and since the mean amount of charge in one discharge decrease with 
height like the HO° production rate. Since this correlation is also observed regarding He 
flown it could be assumed that HO° production depends more on the amount of charges 
transferred by each discharge. It would be interesting to test this hypothesis. 
A-5-1) Matlab program for automatic discharge detection  
clear all 
tic 
 
%ce code permet de faire des statistiques sur le nombre de décharge se 
%produisant dans une periode, et sur la quantité de charge véhiculée par 
%ses dernières. La configuration experimentale choisie est du type "mesure 
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%de lissajous" avec une capacité de mesure CM placé en série avec la cible 
%du plasma 
 
kdeb=0; %indice premier et dernier fichier 
kfin=200; %201 
Cm=104*1e-9; %valeur de la capacité de mesure 
corrsonde=1; %1 pour corriger l'effet de la sonde de tension /10 avec les deux paramètres suivants 
capacorr=11.5*1e-12; %capacité ajouté par la sonde en // de la capacité de mesure Cm 
Rsonde=10*1e6; % résistance existant en parallèle de la capacité de mesure Cm 
 
affichage=1;  % 1 pour afficher et enregistrer les courbes 
%%%les paramètres sont à definir avant cette ligne 
tcell{1,1}='numero de fichier'; 
tcell{1,2}= 'le nombre de pics de courants'; 
tcell{1,3}= 'Energie totale transferée'; 
tcell{1,4}= 'somme des energie des pics'; 
tcell{1,5}= 'Numéro du pic de courant'; 
tcell{1,6}= 'Charge transférée nC'; 
tcell{1,7}= 'Energie du pic uJ'; 
tcell{1,8}= 'Tension de départ de la décharge V'; 
tcell{1,9}= 'Rapport Q/U*1E12'; 
tcell{1,10}= 'Temps ms'; 
 
tcell{1,12}= 'Charge nC'; 
tcell{1,13}= 'Energie uJ'; 
tcell{1,14}= 'Tension V'; 
tcell{1,15}= 'Temps ms'; 
position=2; 
 
dim1=1; 
ratiok=0;             
 
            for k=kdeb:1:kfin 
                 
    %SEL1             
    sel1(k-kdeb+1,1)=k;            
    sel1(k-kdeb+1,3)=0; %initialisation de la valeur             
                 
    if k<1000 
    basenum=strcat('00',num2str(k));     
    end 
    if k<100 
    basenum=strcat('000',num2str(k)); 
    end 
    if k<10 
    basenum=strcat('0000',num2str(k)); 
    end 
        
     
     %Chargement des données de la voie "ALIMHT" en memoire 
 C1 = load(strcat('C1Title',basenum,'.dat')); 
 %origine des temps mise à 0 
C1(:,1)=C1(:,1)-C1(1,1); 
 temps=C1(:,1); 
 C1=C1(:,2); 
 FS=1.0/(temps(10001)-temps(1))*1e4; %fréquence d'échantillonge du signal 
  
  
      %Chargement des données de la voie "CAPACITE CM" en memoire 
 C2 = load(strcat('C2Title',basenum,'.dat')); 
 C2=C2(:,2); 
 %I est le courant tel qu'il est mesuré aux bornes de Cm <> courantde 
 %décharge car bande passante plus faible du fait de la capa 
 if corrsonde==0 
     I=diff(C2)*Cm*FS; 
 else 
     I=diff(C2).*(Cm+capacorr).*FS+C2(1:end-1)./Rsonde; 
 end 
  
  
  %Effectue une moyenne glissante sur (2*lissage_temporel - 1) points 
 
  if affichage==1 
  figure(33) 
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 subplot(2,1,1) 
 title('charges vehiculées') 
 plot(temps,C2*Cm*1e9,'r-'); 
 xlabel ('Temps (s)', 'FontSize', 16) 
ylabel ('Charge (nC)', 'FontSize', 16) 
xlim([temps(1),temps(end)]) 
ylim([min(C2*Cm*1e9) max(C2*Cm*1e9)]) 
  
subplot(2,1,2) 
 title('courant') 
  end 
   
 Nzero=1001;        %taille fit 
C2lisse=abs(sgolayfilt(I,5,  Nzero)); 
lissage_temporel=300.0;    %lissage temporelle detection 
C2l1 = filter(ones(1,lissage_temporel)/lissage_temporel,1, C2lisse); 
C2l2 = filter(ones(1,lissage_temporel)/lissage_temporel,1, C2lisse(end:-1:1,:)); 
C2l2=C2l2(end:-1:1,:); 
C2lisse=(lissage_temporel*(C2l1+C2l2)- C2lisse)/(2*lissage_temporel-1); 
 
C2lisse=detrend(C2lisse); 
C2lisse(1:Nzero)=0; 
C2lisse(end-Nzero:end)=0; 
 
%[pks,locs,w,p]=findpeaks(C2lisse,FS,'MinPeakDistance',3e-
5,'Annotate','extents','SortStr','descend','WidthReference','halfheight','MinPeakWidth',10*1e-6); 
[pks,locs,w,p]=findpeaks(C2lisse,FS,'MinPeakHeight', 2e-5,'MinPeakDistance',7e-
5,'Annotate','extents','SortStr','descend','WidthReference','halfheight','MinPeakWidth', 6e-7); 
 
if affichage==1 
findpeaks(C2lisse,FS,'MinPeakHeight', 2e-5,'MinPeakDistance',7e-
5,'Annotate','extents','SortStr','descend','WidthReference','halfheight','MinPeakWidth', 6e-7); 
end        
            
%ENREG 
  dim1=dim1+1; 
tcell{dim1,1}=k; 
tcell{dim1,2}=size(locs,1); 
 
 
%Calcul de l'integrale u*I lissage de l'integrale du courant 
lissage_temporel2=10.0; 
C2l1 = filter(ones(1,lissage_temporel2)/lissage_temporel2,1,I); 
C2l2 = filter(ones(1,lissage_temporel2)/lissage_temporel2,1,I(end:-1:1,:)); 
C2l2=C2l2(end:-1:1,:); 
C2lisser=(lissage_temporel2*(C2l1+C2l2)-I)/(2*lissage_temporel2-1); 
             
integrenergy=trapz(C2lisser.*C1(1:end-1))*1e6/FS; 
tcell{dim1,3}=integrenergy; %dissipé dans le dispositif plasma + pertes dielectriques en µJ 
deb=dim1; 
 
 
tableaustringC2=cell(size(locs,1),1); 
sumenergy=0; 
fauxpic=0; 
 
 
clear charge tension indicechargeavant indicechargeapres signepicC tableaustringC2 vraipic positif 
negatif 
for tmpk=1:1:size(locs,1) 
    %determination du signe du courant repéré 
    indicepourlesignedeC2=find(temps<=locs(tmpk)+1e-8 & locs(tmpk)-1e-8<=temps); 
    % moyenne autour de la localisation entre -10 et + 10 ns 
    signepicC2(tmpk)=sign(mean(C1(indicepourlesignedeC2))); 
    pks(tmpk)=signepicC2(tmpk)*pks(tmpk); 
    %tension de départ de la décharge 
    indicedepart=find(temps<=locs(tmpk) & locs(tmpk)-2e-6<=temps); 
    tension(tmpk)=mean(C1(indicedepart)); 
     
    %determination de la charge transferée 
     indicechargeavant=find(temps<=locs(tmpk)-2e-5 & locs(tmpk)-3e-5<=temps); 
     indicechargeapres=find(temps<=locs(tmpk)+3e-5 & locs(tmpk)+2e-5<=temps); 
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     if size(indicechargeapres,1)==0 
         indicechargeapres=size(C2,1); 
     end 
      
     if size(indicechargeavant,1)==0 
         indicechargeavant=1; 
     end 
            
 
charge(tmpk)=(mean(Cm*C2(indicechargeapres))-mean(Cm*C2(indicechargeavant)))*1e9; %en nC 
tableaustringC2(tmpk)=cellstr([num2str(tmpk) ' charge' num2str(charge(tmpk)) ]); 
   
  %ENREGISTREMENT POUR CHAQUE DECHARGE DE CHAQUE ACQUISITION 
  dim1=dim1+1; 
 
tcell{dim1,5}= tmpk; 
tcell{dim1,6}= charge(tmpk); %charge arrivant dans Cm 
tcell{dim1,7}= charge(tmpk)*tension(tmpk)*1e-9*1e6; %en µJ 
tcell{dim1,8}= tension(tmpk)/1000; 
tcell{dim1,9}= charge(tmpk)/tension(tmpk)*1e12*1e-9; % en pF 
tcell{dim1,10}= mean(temps(indicechargeapres))*1e3; % en ms 
if charge(tmpk)*tension(tmpk)*1e-9*1e6<0 
fauxpic=fauxpic+1; 
vraipic(tmpk)=0; 
   positif(tmpk)=0; 
    negatif(tmpk)=0; 
else 
sumenergy=sumenergy+charge(tmpk)*tension(tmpk)*1e-9*1e6; 
tcell{position,12}= charge(tmpk); 
tcell{position,13}= charge(tmpk)*tension(tmpk)*1e-9*1e6; 
tcell{position,14}= tension(tmpk)/1000; 
tcell{position,15}=  mean(temps(indicechargeapres))*1e3; 
position=position+1; 
vraipic(tmpk)=1; 
if charge(tmpk)>0 
   positif(tmpk)=1; 
    negatif(tmpk)=0; 
else 
    negatif(tmpk)=1; 
    positif(tmpk)=0; 
end 
 
 
end 
 
end 
 
if size(locs,1)>0 
tcell{deb,4}=sumenergy; %'somme des energie des pics';   sum(charge.*tension*1e-9*1e6) 
tcell{deb,2}=size(locs,1)-fauxpic; 
if integrenergy~=0 
   ratio=(sumenergy-integrenergy)/integrenergy; 
else 
    ratio=0; 
end 
tcell{deb+1,4}=ratio; 
ratiok=ratiok+1; 
ratiotablr(ratiok)=ratio; 
Ndischarge(ratiok)=size(locs,1)-fauxpic; 
tablecharge(ratiok,1)=sum(abs(charge.*vraipic));  %charges absolue transferées dans l'acquisition 
tablecharge(ratiok,2)=sum(charge.*vraipic);%Charge moyenne transférée dans l'acquision 
tablecharge(ratiok,3)=mean(abs(charge.*vraipic));  %charges absolue transferées en moyenne par 
décharges 
tablecharge(ratiok,4)=sum(charge.*positif);%somme charges positives 
tablecharge(ratiok,5)=sum(charge.*negatif);%somme charges negatives 
tablecharge(ratiok,6)=sum(positif);%nombres decharges positives 
tablecharge(ratiok,7)=sum(negatif);%nombres decharges negatives 
if tablecharge(ratiok,6)>0 
tablecharge(ratiok,8)=tablecharge(ratiok,4)/tablecharge(ratiok,6);%moyenne charge decharges 
positives 
end 
 
if tablecharge(ratiok,7)>0 
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tablecharge(ratiok,9)=tablecharge(ratiok,5)/tablecharge(ratiok,7);%moyenne charfe decharges 
negatives 
end 
 
end 
 
tableaustringC2=cellstr(tableaustringC2); 
 
if affichage==1 
text(locs,abs(pks),tableaustringC2); 
end 
 
 
  tcell{1,20}= 'n° fichier'; 
  tcell{1+k-kdeb+1,20}=k;   
  tcell{1,21}= 'Integral energy µJ'; 
  tcell{1+k-kdeb+1,21}=integrenergy;  
  tcell{1,22}= 'Sum pic µJ'; 
  tcell{1+k-kdeb+1,22}=sumenergy;  
  tcell{1,23}= '% diff'; 
  tcell{1+k-kdeb+1,23}=ratio*100;  
tablecharge(ratiok,10)=integrenergy; % integrale energy de U I 
tablecharge(ratiok,11)=sumenergy;    %Somme des pics d'énergie 
   
   
  tcell{1,24}= 'N discharges'; 
  tcell{1+k-kdeb+1,24}=size(locs,1)-fauxpic; 
  tcell{1,25}= 'Decharges +'; 
  tcell{1+k-kdeb+1,25}=tablecharge(ratiok,6); 
  tcell{1,26}= 'Decharges -'; 
  tcell{1+k-kdeb+1,26}=tablecharge(ratiok,7); 
   
   
  tcell{1,27}= 'Somme totale des charges'; 
  tcell{1+k-kdeb+1,27}=tablecharge(ratiok,2); 
  tcell{1,28}= 'Somme valeur absolue des charges'; 
  tcell{1+k-kdeb+1,28}=tablecharge(ratiok,1); 
  tcell{1,29}= 'Somme charges +'; 
  tcell{1+k-kdeb+1,29}=tablecharge(ratiok,4); 
  tcell{1,30}= 'Somme charges -'; 
  tcell{1+k-kdeb+1,30}=tablecharge(ratiok,5); 
   
   
    tcell{1,31}= 'Moyenne decharges +'; 
  tcell{1+k-kdeb+1,31}=tablecharge(ratiok,8); 
  tcell{1,32}= 'Moyenne decharges -'; 
  tcell{1+k-kdeb+1,32}=tablecharge(ratiok,9); 
   
  if affichage==1 
saveas(gcf, ['fichier_', num2str(k),'_Reperagepics'],'png') 
  end 
    k 
    ratio*100 
  end 
             
 
  tcell{1,17}= '%diff sumpic and integral'; 
  tcell{2,17}=mean(ratiotablr)*100;   
  tcell{1,18}= '%std'; 
  tcell{2,18}=std(ratiotablr)*100;  
  tcell{1,19}= '%sem'; 
  tcell{2,19}=std(ratiotablr)*100/sqrt(size(tablecharge,1));  
   
  
   
  tcell{3,17}= 'mean Ndischarge'; 
  tcell{4,17}=mean(Ndischarge);   
  tcell{3,18}= '%std'; 
  tcell{4,18}=std(Ndischarge);  
  tcell{3,19}= '%sem'; 
  tcell{4,19}=std(Ndischarge)/sqrt(size(tablecharge,1));  
   
   
   tcell{6,17}= 'mean'; 
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   tcell{6,18}= 'Std'; 
    
   tcell{7,16}= 'Integral energy'; 
   tcell{8,16}= 'Sum pic'; 
   tcell{9,16}= 'Decharges +'; 
   tcell{10,16}= 'Decharges -'; 
   tcell{11,16}= 'Somme totale des charges'; 
   tcell{12,16}= 'Somme valeur absolue des charges'; 
   tcell{13,16}= 'Somme charges +'; 
   tcell{14,16}= 'Somme charges -'; 
   tcell{15,16}= 'Moyenne charges +'; 
   tcell{16,16}= 'Moyenne charges-'; 
    
   
   tcell{7,17}=mean(tablecharge(:,10)); 
   tcell{8,17}= mean(tablecharge(:,11)); 
   tcell{9,17}= mean(tablecharge(:,6)); 
   tcell{10,17}= mean(tablecharge(:,7)); 
   tcell{11,17}= mean(tablecharge(:,2)); 
   tcell{12,17}= mean(tablecharge(:,1)); 
   tcell{13,17}= mean(tablecharge(:,4)); 
   tcell{14,17}= mean(tablecharge(:,5)); 
   tcell{15,17}= mean(tablecharge(:,8)); 
   tcell{16,17}= mean(tablecharge(:,9)); 
    
    
   tcell{7,18}= std(tablecharge(:,10)); 
   tcell{8,18}= std(tablecharge(:,11)); 
   tcell{9,18}= std(tablecharge(:,6)); 
   tcell{10,18}= std(tablecharge(:,7)); 
   tcell{11,18}= std(tablecharge(:,2)); 
   tcell{12,18}= std(tablecharge(:,1)); 
   tcell{13,18}= std(tablecharge(:,4)); 
   tcell{14,18}= std(tablecharge(:,5)); 
   tcell{15,18}= std(tablecharge(:,8)); 
   tcell{16,18}= std(tablecharge(:,9)); 
   
    
   %SEM 
   tcell{7,19}= std(tablecharge(:,10))/sqrt(size(tablecharge,1)); 
   tcell{8,19}= std(tablecharge(:,11))/sqrt(size(tablecharge,1)); 
   tcell{9,19}= std(tablecharge(:,6))/sqrt(size(tablecharge,1)); 
   tcell{10,19}= std(tablecharge(:,7))/sqrt(size(tablecharge,1)); 
   tcell{11,19}= std(tablecharge(:,2))/sqrt(size(tablecharge,1)); 
   tcell{12,19}= std(tablecharge(:,1))/sqrt(size(tablecharge,1)); 
   tcell{13,19}= std(tablecharge(:,4))/sqrt(size(tablecharge,1)); 
   tcell{14,19}= std(tablecharge(:,5))/sqrt(size(tablecharge,1)); 
   tcell{15,19}= std(tablecharge(:,8))/sqrt(size(tablecharge,1)); 
   tcell{16,19}= std(tablecharge(:,9))/sqrt(size(tablecharge,1)); 
   
   
   xlswrite('Resultat.xls',tcell); 
            toc 
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A-2) Dielectric losses 
First, we give orders of magnitude that are relevant for the material which is used. 
Second, we give a model for dielectric losses in the framework of Dielectric Barrier 
Discharge. We explain, why we need to take into account dielectric losses, on the 
contrary of Kogelschatz et al. [333]. We are led to distinguish two sources of loss: one 
due to low-frequency currents (polarization of the dielectric due to the power supply) and 
one at high frequency due to short pulse discharges. Calculation of loss at low 
frequencies is made with Fourier series decomposition of the high voltage signal. 
The short pulse current is modeled by a triangular pulse in a first approach. A parametric 
study enables to find the value of the losses according to the parameter of the models 
(pulse duration, capacitance, the angle of loss). 
A-1-2) Order of magnitude 
In the presence of an electric field, the dipoles constituting the dielectric orient 
themselves in the direction of the field. The material polarizes and surface charges 
(bonds) appear. Thus a plate of a material (Linear, homogeneous, isotropic) of relative 
permeability εr of surface S and of thickness e behaves like a capacitor of capacitance C 
=ε0εrS/e when edge effects are negligible (see [88] for the calculation of edge effects).  
The dielectric strength of a material is the maximum difference of potential that can be 
applied of a given thickness without electrical breakdown. It is expressed in kV/mm. [334] 
give typical value: 20 kV/mm  for soda-calcium glass, 24 kV/mm  for polyamide-imide 
and more than 100 kV/mm for mica. Dielectric strength decrease with the temperature, 
heating can lead to thermal breakdown. 
The transverse resistivity of insulators is typically between 1011 Ω.cm and 1018 Ω.cm. For 
example: 1012 Ω.cm for soda-lime glass, 1017 Ω.cm for polyamides-imides. For 
comparison: copper resistivity is 17 10 -9 Ω.cm, gold 22 10-9 Ω.cm. The current is only 
defined by the value of the transverse resistance for a constant potential difference. 
In a dielectric exposed to a variable electric field, the material undergoes additional 
heating. This electric heating is at the basis of the operation of microwave ovens. 
Heating losses can be modeled by adding an Equivalent Serie Resistance (RS) in series 
with the equivalent capacitance of the dielectric. The general expression giving the 
power absorbed by the dielectric is expressed: 
ܲ = 2ߨ݂ߝ଴ߝ′௥ tan(ߜ)ܧଶܸ = ܴௌܫோெௌ
ଶ 
with   
 E: uniform electric field of frequency f applied to the material. 
 ܫோெௌ: RMS intensity. 
 V: volume of dielectric material. 
 ε’R: real part of the relative permeability of the material 
 tan (ߜ): tangent of the angle of loss (angle measuring the deviation from 
the phase shift 
of π/2  between the current and the voltage across a capacitor). We have: 
ݐܽ݊ߜ = ߝ′ோ/ߝ′′௥ with ߝ′′௥ : the imaginary part of the relative permeability  
Appendix A Electrical and power measurements 
 Appendix A- 315 
tan ߜ is connected to the capacitance of the electrical plate by tan (δ)  =  RୱCω. 
Therefore ܴ௦(ߥ) =
୲ୟ୬ (ఋ)
ଶగఔ஼
 
Orders of magnitude of tan (ߜ) from [334] are shown in Table 25.  The loss angle 
may increase with the frequency (look at polyacetal row in the table). 
Material tan(δ) 
soda-lime glass 1.5 10ିଶ → 6 10ିଶ at 50 Hz 
Borosilicate glass (for example pyrex) 3.5 10ିଷ  at 50 Hz 
Ceramic alumina 10ିଷ at 50 Hz 
Polyethylene 2 10ିସ at 50 Hz 
polyamide-imide 3 10ିଶ at 50 Hz 
Polyacetal 10ିଷ at 50 Hz and 6 10ିଷ at 1 MHz 
Table 25 Orders of magnitude of ܜ܉ܖ (ࢾ) for different material from [334]. 
A-2-2) Model of dielectric losses in the framework of DBD 
Polarization(s) of a material 
A material polarizes when displacements of charge carriers relative to each other under 
the effect of an external electric field make it possible to form dipoles or redirect pre-
existing dipole. There are therefore several types of polarization, depending on the type 
of charge carrier involved. 
Electronic polarization is due to a relative displacement of the nucleus of the atom with 
respect to the set of electrons that surround it. All atoms exhibit, this type of polarization 
which is established in a very short time, and remains sensitive to frequencies exceeding 
those of visible light. This is why electronic polarization is often referred to as optical 
polarization. 
Ionic polarization is found in ionic crystals (for example NaCl). It results from the 
displacement in opposite directions of positives and negatives ions. This polarization is 
established more slowly than the previous one; it manifests itself to frequencies between 
the microwaves and the infrared. 
Orientation polarization. Most often, a molecule formed of different atoms possesses a 
spontaneous dipole moment that is independent of the existence of an external field. In 
the absence of such a field, these moments are oriented in a random manner, so that 
there are no observable macroscopic polarization. Under the effect of a field, on the 
other hand, moments tend to line up. This result in a polarization called orientation 
polarization, occurring up to frequencies between 1 kHz and 1 MHz. In addition to this 
orientation phenomenon, the field can vary the moment of the molecule, by deformation 
of its orbitals. 
Interfacial polarization.  
Charges carriers, which are never totally absent in a dielectric, migrate under the effect 
of the field and tend to concentrate around defects such as impurities, gaps, grain 
boundary, etc. The polarization resulting from the local accumulations of loads due to all 
the migration phenomena is grouped under the name of interfacial polarization. This 
polarization is characterized by the longest settling time of all: it can reach several 
minutes and even more. 
Polarisability and Debye equation 
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Let us consider a dipole of moment  ݌⃗ in an externe electric field  ܧሬ⃗ . Potentiel energy of 
this dipole is: 
ܧ௣௢௧ = −݌⃗. ܧሬ⃗  
The potential energy is minimal if the dipole is aligned with ܧሬ⃗ . A set of identical electrical 
dipoles of polarization p are distributed in energy according to a Boltzmann distribution: 
݊൫ܧ௣௢௧൯ = ݊଴݁ݔ݌ (−
ா೛೚೟
௞ಳ்
), 
with ݊൫ܧ௣௢௧൯݀ܧ௣௢௧ the volumic density of dipole with an energy in the interval [ܧ௣௢௧ , ܧ௣௢௧ +
݀ܧ௣௢௧]. ݊଴ is a normalization factor, which is determined by the integral of the Boltzmann 
function over the energies space. This integral must be equal to the density of dipoles. 
݊ௗ௜௣௢௟௘ = න ݊଴݁ݔ݌ (−
ܧ௣௢௧
݇஻ܶ
)
௣ா
ି௣ா
݀ܧ௣௢௧ = ”݀݁݊ݏ݅ݐݕ ݋݂ ݀݅݌݋݈݁” 
We defined z-axis along the electric field. Therefore a dipole which makes an angle ߠ 
with z axis has energy: 
ܧ௣௢௧(ߠ) = −݌ܧܿ݋ݏ(ߠ) 
The average polarization P is calculated by integrating the projections of the dipoles on 
the z-axis. 
ܲ = න ݌ ܿ݋ݏ ቀߠ൫ܧ௣௢௧൯ቁ ݊൫ܧ௣௢௧൯
௣ா
ି௣ா
݀ܧ௣௢௧ 
Moreover ݀ܧ௣௢௧ = ݌ܧݏ݅݊(ߠ)݀ߠ and by changing the variable 
ܲ = න ݌ܿ݋ݏ(ߠ)݊଴exp (
݌ܧܿ݋ݏ(ߠ)
݇஻ܶ
)ݏ݅݊(ߠ)݀ߠ
గ
଴
 
By performing the same operation with the normalization factor: 
ܲ = ݊ௗ௜௣௢௟௘݌ 
∫ ܿ݋ݏ(ߠ)݁ݔ݌ (
݌ܧܿ݋ݏ(ߠ)
݇஻ܶ
)ݏ݅݊(ߠ)݀ߠ
గ
଴
∫ ݁ݔ݌ (
݌ܧܿ݋ݏ(ߠ)
݇஻ܶ
)ݏ݅݊(ߠ)݀ߠ
గ
଴
= ݊ௗ௜௣௢௟௘݌
∫ ݔ݁ݔ݌ (
݌ܧݔ
݇஻ܶ
)݀ݔ
ଵ
ିଵ
∫ ݁ݔ݌ (
݌ܧݔ
݇஻ܶ
)݀ݔ
ଵ
ିଵ
=  ݊ௗ௜௣௢௟௘݌ ܮ(
݌ܧ
݇஻ܶ
)  
With L the function of Langevin such as  ܮ(ݔ) = coth(ݔ) − ଵ
௫
=
௫
ଷ
+ ܱ଴(ݔଷ) for small value 
of x. 
order of magnitude of  ࢖ࡱ
࢑࡮ࢀ
:  
 Permanent moment p of water is around 6.3 10ିଷ଴ ܥ. ݉.  
 E is around 20 ܸ݇. ݉݉ିଵ = 2 10଻ ܸ. ݉ିଵ 
݇஻ܶ = 0.025 ܸ݁ for T =20 °C and ݇஻ܶ = 6.7 ܸ݉݁ for T=77.4 K ( temperature of liquid 
nitrogen). Therefore at 20°C : ௣ா
௞ಳ்
= 0.031, at T=77.4 K ௣ா
௞ಳ்
= 0.12. 
Consequently, the linear approximation of Langevin function is true, even in our “worst” 
experimental conditions: dielectric in liquid nitrogen and strong field. Finally, we have: 
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ܲ = ݊ௗ௜௣௢௟௘
݌ଶܧ
3݇஻ܶ
= ݊ௗ௜௣௢௟௘߳଴ߙ௢௥ܧ 
ߙ௢௥ is called orientation polarizability. The previous calculation is valid in static mode. 
Now we will see how to get the results in sinusoidal regime. 
Two factors influence the orientation of permanent dipoles: 
 The thermal agitation, which can be assimilated to the action of shocks inflicted 
on the dipoles. 
 The local field  ܧሬ⃗  
These shocks enable to reorient a part of the dipoles at any time t1. These dipoles are 
distributed according to the statistical distribution of Boltzmann which depends on the 
orientation of the electric field ܧሬ⃗ (ݐଵ). The effect of shocks is predominant
125 with respect 
to that of the local field which tends to align the dipoles parallel to each other (except in 
ferroelectric materials). We can assume, as a first approximation, that the orientation of a 
dipole does not vary in the absence of shocks. On the other hand, since the dipoles are 
not coupled to each other, it is reasonable to assume that, immediately after a shock, the 
energy of a dipole is distributed according to the corresponding Boltzmann distribution 
defined by the value of the local field at the time of the shock. 
We need to evaluate the number of dipoles ݀݊(ߠ) that have undergone a last shock at 
time θ = t – t1 (see Fig 246).The average frequency of the shocks 1/߬ does not depend 
on ܧሬ⃗  and therefore on time. There is no correlation between energy before impact and 
after shock. The shock can be considered instantaneous. ݀݊(ߠ) depends only on the 
time interval θ. The number of dipoles ݀݊(ߠ) undergoing their last shock between θ and 
θ + dθ is proportional to the frequency of the shocks and proportional to the number of 
dipole ݊(ߠ) that have not yet undergone a shock. Their number decreases with θ. 
݀݊(ߠ) =  −݊(ߠ) 1/߬ ݀ߠ 
 
Fig 246 Polarization at time t is the sum of the polarization of each dipole. Among these dipoles, 
some experienced their last shock between t1 and t1 + dt1. This shock caused them to adopt a 
distribution of energy and therefore of orientation corresponding to the value of the electric field at 
time t1. 
                                               
125 Since  ௣ா
௞ಳ்
≪ 1 
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By integration, with the condition  n(θ = 0) = nୢ୧୮୭୪ୣ , we obtain n(θ) = nୢ୧୮୭୪ୣexp (−
஘
த
)  
In sinusoidal regime, the electric field has this expression E = EୟRe(e୨ன୲).  
thus, dP = ୮
మ୉౗
ଷ୩ా୘
exp(jωtଵ)dn(tଵ) =
ି୮మ୉౗
ଷ୩ా୘
exp(jω(t − θ))dn(θ) 
whence the complex expression of P: 
P = ∫
ି୮మ୉౗
ଷ୩ా୘
ାஶ
଴ exp൫jω(t − θ)൯
ି୬ౚ౟౦౥ౢ౛
த
exp (−
஘
த
)dθ =
୮మ୉౗୬ౚ౟౦౥ౢ౛
ଷ୩ా୘த
∫ exp ቀjω(t − θ) −
஘
த
ቁ dθ
ାஶ
଴    
and P =
୮మ୉౗୬ౚ౟౦౥ౢ౛
ଷ୩ా୘த
ିଵ
୨னା
భ
ಜ
exp(jωt)[0 − 1] =
୮మ୉౗୬ౚ౟౦౥ౢ౛
ଷ୩ా୘
ଵ
୨னதାଵ
exp(jωt) 
Thus real expression of P is expressed by Debye equation: 
P = nୢ୧୮୭୪ୣ
pଶ
3k୆T
Re(
E
1 + jωt
exp(jωt)) 
Complex permittivity and dielectric losses, definitions 
According to Clausius-Mossotti relation: ఢೝିଵ
ఢೝାଶ
=
௡೏೔೛೚೗೐  ఈ
ଷ
, which enables to infer the value 
of real and imaginary part of the relative permeability. 
A-3-2) Losses in the framework of Dielectric Barrier 
Discharge 
Kogelschatz describes in the paper [333] why it does not take into account dielectric 
losses : “The area inside the closed curve is proportional to the energy dissipated in the discharge during 
one cycle. The dielectric behaves like an ideal capacitance and does not noticeably dissipate power. This 
can easily be checked: as long as U  <  Umin  the curve collapses to a line on the oscilloscope.”. 
In the devices used by Kogelshatz, the generator supplies charges immediately after one 
microdischarge of few nC. The new charges elicit immediately another micro-discharge 
of few nC which enable to maintain a constant difference of potential across the gas gap. 
In our case the situation is very different: instead of “small” micro-discharges of few nC 
or less which occurs continuously after the supply voltage has reached ignition voltage; 
we have discharges of several tens of nC which occurs quite randomly. Instead of having 
a smooth parallelogram, the Lissajous curves of our devices (DBD and plasma-jet) looks 
like those shown in Fig 247. Consequently, the voltage across the dielectric layers of our 
device could be higher than the voltage that would be reached if the discharge was 
ignited continuously as soon as voltage exceeded ignition voltage. 
Moreover, by choosing a Voltage slightly below the ignition voltage, we have been able 
to check that the line turns into an ellipse (weakly open). A metal electrode connected to 
ground (via the measuring capacitor) was taped at the outside of the DBD and enables 
the direct observation of dielectric losses. 
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Fig 247 Lissajous curve for He-single jet. Helium Flow= 600 sscm. Height= 9 mm, peak to peak 
Voltage is 26 kV. waveform is sinusoidal. Power is 447±7 mW. Single jet parameter :  di=4 mm, e=1.5 
mm. Target is 500 µL of demineralized water in 24 wells costar plate 
Regarding the ozoner, the dielectric losses are negligible compared to the mean power 
of the device. We distinguish two field of dielectric loss: one due to low126 frequency 
currents and one at high frequency (~50 MHz-GHz) due to short pulse discharge (~1 ns -
20 ns). 
A-4-2) Dielectric losses at low frequency 
In the first section, the dielectric losses due to the polarization of dielectric barrier will be 
quantified. The losses are evaluated in the case of the sinusoid power supply and then if 
the power supply is not sinusoidal.  
We have seen that a small number of discharges are observed per period. Under these 
conditions, there is no “active plasma phase” during which a multitude of micro-
discharges enables to build a constant potential across the gas gap.  Calculations of 
losses from experimental signals are discussed in paragraph A-2-4-b) . They were made 
by decomposing the current into Fourier series (see Matlab program described in section  
A-2-4-c). 
A-2-4-a) Sinusoidal power supply, order-of-magnitude calculations 
We consider a dielectric barrier of capacitance 3 pF, which corresponds to the value of 
the measured and calculated capacitance value of the DBD actually used above the 
mice. We assume that tan(δ) = 5 10ିଷ, which correspond to the loss angle of glass. It is 
assumed that the voltage has following waveform: ܸ(ݐ) = ଴ܸcos (߱ݐ) with frequency 
ν =
ன
ଶ஠
= 500 Hz  and amplitude V଴ = 15 kV.  
Under these conditions, the current has the amplitude:  
ܫ = ܥ߱ ଴ܸ = 3 10ିଵଶ × 2ߨ × 500 × 1.5 10ସ ≅ 141 μܣ 
Whence, RMS value of current is Iୖ୑ୗ = 100 μA. 
According to the section A-1-2), equivalent series resistance representing dielectric 
losses is: 
Rୗ =
tan (δ)
2πνC
=
5 10ିଷ
3000π × 10ିଵଶ
≅ 531 kΩ  
                                               
126 ≤ 500 ݇ܪݖ  essentially due to the polarisations curent elicited by power supply 
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Therefore, the power of dielectric losses is: 
ܲ = ܴௌܫோெௌ
ଶ = 5.31 10ହ × (1.41 × 10ିସ)ଶ ≅ 10.5 ܹ݉ 
and energy of losses during one period of the power supply is E ≅ 21.1 μJ. Since the 
mean power consumption of dielectric barrier discharge which was used is around 100 
mW, dielectric losses are not always negligible. 
A-2-4-b) What if the voltage is not sinusoidal? 
The voltage at the terminals of the dielectric can be decomposed into the sum of sines 
and cosines function. This signal is real and periodic at the frequency  ଵ
୘
= 500 Hz: 
therefore Fourier series has real coefficients. Experimentally we will start from the 
current flowing through the device. The voltage of power supply is plotted in red in Fig 
248. The voltage at the terminal of condensers Cm = 104 nF is shown in blue. The 
current is deduced from the value of the voltage at the terminals of the capacitor. The 
bandwidth of this method is limited. This is not an issue since we consider only low-
frequency losses (several-fold the frequency of power supply).  Fourier series takes the 
following form: 
ܫ(ݐ) = ܣ଴ + ෍ ܣ௡ cos(߱݊ݐ) + ܤ௡sin (߱݊ݐ)
ାஶ
௡ୀଵ
 
with:  
 ܣ௡ =
ଶ
்
∫ ܫ(ݐ) ܿ݋ݏ(߱݊ݐ) ݀ݐ
்
଴ ,          ܤ௡ =
ଶ
்
∫ ܫ(ݐ) ݏ݅݊(߱݊ݐ) ݀ݐ
்
଴  for ݊ ≥ 1 
and   ܣ଴ =
ଵ
்
∫ ܫ(ݐ) ܿ݋ݏ(0) ݀ݐ
்
଴ . 
 
In this section, we will compute the value of the dielectric losses which occurs in a layer 
of dielectric material of capacitance 3 pF characterized by the angle of losses  tan(ߜ) =
5 × 10ିଷ. The signal used is plotted in Fig 248. It will be assumed that this signal is 
periodic, the decomposition in Fourier series will lead us to estimate the value of the 
dielectric losses that can be expected. 
 
Fig 248 Red, voltage of the power supply during one period of the power supply (2 ms), Blue, voltage 
at the terminal of measuring capacitor. There are three discharges during this acquisition (sampling 
frequency = 25 MHz) 
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Let's look at the signal in more detail. Fig 249 shows that, for each discharge, the 
amount of charges and the energy consumption can be deduced. It appears that the 
energy consumption is ~323 µJ over one period of 2 ms. It means that if this signal was 
periodic, the average power of the device would be ~160 mW. 
  
Fig 249 Details of Fig 248. Red: voltage of power supply. Blue: voltage at the terminal of condenser 
Cm. Left, one discharge during negative phase of the power supply. Right : Two discharges during 
the positive phase of power supply. The amounts of switched charges, as well as the energy 
consumed, are shown in red. Total energy consumption is ~ 324 µJ. 
The left panel of Fig 250 describes the energy consumption of the whole device over the 
entire period. This energy127 ~ 333 µJ is obtained by numerical integration and contain 
energy consumption due to plasma-discharge and dielectric losses. This value is 
consistent with those found by the summation of the energy associated with each 
discharge (~323 µJ) and would correspond to a power of 160 mW. The right panel 
shows the value computed for the losses over this period as a function of the number of 
harmonics included in the calculation. The dielectric losses are limited to a value of 27.2 
μJ (~ 8 %) which correspond to ~14 mW. Computations were made with the program 
given in next paragraph. 
It would be interesting to be particularly careful when plasma power is “low” (~100 mW in 
such conditions). Since a significant proportion of the power consumption measured by 
integral method128 could be made of dielectric losses. 
                                               
127 As explained in section V.1.5 (page 129), the “overshoot” of the integral  ܧ(ݐ) = ∫ ܷ(ݐ′) ×
௧
଴
ܫ(ݐ′)݀ݐ′ has no physical meaning. On the contrary, the values obtained after the damping of this 
transient regime have one meaning. hence the value of 333 μJ 
128 which is strictly equivalent to Lissajous method i.e. the calculation of an inner area... 
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Fig 250 Left: energy consumption over one period. This curve is ࡱ(࢚) = ∫ ࢁ(࢚′) × ࡵ(࢚′)ࢊ࢚′
࢚
૙
 where U is 
the voltage of the power supply, and I is the current flowing through measuring capacitor (see 
Chapter II, section II.2 page 34). With this method total energy consumption is ~ 333 µJ, this value is 
consistent with those found by the summation of the energy associated with each discharge.  Right: 
dielectric losses computed with Fourier series as a function of the number of harmonic include in the 
sum. The fact that this curve reaches the value 16 µJ when N=4, means that the sum of the dielectric 
losses associated with the frequency f1=500 Hz, f2=1000 Hz, f3= 1500 Hz, f4 = 2000 Hz is equal to ૚૟ μࡶ. 
The dielectric losses are computed for a dielectric layer of capacitance ࡯ = ૜ ࢖ࡲ and the angle of 
losses ࢾ such that ࢚ࢇ࢔(ࢾ) = ૞ × ૚૙ି૜. The energy of the dielectric losses would be ~27.2 μJ per 
period (which would represent a power of 13.6 mW) 
A-2-4-c) Matlab program for the summation of dielectric losses 
clear x y T A Af Bf aff afff affff listefreq pertefreq Rpertes signalcondensateur 
format longeng 
 
 
Nharm=1000;     %Number of harmonics 
 close all 
 
cm=104*1e-9; 
Rsonde=10*1e6; 
 
C=3*1e-12;     %equivalent series capacitance 
tandelta=5e-3;    %angle of losses 
 
 
t=CC21; 
t=transpose(t(1:end-1)-t(1));  %- 1 due to diff 
signalcondensateurCM=CC22; 
%smoothing 
% raw data have a temporal resolution of 4ns, windows = 4 µs 
windowSize=500; 
taille=2*windowSize-1; 
V=signalcondensateurCM; 
            V1 = filter(ones(1,windowSize)/windowSize,1,V); 
            V2 = filter(ones(1,windowSize)/windowSize,1,V(end:-1:1,:)); 
            V2=V2(end:-1:1,:); 
            V=(windowSize*(V2+V1)-V)/(2*windowSize-1); 
            V=V(taille:end-taille,:); 
signalcondensateurCM=V;             
t=t(taille:end-taille);            
 
x=cm.*diff(signalcondensateurCM)./(t(2)-t(1))+signalcondensateurCM(1:end-1)/Rsonde; 
 
% V=CC12  
%V=x; 
%             V1 = filter(ones(1,windowSize)/windowSize,1,V); 
%             V2 = filter(ones(1,windowSize)/windowSize,1,V(end:-1:1,:)); 
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%             V2=V2(end:-1:1,:); 
%             V=(windowSize*(V2+V1)-V)/(2*windowSize-1); 
%             V=V(taille:end-taille,:); 
% x=V;  
% 
 
vvv(1,1)=t(1)*1e3; 
vvv(1,2)=sss(1)*1e6; 
for nn=100:100:498003 
    vvv(nn/100.0,1)=t(nn)*1e3; 
    vvv(nn/100.0,2)=sss(nn,1)*1e6; 
end 
 
 
T=t(end)-t(1); 
 
N=length(t); 
A=zeros(2,N); 
A(1,:)=t; 
A(2,:)=x; 
 
 
 
 
y=zeros(1,N); 
Af=zeros(1,Nharm); 
Bf=zeros(1,Nharm); 
A0=1/T*trapz(A(1,:),A(2,:).*cos(0.*t)); 
y=A0; 
affichage=0; 
 
    for n=1:Nharm 
       % for n=2*1e6-20:2*1e6 
   
        Af(n)=2/T*trapz(A(1,:),A(2,:).*cos(n*(2*pi)/T*t)); 
        Bf(n)=2/T*trapz(A(1,:),A(2,:).*sin(n*(2*pi)/T*t)); 
        y=y+Af(n)*cos(n*2*pi/T*t)+Bf(n)*sin(n*2*pi/T*t); 
         if (mod(n+1,1)==0) 
           q=n/Nharm*100  
        listefreq=1/T:1/T:Nharm/T; 
        Rpertes=tandelta./(C*2*pi*listefreq); 
        pertefreq=Rpertes.*(Af.^2+Bf.^2)*1*T; %energy 
 
        PerteBF=sum(pertefreq(1:10)); 
        perteTot=sum(pertefreq); 
        affichage=affichage+1; 
        aff(affichage)=n; 
        afff(affichage)=perteTot; 
        affff(affichage)=PerteBF; 
        figure(4) 
        plot(aff,afff,'r',aff,affff,'b'); 
         pause(0.01); 
         end 
         
        end 
 
    
figure(1) 
plot(t,transpose(y(1,1:N))-x,'b+') 
 
figure(2) 
plot(t,x,'b+'); 
hold on; 
plot(t,transpose(y(1,1:N)),'r') 
 
 
 
listefreq=1/T:1/T:Nharm/T; 
Rpertes=tandelta./(C*2*pi*listefreq); 
pertefreq=Rpertes.*(Af.^2+Bf.^2)*1*T; %energy 
 
PerteBF=sum(pertefreq(1:10)); 
perteTot=sum(pertefreq); 
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A-5-2) Experimental observation of the aging of DBD device 
The measurement of tan(ߜ) characterizes the dielectric barrier of our DBD device, and 
so, enables to compute dielectric losses. However, these measurements can also be 
used to follow the aging of the dielectric layer. Indeed, in the practical case of medical 
treatment, it would be useful to know when one DBD-device should be change to avoid 
the occurrence of dielectric breakdown and thus electrical shocks. 
The measurements of the capacitance and angle of loss of our DBD-device were 
performed after several hours of aging with a LCR-meter (Keysight, 
reference Ref E4980AL-032 20Hz to 300 kHz with DCR) equipped 
with an adapted alligator clip (Keysight 16089D-FG Alligator Clip 
Lead). 
The head of the DBDs was held by a vise. The coaxial cable and all 
the mobile parts were also fixed on the table. 
One of the crocodile clips is connected to the heart of the coaxial 
cable connected to the inner part of the DBD. The second is 
connected to an 18 mm wide aluminum strip bonded to the surface of 
the DBD (rectangular, length ~3 cm). The measurements were 
repeated 10 times by changing aluminum strip. The ground129 was 
connected to the external conductor of the coaxial cable. Settings of 
the RLC-meter: 
 mode = Cs-D, i.e. measure the equivalent series resistances 
 level = 2 V, amplitude of test voltage 
 frequency ܨ =  5 ݇ܪݖ. 
 measurement time = 240 ms (LONG) averaged over 64 acquisitions. 
First, the measurements were done with a newly manufactured device (Fig 252, zero 
hours of aging). We obtain a capacitance equal to ܥௌ = 2.25 ± 0.05 ݌ܨ and tan(ߜ) =
0.147 ± 0.005. The DBD was powered130 during 12 hours in front of a conductive tape 
connected to the ground. The measurements were repeated with the same protocol 
(aging = 12 h). As the measured aging is not significant, we performed the treatment 
above a liquid target for 12 additional hours (aging = 24 h). The capacitance does not 
decrease significantly; it means that the surface is not significantly eroded. However, a 
significant difference is observed regarding the value of ܜ܉ܖ (ࢾ). 
In this case, there is actually aging of the materials due to the degradation of the upper 
layers of the dielectric layer. This evolution is visible by eye since the plastic becomes 
slightly opaque. The faster aging above the liquid may be due to the production of more 
reactive species in the gas phase above the water. These species could lead to 
accelerated degradation of the plastic. 
                                               
129 provided by another lead of the RLC-meter). 
130 sinusoid power supply, ~30 kV peak to peak. 
Fig 251: head of the 
DBD 
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Fig 252 Red, angle of loss of the dielectric layer of blue resin DBD (see II.1.3, page 29) just after 
manufacturing (0 h), after 12 h of functioning over a solid target (aluminum plate connected to the 
ground). After this step, the aging was done during 12 h above liquid layer (aging = 24 h). Blue: 
capacitance of the device as a function of aging. Error bar represents the standard deviation of 10 
independent measurements. 
A-6-2)  Dielectric losses at high-frequency 
Model 
When one of the discharges takes place an intense current flow for a period of time of 
the order of few ns ([335] and own results). Each discharge carries a quantity of charge: 
between 0.1 nC and few tens of nC ([335] and own results). This transitional current is 
also at the origin of dielectric losses. The question is whether they can be neglected or 
not. The current pulse is modeled by a triangular pulse. The first step is to obtain the 
Fourier transform of this pulse. The second step is to sum the energy of the losses for 
each frequency. We use the assumption tan(ߜ) = ܥݏݐ to known the equivalent 
resistance RS for each frequency. This is true as a first approximation according to [334] 
and the results regarding blue resin.  
Fourier transform of a triangular pulse 
Let us consider a triangular current pulse defined by the parameters A and ଵܶ 
respectively the amplitude and the half of the pulse duration. Pulse is of the the form: 
ܫ(ݐ) =
⎩
⎪
⎨
⎪
⎧ 0, ݐ ≤ − ଵܶ ݋ݎ ݐ ≥ ଵܶ
ܣ ቀ1 +
௧
భ்
ቁ , − ଵܶ ≤ ݐ ≤ 0
ܣ ቀ1 −
௧
భ்
 ቁ , 0 ≤ ݐ ≤ ଵܶ
 
 
The derivative I’ of I is: 
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ܫᇱ(ݐ) =
ܣ
ଵܶ
ݎ݁ܿݐ ൬ݐ + ଵܶ
2
൰ −
ܣ
ଵܶ
ݎ݁ܿݐ ൬ݐ − ଵܶ
2
൰ 
with  
ݎ݁ܿݐ(ܺ) = ൝1, −
ଵܶ
2
≤ ݐ ≤ ଵܶ
2
0, ݋ݐℎ݁ݎݓ݅ݏ݁
 
 
We defined the Fourier transform ܨ[݃] of the function (݃: ݐ → ݃(ݐ)) as ቀܨ[݃]: ߥ →
∫ ݃(ݐ)݁ିଶ௜గఔ௧݀ݐ
ାஶ
ିஶ
൯. 
So Fourier transform of rect is:  ܨ[ݎ݁ܿݐ](ߥ) = ∫ ݎ݁ܿݐ(ݐ)݁ିଶ௜గఔ௧݀ݐ = ଵܶ
ାஶ
ିஶ ݏ݅݊ܿ(ߨ߭ ଵܶ) 
Let us consider Fourier transform of  ܫ′: 
ܨ[ܫᇱ](ߥ) =
ܣ
ଵܶ
൤e
ଶ௜గఔ భ்
ଶ ଵܶݏ݅݊ܿ(ߨߥ ଵܶ) − ݁
ି
ଶ௜గఔ భ்
ଶ ଵܶݏ݅݊ܿ(ߨߥ ଵܶ)൨
=
ܣ
ଵܶ
[2݅ ଵܶsin (ߨߥ ଵܶ)ݏ݅݊ܿ(ߨߥ ଵܶ)]
 
Since ܨ[ܫᇱ](ߥ) = 2݅ߨߥܨ[ܫ](ߥ),  
 ܨ[ܫ](ߥ) = ܣ ଵܶݏ݅݊ܿଶ(ߨߥ ଵܶ) 
 
Dielectric loss of one pulse 
The amount of energy of dielectric losses for the frequencies in the interval [ߥ, ߥ + ݀ߥ] is: 
ܴ௦(ߥ)|ܨ[ܫ](ߥ)|ଶ݀ߥ. 
Since       ܴ௦(ߥ) =
୲ୟ୬ (ఋ)
ଶగఔ஼
, 
ܴ௦(ߥ)|ܨ[ܫ](ߥ)|ଶ  ~
ఔ→଴
   
1
ߥ 
tan (ߜ)
2ߨܥ
 
Therefore, the integral of the spectral density of energy is divergent in 0. This non-
physical behavior is due to the limits of the modeling: actually tan (ߜ) is a function of ߥ.  
Since the experiment itself has a finite duration, it is legitimate to introduce a cut-
off: 1
଴ܶ
ൗ . At high frequency the integral is convergent. Calculations were made with 
“integral” function of MATLAB. Cut-off was chosen at  f = 10-3 Hz. Since tan (ߜ)  
increases wit the frequency f, this model gives a lower bound of dielectric losses. In the 
following figures, the power of the dielectric losses is computed with the assumptions 
that there are two pulses per period. The parametric study presented in Fig 253, Fig 254, 
Fig 255 and Fig 256 show that the power of the dielectric losses depends on: 
 the amount of charge transported 
 the duration of the pulse 
 the angle of losses 
 the capacitance of the dielectric layer 
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Fig 253 Parameter = transported charge. Dielectric losses for a triangular pulse. The pulse has a 
duration of 10 ns. The charge (and the amplitude of current pulse) is variable. The dielectric layer has 
a capacitance C=3 pF and ࢚ࢇ࢔(ࢾ) = ૞ ૚૙૜ is the langle of loss. Left: energy losses for 1 pulse in µJ as 
a function of carried charge in nC. Right: power consumption of the losses with the assumption of 1 
discharge by half-period at 500 Hz. 
 
Fig 254 Parameter = pulse duration. Dielectric losses for a triangular pulse. The carried charge is 45 
nC. The dielectric layer has a capacitance C = 3 pF and ࢚ࢇ࢔(ࢾ) = ૞ ૚૙ି૜ is the tangent of the angle of 
loss. Power consumption of the losses as a function of pulse duration in ns. Assumption “one 
discharge by half-period at 500 Hz”. 
 
Fig 255 Parameter = loss angle. Dielectric losses for a triangular pulse. The carried charge is 45 nC. 
The dielectric layer has a capacitance C=3 pF, and ࢚ࢇ࢔(ࢾ) is variable. Power of the losses as a 
function of  ࢚ࢇ࢔(ࢾ) with the assumption “1 discharge by half-period at 500 Hz”. 
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Fig 256 Parameter = capacitance. Dielectric losses for a triangular pulse. Black: Voltage of discharge 
ignition = 15 kV. Blue : ignition = 7500 V. The dielectric layer has a capacitance between 1 and 300 
pF, ࢚ࢇ࢔(ࢾ) =  ૞ ૚૙ି૜.Power of the losses as a function of  capacitance for a constant Voltage. 
Assumption: “one discharge by half-period at 500 Hz”. 
A-3) What if there is a mouse in the electrical circuit? 
During in-vivo experiments, the cold plasma is directly in contact with the skin of the 
mouse. It is essential to know the electrical characteristics of the treated target to ensure 
that power measurement was not biased by the Joule effect occurring in the skin of the 
mouse. Equivalent series resistance and capacitance were measured with a RLC-
meter131 to understand the electrical behavior of the mouse skin. The upper part of the 
tumor was connected to the RLC-meter with a cut piece of an ECG electrode 
(whitesensor, distrimed). The conductive gel was placed around the tumor (without 
covering it) in the same way that in the in-vivo experiments (section V.2 and following). 
This gel was used to prevent the current from flowing through the internal organs. The 
second lead was connected to the ECG electrode fixed at ~ 3 cm from the tumor (similar 
to in-vivo experiments). A conductive path was established between this ECG electrode 
and the gel located near the tumor (similar to in-vivo experiments). The mouse was 
under anesthesia. 
Equivalent series resistance and capacitance were measured for several frequencies 
between 100 Hz and 300 KHz (Fig 257 Log-Log scale). The capacitance decrease with 
frequency from 488 nF to 1.45 nF. Equivalent series resistance decreases also from 
14 ݇Ω  to 1 ݇Ω.  
The existence of a slope break in Cs(f) curve near to the frequency ݂ =  1 ݇ܪݖ probably 
reflects the fact that it is not the same biological structure that contributes mainly to the 
total capacitance of this piece of skin before and after this frequency. It would be 
interesting to repeat such experiments (this measurement was made on a single mouse) 
and to interpret the slope break with the references [336], [337]. 
                                               
131 The same device was used in section A-5-2). Keysight RLC-meter, Ref E4980AL-032 
20Hz to 300 kHz  and 16089D-FG Alligator Clip Lead (4 Clips) 
Appendix A Electrical and power measurements 
 Appendix A- 329 
 
Fig 257 Capacitance (in nF) and equivalent series resistance acquired at the surface of the skin with 
the LCR meter (E4980AL from Keysight®). 
Regarding power measurement, Fig 258 shows that charges movement take place in ~ 1 
µs (acquired in-vivo, sampling frequency = 10 MHz). Consequently, at this time scale, 
the resistance is probably ~ 1 ݇Ω or below according to previous figure. This is consistent 
with the response time ߬ = ܴܥ deduced from the electrical circuit equivalent to {mouse 
skin + measuring capacitor Cm = 100 nF + measuring system} that should be equivalent 
to a capacitor ܥ ≅ 1.5 ݊ܨ in series with a resistor ܴ = 1 ݇Ω.  
߬ = ܴܥ = 1.45 μݏ 
Moreover, the additional resistance does not contribute significantly to the power 
consumption. Indeed, if it is assumed that the current last ~1 µs in the skin and transport 
~ 100 nC (the upper limit of the charges transported during “one” discharge); the current 
is ~0.1 A. Energy consumption will be ~1 μݏ × ܴܫଶ ≅ 10ି଺ × 10ଷ × 10ିଶ~10 μܬ. Whereas 
the total energy consumption associated with such discharge is around 1000 μܬ (see the 
order of magnitude presented in Fig 239, page 304 which is remain suitable for this 
calculation). So even in an extreme case (that of a powerful discharge which transport 
100 nC) the energy dissipated by the joule effect in mouse skin should not contribute 
significantly to the overall energy balance. 
 
Fig 258 example of signal measured with the capacitor connected to the mouse. Response time is 
approximately ~ 1 µs  
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Appendix B Scavenging of HO° by methanol 
B-1) Methanol: an efficient scavenger of HO° 
The purpose of these experiments was, initially, to precise the origin of H2O2 in liquid 
solution. Sato et al. [338] and Hsieh et al. [339] make the assumption that H2O2 in the 
liquid phase is mostly produced by the recombination of hydroxyl radicals. 
ܱܪ° + ܱܪ° → ܪଶܱଶ (݇௥௘௖௢௠௕௜௡௔௧௜௢௡ = 5.5 ×  10ଽ ܯିଵݏିଵ)   [338] 
These hydroxyls radicals would originate directly from the plasma phase or would be a 
by-product linked to the production of solubilized electrons, or destruction of water 
molecules. 
Scavengers such as methanol or ethanol react very quickly with hydroxyls radicals 
(݇௘௧௛௔௡௢௟ = 10ଽ ܯିଵݏିଵ, ݇௠௘௧௛௔௡௢௟ = 5 × 10଼ ܯିଵݏିଵ at ݌ܪ = 7 according to [338]. The 
reaction constant of the hydroxyl radical with its scavengers is slightly weaker than the 
reaction of the radical with itself (݇௥௘௖௢௠௕௜௡௔௧௜௢௡ = 5.5 × 10ଽ ܯିଵ. ݏିଵ, [121]). However, it 
should be considered that the concentration of the scavenger is in large excess: 
[ܴ − ܱܪ]~1ܯ ≫ [ܱܪ°]. 
Therefore, the speed of reaction with scavenger is several orders of magnitude higher. If 
the hydroxyl radicals are at the origin of H2O2 in liquid phase, the addition of scavenger 
capturing OH° should decrease the production of H2O2.  
This is what Hsieh et al. describe in the paper [339]. The scavenging agent is ethanol in 
liquid phase; the plasma source is a gliding arc. H2O2 concentration is measured with 
TiOSO4 diagnostic.  
Sato et al. also observe a decrease in the production of H2O2 in the presence of 
methanol or ethanol [338]. In this case, plasma source is an underwater discharge 
generated with High Voltage pulses. The concentration of H2O2 is measured indirectly 
with Glucose CII-Test  Wako Method that measures the total quantity of oxidizing 
species: addition of catalase which destroys H2O2 allows to assert that H2O2 is 
predominantly formed among the oxidizing species. 
The results presented in the following sections show different results from those of Sato 
et al. [338] and Hsieh et al. [339]. H2O2 is not only formed in the presence of methanol, 
but also there is a slight increase in the production of H2O2 in the presence of methanol 
compared to pure water. 
First, it was checked that methanol is an efficient scavenger of HO°. Fig 259 gives the 
fluorescence of several solutions at the emission and excitation wavelength132 of TPA-
OH. Seven experiments were made in duplicate. From left to right: 
 A well which contains 500 µL of [TPA]=4.11 mM, [KOH]=20 mM, was treated by 
the single-channel plasma jet. Unfortunately, treatment conditions were not 
correctly recorded133 but were the same for all wells. After the experiment 50 µL 
                                               
132 Fluorometer parameter are λex=317nm, λem=435nm, with Δλ= 5 nm for excitation and 
emission, see section II.3.4.2 page 54). 
133 treatment conditions were probably: 27 kV peak to peak, 500 sscm, 3 min, height= 5 mm since 
we choose the standard condition used during parametric experiment 
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of pure methanol and 950 µL of untreated TPA+KOH solution were mixed with 
this solution in a spectroscopic cuvet (PMMA) 
 A well which contains 500 µL of [TPA]=4.11 mM, [KOH]=20 mM, was treated by 
the single-channel plasma jet, and then mixed with 1000 µL of untreated 
TPA+KOH solution in a spectroscopic cuvet. 
 A well which contains 500 µL of [TPA]=4.11 mM, [KOH]=20 mM and 1 ppmv of 
methanol, was treated by the single-channel plasma jet, and then mixed with 
1000 µL of untreated TPA+KOH solution in a spectroscopic cuvet. 
 A well which contains 500 µL of [TPA]=4.11 mM, [KOH]=20 mM and 10 ppmv of 
methanol, was treated by the single-channel plasma jet, and then mixed with 
1000 µL of untreated TPA+KOH solution in a spectroscopic cuvet. 
 1500 µL of untreated TPA+KOH solution (i.e. [TPA]=4.11 mM, [KOH]=20 mM) 
 500 vµL of untreated TPA+KOH solution+1 ppmv of methanol mixed with 1000 
µL of untreated TPA+KOH solution 
 500 vµL of untreated TPA+KOH solution+10 ppmv of methanol mixed with 1000 
µL of untreated TPA+KOH solution 
The comparison of the first and second column shows that methanol does not 
significantly  modify the fluorescence of TPA-OH. 
The comparison of column five, six and seven prove that methanol does not increase the 
fluorescence of TPA (excited in the range of wavelength for TPA-OH detection). 
Consequently, the comparison of column one, three, four and five, show that methanol is 
a competitive scavenger with respect to TPA. An order-of-magnitude calculation enables 
to  check this: 
We use the order of magnitude of [HO°] found in section  III.5.2 (page 85): [ܪܱ°] = 6.9 ×
10ିସ  ܯ . 
1-Recombination reaction: 
݀[ܪܱ°]
݀ݐ
= −2݇ଶ[ܪܱ°]ଶ = −5.24 × 10ଷ ݉݋݈. ܮିଵ. ݏିଵ 
2- Scavenging reaction (with [TPA]=4.11 mM) 
݀[ܪܱ°]
݀ݐ
= −݇ଵ[ܶܲܣ][ܪܱ°] = −9.36 × 10ଷ ݉݋݈. ܮିଵ . ݏିଵ 
3—scavenging due to 1 ppmv methanol, [ܥܪଷܱܪ] ≅ 0.025 ܯ 
݀[ܪܱ°]
݀ݐ
= −5 × 10଼ × [ܥܪଷܱܪ][ܪܱ°] = −8.6 × 10ଷ ݉݋݈. ܮିଵ. ݏିଵ 
3’—scavenging due to 10 ppmv methanol, [ܥܪଷܱܪ] ≅ 2.5 ܯ 
݀[ܪܱ°]
݀ݐ
= −5 × 10଼ × [ܥܪଷܱܪ][ܪܱ°] = −860 × 10ଷ ݉݋݈. ܮିଵ. ݏିଵ 
Note that the speed of reaction 3 is comparable with those of reaction 1 and 2, this is 
consistent with the fact that the third column (from the left of Fig 259) show a significant 
decrease in TPA-OH production, without a total cancel of TPA-OH production. This 
experiment confirms the value of the order of magnitude of [HO°] found in Chapter III. 
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The speed of reaction 3’ is 100-fold higher than others reactions, that’s why methanol 
entirely scavenge the production of TPA-OH (column four from the left of Fig 259). 
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Fig 259 Methanol is an efficient scavenger of HO°. Duplicate experiment. The treatment conditions 
were the same for the four first column but have not been adequately recorded. see footnote 133 
B-2) H2O2 production in plasma-treated methanol 
solution 
protocol and experimental setup. Solutions of 1 mL were prepared by mixing water 
and methanol in varying proportions. We use the approximation that the total volume is 
the sum of the volume of each solution. These solutions are in the wells of a 24-well 
plate (Costar®). Solutions are treated for 6 min with the single-plasma-jet (di=3, e=1.5, 
H=60). We use the “square+resonnance” power supply (as in the experiments described 
in Chapter III), with a peak to peak voltage of 30 kV. He flows is 600 sscm. and the 
output of the jet is 3 mm above the liquid. After each treatment, 100 µL of the TiOSO4 
solution at 2% is added to the well. Thus, dismutation of H2O2 is avoided as much as 
possible. TiOSO4 is not in solution before plasma treatment. This choice prevents 
eventual interference134. 
Since methanol has a density and molar mass different from that of water: molar ration of 
CH3OH is not proportional to the proportion by volume (Fig 260, left): by mixing 900 μL of 
methanol with 100 μL of water the molar proportion of methanol is only 80%. Since 
methanol is more volatile than water, the samples prepared with higher concentration of 
                                               
134 Moreover one of our experiment show that the addition of TiOSO4 solution do not indue an 
interference caused by the formation of peroxinitrite from H2O2 and nitrite in acidic medium. Since 
TiOSO4 is added after plasma-liquid interaction, the kinetic of peroxinitrite formation (several min 
see II.3.3.1, page46) is negligible compared to the speed of formation of coloured complex (quasi 
instantaneous) 
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methanol undergone increased evaporation135. Consequently, the volume of the wells 
containing methanol is lower than those containing water (Fig 260, right panel). 
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Fig 260 Left: Since methanol has a density and molar mass different from that of water: molar ration 
of CH3OH is not proportional to the proportion by volume. Right: comparison of a blank of 1100 µL 
(700 µL methanol+300 µL H2O+100 µL TiOSO4 2 w%.), with the remaining volume after treatment + 
100 µL of TiOSO4. Yellow color proves that H2O2 is present. Approximately half of the methanol 
evaporates in each well.  
Methanol is added to the treated solutions to compensate this evaporation. A blank 
solution which has the same composition than the treated solution (+100 μL of TiOSO4) 
were prepared.  Methanol is added to the treated solution mixed with 100 µl of TiOSO4 
so that the mass of the two cuvets are equal. Since methanol is more volatile than water, 
it is reasonable to replace the entire evaporated volume by methanol136. A schematic of 
the protocol is shown in Fig 261. 
 
Fig 261 First, 1 mL of a mixture of methanol/water is exposed to single-channel plasma jet for 6 min 
(height = 3 mm, He flow = 600 sscm, Voltage = 30 kV). Just after the treatment 100 µL of TiOSO4 were 
added. Then,  the volume of evaporated methanol is compensated by adding methanol in the cuvet. 
Finally, the absorbance of the solution is measured at 408 nm; the value is proportional to the final 
H2O2 concentration in the treated sample. 
Results During these experiments, the proportion by volume of methanol is modified 
between 10% and 90%. The nature of the solvent is modified, and this could have effects 
(called solvatochromic) on the absorption spectra of the chemical species. In particular 
                                               
135 The liquid-vapor diagram for water-methanol mixture has no azeotrope (instead of 
ethanol-water mixture for instance). Since the boiling point of methanol is 64.2 °C at 
atmospheric pressure, the impinging jet cause an increased evaporation compared to 
the pure water solution. The vapor is enriched in methanol, and it could be shown that 
the majority of the evaporated volume consists of methanol.  
136 In reality, water also evaporates. But even replacing a small part of the water evaporated with 
methanol is not an issue because it has no influence on the absorbance of the solutions and the 
measurement of H2O2, this point is discussed with Fig 262. 
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TiOSO4 and the colored species formed with its reaction with  H2O2. The absorbance at 
408 nm of blank solutions containing a variable proportion of methanol +100 µL TiOSO4 
at 2 w% is plotted in the left panel of Fig 262 to address this question. The level of the 
signal is in the amplitude of noise originating from the individual difference between 
cuvets (~10ିଶ). This graph proves that there is no solvatochromic effect related to 
TiOSO4 in the methanol-water mixture. 
The right panel of Fig 262 shows that there is not solvatochromic effect related to the 
colored product formed by the reaction between H2O2 and TiOSO4. 
 
Fig 262 Left: Absorbance  at ࣅ = ૝૙ૡ ࢔࢓  of blanks solutions containing 100 µL of TiOSO4 2 w% and 
1000 µL of water-methanol solutions with variable proportion of methanol. This graph proves that 
there is no solvatochromic effect on TiOSO4. Right Absorbance at 408 nm of cuvets containing 
variable proportions of methanol,100 µL of TiOSO4 solution at 2 w% and 8 µL of H2O2 at 0.3 w% ; 
[H2O2]=637 µM  in 1108 µL. Blank is pure water + 100 µL TiOSO4 solution. This graph proves that 
methanol does not destroy H2O2 and that there is no solvatochromic effect on the coloured complex. 
However, we could imagine that changing the solvent could change the nature of the 
plasma discharge (especially its power). This is not the case as shown in Fig 263. 
 
Fig 263 energy and power consumption associated with each treatment. (height = 3 mm, He flow = 
600 sscm, Voltage = 30 kV). single experiment. 
The absorbance of samples treated by plasma is plotted in Fig 264. It appears that the 
scavenging of HO° by methanol does not decrease the production of H2O2 in liquid 
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phase even if the concentration of methanol is high enough to prevent137 the 
recombination reaction: ܱܪ° + ܱܪ° → ܪଶܱଶ. On the contrary, it seems that the 
absorbance at 408 nm and so the production of H2O2 is higher with methanol than 
without. How to explain this? 
 
Fig 264 Left panel: absorbance at ࣅ = ૝૙ૡ ࢔࢓ of the samples exposed to the single-channel plasma 
jet for 6 min (height = 3 mm, He flow = 600 sscm, peak to peak voltage = 30 kV). Single experiment. 
Each sample has a volume of 1 mL with the molar fraction of methanol shown in abcissa. Before 
absorbance measurements, 100 µL of TiOSO4 were added and the evaporated-volum was 
compensated (according to the previous protocol described in Fig 261). Right panel: absorbance 
divided by energy consumption 
Discussion 
It turns out that the radical chemistry does not stop with the reaction between HO° and 
methanol: 
࡯ࡴ૜ࡻࡴ + ࡴࡻ° → °࡯ࡴ૛ࡻࡴ + ࡴ૛ࡻ        ࢑ = ૚૙ૢ ࡹି૚࢙ି૚    [340] 
This radical can react with dissolved oxygen leading to the formation of ܪܱଶ° and then 
ܪଶܱଶ. The reactions invovled in the production of H2O2 are described in detail in the 
papers of Robl et al. [340] and Westbrook et al. [341]. The presence of methanol or 
ethanol increase the production of H2O2 (Fig 265). More work would be needed to obtain 
a more precise comparison between photolysis experiments and plasma experiments. In 
particular, chemistry calculations should enables to compare the increase in H2O2 
production with the modeling. This type of simulation  is potentially easy to carry out 
since the reactions and, reaction constants are well known from photolysis experiment 
[342]–[346]. However, it would be interesting to have superoxide measurement to model 
this kind of experiment. 
How to explain the discrepancy between this result (an increase in H2O2 
production when the [MeOH]↗ ) compare to those of Hsieh et al. [339] and Sato et 
al. [338]? 
In the work of Hsieh et al. it is likely that the solution is deoxygenated since the liquid is 
enclosed in a cavity purged with Ar and Co flux [339]. This could limit the reaction 
following the formation of °࡯ࡴ૛ࡻࡴ ࢕࢘ ࡯ࡴ૜ࡻ° with O2 and thus the formation of H2O2. 
                                               
137 note that 1 ppmv of methanol is enough to compete with TPA+OH reaction according 
to the previous section, and here it is far higher 
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In the paper138 of Sato et al. [338] the fact that H2O2 does not increase with MeOH or 
EtOH concentration is probably due to more complex reasons, perhaps related to the 
nature of the discharge (underwater discharge). It should also be checked that the 
presence of scavenger does not cause interference in the operation of the chemical 
diagnosis (Glucose CII-Test Wako Method). 
 
Fig 265 Legend and figure from the work of Robl et al. Evolution of [H2O2] produced by VUV-
photolysis (172 nm) of O2-saturated aqueous CH3OH of varying initial concentrations. [CH3OH]0: (1) 
0 mM; (2) 0.25 mM; (3) 0.50 mM; (4) 0.75 mM; (5) 1.00 mM. [340] © The Royal Society of Chemistry and 
Owner Societies 2012 
More discussion would be needed to precise the complete radical chemistry of the liquid 
phase and the link between HO° and H2O2 like those conducted by Locke et al. [347] and 
Sahni et al. [113], [348]. It would be interesting to compare such result with spatially 
resolved simulation. During this thesis, we have also observed the discoloration of 
methylene blue, which is generally attributed to the action of HO°. It would be interesting 
                                               
138 Note also that the following statement of paper [338] is debatable: “2) total oxidation without 
H202 (a catalase is used to selectively remove the H2O2) … This method determined that the only oxidizing 
agent present in significant amounts was H2O2“. Since catalase (and SOD) are also scavenger of 
HO° (Buxton et al. [121]). One of our experiment show that increasing concentration of catalase 
decrease the production of TPA-OH. during plasma exposure (see the following figure) (Single 
channel jet, time = 2 min, voltage = 30 kV, height = 14 mm, Helium flow = 200 sscm, liquid 
volume = 500 µL power 539 ± 14 mW, triplicate experiment). The addition of an enzyme has a 
considerable influence on liquid chemistry. 
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to compare this result with those obtained with TPA even if the methylene blue chemistry 
is not precisely known.  
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Appendix C in-vitro experiments, additional 
data 
For the experiments which involve an incubation time of 24 and 48 hours, the flow of 
helium is 400 sscm, the distance between the nozzle and the surface of the liquid is 
about 3 mm. Peak to peak voltage is around 18.5 kV for the following energies: {2.5, 5, 
10, 15, 20, 25, 30, 40, 50 J}. It takes about 5 min to reach the energy of 50 J. For higher 
target energies, the peak-to-peak voltage is increased to decrease the total treatment 
time. The following targets of energy {50, 70, 80,100, 200 J}, are reached with a peak-to-
peak voltage of 30 kV. It takes about 5 min to obtain 200 J. Most treatments are done in 
duplicate. 
Fig 266 shows the count obtained after 24h of incubation (trypan blue diagnostic). This is 
a comparison between the effect of direct treatments (plasma-jet, red dots) and PAM 
treatments (orange dots). 
During direct treatments, the wells containing the cells and the medium are treated with 
the single-channel plasma jet. The plasma plume touches the surface of the liquid. PAMs 
are prepared from the complete medium (without cells). Just after the preparation of 
PAM, the medium in which the cells are immersed is replaced by the PAM (less than 1 
min after its preparation). Since the treatments exhibit significant variability, it would be 
necessary to use more replicates. The results were grouped by the range of energy. No 
significant differences appear between treated and untreated wells since the error bars 
of the treatments done at the energy  ܧ = 200 ܬ are just below those of the untreated 
group. Moreover, there is no significant difference between direct and indirect 
treatments. 
Therefore, it can be concluded that no deleterious effect on viability occurs after 24 hours 
of incubation in this range of energy. 
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Fig 266 Cell count of living cell after 24 h of incubation. The error bars represent the standard 
deviation of the data. The red dots represent the results of direct plasma treatments. Orange dots 
represent the results of indirect treatments (PAM). The number in brackets refers to the range of 
energy pooled in the bar. For example, “Jet (26-50)” means that the cell counts of treatments with an 
energy between 26 and 50 J are pooled. 
Fig 267 shows the results of trypan blue diagnostic after 48h of incubation. The red dots 
represent the results of direct plasma jet treatments. The treatments were grouped by 
energy range. The conclusions are precisely the same as after 24 hours of incubation. It 
can be concluded that no significant deleterious effect appears after 48 hours of 
incubation with this range of energy. No significant differences appear between direct 
and PAM treatments (orange dots). 
 
Fig 267 Cell count of living cell after 48 h of incubation. The error bars represent the standard 
deviation of the data. The red dots represent the results of direct plasma jet treatments. Orange 
points represent the results of indirect treatments by PAM. The number in brackets refers to the 
range of energy pooled in the bar. For example, “Jet (26-50)” means that the cell counts of 
treatments with an energy between 26 and 50 J are pooled. 
Fig 268 shows the results of trypan blue diagnostic after 72h of incubation. The blue dots 
(black bars) represent the results of plasma jet treatments. The green dots represent the 
cell counts after exposure to H2O2 diluted in the medium. 
The treatment conditions have been slightly modified. Half of the plates were treated with 
a flow rate of 400 sscm, with a height of 9.7 mm between the surface of the liquid and 
the nozzle. The other plates were treated at 200 sscm and a height of 1.7 mm. Similarly, 
the targeted energies (100 and 200 J) were carried out with a peak-to-peak voltage of 30 
kV while the other energies (2, 4, 5, 6, 8, 10, 20, 50 J) were reached with a peak-to-peak 
voltage of 19-20 kV. At 30 kV, 200 J are approximatively equivalent to one treatment of 4 
min. 6 min of treatment are needed at 19-20 kV to obtain 50 J. 
The cell division rate is unusually high as evidenced by the control group (over 2 million 
cells). The results of the untreated group are dispersed. However, the effect on cell 
viability is significant after 72h of incubation. The error bars represent the standard 
deviation of the data. The analysis of the results did not show any significant differences 
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for the same energy in the two conditions of treatments (200 sscm/1.7 mm vs. 400 
sscm/9.7 mm). Consequently, the results of the two plates have been pooled. 
The treatment at ܧ = 10 ܬ is placed under the same brakets since the wells are exposed 
to a concentration of 40 μM of H2O2, which corresponds to the concentration of H2O2 
produced by the plasma for this energy. The second brace corresponds to 50 J/200 µM. 
 
Fig 268 Cell count of living cell after 72 h of incubation. The numbers in the brackets describe the 
range of energy consumption measured during the experiment. 
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Appendix D Benchmark of the simulation 
The simulations produce realistic behaviors regarding the propagation of heat. This 
point, although necessary, is not enough; the result must be numerically exact.To check 
that, we compare the result given by the simulation and an exact analytical solution. The 
main point to test is that the program correctly models the propagation of heat by 
conduction.  
As a benchmark, we consider a homogeneous material bar subjected to constant heat 
flux. [277] give an analytical expression of the temperature inside at depth x, for any time 
t. 
ࢀ(࢞, ࢚) = ࢀ࢏࢔࢏ +
૛ ࣘ√࢚
ඥࣅ࣋࡯
න ࢋ࢘ࢌࢉ(࢛)ࢊ࢛
ஶ
࢞/(૛√ࢇ࢚)
 (࢚ ≥ ૙) 
Where ܂ܑܖܑ is the initial temperature of the material, ࣘ the thermal flux in  ܅. ܕି૛, ࣅ the 
thermal conductivity in ࢃ. ࢓ି૚. ࡷି૚, ࣋ the density in ࢑ࢍ. ࢓ି૜, C the specific heat in 
ࡶ. ࢑ࢍି૚. ࡷି૚. ࢞ = ૙ corresponds to the surface of the material, x is positive inside the bar. 
ࢋ࢘ࢌࢉ is the complementary error function : 
ࢋ࢘ࢌࢉ(࢞) = ૚ −
૛
√࣊
න ࢋି࢚
૛
ஶ
࢞
ࢊ࢚ 
First of all, the usual conditions of temporal and spatial resolution are chosen to do the 
comparison with the benchmark (these conditions are discussed in VI.1.7.2). Regarding 
the spatial resolution, the size of the mesh is around 10 μm in the first few hundred 
micrometers (see the mesh Fig 269). The temporal resolution is 0.05 s. 
 
Fig 269 Mesh of the bar in the “usual conditions” of spatial resolution. ࢠ = ૚, corresponds to ࢞ = ૙, in 
the analytical expression. All boundaries are insulating except the boundary definded by ࢞ = ૙ where 
the thermal flux is equal to 10,000 W / m². 
The parameters of the modeling are given below: 
Size of the cylinder: radius = 2 mm, length L = 5 mm 
 ߣ = 0.5 ܹ. ܭିଵ. ݉ିଵ  
ߩ=1500 ݇݃.݉ିଷ  
ܥ = 3600 ܬ. ݇݃ିଵ. ܭିଵ 
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diffusivity ܽ = ఒ
ఘ஼
≅ 9.3 × 10ି଼ ݉ଶ. ݏିଵ 
߶ = 10 000 ܹ. ݉ିଶ 
Note that the diffusivity, the length of the bar, and the total duration of the simulation 
(ܶ = 10ݏ) satisfy the condition of validity of the analytical expression: 
ܮଶ ܽ⁄ ≅ 270 ݏ ≫ ܶ = 10 ݏ ([277]) 
The integral of erfc is computed with the Simpson's rule. Fig 270 shows the comparison 
between the simulation and the exact solution. The error is between -0.05 and 0.05 °C 
below 10 µm. Logically, the error regarding the surface temperature is more important in 
the first moments. In the simulations of Chapter VI, the flow imposed is lower, which will 
further reduce the error. The precision achieved is therefore relatively good, in any case, 
sufficient compared to other uncertainties regarding the skin model and the modeling of 
damages. 
 
Fig 270 Comparison of the simulation with the exact analytical solution. The temporal resolution is 
ࢊ࢚ = ૙. ૙૞ ࢙.  Left, the curves describing the temperature at the surface and at 500 μm depth are 
confounded. Right: the error defined by “results of the simulation” minus “analytical solution is 
plotted as a function of time. 
What happens if the temporal resolution is reduced? In Fig 271, the temporal 
resolution of the simulation is decreased to dt = 0.5 s. The error is approximately 
multiplied by three. The error is close to one-tenth of a degree, which is excessive, so all 
the results presented in Chapter VI were made with a temporal resolution of 0.05 or 0.01 
seconds. 
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Fig 271 Comparison of the simulation with the exact analytical solution. The temporal resolution is 
ࢊ࢚ = ૙. ૞ ࢙.  
What happens if the spatial resolution is reduced? The number of points defining the 
boundary is approximately divided by 20 in the next simulation (Fig 272). The temporal 
resolution is still 0.05 s. 
 
Fig 272 Mesh of the bar when the spatial resolution is reduced. ࢠ = ૚, corresponds to ࢞ = ૙, in the 
analytical expression. All boundaries are insulating except the boundary definded by ࢞ = ૙ where the 
thermal flux is equal to 10,000 W / m². 
Surprisingly, the error made is quite similar to that obtained with a more refined mesh 
(see Fig 273). It is recalled that in the finite element simulations any field is interpolated 
by polynomials of degree 2. Finally, this degree of interpolation enables to represent the 
temperature field with few exactly calculated points. 
 
Fig 273 Comparison of the simulation with the exact analytical solution.  ࢊ࢚ = ૙. ૙૞ ࢙. The spatial 
resolution has been decreased compared to that of Fig 270. 
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Appendix E The reliability of damage prediction 
The section VI.1.6 describes thermal properties chosen to model the tumor. However, 
these values suffer from strong uncertainties. The aim of this section is to study the 
influence of the thermal properties on the damage field for a known temperature field. 
Therefore, we will not only have to modify the thermal parameters of the model but also 
modify the incident plasma power so that the model can reproduce the observed 
experimental temperature field. 
The four parameters considered are: 
 The area of plasma-skin interface (parameter Θ) 
 The value of blood perfusion inside the tumor ߱௧௨௠௢௥  
 The thermal conductivity of tumor tissue ߣ௧௨௠௢௥   The value of A and Ea in the expression of damage function 
Ω = ∫ ܣ݁ݔ݌ ቀ−
ாೌ
ோ்
ቁ ݀ݐ
௧
଴  
We choose to study the behavior of the skin submitted to the fractioned treatment 
described in section VI.2.8 “fractioned treatment”. More particularly, we are interested in 
the heating scheme: 
{5 ݏ ݋݂ ℎ݁ܽݐ݅݊݃ ݀ݑ݁ ݐ݋ ݌݈ܽݏ݉ܽ + 15 ݏ ݋݂ ܿ݋݋݈݅݊݃} ݎ݁݌݁ܽݐ݁݀ ݀ݑݎ݅݊݃ 20 ݉݅݊ 
In such experimental situation, the transient thermal responses of the skin play a key 
role. The position and extent of damage are, therefore, more sensitive to parameter 
changes than continuous treatment. 
As previously, there are two steps: first, we reproduce the temperature distribution in 
dead mice at thermal equilibrium by modifying  ݍ௣௟௔௦௠௔. Then the damage are calculated 
in the case of a living mouse submitted to fractionned treatment with the value of ݍ௣௟௔௦௠௔ 
found in the first step. All the results are compared to the damage field obtained after 
1200 seconds of simulation (see section VI.2.8, page 244). Fig 274 shows damage map 
after 1200 seconds. 
 
Fig 274 Field of temperature (left) and damage (right) for  ࢗ࢖࢒ࢇ࢙࢓ࢇ = ૠ૙૙૙ ࢃ. ࢓ି૛. દ = ૡ૙°  At time t = 
1200s, with fractional treatment (plasma on =5 s and cooling = 15 s). 
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E-1) Area of plasma-skin interface 
It is recalled that, in this simulation, the area of the plasma-skin interface is the portion of 
the sphere defined by half-angle to the top Θ. Thus, the plasma-skin interface has an 
area: 
 ܵ = 2ߨݎଶ(1 − cos(Θ)) 
What happens if the area of plasma-skin interaction decreases? Here, we consider 
that Θ = 40 ° (instead of Θ = 80 °). The value of the incident power needed has already 
been calculated to be ~ 23 000 W/m² (instead of 7000 W/m²). Fig 275 shows this result; 
this is a part of the curves shown in Fig 204 which has already been discussed in the 
main document. The temperature modeled in the center of the tumor (orange dotted 
curve) is consistent with the experimental values (error bar and black dots) measured by 
Chernets et al. [79]. 
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Fig 275 Temperature in the center of the tumor as a function of time. Comparison of the temperature 
modeled in the center of the tumor for three incident power (dotted line), with the experimental value 
measured by Chernets et al. [79]. postmortem mouse tumors. 
 
The radial diffusion of heat causes a rapid decrease in temperature as a function of 
depth. Since the plasma-skin interface is smaller, the radial diffusion is more efficient to 
decrease the temperature as a function of depth and time. 
The total incident thermal power is 
ܲ = q୮୪ୟୱ୫ୟܵ ≅ 304 ܹ݉ (instead of 327 mW in the case 7000 W/m², Θ = 80°) 
The result of the simulation in "fractioned mode" (Fig 276), shows that the damage 
extends much more deeply in the case Θ = 40 ° than in the case Θ = 80 °. The damaged 
depth is around 1800 μm against 1000 μm for Θ = 80 °. Finally, it is found that the area of 
plasma-skin interaction has a strong influence on the depth of damage for the same 
distribution of temperature in the center of post-mortem tumor. 
 
Appendix E The reliability of damage prediction 
 
346 
 
Fig 276 Field of temperature and damage for   ࢗ࢖࢒ࢇ࢙࢓ࢇ = ૛૜ ૙૙૙ ࢃ. ࢓ି૛ and દ = ૝૙ °.  At time t = 
1200s, with fractionned DBD protocol (plasma on =5 s + cooling = 15 s) during 20 min. 
E-2) Blood perfusion of tumor 
As explained in section VI.1.6 and according to [302], the perfusion rate of mouse tumor 
is between 0.01 and 0.22 ml/min/g. We will consider the two extreme values of perfusion 
rate: 0.01 and 0.22 ml/min/g which corresponds respectively to 
min:   ߱଴ = 1.67 × 10ିସ ݈݉. ݏିଵ. ݈݉ିଵ 
max:    ߱଴ = 3.7 × 10ିଷ ݈݉. ݏିଵ. ݈݉ିଵ  
It is recalled that in the simulations presented in Fig 274, blood perfusion is 
߱଴ = 1.33 × 10ିଷ ݈݉. ݏିଵ. ݈݉ିଵ ≈ 0.08 ml. minିଵ. gିଵ 
Fig 277 and Fig 278 show that at the end of the treatment of 1200 s; the extension of 
damage is higher for the higher value of perfusion rate. At first glance, this is surprising. 
This is due to the fact that in the overheated volume, blood perfusion reach quickly zero 
because of vessels damages. The increase in tumor blood perfusion is not efficient to 
decrease the temperature of this part of the tumor. 
In the part of the tumor that is not heated, an increase in blood perfusion also increase 
the mean temperature of the tissue (if tissues temperature is below the arterial 
temperature of 35 °C). Indeed, in the case of “max perfusion”, the minimum temperature 
of the tissue is 33.6 °C after 1200 seconds, whereas it is only 29.5 °C for “min perfusion”. 
This increased in average temperature is high enough to hide the positive effect of better 
blood perfusion on mild-heated area. 
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Fig 277 Field of temperature and damage for the blood perfusion ࣓૙ = ૚. ૟ૠ × ૚૙ି૝ ࢓࢒. ࢙ି૚. ࢓࢒ି૚ 
(which corresponds to the minimum) 
 
Fig 278 Field of temperature and damage for the blood perfusion ࣓૙ = ૜. ૠ × ૚૙ି૜ ࢓࢒. ࢙ି૚. ࢓࢒ି૚ (which 
corresponds to the maximum) 
Finally, the blood perfusion of the tumor has a strong influence on the extent of the 
damage. If we consider the effect of damage to blood vessels and the increase in 
average temperature induced by higher blood perfusion can lead to paradoxical effects: 
an increase in blood perfusion leads to more damages... In all case, the skin and the 
tumor are always deeply damaged whatever the blood perfusion. With more moderate 
heating, such a paradoxical effect does not occur, because the entire heated zone does 
not undergo enough damage to induce a cut in the blood circulation and we observe that 
an increase in blood flow reduces the damage. 
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E-3) Thermal conductivity 
In this section, the thermal conductivity of the tumor tissue is modified compared to the 
value ߣ௧௨௠௢௥ = 0.561 ܹ. ݉ିଵ. ܭିଵ used for the simulation whose damage are plotted in 
Fig 274 
A change in conductivity considerably changes the value of center temperature obtained 
in post-mortem model. It is, therefore, necessary to find the ݍ௣௟௔௦௠௔ which reproduce the 
temperature in the center of the tumor.  
This work is done for the two conductivities. ߣ௧௨௠௢௥ = 0.2 ܹ. ݉ିଵ. ܭିଵ, which represents 
the conductivity of the most insulating soft tissu, the fatty tissu and 
ߣ௧௨௠௢௥ = 0.7 ܹ. ݉ିଵ. ܭିଵ which would be a soft tissu with the conductivity of water 
(higher than all known value of conductivity). 
However for ߣ௧௨௠௢௥ = 0.2 ܹ. ݉ିଵ. ܭିଵ, it appears that it is impossible to find a good 
compromise which enables to reproduce the experimental data. Fig 279 show that it is 
impossible to obtain temperature value at t=60 s and a correct temperature for t= 5, 6 or 
7 min whatever ݍ௣௟௔௦௠௔. 
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Fig 279 Temperature in the center of the tumor as a function of time for ࢗ࢖࢒ࢇ࢙࢓ࢇ = ૞૙૙૙ ࢃ/࢓² (left) 
and ࢗ࢖࢒ࢇ࢙࢓ࢇ = ૟૙૙૙ ࢃ/࢓²  with ࣅ࢚࢛࢓࢕࢘ = ૙. ૛ ࢃ. ࢓ି૚. ࡷି૚. 
An acceptable compromise can be obtained for λ୲୳୫୭୰ ≥  0.4 W. mିଵ. Kିଵ. For ߣ௧௨௠௢௥ =
0.4  W. mିଵ. Kିଵ, ݍ௣௟௔௦௠௔ = 6000 ܹ. ݉ିଶ 
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Fig 280 Temperature in the center of the tumor (r=0, z=0). ࢗ࢖࢒ࢇ࢙࢓ࢇ = ૟ ૙૙૙ ࢃ/࢓² and  ࣅ࢚࢛࢓࢕࢘ =
૙. ૠ ࢃ. ࢓ି૚. ࡷି૚. 
 
Fig 281 shows the fields of damage after the fractionated treatment. The extent of 
damage observed is very similar to the case  λ୲୳୫୭୰ = 0.56 W. mିଵ. Kିଵ 
 
Fig 281 Field of temperature and damage for  ࣅ࢚࢛࢓࢕࢘ = ૙. ૝ ࢃ. ࢓ି૚. ࡷି૚ and ࢗ࢖࢒ࢇ࢙࢓ࢇ = ૟૙૙૙ ࢃ. ࢓ି૛.  
For ߣ௧௨௠௢௥ = 0.7 ܹ. ݉ିଵ. ܭିଵ, the choice ݍ௣௟௔௦௠௔ = 8 000 ܹ. ݉ିଶ enables to reproduce 
the temperature in the center of the tumor (Fig 282). 
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Fig 282 Temperature in the center of the tumor (r=0, z=0). ࢗ࢖࢒ࢇ࢙࢓ࢇ = ૡ ૙૙૙ ࢃ/࢓² and  ࣅ࢚࢛࢓࢕࢘ =
૙. ૠ ࢃ. ࢓ି૚. ࡷି૚. 
Fig 283 shows that damages are very close to the case ߣ௧௨௠௢௥ = 0.56 ܹ. ݉ିଵܭିଵ (Fig 
274). Finally the value of the thermal conductivity of the tumor does not question the 
reliability of damage prediction since the qualitative result “at least a part of the tumor 
has been exposed to strong hyperthermia” remain true.  
 
Fig 283 Field of temperature and damage for  ࣅ࢚࢛࢓࢕࢘ = ૙. ૠ ࢃ. ࢓ି૚. ࡷି૚ and ࢗ࢖࢒ࢇ࢙࢓ࢇ = ૡ૙૙૙ ࢃ. ࢓ି૛.  At 
time t = 1200s, with fractioned treatment protocole (plasma on =5 s + cooling = 15 s). 
E-4) Expression of thermal damages 
The expression of damage function takes the form  Ω = ∫ ܣ݁ݔ݌ ቀ−
ாೌ
ோ்
ቁ ݀ݐ
௧
଴ , where Ea is an 
energy of activation, and A a factor in s-1. The literature proposes several values of the 
coefficients A and Ea. The majority of studies involve human, rat or pig skin. Different 
coefficients are sometimes defined according to the temperature range used, the skin 
layer studied (dermis or epidermis). Relatively few studies are available. The values 
obtained are to be considered with caution. It may happen that the coefficients obtained 
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vary according to the method of heating the skin and the position of the heated zone. 
The book ([210], page 48) review 15 differents values of A and Ea. Six of them were 
selected since they correspond to the temperature range encountered in the center of 
mouse tumor. Four additional values of (Ea, A) were considered ([215]).The data are 
grouped in Table 26. 
Table 26 Coefficients are defining damages functions. The first pair of coefficient dam1 is used in all 
other simulations outside this section. The data are valid for human skin and tissues except for dam 
3 and dam 7, which concern rat and pig skin respectively. No mouse-specific data were found. 
Index Ea (J/mol) A (s-1) Reference Comment 
dam1 5.064×1e5 2.984×1e80 [274] Used in all other simulations of the thesis 
dam2 4.6×1e5 2.86×1e69 [210] Dermis, whole range of T, 
dam3 3.06×1e5 1.606×1e45 [210] Rat skin collagen, birefringence 40-60 °C 
dam4 4.6×1e5 1.43×1e72 [210] Epidermis, whole range of T 
dam5 6.27×1e5 3.1×1e98 [210] Dermis, ܶ ≤ 50 
dam6 6.69×1e5 9.389×1e104 [210]  Dermis 50 ≤ ܶ ≤ 60 
dam7 3.39×1e5 4.11×1e53 [210] Porcine epidermis, 48 ≤ ܶ ≤ 57 
dam8 55 000×8.31 1.43×1e72 [215] Human epidermis 
dam9 55 000×8.31 2.86×1e69 [215] Human dermis 
dam10 93 535×8.31 
39 109×8.31 
2.185×1e124 
1.823×1e51 
[215] 44 ≤  ܶ ≤ 50 human epidermis 
50 ≤ ܶ human epidermis 
dam11 50 000×8.31 
80 000×8.31 
4.32×1e64 
9.39×1e104 
[215] 44 ≤  ܶ ≤ 50 human dermis 
50 ≤ ܶ ≤ 60 human dermis 
One could be discouraged by such a disparity, which enables to predict everything and 
its opposite. Fortunately, we have experimental data. The data acquired during the 
treatments performed with the non-refrigerated multijet are used. It is recalled that the 
incident power ݍ௣௟௔௦௠௔ = 7250 ܹ. ݉ିଶ was chosen so that the simulation reproduces the 
surface temperature actually observed. By repeating these simulations with the pairs of 
values proposed in the Table 26; we can see if there are major inconsistencies between 
the severity of damage predicted and observed. Table 27 gives the qualitative result of 
these simulations. Three pairs of values yield results consistent with experimental 
observations. All other simulations predict a total absence of damage after 5 min of 
treatment. 
Table 27 Summary of results obtain during the simulation obtain during treatment with the 
nonrefrigerated multi-jet (ࢗ࢖࢒ࢇ࢙࢓ࢇ = ૠ૛૞૙ ࢃ. ࢓ି૛ , દ = ૞૙ ° ) 
Index Simulation of non-refrigerated multi-channels plasma 
jet 
dam1 See section VI.2.2.1, consistent 
dam2 No damage at all, after 5 min 
dam3 No damage at all, after 5 min 
dam4 No damage at all, after 5 min 
dam5 No damage at all, after 5 min 
dam6 No damage at all, after 5 min 
dam7 No damage at all, after 5 min 
dam8 consistent with damages observed 
dam9 No damage at all, after 5 min 
dam10 consistent with damages observed 
dam11 No damage at all, after 5 min 
This can be explained by the fact that in most cases the damage function is defined in a 
phenomenological way. More often, what is measured is the time necessary to produce 
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burns of the first, second, or third degree.  Since the dermis and epidermis are thicker (at 
least 10 times in humans than in mouse); the exposure time for observing significant 
damage is more delayed in human than in mouse. Not only, the thickness that must be 
overcome by thermal diffusion is thicker, but blood perfusion removes more heat in a 
bigger volume and slows down the heating. Consequently, the values (A, Ea) tend to 
simulate less severe damage than in the case of faster heating. 
These coefficients lead to an underestimation of Ω because the thinner skin of mouse 
has a faster response to thermal disturbances. Moreover, the coefficients that describe 
damage to human epidermis are more adapted than those dealing with human dermis 
since, in this situation, the error induced by the delay is smaller. This explains why 
simulation based on dam8 and dam10 functions give a result consistent with the 
observation.  
Dam7 function describes the behavior of epidermis at a higher temperature (48 ≤ ܶ ≤
57) than the one observed. Since the program cancels the increase of damage for out-
of-range temperature; it is logical to fail in the prediction of damages (even if this function 
describes the epidermis). 
dam4 function describes the thermal response of epidermis in the context of flash fire. 
Torvi et al. also observe that this precise function gives less damage and is 
inconsistent139 with others damages functions [215]. 
Dam1 function regards the damage induced by RF heating [274], the propagation of 
thermal disturbances is not slowed down by the skin. Consequently, it seems logical that 
such coefficients correctly predicted the nature of the damage observed in the 
experiment. 
The results of the simulation of an intermittent DBD treatment (plasma on = 5 s, cooling 
by natural convection = 15 s) are shown in Fig 284 and Fig 285, respectively for the 
damages functions dam8 and dam10. 
 
Fig 284 Field of temperature and damage for damage function dam8. At t = 1200s, with “intermittent 
DBD protocol (plasma on =5 s + cooling = 15 s). 
                                               
139 I was unable, however, to find the paper which contains the original data (Mehta A K, Wong F 
C. Measurement of Flammability and Burn Potential of Fabrics. Full Report from Rules Research 
Laboratory, 1973). 
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Fig 285 Field of temperature and damage for damage function dam10. At t = 1200s, with “intermittent 
DBD protocole (plasma on =5 s + cooling = 15 s). 
Damage is slightly deeper for dam8 than dam10. The extent of damage predicted by 
dam1 (Fig 274) is very similar to that of dam8. In the three cases considered, the 
epidermis and the dermis are entirely destroyed. In all cases, subcutaneous fat and the 
external part of the tumor. 
To summarize, changing the damage functions does not question the reliability of the 
results of the simulation. A choice of damage function compatible with our results leads 
to predict that the protocol of fractionated treatment completely destroys the skin of the 
mouse and a part of the tumor.  
Whatever the parameter considered, the simulation of “intermittent DBD” always predicts 
damage that completely destroys the skin. This could be a bias since inflammation, and 
immune reactions are triggered by the thermal damage (see the references and the 
discussion on thermal effects in the context of antitumor studies, concluding Chapter VI). 
In all realistic cases, significant damage also occurs also in the upper layers of the 
tumor. 
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Appendix F Effective tissue thermal 
conductivity 
aThe convective transport of heat  could be modeled by considering an effective thermal 
conductivity value ߣ݂݂݁ which depends linearly on blood perfusion. This model is the 
subject of  a recent paper, and the relevance of this model is not fully established. 
Further informations can be found in the paper [268] and [270]. 
According to the work of Kolios et al. [269] 
ߣ௘௙௙ = ߣ௧௨௠௢௥ (1 + ߙ߱) with ߙ = 0.12 (ml/100g/min)
-1, which gives ߙ = 720 (ml/g/s)-1. 
The following simulation was done with the model described in section VI.2.2.1 (page 
210) i.e., model of the non-refrigerated multijet. The thermal conductivity is modified 
according to the expression of Kolios et al. [269]. Energy exchanges due to blood 
circulation are disabled since the effective conductivity is another tool to take into 
account the convective transfer of heat due to blood. The damage to blood vessels is 
taken into account. In this simulation ݍ௣௟௔௦௠௔ = 7250 ܹ. ݉ିଶ. This model of thermal 
conductivity increases the diffusion of heat in skin and tumor leading to a smaller 
temperature than observed and successfully modeled with the parameter ݍ௣௟௔௦௠௔ =
7250 ܹ. ݉ିଶ in section VI.2.2.1. 
With such a model it would be necessary to increase the incidental power to obtain a 
simulation consistent with experiments. It could be done without difficulties. The results 
given by this model does not really differ fundamentally, except that the parameters 
characterizing convective transfer due to blood perfusion are less known and 
questionable... 
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Fig 286 Damage and temperature map after one, three or five minutes of treatments. ࢗ࢖࢒ࢇ࢙࢓ࢇ =
ૠ૛૞૙ ࢃ. ࢓ି૛, ࣂ = ૡ૙°. 
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Appendix G Which parameters play in the 
cooling of the skin after treatment? 
The purpose of this part is to compare the results concerning the cooling of the treated 
surface with the result given by the simulations. The section 0 gives an example of this 
kind of measurements. Several infrared images of the tumor are acquired at different 
times during the cooling of one tumor. For each image, the maximum temperature 
reached at the surface of the tumor is recorded. Table 24 shows three pictures of a 
mouse during the cooling, which follows a 6-min exposure to the refrigerated plasma-jet. 
The three images have the same orientation. The maximum temperature is visible in the 
third column. This temperature will be compared with the maximum surface temperature 
given by the simulation (the temperature of the point defined by r = 0 and z = 5 mm). 
Table 28 Infrared picture of a tumor treated during 6 min with the refrigerated multi-channel plasma 
jet. The picture of the second line is acquired 8 s after that of the first line. Picture of the third, 12 
seconds later. 
Time Infrared image Maximum 
temperature 
 
 
 
The first 
image 
defines 
the time 
t =0 s 
 
 
43 °C 
 
 
 
t = 8 s 
 
38.5 °C 
 
 
 
 
t = 12 s 
 
37.4 °C 
Head anesthesia 
system 
Tumor 
Gel 
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Unfortunately, this type of use of infrared images was not foreseen at the time of the 
experiment. The infrared images were used to attest that the tissues were not subjected 
to hyperthermia. Consequently, there is not many usable data because it is necessary to 
have at least two successive pictures of the tumor. Moreover, there is uncertainty 
regarding the time between the end of plasma-exposure and the acquisition of the first 
picture. This time is of the order of five seconds or less, but, without the exact value, it is 
not possible to use the first image. Only the time difference between two images 
(provided by the image metadata) can be exploited. Ideally, it would have been 
necessary to film the cooling of the skin, with a scale of length in the field of observation. 
Fig 184 shows the maximum temperature as a function of time for several mice. The 
time of the first image defines the time ݐ = 0 ݏ . It can be seen that among the 
measurements which start from the same temperature at ݐ = 0 gives dispersed 
measurements after cooling. Several factors could explain this dispersion:  
 Differences in the distributions of temperature ܶ(ࡹሬሬሬ⃗  ) from one mouse to another 
due to the inhomegeity of the treatment. 
 Differences in biological parameters of the tumor from one mouse to another 
߱௧௨௠௢௥ , ௕ܶ௟௢௢ௗ . 
  Differences in thermal environment, enhancement of the natural convection...  
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Fig 287 Maximum temperature of the surface of the skin as a function of time. The pictures were 
acquired during the in-vivo experiments described in section 0. These experiments concern the 
cooling of the skin after an exposure of 6 min to the refrigerated multichannel plasma-jet. 
Fig 184 shows that the speed of cooling is of the order of several °C for 5 s when T>30 
°C. Now, we compare this observation with the simulations. The first point (at time t=0 s 
in Fig 184) of each set of measurements is positioned on the curve which represents the 
temperature as a function of time. The next step is to see if the points of the same 
measurement group are distributed on the simulated curve or not. It would be possible to 
quantify the proximity of the experimental points with the simulated curve. But here we 
will only proceed with a purely graphic approach, the results being rather eloquent. 
Moreover, the lack of experimental points and the uncertainty associated with the latter 
would make this type of quantification unnecessary in our experimental situation. 
For the sake of clarity: 
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 The experimental data are represented by different sets of dots (from A to J). 
Each set corresponds to the data acquired on one mouse. 
 The results of the simulation are represented by a continuous line. 
 The first point of each set (from A to J) is positioned on the red curve called “last 
fit”. Then, the other points are positioned with respect to the first point according 
to the values shown in Fig 184. The simulation producing this curve will be 
described later. The experimental points should be replaced on each curve to 
visualize in what extent the simulation is consistent with experimental results. 
However, this would make the figures illegible. Consequently, the experimental 
data are only represented with the temporals offsets associated with the curve 
“last-fit”. For the needs of the present discussion, it is sufficient. 
Fig 288 compare the cooling of the skin predicted by the simulations of the multichannel 
plasma jet and the experimental results. It is recalled that, in this case, the source is not 
refrigerated (section VI.2.2). The simulations are exactly the same than in the 
subsections VI.2.2.1 and VI.2.2.2. The area of the plasma-skin interface is defined by the 
angle Θ = 50 °. The arterial temperature of the blood is assumed to be equal to 35°C. 
The two simulations regard the two alternatives envisaged (i, black) heat transfer is 
constant and equal to 7250 ܹ. ݉ିଶ, the gas is at ܶ = ܾܶܽ݉ = 20 °ܥ (ii, blue) heat 
transfer at the interface is due to the convection of Helium at ܶ = 55 °ܥ. It may seem 
surprising that the rate of cooling is different for these two simulations even though the 
same surface temperature is reached in both cases. In fact, the field of temperature is 
imposed by the value of the heat transfer at the interface. Heat transfer imposed in the 
simulation “hot helium” has this magnitude: 
ݍௗ௨௘ ௧௢ ௛௢௧ ு௘ ≈ 203 × (55 − 45) = 2030 ܹ. ݉ିଶ 
Since this value is lower than  ݍ௣௟௔௦௠௔ = 7250 ܹ. ݉ିଶ. The gradient of temperature which 
ensure the flux imposed at the interfce is less abrupt for “hot helium” simulation. The 
temperature is higher below the surface, resulting in a slower cooling rate. It appears that 
the rate of cooling predicted by the simulations is inconsistent with experimental data. In 
the simulations, the cooling is too slow (several tens of seconds to lose 2 °C). In the next 
paragraph, we see what happens, when we used the refrigerated device. 
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Fig 288 Cooling of the skin as a function of time. Experimental data are represented by the dots from 
A to J. Lines represents the simulations.  Black curve corresponds to the cooling of the surface after 
treatment by the multichannel jet simulated in the section VI.2.2.1 (heat transfer is a 
constant   ࢗ࢖࢒ࢇ࢙࢓ࢇ = ૠ૛૞૙ ࢃ. ࢓ି૛). Blue curve is the cooling of the surface after a treatment by the 
multichannel jet simulated in the section VI.2.2.2 (heat transfer is due to the convection of Helium at 
55 °C). The blood has an arterial temperature  ࢀ࢈࢒࢕࢕ࢊ = ૜૞ °࡯ . Plasma-skin interface has an area 
defined by the half angle to the top દ = ૞૙ °.. The cooling predicted by the blue and black curve is too 
slow to be consistent with the experimentales data.  
Fig 289 describes the cooling of the surface when several parameters are modified. The 
following points are analyzed: 
 The speed of cooling when the device is refrigerated or not. 
 The effect of a 10% increase in the heat transfer coefficient due to the natural 
convection. Indeed, there might be a difference between the model of natural 
convection and the reality. It may be that a slight increase in the heat transfer 
coefficient ℎ௖௢௡௩ could increase therate of cooling so that the simulation would be 
consistent with the experiment. 
 The effect of changes in the value of the arterial temperature of the blood. It is 
recalled that the contribution of blood perfusion in heat exchanges takes the form: 
ݍ௣௘௥௙ = ߱௧௜௦௦௨ߩ௕௟௢௢ௗܿ௕௟௢௢ௗ(ܶ − ௔ܶ) ݅݊ ܹ. ݉ିଷ. A change in the value of  ௔ܶ, the 
arterial temperature enables to emulate a higher perfusion rate or a lower blood 
temperature. ௔ܶ is modeled in the interval [25°C; 35 °C]. For instance, a volume 
of tissue at 40 ° C will exchange 3 times more energy when the blood is modeled 
at 25 ° C than when modeled at 35 ° C. It is unlikely that the temperature of the 
blood entering the tissue is only 25 ° C, although the blood may be somewhat 
cooled before reaching the tumor and the fact that the mice sometimes seemed 
to be close to the hypothermia. On the other hand, it is conceivable that the rate 
of perfusion is greater than that which has been modeled so far (see the section 
Physical properties of living tissues VI.1.6  and the Table 23). 
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It appears that the modification of these parameters does not significantly modify the 
temperature of the skin during the treatment. It is recalled that in the case of the 
refrigerated device, the temperature of the skin is simulated by the convection of helium 
at temperature 
ுܶ௘(ݐ) = 3.5√ݐ − 31 °ܥ   for   3.5√ݐ − 31 °ܥ ≤ 55 °ܥ 
ுܶ௘(ݐ) = 55 °ܥ   for  3.5√ݐ − 31 °ܥ > 55 °ܥ 
The fives simulations of the refrigerated devices verify the experimental criteria: 
 At the beginning, the temperature of the skin is between 8 and 10 °C. 
 The mean temperature is 17 °C after 3 min. 
 The mean temperature is 31 °C after 6 min. 
It is sufficient to imagine that the plasma source operates a little longer than 6 min to 
obtain higher temperatures (~45 °C). The curve which corresponds to the cooling of the 
point of coordinates (r = 0, z = 5) is recorded as soon as the treatment is stopped. The 
skin cools in ambient air (natural convection). The cooling is plotted for the temperatures 
below 43 °C. 
Fig 289 includes the three same curves that the Fig 288. Black and blue curves 
represent the cooling after treatment by the non-refrigerated plasma-jet. The red curve is 
associated with a simulation presented in the last part of this section.This curve gives the 
time offset of the experimental points. 
The five other curves correspond to the simulations of the refrigerated plasma-jet. The 
black dotted lines show the cooling under the conditions that were studied in the section 
VI.2.3 (refrigerated multijet, blood temperature at 35 ° C, no change in natural 
convection). At first glance, it is surprising that the cooling rate is faster than that of the 
blue curve. This is caused by the fact that the steady state is not reached when the 
plasma is switched off. Consequently, even if the surface temperature is the same, the 
underlying tissues are colder when treated by the refrigerated jet. This increases the 
cooling rate of the surface. 
Except for the convection, the pink curve is calculated in the same conditions than the 
black dotted (refrigerated multijet, blood temperature at 35 °C). The efficiency of natural 
convection (NC) is increased by 10%; to that end, heat transfer coefficient is multiplied 
by 1.1. 
qୡ୭୬୴  = 1.1 × h(Ts − Tair) =  1.1 × 5.21 ×  (Ts − Tair)ଵ.ଵ଼଼ W. mିଶ 
It appears that the black dotted line curve is above the pink one. This is consistent. 
However, the influence on the cooling rate is quite low. It can be noted that the cooling 
rate predicted by these two curves is still inconsistent with the experimental data. The 
natural convection rate would have to be several orders of magnitude higher than the 
value calculated so far to obtain a result consistent with the experiment. This hypothesis 
is not realistic despite the assumptions made for the calculation of the natural convection 
rate. The reality is that the surface is not cooled by the exterior for the essentials, but 
from the inside with heat transfer caused by blood perfusion and conduction. 
The three last curves (orange line, dotted green, blue dotted) show what happens when 
the arterial temperature is changed. These three curves are below the previous ones, 
which is quite coherent. By decreasing the blood temperature / increasing the perfusion 
rate, the amount of energy removed from the surface is increased. Unfortunately, the 
rate of cooling is still incompatible with the experimental results (in particular for the 
points 31 and 35 ° C). And yet, assuming that the blood is 10 ° C colder is a rather 
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extreme hypothesis. To summarize, none of the three parameters mentioned above can 
be used to simulate the rate of cooling of tumors satisfactorily. Even when combined 
(cold blood + increased convection + refrigerated device). 
 
Fig 289 Cooling of the skin as a function of time. Non-refrigerated device: continuous black and blue 
line. These two curves, as well as the red curve, are the same in the previous figure (see Fig 288 for a 
detailed description). Refrigerated device: dotted black line, dotted blue line, dotted green line, 
orange and pink line. The arterial temperature of the blood is indicated in the legends of the curves. 
The value of the heat transfer coefficient was increased by 10% in the case of pink and green dotted 
curves. દ = ૞૙ °. Experimental data are represented by the dots from A to J. Lines represent the 
simulations 
Until then we have assumed that the surface undergoing the thermal flux is defined by 
the half angle at the apex Θ = 50 °, which defined a circle of diameter ݀ ≅  8.7 ݉݉, and 
area ܵ = 2ߨݎଶ(1 − cos(Θ)) ≅ 56 ݉݉ଶ on the surface of the sphere. 
This value of Θ is of the order of magnitude of the size covered by the plasma (according 
to the pictures). On the other hand, nothing ensures that the heat transfer is efficient over 
the totality of this portion of the sphere. The distribution of filaments striking the surface 
is also not known, but it can be assumed that the density of filaments is greater directly 
below the gas stream than at the side. The area of heat transfer is likely smaller. Θ is 
divided by two in the following paragraphs. 
The procedure is exactly the same as described in the sections VI.2.2.2 and VI.2.3. First, 
the temperature of helium gas is found. The temperature and the simulated damage 
must verify the following conditions: 
 Skin temperature after treatment of 3 or 5 min was around 45-48 °C. 
 Treatment of one min gave no damages. 
 One treatment of three min gave no damages, but the repetition of this treatment 
at two days intervals gave damages after two or three treatments. 
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 Treatment of 5 min systematically gave damages. 
The value  ுܶ௘ = 64 °ܥ enables to verify all of theses conditions. Fig 290 proves the 
previous assertions. ுܶ௘ = 65 °ܥ is also suitable. On the other hand, a temperature of 
66°C produces too much damage. 
 
Fig 290 Temperature and damage as a function of time, for several depths under the plasma-skin 
interface. This device is not refrigerated. દ = ૛૞ °, ࢀࡴࢋ = ૟૝ °࡯. The red curve represents the surface 
temperature of the tumor. The temperatures reached at 3 min and 5 min are compatible with the 
experimental observations. The level of damage caused at 50 μm of depth (blue curve) makes it 
possible to conclude that one third of the thickness of the dermis is severely damaged. 
 
Fig 291 Field of temperature and damage at the time t= 5 min.  This device is not refrigerated. 
દ = ૛૞ °, ࢀࡴࢋ = ૟૝ °࡯. The level of damage obtained is consistent with the experimental observations. 
As described in the section VI.2.3, the choice of a function, ுܶ௘(ݐ), that describes the 
temperature of the gas over time; enables to reproduce the temperature of the skin. The 
following three criteria must be verified. 
 At the beginning, the temperature of the skin is between 8 and 10 °C. 
 The mean temperature is 17 °C after 3 min. 
Appendix G Which parameters play in the cooling of the skin after treatment? 
 Appendix G- 363 
 The mean temperature is 31 °C after 6 min. 
The red curve of Fig 292 proves that these criteria are checked by the function: 
  ுܶ௘(ݐ) = −24 +
୲
ହହ଴
൫64 − (−24)൯ °C  for   ݐ ≤ 550 
  ுܶ௘(ݐ) = 64 °C     for   ݐ ≥ 550 
where t is expressed in seconde and ுܶ௘ in °C. Note that a linear function has been 
chosen. The choice of a function in ܣ√ݐ + ܤ do not provide a simulation that respects the 
previous criteria (deviation of several °C regarding the surface temperature). Even if the 
dependence in √ݐ has more physical meaning (despite the severe limitations of this 
model), it is desirable to choose the best fit of the experimental data. 
 
Fig 292 Red: temperature of the point (r=0, z=5 mm), at the surface of the skin. Blue:  1 mm below the 
surface. The red curve passes through the coordinates (180 s, 17 ° C), (360 s, 31 ° C). ࢀ࢈࢒࢕࢕ࢊ = ૜૞ °࡯.  
ࢀࡴࢋ = ૟૝ °࡯. દ = ૛૞ °. 
The curves representing the cooling of the skin were extracted for several values 
of  ௕ܶ௟௢௢ௗ  (Fig 293). Green, black and blue lines represents the cooling of the skin at (r=0 
mm, z=5 mm) for the non-refrigerated multichannel-jet. The other curves correspond to 
the refrigerated device. 
First, the comparison of green and blue curves show that the decrease of Θ increases 
the speed of cooling. The diffusion of heat in the radial direction (along r axis r) is more 
efficient in the cooling of surface when Θ is small. On the contrary, when Θ is large, the 
diffusion in the vicinity of the point (r = 0, z = 5 mm) is almost a 1-D-diffusion along to z. 
Consequently, less efficient in the cooling of heated area. 
Again, the curves derived from the simulations of refrigerated devices are below those of 
non-refrigerated device.  A decrease in blood temperature results in an increase in the 
rate of cooling. It turns out that orange and red curves (called “last fit” in the previous 
figure), are more compatible with the experimental data. The cooling rate of  the 
experimental points between 31 ° C and 40 ° C is correctly predicted.  
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Fig 293 Cooling of the skin as a function of time. Non-refrigerated device: black green and blue. 
Refrigerated device: orange and red. The arterial temperature of the blood is indicated in the legends 
of the curves. દ = ૛૞ °. Experimental data are represented by the dots from A to J. Lines represent 
the simulations. 
On the other hand, the predicted cooling rate for the set of points I and J are clearly 
false. It would be possible to decrease the angle Θ to obtain a rate of cooling consistent 
with all of the experimental results. However, it would be interesting to raise another 
problem of the intellectual approach adopted until then. 
The cooling depends on the initial conditions. However, the experimental measurements 
are dispersed. The treatments were slightly different from one mouse to another, 
resulting in an average final temperature of 31 ° C with a standard deviation of 6°C (see 
Fig 154) before cooling. Therefore, the initial conditions are different from one mouse to 
another. 
The totality of the simulation is represented in sub-figure A of Fig 185. The processing 
time of duration tc (indicated in the legend) is followed by cooling in the ambient air 
(natural convection). The sub-figure B shows the curves which represent the cooling with 
the same temporal origin. The Fig 185 (sub-figure A and B) prove that the rate of cooling 
at a certain temperature T, for instance, 31 °ܥ, depends on the duration of treatment tc 
(see the slope of the curve at 31 °C). The lower the maximum temperature reached by 
the skin, the higher the cooling rate at 31 ° C. It also becomes possible to have 
simulations consistent with experimental results with less extreme assumptions about 
blood temperature / perfusion rate. The sub-figure C shows the cooling curves for two 
treatment times and three blood temperatures. 
It is therefore somewhat futile to try to obtain a curve on which all the points of 
measurement would be distributed since they correspond to several initial conditions. On 
the other hand, the approximation should be correct for similar initial conditions. In this 
case, it means that the initial conditions are within a temperature range with a width of 
less than 5 ° C. It appears in sub-figure D that: 
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 The black curve (ݐܿ = 390 ݏ, ܾܶ = 30 °ܥ) is a good fit for the sets of data I and J 
(at least, a better fit than that shown in Fig 293). These treatments are 
characterized by the lowest initial temperature. 
 The blue curve (ݐܿ = 460 ݏ, ܾܶ = 30 °ܥ) fit the sets A, B, D, E, F, G, and H. These 
sets have an initial temperature between 33 and 38 °C. 
 The set C is fitted by the red curve (ݐܿ = 600 ݏ, ܾܶ = 30 °ܥ). (this result does not 
have a profound meaning: there is only two points in the set ...) 
 The assumption  ௕ܶ௟௢௢ௗ = 30 °ܥ  enables to obtain simulations that explain the 
rate of cooling. This is a more realistic assumptions than ௕ܶ௟௢௢ௗ = 25 °ܥ. 
 
Fig 294 Temperature as a function of time, દ = ૛૞°.  A) for severals time of heating (tc = 390, 410, 460 
and 600 s) and two depth (1 mm and 0 mm = surface). Only the phase of cooling is represented in the 
following figures. Blood temperature = ࢀ࢈ = ૜૞ °࡯   B)  zoom on the cooling phase. The rate of 
cooling at 31 °C is different for the different durations of heating. C) skin temperature for two 
durations of treatment and three different temperatures of blood. D) The dots represent the 
experimental data. The three simulations are made with Tb = 30 ° C and three processing times (tc = 
390, 460, 600 s). 
In conclusion, the studies of the cooling show that: 
1. The mains parameters imply in the cooling are the conduction and the thermal 
effect of blood perfusion. The possible errors in the terms which represent the 
natural convection cannot explain the values of the cooling rates. 
2. The area on which the heat transfer takes place is likely smaller than what was 
previously imagined. It would be interesting to couple electrical measurements 
with thermal measurements (to find out if the numbers of filaments striking the 
surface and their distribution alone are sufficient to predict the heating of the 
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surface, or whether the quantity of charges transferred by each filament plays a 
role). The simulations could be easily generalized to distributions of incident flux 
of any form. For instance, ݍ௣௟௔௦௠௔(ߙ) = ݍ଴exp (−
ఈమ
ଶఉమ
). Where ߙ is an angle, and 
ߚ the characteristic angular size of the heated area. 
3. The cooling of the tumor may be slightly more effective than previously thought. 
In combination with the effect of the area, ௕ܶ௟௢௢ௗ = 30 °ܥ enables to reproduces 
the value of the cooling rate. Another interpretation, is that the rate of perfusion, 
߱, is higher than previously modelled. Beware; the two interpretations are not 
mathematically equivalents: the two factors play in a non-trivial way on the 
asymptotic temperature reached. 
4. The cooling is a non-steady problem which strongly depends on the initial 
temperature. This enables to propose more realistic simulations of the cooling 
according to the range of initial surface temperature. 
5. Very simple experiments would make possible to deepen the comparisons 
between simulations and experiments. In particular, the recording of the cooling 
of the tumor with the thermal camera in the form of a film. The film should start at 
a known time after the end of the treatment. It would be wise to have a length 
scale in the field of view, by bonding a metal strip (different emissivity) of known 
length to the skin surface of the mouse. The curvature of the tumor could be 
problematic. 
This section concerns the cooling phase whose dynamics are particularly sensitive to the 
parameters of the model. In contrast, the reliability of the model regarding the prediction 
of the damage still remains with larger modifications of the model (see Appendix E). 
However, this section is not useless. It is not only a test of the model and its limitations; it 
is also the first step of a work enabling a better understanding of the heating during 
plasma-skin interaction. 
Plasma-skin interaction has been modeled either by the assumption that only hot helium 
( ுܶ௘ =  55 °ܥ assumption), or the ionic bombardment of the surface (ݍ௣௟௔௦௠௔ = ܥݏݐ (ݐ) 
assumption) is at the origin of skin heating. This can guide, in the choice of an 
experimental setup which could really prove or question these assumptions. 
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Appendix H Fractioned treatment: temperature 
and damage as a function of time 
 
Fig 295 Temperature and damage as a function of time. Fractioned treatments.  
ࢗ࢖࢒ࢇ࢙࢓ࢇ = ૠ૙૙૙ ࢃ. ࢓
ି૛, ࣂ = ૡ૙ °. 
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Fig 296 Temperature and damage as a function of time. Fractioned treatments.  
ࢗ࢖࢒ࢇ࢙࢓ࢇ = ૠ૙૙૙ ࢃ. ࢓
ି૛, ࣂ = ૡ૙ °. 
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Appendix I FreeFEM++ instructions for the 
simulation of  heat propagation 
real actev=0,actrad=1,actcv=1;  
// CHOOSE 0 or 1 to take into account or not FOR evaporation, radiation, convection 
real actplasma=1;    // constant flux or not (for test) 
real actvesseldamage=1;   //1 for the effect of damage on blood vessel 
real actmeta=1,actblood=1;   // activity of metabolism, activity of blood perfusion 
string expname="continuous-7000-80-alive"; //NAME OF EXEPERIMENT 
 
real qqq=7000; //INCIDENT POWER: W/m² 
real degc=80; //angle to the top defining the aera hitten by Helium flow and plasma //50.7238 utilisé ici 
 
//FOR THE SIMULATION OF A DBD WITH ALTERNATING PHASES OF HEATING AND COOLING 
real DBDinter=2; // 1= YES, 2= NO 
 
//Mouse anesthesia 
real anesthesia=0; //0 =anesthesia, 1= awake 
  
//MESH RESOLUTION 
int vite=1; //FOR FAST SIMULATIONS, this factor decrease the number of vertex at each boundary. Decrease the 
spatial resolution 
 
 
//TIME 
real T=420+100, dt=0.05;      //T= Total time of simulation, dt = temporal resolution  
 
//FIELD of temperature at t=0 s 
func v0=(anesthesia==0)*(273.15+30.001)+(anesthesia==1)*(273.15+33); 
//ROOM TEMPERATURE 
real Tamb=20+273.15; 
 
real depimesh=13*1e-6,ddermmesh=162*1e-6,dadiposemesh=189*1e-6; //definition of layer thickness for C57BL6 
//real depimesh=12.08*1e-6,ddermmesh=156.65*1e-6,dadiposemesh=168*1e-6; //definition for BALBC 
real dexttum=500*1e-6; //TUMOR EXTERN PART = 500 µm under the tumor_subcutaneous fat interface 
//THE SPATIAL RESOLUTION OF the calculation was increased in this region of interest 
 
//BOUNDARIES DEFINITION 
//!!! b != a was not implemented in the definition of physical field (lambda, density,..) 
//b was implemented in the definition of boundaries, use only a=b 
real a=0.3*1e-2, b=0.3*1e-2; //little and big half size of ellipsoide in m V=pi/6*a*b*b  
 
real b2=4*a;  //couche de peau qui n'est pas sous la tumeur, voir schéma 
real a2=4*a; //tissus en dessous de la tumeur 
real a3=a; //ditance de la frontière du calcul HR,au centre de la tumeur de rayon 3 mm il faut que a3>=a-
z4 
 
 
//Definition des 4 profondeurs associés à chaque couche et des quatres rayons 
real z1=depimesh; 
real z2=depimesh+ddermmesh; 
real z3=depimesh+ddermmesh+dadiposemesh; 
real z4=depimesh+ddermmesh+dadiposemesh+dexttum; 
 
real r1=a-z1; 
real r2=a-z2; 
real r3=a-z3; 
real r4=a-z4; 
 
//Definition des 4 angles associés à chacune des couches du prog, degc déjà defini 
real th1=asin(z1/r1); 
real th2=asin(z2/r2); 
real th3=asin(z3/r3); 
real th4=asin(z4/r4); 
 
//DECLARATION of BOUNDARY HANDLE 
int C1=99, C2=98,C3=97, 
C4=96,C5=95,C6=94,C7=93,C8=92,C9=91,C10=90,C11=89,C12=88,C13=87,C14=86,C15=85,C16=84,C17=83,C18=82,C19=81,C20=80
,C21=79,C17p=78,C18p=77,C19p=76,C20p=75; 
 
border b1(t=0,a3+r4){x=-a3+t; y=0; label=C1;} 
border bo2(t=0,dexttum){x=r4+t; y=0; label=C2;} 
border b3(t=0,dadiposemesh){x=r3+t; y=0; label=C3;} 
border b4(t=0,ddermmesh){x=r2+t; y=0; label=C4;} 
border b5(t=0,depimesh){x=r1+t; y=0; label=C5;} 
                   
 
border b6(t=0,degc/180*pi){ x=a*cos(t);y=a*sin(t);label=C6;} 
border b7(t=degc/180*pi,pi/2.0){x=a*cos(t); y=a*sin(t); label=C7;} 
border b8(t=0,b2){x=0;y=a+t;label=C8;} 
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border b9(t=0,z1){x=-t;y=b2+a;label=C9;} 
border b10(t=0,z2-z1){x=-z1-t;y=b2+a;label=C10;} 
border b11(t=0,z3-z2){x=-z2-t;y=b2+a;label=C11;} 
border b12(t=0,z4-z3){x=-z3-t;y=b2+a;label=C12;} 
border b13(t=0,a3-z4){x=-z4-t;y=b2+a;label=C13;} 
border b14(t=0,a2+a-a3){x=-a3-t;y=b2+a;label=C14;} 
border b15(t=0,b2+a){x=-a2-a;y=b2+a-t;label=C15;} 
border b16(t=0,a2+a-a3){x=-a2-a+t;y=0;label=C16;} 
border b17(t=0,pi/2+th1){x=r1*cos(t);y=r1*sin(t);label=C17;} 
border b17p(t=0,r1*(1-cos(th1))+z1+b2){x=-z1;y=r1*sin(pi/2+th1)+t;label=C17p;} 
border b18(t=0,pi/2+th2){  x=r2*cos(t);y=r2*sin(t);label=C18;} 
border b18p(t=0,r2*(1-cos(th2))+z2+b2){x=-z2;y=r2*sin(pi/2+th2)+t;label=C18p;} 
border b19(t=0,pi/2+th3){x=r3*cos(t);y=r3*sin(t);label=C19;} 
border b19p(t=0,r3*(1-cos(th3))+z3+b2){x=-z3;y=r3*sin(pi/2+th3)+t;label=C19p;} 
border b20(t=0,pi/2+th4){x=r4*cos(t);y=r4*sin(t);label=C20;} 
border b20p(t=0,r4*(1-cos(th4))+z4+b2){x=-z4;y=r4*sin(pi/2+th4)+t;label=C20p;} 
border b21(t=0,b2+a){x=-a3;y=b2+a-t;label=C21;} 
 
//MESH GENERATION 
//THIS IS THE NUMBER OF VERTICES ON BOUNDARIES 
 
 
mesh Th=buildmesh(b1(30)+ 
   bo2(20)+ 
   b3(20)+ 
   b4(20)+ 
   b5(20)+ 
   b6(100)+ 
   b7(80)+ 
   b8(80)+ 
   b9(20)+ 
   b10(20)+ 
   b11(20)+ 
   b12(20)+ 
   b13(20)+ 
   b14(20)+ 
   b15(20)+ 
   b16(20)+ 
   b17(120/vite)+b17p(120/vite)+ 
   b18(120/vite)+b18p(120/vite)+ 
   b19(120/vite)+b19p(120/vite)+ 
   b20(120/vite)+b20p(120/vite)+ 
   b21(40)); 
 
plot(Th,wait=1); 
savemesh(Th,expname+" "+"Th.am_fmt"); 
 
fespace Vh(Th,P2); //space of function 
 
 
//Position points de mesures 
real actpunc=1; //1 TO PRODUCE A .txt file, which contain temperature and damage information for the point of 
coordiantes (puncx(i),puncy(i)) 
real [int] puncx=[a,a-depimesh,a-depimesh-ddermmesh,a-depimesh-ddermmesh-dadiposemesh,a-500*1e-6,a-1e-3,a-2e-
3,a-3e-3]; 
real [int] puncy=[0,0,0,0,0,0,0,0];//coordx //coordy 
 
 
//CONDUCTION 
real rhoepi=1500;  //density 1200 kg/m3 of stratum corneum 
real Cepi= 3600;   //massic specific heat 3600 J/kg/K of stratum corneum 
real coepi=0.235;   //conductivity of stratum corneum layer 
//the four next functions define density, specific heat and conductivity of the tumor drom following parameters 
 
real depi=depimesh,dderm=ddermmesh,dadipose=dadiposemesh; //thickness of three different layers of mouse skin m 
real rhoderm=1116,rhoadipose=971,rhotumor=1050;         //density of different layer 
real Cderm=3300,Cadipose=3700,Ctumor=3669;  //specific heat of different layer 
real coderm=0.445,coadipose=0.21,cotumor=0.561;  //thermal conductivity 
//fat 2700 J/kg/K, lean 3669 (FABER 95), coadipose=0.185 
 
func norme=sqrt(x^2+y^2); 
func anglatmp=y/x*(x!=0); 
 
func rhotiss=rhotumor+(rhoepi-rhotumor)*(norme(x,y)>=r1)*(norme(x,y)<=a)*(x>=-z1) 
    +(rhoepi-rhotumor)*(norme(x,y)>a)*(x>=-z1)*(x<=0) 
    +(rhoderm-rhotumor)*(norme(x,y)>=r2)*(norme(x,y)<r1)*(x>=-z2) 
    +(rhoderm-rhotumor)*(norme(x,y)>r1)*(x>=-z2)*(x<=-z1) 
    +(rhoadipose-rhotumor)*(norme(x,y)>=r3)*(norme(x,y)<r2)*(x>=-z3) 
    +(rhoadipose-rhotumor)*(norme(x,y)>r2)*(x>=-z3)*(x<=-z2);  
         
func Ctiss=Ctumor+(Cepi-Ctumor)*(norme>=r1)*(norme<=a)*(x>=-z1) 
    +(Cepi-Ctumor)*(norme>a)*(x>=-z1)*(x<=0) 
    +(Cderm-Ctumor)*(norme>=r2)*(norme<r1)*(x>=-z2) 
    +(Cderm-Ctumor)*(norme>r1)*(x>=-z2)*(x<=-z1) 
    +(Cadipose-Ctumor)*(norme>=r3)*(norme<r2)*(x>=-z3) 
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    +(Cadipose-Ctumor)*(norme>r2)*(x>=-z3)*(x<=-z2); 
   
Vh lambda=cotumor+(coepi-cotumor)*(norme>=r1)*(norme<=a)*(x>=-z1) 
    +(coepi-cotumor)*(norme>a)*(x>=-z1)*(x<=0) 
    +(coderm-cotumor)*(norme>=r2)*(norme<r1)*(x>=-z2) 
    +(coderm-cotumor)*(norme>r1)*(x>=-z2)*(x<=-z1) 
    +(coadipose-cotumor)*(norme>=r3)*(norme<r2)*(x>=-z3) 
    +(coadipose-cotumor)*(norme>r2)*(x>=-z3)*(x<=-z2);   
       
func k=lambda/(rhotiss*Ctiss); //thermal diffusivity lambda/(rho*C) m²/s as a function of space 
 
//CONVECTION (these coefficient are redefined in time dependent loop) 
Vh hwithHe=0, hwithouthel=0; //heat convective coefficient W/m²/K 
Vh The=0;   // temperature of Helium K 
Vh alpha, alphahe;   //heat convective coefficient divided by rho*Ctiss at the extern boundary 
 
//RADIATION (urad2 coefficient are redefined in time dependent loop) 
Vh urad2=0; //temperature of the room for radiative heat exchange K 
Vh rad=5.67e-8/(rhoepi*Cepi); //Stefan–Boltzmann constant divided by rho*Ctiss at the extern boundary of the 
skin (stratum corneum) 
 
//METABOLISM power release of the cells during their life (higher in tumor). 
//qmet is in W/m3 
real qderm=200, qadipose=5, qtumor=7700; //W/m² 
//qtumor=4200*(1-anesthesia)+anesthesia*7700; 
Vh qmet=qderm*(sqrt(x^2+y^2)<a-depi)*(sqrt(x^2+y^2)>=a-depi-dderm)+qadipose*(sqrt(x^2+y^2)<a-depi-
dderm)*(sqrt(x^2+y^2)>=a-depi-dderm-dadipose) +qtumor*(sqrt(x^2+y^2)<a-depi-dderm-dadipose); 
func qred=qmet/(rhotiss*Ctiss)*actmeta; 
 
//BLOOD PERFUSION (defined here, no time dependance (assumption)) 
real rhoblood=1060;    //blood density 1000 kg/m3 //bioheat transfer liu p231 
real Cblood=3770;     // massic specific heat of blood 4200 J/kg/K 
real Tblood=35+273.15+anesthesia*2; //Blood temperature : 35 with anesthesia, 37 without 
real bloderm=0.00133, bloadipose=0.0005,blotumor=0.0013*(1-anesthesia)+0.01*anesthesia; //ml/s/ml 
//REDEFINI DANS LA BOUCLE DEPENDANT DU TEMPS POUR PRENDRE EN COMPTE L'effet des domages et de la température sur 
la circulation sanguine 
Vh omegaval=blotumor*(sqrt(x^2+y^2)<a-depi-dderm-dadipose)+bloadipose*(sqrt(x^2+y^2)>=a-depi-dderm-
dadipose)*(sqrt(x^2+y^2)<=a-depi-dderm)+bloderm*(sqrt(x^2+y^2)<a-depi)*(sqrt(x^2+y^2)>=a-depi-dderm); // omegab 
en ml/s/ml represents blood perfusion, values are chosen from papers, in the tumor or not, during anesthesia or 
not 
Vh omegab=omegaval*rhoblood*Cblood/(rhotiss*Ctiss)*actblood; // unis s^-1 
Vh DS=1; 
Vh relativeperf=0; 
 
//PARAMETER FOR SKIN EVAPORATION (defined here) 
real RH=0; //relative humidity of air 
 
//ENERGY DEPOSITION DUE TO PLASMA (redefined in temporal loop) 
real qplasm = 0.0; //Thermal flux due to plasma surface interaction W/m² 
real qpla=qplasm/(rhoepi*Cepi); 
 
//DAMAGES FUNCTION 
Vh damageadd=0, damage=0, damageperfusion=0; //integral of Omega=Aexp(-Ea/RT) 
real A, B, Aperfusion,Bperfusion; 
A=2.984*1e80;// A en s^-1 //Les deux autres variables sont attribuées dans la boucle dépendant du temps. 
B=5.064*1e5/8.31;//   B = Ea/R en /K  
 
Vh vold,w,v,cc2,cc3,cr2,cr3,qev2,qev3,vaff; //variables for the resolution,v is the field of temperature, w a 
function of the same regularity than v for the resolution. 
int optp=1; //optp=0 No mesh optimization, optp=1, mesh optimization (solver) 
v=v0; //INITIALISATION 
 
//PROBLEM DEFINITION, WEAK FORMULATION 
problem thermaxi(v,w)=int2d(Th,optimize=optp)((v*w/dt + k*(dx(v)*dx(w) + dy(v)*dy(w)))*y)- 
int2d(Th,optimize=optp)(vold*w*y/dt)+ 
int1d(Th,C6,optimize=optp)(cr2*y*v*w)- 
int1d(Th,C6,optimize=optp)(cr2*y*The*w)+ 
int1d(Th,C7,optimize=optp)(cr2*y*v*w)- 
int1d(Th,C7,optimize=optp)(cr2*y*The*w)+ 
int1d(Th,C8,optimize=optp)(cr3*y*v*w)- 
int1d(Th,C8,optimize=optp)(cr3*y*Tamb*w)+ 
int1d(Th,C6,optimize=optp)(cc2*y*v*w)- 
int1d(Th,C6,optimize=optp)(cc2*y*The*w)+ 
int1d(Th,C7,optimize=optp)(cc2*y*v*w)- 
int1d(Th,C7,optimize=optp)(cc2*y*The*w)+ 
int1d(Th,C8,optimize=optp)(cc3*y*v*w)- 
int1d(Th,C8,optimize=optp)(cc3*y*Tamb*w)- 
int2d(Th,optimize=optp)(qred*w*y)+ 
int2d(Th,optimize=optp)(omegab*v*w*y)- 
int2d(Th,optimize=optp)(omegab*Tblood*w*y)+ 
int1d(Th,C6,optimize=optp)(y*qev2*v*w)- 
int1d(Th,C6,optimize=optp)(y*qev2*The*w)+ 
int1d(Th,C7,optimize=optp)(y*qev2*v*w)- 
int1d(Th,C7,optimize=optp)(y*qev2*The*w)+ 
int1d(Th,C8,optimize=optp)(y*qev3*v*w)- 
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int1d(Th,C8,optimize=optp)(y*qev3*Tamb*w)- 
int1d(Th,C6,optimize=optp)(y*qpla*w);// 
 
//dirichlet = value of the function at the boundarie +on(C4,v=37+273.15)+on(C5,v=37+273.15); 
//Neumann = imposer la valeur de la dérivée fonction à la frontière commande fait avect int1d sur la frontière; 
//ROBIN as previous + v dependance 
 
//OPENING OF PUNC.TXT file for writing 
string namepunc=expname+ " punc.txt"; 
{ofstream fff(namepunc);  
 
//TIME LOOP 
for(real t=0;t<=T;t+=dt){ 
    vold=v; 
    //Loop FOR NON-LINEAR RESOLUTION 
  for(int m=0;m<2;m++){ 
   
   //PLASMA-SURFACE INTERACTION 
   qplasm=qqq*(t<=420); 
   if (DBDinter==1) qplasm=qqq*(t%15<=5)*(t<=900);    
   qpla=qplasm/(rhoepi*Cepi)*actplasma; 
       
//TEMPERATURE OF HELIUM, and temperature of radiative environnment seen by the surface which interact with 
plasma 
   The=Tamb; 
   urad2=The;    
    
   //CONVECTION 
   hwithHe=(5.21 * (abs(v-The))^0.188); 
   hwithouthel=(5.21 * (abs(v-Tamb))^0.188); //NATURAL CONVECTION         
    
   alphahe=hwithHe/(rhoepi*Cepi); 
   alpha=hwithouthel/(rhoepi*Cepi); 
   cc2= alphahe*actcv; 
   cc3= alpha*actcv; 
      
   //RADIATION    
   //division by (rhoepi*Cepi) was include in the definition of rad 
      cr2= (actrad==1)*rad * (v+urad2)*(v^2+urad2^2);  
   cr3= (actrad==1)*rad * (v+Tamb)*(v^2+Tamb^2);    
    
  //BLOOD PERFUSION 
  rhoblood=1060;    //blood density 1000 kg/m3 //bioheat transfer liu p231 
  Cblood=3770;     // massic specific heat of blood 4200 J/kg/K 
  Tblood=35+273.15+anesthesia*2; //Blood temperature : 30 with anesthesia, 37 without 
   
  bloderm=0.00133;                                     //ml/s/ml 
  bloadipose=0.0005;                                  //ml/s/ml 
  blotumor=0.00133*(1-anesthesia)+0.01*anesthesia;    //ml/s/ml 
   
  if (actvesseldamage==0) 
  { 
//THE EFFECT OF TEMPERATURE AND DAMAGES ON BLOOD PERFUSION ARE DIASBLED 
omegaval=blotumor+(-blotumor)*(norme>=r1)*(norme<=a)*(x>=-z1) 
   +(-blotumor)*(norme>a)*(x>=-z1)*(x<=0) 
   +(bloderm-blotumor)*(norme>=r2)*(norme<r1)*(x>=-z2) 
   +(bloderm-blotumor)*(norme>r1)*(x>=-z2)*(x<=-z1) 
+(bloadipose-blotumor)*(norme>=r3)*(norme<r2)*(x>=-z3) 
   +(bloadipose-blotumor)*(norme>r2)*(x>=-z3)*(x<=-z2); 
omegab=omegaval*rhoblood*Cblood/(rhotiss*Ctiss)*actblood; // unis s^-1 
} 
else{ 
//THE EFFECT OF TEMPERATURE AND DAMAGES ON BLOOD PERFUSION ARE ACTIVATED 
// (The damage function is not the same for blood vessels, value from the paper of D. J. Schutt and D. 
Haemmerich: RF ablation perfusion model 2008) 
Aperfusion=1.98*1e106; 
Bperfusion=6.67*1e5/8.314; 
damageperfusion=damageperfusion+Aperfusion*exp(-Bperfusion/v)*dt; 
DS=1-exp(-damageperfusion); 
relativeperf=(30*DS+1)*(DS<=0.02)+(-13*DS+1.86)*(DS>0.02)*(DS<=0.08)+(-0.79*DS+0.884)*(DS>0.08)*(DS<=0.97)+(-
3.87*DS+3.87)*(DS>0.97)*(DS<=1)+0; //VOir papier pour explication 
 
//CALCULATION OF BLOOD PERFUSION 
 
omegaval=blotumor+(-blotumor)*(norme>=r1)*(norme<=a)*(x>=-z1) 
   +(-blotumor)*(norme>a)*(x>=-z1)*(x<=0) 
   +(bloderm-blotumor)*(norme>=r2)*(norme<r1)*(x>=-z2) 
   +(bloderm-blotumor)*(norme>r1)*(x>=-z2)*(x<=-z1) 
   +(bloadipose-blotumor)*(norme>=r3)*(norme<r2)*(x>=-z3) 
   +(bloadipose-blotumor)*(norme>r2)*(x>=-z3)*(x<=-z2); 
 
omegab=omegaval*rhoblood*Cblood/(rhotiss*Ctiss)*actblood*relativeperf; // unis s^-1 
 
} 
//RODENTS DO NOT SWEAT !!!!!!!!! 
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//EVAPORATION actev=0 or 1, to take evaporation into account or not 
//HUMAN FORMULATION 
   qev2= (actev==1)*(v>Tamb)*(v>273.15)*abs(v-Tamb)/(v-Tamb)*9.66*1e-8*(abs(v-
Tamb))^(0.25-1)*(10^(0.0265*v)-RH*10^(0.0265*Tamb))/(rhoepi*Cepi); 
   qev3= (actev==1)*(v>The)*(v>273.15)*abs(v-The)/(v-The)*9.66*1e-8*(abs(v-The))^(0.25-
1)*(10^(0.0265*v)-RH*10^(0.0265*The))/(rhoepi*Cepi); 
      thermaxi; //RESOLUTION WITH UMFPACK SOLVER 
    }    //END OF NON LINEAR LOOP 
    
  vaff=v-273.15; //Conversion in °C for vizualization 
  string afff="t="+real(t)+" s T  Tc = "+vaff(0,0); 
   
  Vh damageaff; 
  damageadd=A*exp(-B/v)*dt; 
  damage=damage+damageadd; 
  //plot(DS,value=true,fill=true,cmm=afff); 
  plot(vaff,value=true,fill=true,cmm=afff); 
  //plot(relativeperf,value=true,fill=true,cmm=afff); 
  //plot(damageadd,value=true,fill=true,cmm=afff+" DAMAGE ADD"); 
  //plot(damage,value=true,fill=true,cmm=afff+" SUM"); 
 
//SAVING OF TEMPERATURE AND DAMAGE FIELDS (on each vertex) 
string name=expname+ " t="+real(t/dt)+"data.txt"; 
{ofstream ff(name); //Th(i) verteri, Th(k) Triangle k 
for (int i=0;i<Th.nv;i++) 
ff<<vaff(Th(i).x,Th(i).y)<<" "<<damage(Th(i).x,Th(i).y)<<endl; 
} 
 
//SAVING OF TEMPERATURE AND DAMAGE OF SEVERAL POINTS OF INTEREST (Defined by coordinate in vector puncx and 
puncy. 
if (actpunc==1){ 
fff<<t<<" "; 
for (int co1=0; co1<8;co1++){ 
fff<<vaff(puncx(co1),puncy(co1))<<" "<<damage(puncx(co1),puncy(co1))<<" "; 
} 
fff<<endl; 
} 
 
} 
} 
plot(vaff,value=true,wait=1,fill=true); 
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Appendix J Matlab instructions for displaying 
damage and heat map 
clear all;    % matlab file is in the same folder than .edp file 
exp='DBDinter9700dt1dam10'; % name of experiment 
T=900;     %Total time 
dt=0.01;     %Temporal resolution 
 
%MIN ET MAX OF TEMPERATURE AND DAMAGE COLORBARS 
mint=30; 
maxt=65; 
 
mindam=0; 
maxdam=1; 
%SIZE (in mm) OF Z AND R AXIS 
xmin=4; 
xmax=5; 
ymin=0; 
ymax=1; 
%NUMBER OF TIME-STEP BETWEEn EACH PICTURE 
past=2*dt; 
nbframe=20; %framerate of movie 
 
%READING MESH FILE (see FREEFEM++ doc, for the structure of mesh file) 
fiche=fopen(strcat(exp,' Th.am_fmt'),'r'); 
formatSpec = '%f %f %f %f'; 
sizeA = [2 1]; 
a = fscanf(fiche,formatSpec,sizeA); 
a=a.'; 
nbv=a(1,1); 
nbt=a(1,2); 
sizeB = [3 nbt]; 
nu=fscanf(fiche,formatSpec,sizeB); 
nu=nu.'; 
sizeC= [2 nbv]; 
c=fscanf(fiche,formatSpec,sizeC); 
c=c.'; 
reft=fscanf(fiche,formatSpec,nbt); 
reft=reft.'; 
 
refs=fscanf(fiche,formatSpec,nbv); 
refs=refs.'; 
fclose(fiche); 
 
%CONVERSION IN MM OF THE COORDINATE OF EACH VERTEX 
for i=1:nbv 
x(i)=c(i,1)*1e3;  
y(i)=c(i,2)*1e3; 
end 
 
verts = c*1000; %verts =contain the coordinate of each vertex in mm 
faces = nu;  %face =contain the index (in table c) of the three vertex defining one 
triangle 
 
%LOADING OF FIRST FILE 
dataf=fopen(strcat(exp,' t=',num2str(0/dt),'data.txt'),'r') ; 
data=fscanf(dataf,'%f %f',[2,nbv]); 
data=data.'; %transposition 
fclose(dataf); 
cdat=data(:,1); 
cdat2=data(:,2); 
 
%OPENING OF TEMPORARY MOVIE FILE 
F= struct('cdata',[],'colormap',[]); 
v = VideoWriter(strcat(exp,' ','Temperature-Damage','.avi')); 
v.FrameRate = nbframe; 
open(v) 
 
%MAXIMIZATION OF FIG WINDOW 
fig=figure('Name','Temperature Damage','NumberTitle','off'); 
set(fig,'Units','normalized') 
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set(fig,'Position',[0,0.0444,1.0000,0.8759]) 
 
%TIME LOOP 
for t = 0:past:T 
%SUBPLOT TEMPERATURE 
pos = [0.05 0.15 0.5 0.77];  %position of subplot 
left=subplot(1,2,1,'Position',pos);  
 
%PATCHING AND AXIS CHARACTERISTIC OF LEFT SUBPLOT 
p=patch('Faces',faces,'Vertices',verts); 
set(p,'FaceColor','interp','FaceVertexCData',cdat,'EdgeColor','interp','LineWidth',0.001,'CDataMap
ping','scaled') 
axis equal 
ax = gca(); 
ax.FontSize = 25; 
ax.TickDir = 'out'; 
ax.Box = 'on'; 
xlabel('Z axis (mm)') 
ylabel('r axis (mm)') 
xlim([xmin xmax]) 
ylim([ymin ymax]) 
 
set(gca,'CLim',[mint maxt]) 
cc = colorbar; 
cc.Label.String = 'Temperature (°C)'; 
cc.Location='northoutside'; 
colormap(jet(5000));   %Number of colors defining colorbar 
 
 
%SUBPLOT DAMAGES 
pos2 = [0.45 0.15 0.5 0.77];  %position of subplot 
right=subplot(1,2,2,'Position',pos2); %handle of subplot 
xlabel('Z axis (mm)') 
%ylabel('r axis (mm)') 
xlim([xmin xmax]) 
ylim([ymin ymax]) 
 
p2=patch('Faces',faces,'Vertices',verts); 
set(gca,'CLim',[mindam maxdam]) 
ccc = colorbar; 
ccc.Label.String = 'Damage \Omega'; 
colormap(jet(5000));   %Number of colors defining colorbar 
ccc.Location='northoutside'; 
%PATCHING AND AXIS CHARACTERISTIC OF RIGHT SUBPLOT 
set(p2,'FaceColor','interp','FaceVertexCData',cdat,'EdgeColor','interp','LineWidth',0.001,'CDataMa
pping','scaled') 
axis equal 
 
ax2 = gca(); 
ax2.FontSize = 25; 
ax2.TickDir = 'out'; 
ax2.Box = 'on'; 
 
 
t/T*100 %DISPLAY PERCENTAGE BEFORE END 
 
%OPENING AND READING OF DATA FILE 
dataf=fopen(strcat(exp,' t=',num2str(t/dt),'data.txt'),'r') ; 
data=fscanf(dataf,'%f %f',[2,nbv]); %FIRST LINE=TEMPERATURE, SECOND LINE=DAMAGE 
data=data.'; 
fclose(dataf); 
cdat=data(:,1); 
cdat2=data(:,2); 
 
%REPATCHING OF OBJECT p (map of temperature) 
set(p,'FaceColor','interp','FaceVertexCData',cdat,'EdgeColor','interp','LineWidth',0.001,'CDataMap
ping','scaled'); 
xlim([xmin xmax]) 
ylim([ymin ymax]) 
dim = [.30 .4 .3 .4]; 
stri = strcat('t=',num2str(t), ' s'); 
% tex1 = annotation('textbox',dim,'String',stri,'FitBoxToText','on','LineStyle','none'); 
% tex1.FontSize = 25; 
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%REPATCHING OF OBJECT p2 (map of damage) 
set(p2,'FaceColor','interp','FaceVertexCData',cdat2,'EdgeColor','interp','LineWidth',0.001,'CDataM
apping','scaled'); 
xlim([xmin xmax]) 
ylim([ymin ymax]) 
 
%DISPLAY TEMPERATURE MIN and MAX and Time on fig 
dim2 = [.45 .705 .3 .3]; 
tex2 = annotation('textbox',dim2,'String',stri,'FitBoxToText','on','LineStyle','none'); 
tex2.FontSize =25; 
%pause(0.5) 
 
dim3 = [.05 0 .3 .1]; 
tex3 = annotation('textbox',dim3,'String',strcat('Tmin=',num2str(min(cdat)),' 
°C'),'FitBoxToText','on','LineStyle','none'); 
tex3.FontSize =20; 
dim4 = [.4 0 .3 .1]; 
tex4 = annotation('textbox',dim4,'String',strcat('Tmax=',num2str(max(cdat)),' 
°C'),'FitBoxToText','on','LineStyle','none'); 
tex4.FontSize =18; 
    drawnow(); 
    writeVideo(v,getframe(fig)); 
%     tex1.delete 
if (t<T) 
    tex2.delete 
    tex3.delete 
    tex4.delete 
end 
end 
close(v); %SAVING MOVIE 
%IN ORDER TO SAVE ONLY ONE FIGURE, USE .bmp to keep axis definition at time T 
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Appendix K VBS code for the calculation of 
power in real time with an oscilloscope 
This code works on Lecroy oscilloscopes equipped with the Xdev option which enable to 
customize the operations performed on waveforms. In order to minimize the numerical 
error, the signals must be represented on the whole screen (in order to maximize the 
step in voltage). 
Function Update() 'VBS code  
 coeffaffichage=1e7 'This coefficient enables the display and the calculation of the 
integral of power 
 
 capa=100*1e-9'value of the capacitance Cm = 100 nF 
 Rsonde=10e6 'probe resistance = equivalent resistance of measurement system 
 fs=10*1e6 'frequency of sampling 
 ts=1.0/fs 'time between two samples 
  
 startData = 0 
 endData = InResult1.Samples 
 scaledData1 = InResult1.DataArray(True) 
 scaledData2= InResult2.DataArray(True)  
  
 Redim Tension(endData) 'High voltage,  
 Redim ucm(endData)  'Voltage cross the capacitance 
 Redim Courant(endData) 'current 
 
 For i = 0 To endData-1-1 
 Tension(i)=scaledData1(i) 
 ucm(i)=scaledData2(i) 
 ucm(i+1)=scaledData2(i+1) 
 Courant(i)=capa*(ucm(i+1)-ucm(i))/ts+ucm(i)/Rsonde 'current crossing the DBD 
 Next 
 
'This code provides the sliding average on 2 *taillefen-1 samples 
 'LastPoint = endData - 1 ' 
 'ReDim lisse1(endData)  
 'ReDim lisse2(endData) 
 'For i = 0+taillefen To LastPoint-taillefen 
 ' somme1=0 
 ' somme2=0 
 ' For j=i-taillefen TO i+taillefen 
 ' somme1 = somme1+scaledData1(j) 
 ' somme2 = somme2+scaledData2(j) 
 ' Next 
 ' lisse1(i)=somme1/(2*taillefen+1) 
 ' lisse2(i)=somme2/(2*taillefen+1)*capa 
 'Next 
 'OutResult.DataArray(True) = lisse1 'ou 2 affichage du signal lissé 
 
 OutResult.Samples=endData  ' Trace length + 1  
 
ReDim somme(endData)  'contains the primitiv function of power as a function of t 
 
somme(0)=0 
for i=1 TO endData-1 'integral calculation 
somme(i)=somme(i-1)+coeffaffichage*((Tension(i-1)*Courant(i-1)-ucm(i-1)*ucm(i-1)/Rsonde)*Ts) 
Next 
OutResult.DataArray(True) = somme 
 
End Function   
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Appendix L NBD-CL, a probe for superoxide 
radical? 
During this thesis, we have also tried to measure the production of superoxide radical of 
the single-channel plasma jet in the liquid phase. A fluorescent probe has been 
particularly tested: 4-Chloro-7-nitrobenzo-2-oxa-1,3 diazole  (abbreviated NBD-Cl) 
purchased from Sigma-aldrich (reference : 25455-25G). The chemical structure of NBD-
CL is visible in Fig 297. 
 
Fig 297 NBD-Cl = 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole, CAS Number 10199-89-0  
The reaction product of this probe with ܱଶି absorbs at  ߣ = 470 ݊݉ (maximum of 
absorbance). The solution is clear yellow. The maximum fluorescence is around 560 nm 
(see Fig 298 & Fig 299). These values are consistent with those reported in the literature 
[349], [350]. 
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Fig 298 absorbance of a solution of NBD-CL put in contact with KO2(s). Blank = before the addition 
of few mg of KO2(s). 
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Fig 299 Fluorescence signal of a solution of NBD-CL exposed to KO2 (s), emission spectrum 
(λex=460 nm, λem= adjustable, Δλex=10, Δλem=5nm). Blank = before the addition of few mg of 
KO2(s). 
This probe is mentioned in the review of Bartosz, which describe the functioning of 
several RONS-probes [350]. According to the work of Olojo et al. (and own experiments), 
the fluorescence of the product is enhanced by the addition of an organic solvent prior to 
measurement [349]. We use acetonitrile in a proportion of 2/3. 
NBD-CL has also been used for years to detect amino, imino acids and amines [351]. 
Baines et al. precise that NBD-CL is an electrophilic reagent [352]. 
The crucial point with this probe is that Ikhlaq et al. report that H2O2 and HO° doesn’t 
interfere with NBD-Cl [353]. This characteristic makes it very attractive for the study of 
the plasma-liquid interaction (see Fig 300). Ikhlaq et al. prepare a mixture of H2O2 and 
NBD-CL at a concentration of 294 µM and 50 µM respectively to prove that. No change 
in fluorescence was observed after 1 hour of reaction. The absence of interference due 
to HO° was investigated using tertiary butyl Alcohol as HO° scavenger. The absence of 
interferences caused by H2O2 was also evoked by Olojo et al.: 
 “Additional experiments (data not shown) confirmed that the presence of biological species, such as H2O2, 
NADH, NADPH, and NAD+, does not interfere with NBD-Cl reactions and especially its ability to quantify 
superoxide ion in solution.” [349]. 
 
Fig 300 Absorbance and fluorescence of a solution made with 500 µL of PBS1X + 5 µL of NBD-Cl at 
450 µM. After treatment: addition of 1000 µL of PBS1X and then absorbance measurement (ࣅ =
૝ૠ૙ ࢔࢓). Subsequently, 100 µL of acetonitrile are added, enough to enhanced  the fluorescence 
(ࣅࢋ࢞ = ૝ૠ૙ ࢔࢓,  ࣅࢋ࢓ = ૞૟૙ ࢔࢓, ઢࣅ(ࢋ࢞ & ࢋ࢓) = ૚૙ ࢔࢓). single-channel jet: helium flow=1000 sscm, 
peak to peak voltage = 28.7 kV, height ~ 5.5 mm. Power ~ 490 mW. Mean value of duplicate 
experiment. 
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However, my own tests showed the existence of a reaction between H2O2 and NBD-Cl 
leading to the production of a fluorescent product. This test was done in the range of 
concentration encountered during plasma-liquid interaction ([ܪଶܱଶ] = 2 ݉ܯ, [NBD-
Cl]=450 µM). It is perhaps this difference in terms of concentration that explains this 
discrepancy between our observation and those of Olojo et al. and Ikhlaq et al. 
The use of catalase enzyme do not enable to prevent this interference by the scavenging 
of H2O2.: more precisely we did not find the range of catalase concentration which 
scavenges efficiently H2O2 without causing a strong modification of the absorbance or 
fluorescence spectra. 
 
 
 
  
Appendix M Design of refrigerated multi-channel jet 
 Appendix M- 381 
Appendix M Design of refrigerated multi-
channel jet 
The following lines describe the design of the multi-channel plasma jet in the software 
OpenScad. 
$fn=80; 
ddie=1.4; 
difference(){ 
    union(){ 
 //corps        
        translate([-13,-10,0]) cube(size=[22,100,4.4+3+2]); 
        translate([-23,7,0]) cube(size=[11,43,4.4+3+2+1]); 
        translate([-29,16,0]) cube(size=[14,28,4.4+3+2+1]); 
//fixation support 
   hull(){ 
    #translate([-13+10,59.5-10,0]) cylinder(d=25,h=4); 
    #translate([-47,59.5+40,0]) cylinder(d=6.5+9,h=4); 
    #translate([-47+25,59.5+40,0]) cylinder(d=6.5+9,h=4); 
    #translate([-47+2*25,59.5+40,0]) cylinder(d=6.5+9,h=4); 
   }   
//acces HT 
        translate([-70,65,0]) cube(size=[60+0.1,16.5,10.5+6]); 
// acces gaz 
          translate([-54.5,22.5,0]) cube(size=[28,14,13]);     
  //embout  
   //accès refoidissement azote 
   translate([-13+22,8,0]) cube(size=[22,44,5+2.8]); 
   translate([25,8,0]) cube(size=[6,44,6.5+4]); 
   difference(){ 
       translate([-13+22,8,0]) cube(size=[22,44,5+2.8+45]); 
       translate([-13+3+22,8+3,5+2.8]) cube(size=[22-6,44-6,45.1]); 
   }  
   difference(){ 
       hull(){ 
       translate([-13+22,8,5+2.8+45]) cube(size=[22,44,0.1]); 
        translate([-13+3+22-15-3,8+3-15-3,5+2.8+45+20]) cube(size=[22+15,44-6+30+6,0.05]); 
       } 
  #hull(){ 
  translate([-13+3+22,8+3,5+2.8+45]) cube(size=[22-6,44-6,0.1]); 
  translate([-13+3+22-15,8+3-15,5+2.8+45+20]) cube(size=[22-6+15,44-6+30,0.1]); 
     } 
   } 
   //embout 
   difference(){ 
   hull(){ 
   translate([30,12,0]) cube([2,34,10]); 
   translate([30+20,12+9.75-2,0]) cube([2,15+4,10]); 
   } 
       //embout 
    #translate([70-7,29,-1]) cylinder(d=30,h=20); 
   }     
    } 
    //acces gaz 
  #translate([-60+5,59.5/2,7.2/2+3]) rotate([0,90,0]) cylinder(d=7.2,h=25); 
    //liaison acces gaz, production de plasma     
  #translate([-8+1-10,3+8+(1.5+1.5)*(3-1)+1,3.5]) rotate([0,0,180-40]) 
cube(size=[19,1.5*1.5,1.5*4/1.5]); 
  #translate([-8+1-10,4+8+(1.5+1.5)*(7-1)+1,3.5]) rotate([0,0,180]) cube(size=[17,1.5*1.5,4]);   
  #translate([-8+1-10-2,5+8+(1.5+1.5)*(10.5-1)+1,3.5]) rotate([0,0,180+40]) 
cube(size=[17,1.5*1.5,4]);    
  #translate([-8+3-13-1,3+8+(1.5+1.5)*(1-1)+1,3.5])  cube(size=[2,34.5,4]); 
        
//    #translate([62,59.5/2+12,4.5]) rotate([90,0,0]) cylinder(d=6,h=24);    
    //acces embout     
    //liaison extreme-gauche 
    #translate([9+20,12,3.5]) cube(size=[1.5,1.5*5,3]); 
        //liaison gauche 
    #translate([9+20,21,3.5]) cube(size=[1.5,1.5*3,3]); 
        //liaison centre 
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    #translate([9+20,27,3.5]) cube(size=[1.5,1.5*3,3]); 
        //liaison droit 
    #translate([9+20,33,3.5]) cube(size=[1.5,1.5*3,3]); 
    //extr droite 
    #translate([9+20,39,3.5]) cube(size=[1.5,1.5*5,3]);    
    //centre 
    #translate([9+20,2+4+7+5+5.5*2,3.5]) rotate([0,6,0]) cube(size=[30,1.5,1.5]); 
    #translate([9+20,2+4+7+5+5.5*2,3.5]) rotate([0,-6,0]) cube(size=[30,1.5,1.5]); 
    //extreme gauche 
    #translate([0,-5.5*2,0]){ 
    translate([9+20,15+5.5*2,3.5]) rotate([0,6,18]) cube(size=[30,1.5,1.5]); 
    translate([9+20,15+5.5*2,3.5]) rotate([0,-6,18]) cube(size=[30,1.5,1.5]); 
    }     
        //extreme droite 
    #translate([0,5.5*2,0]){ 
    translate([9+20,20+5.5*2,3.5]) rotate([0,6,-18]) cube(size=[30,1.5,1.5]); 
    translate([9+20,20+5.5*2,3.5]) rotate([0,-6,-18]) cube(size=[30,1.5,1.5]); 
    }  
            //droite 
    #translate([0,5.5*1,0]){ 
    translate([9+20,2+4+7+5+5.5*2,3.5]) rotate([0,6,-9]) cube(size=[30,1.5,1.5]); 
    translate([9+20,2+4+7+5+5.5*2,3.5]) rotate([0,-6,-9]) cube(size=[30,1.5,1.5]); 
    } 
         //gauche 
    #translate([0,-5.5*1,0]){ 
    translate([9+20,17+5.5*2,3.5]) rotate([0,6,9]) cube(size=[30,1.5,1.5]); 
    translate([9+20,17+5.5*2,3.5]) rotate([0,-6,9]) cube(size=[30,1.5,1.5]); 
    }         
    //fixation support         
    #translate([-47,59.5+40-1]) cylinder(d=6.5,h=6); 
    #translate([-47+25,59.5+40,-1]) cylinder(d=6.5,h=6); 
    #translate([-47+2*25,59.5+40,-1]) cylinder(d=6.5,h=6);     
    //pente douce 
    hull(){ 
        translate([-10+2.5,4,3.5+1.5-0.1]) cube(size=[10,1.5*5+4*4+2*10+8,0.001]); 
        translate([-10-2,4,3.5+1.5-0.1+ddie+3.1]) cube(size=[10+3+6,1.5*5+4*4+2*10+8,0.001]); 
    }     
    //hypothèse conducteur de largeur 4mm, 3 mm de part et d'autre +2.5 de part et d'autre pour la 
pente douce 
    //rainures gaz 
    for(k=[1:1:12]){ //ces rainures ont une longeur de 36mm !!! +2 mm pour la HT+2 mm pour la 
masse : écart de 32 mm ? est ce trop peu ? 
        #translate([-8-10,4+8+(1.5+1.5)*(k-1),3.5]) cube(size=[38+10,1.5,1.5]);   
    }   
    //acces HT 
    #translate([-16,65+16.5/2,16.5/2]) rotate([0,-90,0]) cylinder(d=10.5,h=56);       
    translate([-22,65+16.5/2+-5,16.5/2+2]) cube(size=[20,10,10]); 
    #translate([-22+13,16.5/2-15,5+1.4]) cube(size=[13,90,10]); 
    #translate([-22,65+16.5/2-5,5]) cube(size=[10,10,10]); 
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